Page last updated: 2024-08-22

angiotensin ii and Cardiomegaly

angiotensin ii has been researched along with Cardiomegaly in 1148 studies

Research

Studies (1,148)

TimeframeStudies, this research(%)All Research%
pre-199040 (3.48)18.7374
1990's178 (15.51)18.2507
2000's304 (26.48)29.6817
2010's438 (38.15)24.3611
2020's188 (16.38)2.80

Authors

AuthorsStudies
Guo, G; Li, K; Pan, J; Song, Z; Wang, D; Xu, C; Xu, Z; Zhong, K1
Liu, A; Shang, Z; Zhang, Y1
Cao, Y; Lai, S; Liu, C; Tao, E; Wan, L; Wang, F; Wang, Q; Wang, W; Zou, H1
Bunbupha, S; Chaihongsa, N; Iampanichakul, M; Maneesai, P; Meephat, S; Pakdeechote, P; Prasatthong, P; Wunpathe, C1
Dong, S; Li, Y; Liu, Y; Shen, T; Wang, X; Xu, X; Zhou, L1
Chang, YM; Chen, RJ; Chiu, PL; Day, CH; Huang, CY; Huang, HY; Kuo, WW; Liang-Yo, Y; Lin, HJ; Mahendran, R; Padma, VV1
Guo, X; Kong, X; Miao, J; Sun, W; Tu, J; Weng, L; Wu, T; Wu, X; Xu, T; Yang, C; Zhang, D; Zhang, J; Zhao, K; Zhou, B1
Guo, S; Han, X; Huang, F; Jiao, M; Ma, W; Mi, S; Niu, Q; Zhan, H; Zhang, K; Zhao, Z1
Chen, L; Geng, Q; Jiang, W; Li, N; Wang, B; Wang, W; Xiong, R1
Chen, T; Fan, X; He, S; Huang, CL; Jiang, F; Jiang, Q; Lei, M; Li, T; Ou, X; Tan, X; Yang, B; Zeng, X1
Ba, B; Cao, G; Guo, Y; Mayila, A; Xing, S; Xu, J1
He, Y; Li, X; Li, Y; Shi, Y; Yang, J1
Cao, JW; Gao, J; Hu, LL; Huang, ZR; Ji, Y; Song, TY; Wang, ZY; Xie, LP; Zhao, S1
Carletti, R; Castoldi, G; di Gioia, CRT; Ippolito, S; Pelucchi, S; Stella, A; Zatti, G; Zerbini, G1
Dai, H; Jia, G; Li, W; Liang, C1
Al-Hasani, J; Friede, PAP; Ghosh, S; Hecker, M; Nahar, T; Reil, JC; Sens-Albert, C; Trogisch, FA1
Ding, XL; Qian, HB; Xue, DJ; Yang, FM; Yuan, QQ; Zhu, YZ1
Diao, H; Guo, J; Hu, Y; Leng, M; Li, X; Li, Y; Rong, X; Shao, X; Sun, M; Wang, D; Wang, L; Wang, R; Yan, M; Zhang, Y1
Hu, G; Ji, M; Xu, Z; Zhang, M; Zuo, Z1
Bai, J; Li, HH; Lin, QY; Yin, L; Yu, WJ; Zhang, YL1
Ning, Z; Song, X; Song, Z; Wu, J; Zhong, X1
Chen, X; Gu, Y; Li, Y; Liu, Y; Zhang, S1
Lei, X; Lin, X; Lu, Q; Ma, A; Zhang, L; Zhang, W1
Bai, J; Chi, J; Gao, Y; Liu, J; Liu, S; Lv, Y; Yang, H; Yang, W; Yang, X; Zhan, C; Zhong, L1
Bai, Y; Deng, X; Li, D; Shen, M1
Hua, D; Li, P; Li, Y; Mao, Y; Wu, X; Yong, Y; Zhao, K; Zhou, Z1
Liu, X; Tu, Y; Warusawitharana, HK; Xia, C; Yang, Y; Zhou, H1
Chen, PP; Deng, J; Gao, Y; Gong, QH; Li, YY; Lin, HC; Luo, M; Shi, WL; Wen, ZQ; Xu, RX; Xu, SF1
Ge, J; Li, R; Li, Y; Lin, L; Shi, Y1
Guo, S; Qian, W; Shen, L; Yang, Y; Yao, Y; Zhou, G; Zhou, J1
Kulhari, U; Kumar, A; Kundu, S; Mohapatra, P; Mugale, MN; Murty, US; Ram, C; Sahu, BD; Syed, AM1
Du, J; Kong, L; Li, Y; Yang, C; Yao, R; Zhao, G1
Bai, Y; Chen, C; Gao, Z; Jiang, X; Meng, Y; Zhang, X; Zheng, C1
Cheng, Z; Feng, J; Gao, Y; Hou, L; Li, C; Wang, J; Zhou, J1
Ji, H; Peng, W; Qu, J; Yang, L1
Dong, R; Du, T; Ferrucci, L; Hu, X; Jin, Y; Liu, H; Pang, H; Sun, L; Tanaka, T; Tang, X; Tian, R; Tian, Z; Wang, H; Wang, L; Xiao, S; Xiao, Y; Yang, X; Ye, Y; Zhang, S; Zhang, Y1
Chattipakorn, N; Chen, R; Chen, Y; Dai, C; Huang, W; Liang, G; Luo, W; Shen, S; Wang, J; Wang, Z1
Alharbi, HO; Barrington, C; Cameron, AJM; Chotani, S; Clerk, A; Cook, AC; Cooper, STE; Cull, JJ; Herbert, E; Marshall, JJT; Meijles, DN; Mohun, T; Parker, PJ; Priestnall, SL; Prin, F; Rackham, OJL; Siow, B; Snoeks, T; Stuckey, DJ; Suáarez-Bonnet, A; Vanyai, H; Zaw Thin, M1
Chen, L; Liang, Q; Liu, M; Qian, L; Xu, H; Yan, J; Yang, G1
Chen, R; Das, S; Jin, B; Li, G; Li, J; Sha, Z; Wang, S; Wang, Z; Xiao, J; Xu, J; Xu, W; Yan, Y; Yang, L; Yang, T; Yao, J; Yuan, W; Zhu, X1
Cao, L; Cong, H; Du, X; Geng, J; Hu, Y; Wang, J; Zhang, R; Zhang, Y; Zhao, X; Zheng, L1
Chen, X; Hao, C; Ji, Z; Ma, G; Qu, Y; Su, Y; Yang, M; Yao, Y; Zhang, R; Zuo, W1
Gao, Y; Guo, X; Hu, L; Li, Y; Liu, Y; Ma, S; Tang, J; Wang, Z; Wei, J; Zhang, Q; Zhang, X; Zhang, Y1
Salama, G1
Chang, WT; Chen, CL; Chen, ZC; Chu, JS; Huang, TL; Lin, YW; Liu, PY; Shih, JY1
Betazza, MC; Cianciulli, TF; Fontana Estevez, FS; Gironacci, M; González, GE; Goren, N; Medina, V; Miksztowicz, V; Morales, C; Penas, F; Selser, C; Seropian, IM; Silva, MG; Touceda, V; Villaverde, A1
Dong, L; Ren, L; Yu, L1
Ji, M; Li, Y; Lin, L; Liu, Y; Xu, C; Zuo, Z1
Li, G; Liang, G; Liang, S; Luo, W; Sun, J; Wang, M; Yu, T; Zou, C1
Ding, YY; Hong, JH; Li, JM; Liu, Y; Pan, XC; Zhang, HG1
Yuan, G; Yuan, J1
Dai, S; Fan, X; Han, B; Han, J; Hong, X; Huang, W; Lin, S; Lin, W; Shi, X; Su, L; Xu, J; Ye, B; Zhong, L; Zhong, X1
Elyagon, S; Etzion, S; Etzion, Y; Kapiloff, MS; Klapper-Goldstein, H; Levitas, A; Parvari, R; Segal, L; Shahar, M1
Chen, L; Li, Y; Liu, X; Wang, Y; Xing, Y; Zhang, G1
Ding, Y; Gu, Y; Li, Y; Shang, Z; Zhang, X1
Du, Y; Guan, C; Huang, Z; Li, P; Wang, K; Zhang, Y; Zhou, M1
Chen, RL; Dang, X; Hong, YX; Hu, Y; Li, G; Li, GR; Li, YD; Mao, L; Song, F; Wang, Y; Wu, C; Zhou, XX1
Bottermann, K; Deenen, R; Fischer, JW; Gödecke, A; Grandoch, M; Harris, TE; Hemmers, A; Herebian, D; Kalfhues, L; Köhrer, K; Leitner, LM; Nederlof, R; Nemmer, J; Oenarto, V; Petzsch, P; Pfeffer, M; Raje, V; Reichert, AS; Stegbauer, J; Zabri, H1
Akiba, Y; Fukuda, K; Funahashi, A; Hashimoto, H; Katsuki, T; Kimura, M; Komuro, J; Kuoka, T; Kusumoto, D; Nakamura, T; Seki, T; Tokuoka, Y; Yamada, T; Yuasa, S1
Huang, C; Tang, Y; Wang, X; Zhao, H; Zhao, Q1
Bhullar, SK; Dhalla, NS1
Ahluwalia, A; Aziz, D; Hoa, N; Levin, ER; Moreira, D; Patel, KN; Singh, K1
Chen, J; Chen, S; Li, L; Li, T; Liao, Z; Ruan, H; Wang, X; Wei, S; Zuo, H1
Fan, H; Gao, X; Liu, D; Wang, Z; Xu, M; Zhang, L1
Cicalese, SM; Coffman, TM; Eguchi, S; Hashimoto, T; Okuno, K; Preston, K; Rizzo, V; Sparks, MA; Torimoto, K1
Fukamizu, A; Kim, JD; Kwon, C; Mori, H; Muroi, SI; Muromachi, N; Nakagawa, Y; Nakamura, K; Saito, H; Yamada, Y1
Dong, Z; Li, T; Lu, J; Sheng, S; Shi, Y; Yuan, M; Yue, L1
Li, Y; Wang, L; Wang, W; Yang, M1
Fujioka, R; Inamitsu, M; Kobayashi, S; Maruta, A; Nakamura, Y; Oda, T; Tominaga, N; Yamamoto, T; Yano, M1
Guo, X; Hong, J; Li, C; Li, Y; Mao, J; Tang, Y; Wang, Y; Xu, B; Yu, J; Zhou, M1
Chang, J; Dong, Z; Fan, C; Jiao, Y; Jin, Q; Li, X; Que, Y; Song, Q; Yang, C; Zhang, Y1
Cai, Y; Craig Wan, C; Du, R; Gao, S; Huang, C; Jiang, S; Shen, A; Xiao, Y; Yan, T; Yang, W; Zhang, X; Zheng, G1
Ates, E; Kang, MJ; Mahmud, J; Seo, HS; Thi My Ong, H1
Bai, X; Meng, Z; Su, Y; Wang, Y; Xu, L; Yang, X; Zhuo, C1
Han, X; Ji, Q; Li, C; Shang, H; Xie, X; Ye, H; Zhang, L1
Chen, H; Fu, D; Fu, Y; Li, L; Luo, J; Wen, T; Wu, Y; Xiong, W; Zhang, L1
Gao, L; Jia, M; Wang, Z; Wu, L; Xiao, L; Yao, R; Zhang, Y1
Alammari, AH; El-Kadi, AOS; Gerges, SH; Isse, FA1
Jia, B; Jia, S; Leng, M; Liu, R; Weng, L; Xiong, Y; Yan, S; Yang, F; Ye, J; Zhao, J; Zheng, M; Zhou, Y1
Hou, Y; Ji, W; Li, L; Li, T; Li, X; Li, Y; Liang, H; Lv, L; Shan, H; Yang, N; Yang, R; Yu, T; Zhang, J; Zhang, Y1
Bao, X; Feng, J; Jing, Z; Lu, Y; Wu, M; Zeng, Z1
Chen, L; Ge, F; Guo, J; He, Y; Hu, K; Jia, M; Jiang, L; Jin, J; Li, L; Li, Q; Lv, X; Ma, S; Meng, D; Osto, E; Wang, X; Wei, X; Wu, H; Wu, J; Yang, Z; Zhang, J; Zhi, X1
Chang, CC; Cheng, HC; Chou, WC; Chu, PM; Hsieh, PL; Huang, YT; Lee, SD1
Cai, L; Chen, S; Chen, X; Ding, Y; Li, J; Li, X; Li, Y; Liu, S; Lu, X; Wei, Y; Wu, X; Xu, J; Zhou, G1
Li, L; Lu, Z; Yang, J; Zheng, X; Zhou, H1
Carletti, R; Castoldi, G; Colzani, M; di Gioia, CRT; Ippolito, S; Pelucchi, S; Perseghin, G; Zatti, G; Zerbini, G1
Chen, S; Hou, J; Liu, Q; Luo, T; Wang, D; Wang, P; Wang, X; Yan, P; Yang, Y; Zhou, Y1
Hua, D; Kong, X; Li, P; Li, Y; Mao, Y; Sheng, Y; Sun, W; Wu, X; Yang, C; Zhao, K1
Abassi, Z; Aronson, D; Cohen-Segev, R; Hamoud, S; Kabala, A; Karram, T; Kinaneh, S; Nativ, O1
Chen, J; Ma, E; Peng, L; Ren, DN; Wo, D; Wu, C; Yan, H; Zhu, W1
Ding, L; Dong, H; Jia, W; Lin, S; Lin, Y; Ren, S; Wang, Y; Wei, C; Xiao, D; Yan, P; Zhang, Y; Zhao, Y1
Chen, S; Gao, Q; Hao, L; Lei, M; Li, J; Li, W; Liu, Y; Su, F; Wei, M; Zhang, C; Zhang, Y; Zheng, X1
Cho, S; Jeong, D; Lee, C1
Alcalai, R; Arad, M; Guetta, T; Hochhauser, E; Kornowski, R; Ofek, E; Petrover, Z; Seidman, CE; Seidman, J; Yadin, D1
Chen, X; Dai, J; Fang, R; Feng, M; Shen, C; Shu, T; Wang, J; Wang, S; Wu, N1
Bin, J; Chen, L; He, M; Li, M; Liao, W; Liao, Y; Lin, H; Lu, W; Ma, S; Shen, M; Xie, J; Xiu, J; Zheng, C; Zhu, Y1
Gu, A; Jin, J; Li, W; Liang, J; Liao, X; Liu, Q; Weng, Z; Xu, C; Zhou, S; Zhou, Y1
Bangwei, Z; Bin, S; Huan, P; Jiming, W; Jing, J; Jinlai, G; Shihui, L; Xiaochun, Z; Xiaoqin, Z; Xinyi, F; Yi, H; Zhouqi, L; Ziyue, L1
Liu, F; Liu, SL; Xu, ST; Ye, JT; Zhang, YX1
Geng, J; Lv, C; Meng, Y; Yuan, H; Zhou, L1
Aubdool, A; Baliga, RS; Bedi, KC; D'Amico, G; Dukinfield, M; Hobbs, A; Hodivala-Dilke, K; Maiques, O; Maniati, E; Margulies, KB; Reynolds, LE; Sanz-Moreno, V; Wang, J1
Chang, RL; Chen, RJ; Day, CH; Ho, TJ; Huang, CY; Kuo, WW; Lai, CH; Padma, VV; Pai, PY; Pandey, S1
Agbo, E; Li, MX; Massaro, J; Saahene, RO; Tian, GZ; Wang, YQ1
Boylston, J; Casin, KM; Fillmore, N; Kohr, MJ; Liu, C; Ma, H; Murphy, E; Noguchi, A; Sinha, P; Sun, J; Wang, N; Zhou, G1
Ge, LJ; Peng, XD; Sun, JC; Tan, X; Wang, WZ; Yang, RH1
Ruan, Z; Shen, Y; Song, G; Wang, R; Zhu, L1
Boini, KM; Chen, Y; Deng, M; Lu, A; Tan, Z; Wang, L; Wu, C; Yang, T; Zhang, L; Zhu, Q1
Dou, L; Guo, J; Huang, X; Li, J; Man, Y; Shen, T; Tang, W; Wang, Q; Wang, S; Yan, M; Yu, X; Zhu, K1
Chiasson, V; Guleria, RS; Gupta, S; Takano, APC1
Huang, H; Liu, YM; Lv, YG; Wu, RD; Xu, JQ; Zhu, W1
Gugerell, A; Gyöngyösi, M; Lukovic, D; Mester-Tonczar, J; Podesser, B; Spannbauer, A; Traxler, D; Winkler, J; Zlabinger, K1
Bian, R; Dai, YJ; Gong, JX1
Che, Y; Jin, YG; Meng, YY; Shen, D; Wang, SS; Wang, ZP; Wu, QQ; Yuan, Y; Zhou, H1
Bai, F; Bose, HS; James, EA; Sturdivant, K; Wang, NP; Zhang, WW; Zhao, ZQ; Zheng, RH1
Tao, L; Yang, X; Zhang, S; Zhu, J1
Han, L; Jin, L; Piao, J; Zhou, Y1
Chen, MJ; Fan, G; Wei, J1
Feng, J; Jin, X; Li, C; Yang, M; Zhang, J; Zhou, G1
Ahmed, MS; Attramadal, H; Aukrust, P; Holt, MF; Lien, E; Louwe, MC; Mollnes, TE; Nilsson, PH; Schjalm, C; Shahini, N; Yndestad, A; Øgaard, JDS1
Li, Q; Wang, F; Wei, X; Zhang, J; Zhang, W1
Alonso, J; Ballester-Servera, C; Cañes, L; Galán, M; Herraiz-Martínez, A; Hove-Madsen, L; Martí-Pàmies, I; Martínez-González, J; Muniesa, P; Nistal, JF; Osada, J; Rodríguez, C1
Guo, D; Liu, H; Zhao, Z1
Angermann, JE; Bender, A; Burnett, L; Evans, LW; Ferguson, BS; Godoy, L; Shen, Y; Staten, D; Zhou, T1
Baruscotti, M; Guo, R; Liu, H; Liu, N; Wang, Y; Zhang, H; Zhang, J; Zhao, L1
Akhondzadeh, F; Astani, A; Najjari, R; Ranjbar, AM; Rezvani, ME; Safari, F; Samadi, M; Zare, F1
Aono, T; Arimoto, T; Goto, J; Kato, S; Kutsuzawa, D; Narumi, T; Nishiyama, S; Otaki, Y; Shishido, T; Sugai, T; Takahashi, H; Takahashi, T; Tamura, H; Toshima, T; Wanezaki, M; Watanabe, K; Watanabe, M; Watanabe, T1
Jiang, F; Sun, H; Wang, H; Xu, L; Zhang, D1
Gotoh, T; Hoshizaki, M; Imai, Y; Inagaki, T; Koyota, S; Kuba, K; Minato, T; Motoyama, S; Nakahara, K; Nakaoka, Y; Natsui, M; Nirasawa, S; Ozawa, R; Penninger, JM; Sato, T; Takahashi, S; Watanabe, H; Yamaguchi, T; Yokota, S; Yoshihashi, T; Yoshiya, T; Yoshizawa-Kumagaye, K1
Chen, W; Wang, Y; Zhang, Y1
Jiang, C; Lu, Y; Zhang, S1
Deguchi, H; Enzan, N; Ide, T; Ikeda, M; Ikeda, S; Ishikita, A; Matsushima, S; Okabe, K; Sada, M; Shinohara, K; Tadokoro, T; Tsutsui, H; Yamamoto, T1
Cao, W; Chen, Y; Ge, Z; Hu, Q; Huang, S; Li, Y; Weng, Y; Zhai, C; Zhou, L1
Gao, L; Guo, S; Li, Y; Liu, Y; Shen, J; Shi, Q; Xiao, F; Xing, S; Yang, F; Zhang, W; Zhao, L1
Alammari, AH; El-Kadi, AOS; Maayah, ZH; Shoieb, SM1
Jiang, W; Lei, L; Li, Q; Ni, Y; Wan, Z; Wei, J1
Deng, S; Li, Y; Liu, H; Tian, J; Zhao, Z1
Cai, J; Chen, J; Cui, Q; Geng, B; Li, S; Meng, Y; Xiang, R; Xu, M; Yan, H; Yang, J; Yang, Y1
Gao, L; Hackfort, BT; Hu, G; Tian, C; Zucker, IH1
Cai, K; Chen, H1
An, X; Tan, A; Wang, L; Xia, Y; Xie, Y1
Li, Z; Long, Y; Wang, L1
Chen, GH; Hu, J; Li, JL; Wang, HN; Xu, T; Yao, HQ1
Gao, C; Hu, H; Jiang, X; Liang, F; Ma, W; Sun, Q; Zhan, H; Zhang, K; Zhang, X; Zhao, Z1
Cai, DF; Cai, SA; Chen, MS; Chen, XH; Cheng, CF; Hou, N; Huang, Y; Li, AQ; Li, LR; Liu, SM; Liu, XW; Luo, CF; Qiu, XX; Xie, JX; Yuan, WC; Zhao, GJ1
Cong, W; Dong, E; Feng, Y; Hu, G; Li, M; Song, Y; Wang, S; Xiao, H; Zhang, Y1
El-Kadi, AOS; Shoieb, SM1
Bao, Y; Han, Y; Li, C; Li, Y; Ren, L; Wang, W; Wu, C1
Chen, DX; Huang, DJ; Huang, HL; Huang, JH; Lin, YB1
Cao, W; Li, Y; Qian, Y; Wang, J; Zhao, P; Zhu, H1
Cai, SY; Fu, YL; Lin, Q; Peng, FH; Tao, L; Wang, Q; Zheng, NZ1
Chakraborty, K; Joy, M; Krishnan, S2
Bao, Y; Dai, Y; Jia, K; Jin, Q; Li, X; Liu, A; Lu, L; Wu, L1
Deng, KQ; Hu, F; Ji, YX; Li, H; Liu, X; Montezano, AC; Ouyang, S; She, ZG; Tian, S; Touyz, RM; Zhang, C; Zhang, P; Zhang, XJ; Zhao, CL; Zhao, GJ; Zhu, L; Zhu, XY1
Chen, F; Geng, J; Li, X; Xie, J; Xu, B; Zhao, J1
Barreto-Chaves, MLM; Senger, N; Takano, APC1
Chen, Z; He, X; Liu, X; Lu, Y; Miao, R; Wang, J1
Chao, SP; Chen, XL; Cheng, WL; Gong, FH; Song, BJ; Xiao, XQ; Yang, YS; Zhang, Q1
Hu, YH; Mei, ZL; Wang, HB; Xiong, L1
Bianchi, K; Crespo-Leiro, MG; Domenech, N; Eaton, P; Eykyn, TR; Fernandez-Caggiano, M; Francois, AA; Kamynina, A; Krasemann, S; Morales, V; Prysyazhna, O; Vieites, MG1
Cao, Y; Chen, Y; Liu, Y; Qi, H; Ren, J; Shi, P; Song, C; Sun, H; Wang, L; Zhang, S1
Huang, Z; Kong, LY; Li, YP; Tian, XY; Wang, ZM; Wu, LM; Yao, R; Zhang, DH; Zhang, JL; Zhang, YZ1
Chen, W; Gu, Y; Ma, L; Wang, G; Wang, W; Xiao, Y; Yang, F; Yu, Y; Zhang, B1
Cai, SD; Ding, YQ; Hu, YH; Li, B; Li, JY; Liu, PQ; Lu, J; Wang, PX; Ye, JT; Yu, WJ; Yue, ZB; Zhang, YH1
Du, J; Hu, H; Pei, H; Shen, Y; Xu, R; Yang, D; Yang, Y1
Gao, P; Gao, R; Ge, W; Guo, W; Guo, X; Hou, C; Li, B; Liu, Y; Song, X; Wang, J; Zhang, W; Zhao, H1
Bai, N; Li, G; Li, J; Li, L; Li, T; Li, W; Liu, G; Lou, Q; Wang, Y; Yang, W; Zhan, C; Zhang, L; Zhao, H; Zheng, M1
Abraham, DM; Bouknight, L; Coffman, TM; Crowley, SD; Diaz, E; Gurley, SB; Hoang, T; Pennathur, S; Revoori, R; Rianto, F; Ruiz, P; Sparks, MA; Stegbauer, J; Vivekanandan-Giri, A1
Badrealam, KF; Chen, RJ; Day, CH; Huang, CY; Kung, YL; Kuo, WW; Lu, CY; Lu, SY; Padma, VV; Shibu, MA1
Ge, J; Jiang, H; Su, Y; Wang, J; Wu, J; Yu, Y; Zhang, B; Zhang, L; Zou, Y1
Consegal, M; Rodríguez-Sinovas, A; Valls-Lacalle, L1
Gu, J; Ji, Y; Lu, Y; Qian, Z; Qiu, M; Sun, W1
Chuprun, JK; Coleman, R; Eguchi, A; Gao, E; Gresham, K; Ibetti, J; Koch, WJ1
Hou, L; Huo, C; Jia, X; Li, X; Liu, Y; Wang, X; Xu, R1
Chen, J; Chen, Y; Fang, L; Gao, H; Li, H; Lin, J; Lv, R; Lyu, L; Wang, W; Xu, F; Yan, T1
Cheng, Y; Gu, W; Li, Z; Sun, T; Wang, S1
Bai, W; Peng, Y; Qin, L; Wang, Z; Yu, H1
Altara, R; Booz, GW; Massoud, GP; Zouein, FA1
Chen, W; Chen, X; Li, W; Ma, L; Qiu, J; Shi, W; Tao, J; Wang, S; Zhou, N; Zou, M; Zou, R1
Cai, L; Collins, DM; Duan, Q; King, C; Kutz, LC; Lingrel, JB; Marck, PV; Pessoa, MT; Pierre, SV; Tian, J; Wang, X; Xie, JX; Xie, Z; Xu, Y; Yan, Y1
Alexis, JD; Ashton, JM; Burke, RM; Dirkx, RA; Lighthouse, JK; Mohan, A; O'Brien, M; Phipps, RP; Quijada, P; Small, EM; Woeller, CF; Wojciechowski, W1
Morishima, M; Ono, K1
Chen, RJ; Ho, TJ; Huang, CY; Kumar, VB; Kuo, CH; Lin, KH; Padma, VV; Shanmugam, T; Shibu, MA; Yeh, YL1
Bi, X; Gao, Y; Liu, Y; Meng, T; Xie, WZ; Xu, C; Zhang, P; Zhao, D; Zhao, Z1
Boen, JRA; De Keulenaer, GW; De Meyer, GRY; De Moudt, S; Guns, PDF; Hendrickx, JO; Jacobs, G; Leloup, AJA; Segers, VFM; Shakeri, H1
Chang, W; Chen, Y; Huang, S; Ke, J; Wang, L; Wang, Q; Zhou, Z1
Chen, C; Lu, Q; Shi, JY; Su, YL; Xu, X1
Cai, J; He, B; Ji, Q; Li, Y; Pan, X; Shen, L; Shen, Y; Wang, X; Xiao, Q; Yang, X; Yin, A; Yuan, R1
Gan, WQ; Hou, YF; Li, TG; Lv, SL; Wang, WQ; Yan, Z; Yang, M; Zeng, ZF; Zhang, RX1
Chu, Z; Han, B; Han, J; Lu, Q; Shi, X; Zhang, B; Zhang, X1
Jiang, Q; Li, J; Lu, M; Zhu, Z1
Chen, H; Gao, Z; Gong, M; Li, C; Li, K; Meng, Y; Wang, L; Zhang, H; Zhang, X; Zheng, C; Zheng, Y1
Hernandez, R; Lu, W; Meng, Z; Zhou, C1
Cheng, XS; Lu, P; Peng, XG; Sheng, ZY; Wu, QH; Wu, YQ; Xu, Y; Zhang, JJ; Zhu, K1
Cai, SA; Hou, N; Huang, Y; Li, LR; Liu, XW; Luo, CF; Pan, WB; Shi, YY; Yuan, WC; Zhan, HX; Zhao, GJ1
Fan, S; Niu, Y; Qin, J; Shi, Y; Wang, J; Xiong, Q; Zhang, L; Zhang, X1
Du, J; Guo, HC; Lai, YQ; Li, G; Li, Y; Ma, K; Qiao, B; Shao, Y; Zhi, Y1
Han, Q; Li, H; Shi, H; Xue, H; Zhang, F; Zhang, Y1
De Gregorio, N; Díaz-Araya, G; Espinoza, C; Espitia-Corredor, J; Lavandero, S; Olivares-Silva, F; Osorio, JM; Peiró, C; Sánchez-Ferrer, C; Silva, D; Vivar, R1
Huang, S; Jia, Z; Niu, Y; Shi, W; Wang, S; Yu, J; Zhang, A; Zhang, Y; Zhou, W1
Cheng, T; Fan, P; Hua, C; Wang, J; Xia, Q; Zhang, L; Zhao, L; Zhou, J1
Alfadda, AA; Alsalman, N; Bazighifan, A; Gul, R1
Li, JD; Wu, MP; Xu, X; Yan, C; Zhang, YS; Zhou, Q1
Chen, W; Chen, X; Huang, F; Khan, A; Li, L; Qiu, Z; Wang, L; Wang, X; Zhang, J1
Guo, L; O'Rourke, ST; Sun, C; Yin, A; Zhang, Q; Zhong, T1
Dong, ZX; Hai, X; Han, W; Hou, HL; Liu, GZ; Shi, YQ; Wan, L; Wang, RJ; Zheng, SJ1
Abdelhamid, G; El-Kadi, AOS; El-Sherbeni, AA; Elkhatali, S; Elshenawy, OH; Maayah, ZH; Shoieb, SM1
Chen, J; Chen, XM; Hou, JW; Li, G; Li, W; Li, YG; Wang, H; Wang, Q; Wang, YP; Wei, SS; Xu, WP; Zhou, Q1
Bao, Q; Chen, L; Li, J; Liu, X; Wu, S; Wu, W; Zhao, M1
Cao, TT; Chen, HH; Dong, Z; Guo, W; Lu, R; Wei, HC; Xu, YW; Zhang, C; Zhao, P1
Han, Y; Ji, Y; Liu, J; Liu, L; Liu, S; Meng, G; Song, Q; Xie, L1
Gao, L; Huang, K; Li, H; Wang, G; Wang, J; Wang, L; Wang, Z; Yang, M1
Aguiló, S; de Diego, A; Galán, M; García-Dorado, D; Guadall, A; Martínez-González, J; Navarro, MA; Navas, M; Orriols, M; Rodriguez, C; Rodríguez-Sinovas, A; Varona, S1
Burridge, PW; Eren, M; Flevaris, P; Ghosh, AK; Gupta, S; Khan, SS; Lee, DC; Schuldt, AJT; Shah, SJ; Shapiro, AD; Vaughan, DE1
Ogita, H; Sato, A; Shimizu, A; Zankov, DP1
Chen, X; Duan, W; Jin, Z; Jing, L; Li, B; Li, K; Liang, H; Liu, J; Liu, Z; Reiter, RJ; Ren, K; Yang, J; Yang, Y; Yi, D; Yi, W; Yu, B; Yu, S; Zhai, M; Zhang, B; Zhang, M1
Gao, Y; Hu, D; Li, J; Li, Y; Shang, H; Xing, Y; Zhang, Y1
Inagaki, Y; Kaneko, S; Kitano, T; Ohkura, SI; Okamoto, Y; Sugimoto, N; Takamura, M; Takashima, SI; Takuwa, N; Takuwa, Y; Usui, S; Wada, T; Yoshioka, K1
Hays, TT; Ma, B; Qiu, H; Stoll, S; Zhou, N1
Chen, RJ; Chen, YF; Chung, LC; Huang, CY; Kuo, WW; Lee, NH; Padma Viswanadha, V; Pai, PY; Rajendran, P; Shen, CY1
Chen, Y; Jiang, G; Lv, Q; Yuan, J; Zhu, J; Zou, Y1
Chen, Y; Fillmore, N; Gao, S; Harrington, J; Liu, P; Murphy, E; Springer, D; Stoehr, A; Wang, X; Yang, Y; Zhang, X; Zhu, J1
Bu, J; Gao, J; Huang, C; Huang, G; Shen, W; Sun, M; Wei, T; Wu, J1
Aroor, AR; Bender, SB; Brown, SM; Chandrasekar, B; Cleeton, HM; DeMarco, VG; Khan, M; Meininger, GA; Meuth, AI; Nistala, R; Smith, CE; Sowers, JR1
Gu, C; He, L; Huang, Z; Li, J; Pan, L; Sheng, M; Teng, L; Xu, C; Yi, C; Zhu, Z1
Gao, L; Guo, S; Li, L; Li, R; Li, Y; Liu, Y; Niu, X; Wang, S; Yan, X; Yang, H; Yao, L; Zhang, Y; Zhao, X1
Ayme-Dietrich, E; Birling, MC; Bouabout, G; Champy, MF; Fertak, LE; Herault, Y; Jacob, H; Madeira, L; Monassier, L; Mudgett, J; Pavlovic, G; Petit-Demoulière, B; Sorg, T1
Ge, L; Hoa, N; Korach, KS; Levin, ER1
Gao, H; Huang, P; Huang, X; Li, Y; Liu, H; Peng, Y; Tang, T; Wang, D1
Choi, SY; Jeong, MH; Jin, L; Kee, HJ; Kim, GR; Lin, MQ; Liu, B; Piao, ZH; Ryu, Y; Seok, YM; Sun, S1
Chen, RJ; Ho, TJ; Huang, CY; Kuo, CH; Kuo, WW; Lin, YM; Pai, PY; Tsai, FJ; Vijaya Padma, V1
Chen, WQ; Cheng, J; Ji, XP; Mao, Y; Qiao, L; Tie, YY; Xu, QB; Xu, YY; Zhai, CG; Zhang, C; Zhang, Y1
Gong, H; Lian, X; Peng, F; Wang, L; Ye, N; Zhang, H1
Gao, L; Li, AL; Lv, JB1
Cheng, M; Hu, S; Hu, Z; Huang, C; Jiang, H; Lai, X; Liu, B; Wang, S; Wu, G; Zou, Q1
Lu, Y; Wu, F1
Huang, Y; Ji, Q; Jiang, H; Lin, Y; Liu, J; Liu, L; Shi, L; Shi, Y; Wan, J; Wang, M; Wang, Z; Xu, Y; Ye, J1
Cui, LB; Jiang, S; Jiao, B; Ru, NY; Yu, ZB; Zhang, L1
Chen, D; Gao, P; Huang, J; Ji, K; Li, X; Xu, T; Yan, C; Yang, Y; Zhu, D; Zuo, C1
Alves, F; Bader, M; Guatimosim, S; Jesus, ICG; Marques, K; Rocha-Resende, C; Santos, RAS; Scalzo, S1
Bai, J; Cao, HJ; Du, J; Guan, XM; Li, HH; Lin, QY; Liu, Y; Ma, XL; Wang, L; Xia, YL; Zhang, YL1
Paradis, P; Schiffrin, EL1
Hao, Q; Li, GH; Liu, K; Wei, J; Wu, Y; Zhao, YF1
Du, B; Gao, L; Huang, Z; Li, P; Li, Y; Liang, C; Wang, Z; Wu, L; Xiao, L; Yao, R; Zhang, D; Zhang, Y1
Liu, HB; Liu, ZH; Wang, J1
Cho, S; Jeong, J; Lee, J; Lee, ME; Lim, S; Park, S; Seo, M1
Laurindo, FRM; Pescatore, LA1
Dai, F; Ma, S; Wang, Q; Yang, D; Yang, Y; Zhang, Y1
Cai, W; Hua, J; Lai, W; Liu, Z; Ren, H; Xu, D; Zeng, Q; Zhan, Q1
Liu, HQ; Liu, Y; Luo, JD; Shen, HJ; Wang, XQ; Zheng, LY1
Du, J; Hou, CL; Lai, S; Li, HH; Li, WJ; Tian, C; Wang, HX; Yang, H; Zhang, YL1
Badrealam, KF; Chen, BC; Chiang, JT; Huang, CY; Kuo, CH; Kuo, WW; Lin, YM; Shibu, MA; Viswanadha, VP1
Frank, DU; Saucerman, JJ; Sutcliffe, MD1
Guo, Z; Li, Q; Li, ZM; Liu, PQ; Lu, J; Sun, SY; Wang, LP; Wang, PX; Yang, HW; Ye, JT1
Cai, YY; Chen, HY; He, JH; Jiang, W; Lan, J; Li, H; Li, RL; Li, X; Tang, CS; Wang, W; Wang, XX; Wu, SS; Wu, Y; Xin, JJ; Xue, KY; Zhang, HY; Zhuo, CL1
Bisping, E; Heinzel, FR; Klein, O; Mhatre, KN; Pieske, B; Völkl, J; Wakula, P1
Gupta, S; Li, L1
Gopalakrishnan, K; Kumar, S; Mishra, JS; More, AS1
Chen, L; Lei, L; Li, Q; Li, T1
Jing, Y; Liu, S; Ni, B; Zhou, D1
Andrews, KL; Chin-Dusting, JPF; Dragoljevic, D; Gaspari, T; Jefferis, AM; Jennings, GL; Khan, SI; Lee, MKS; Moore, XL; Murphy, AJ; Shihata, WA; Vinh, A1
He, W; Jiang, H; Zhang, C1
Gao, L; Kong, L; Shi, H; Tian, X; Wang, Z; Xiao, L; Zhao, L1
Cheng, M; Hu, S; Hu, ZQ; Huang, CX; Jiang, H; Liu, BL; Wang, L; Wang, S; Wu, G1
Bi, HL; Lai, S; Li, HH; Shu, Q; Wang, XM; Yang, XL; Zhang, YL1
Aisicovich, M; García, SI; Landa, MS; Peres Diaz, LS; Pirola, CJ; Schuman, ML; Toblli, JE1
Deng, W; Hu, C; Liao, HH; Tang, QZ; Wang, SS; Wei, WY; Yang, Z; Zhang, N1
Cornelissen, G; El-Kilany, G; Fedacko, J; Hristova, K; Singh, RB1
Bers, DM; Fukui, G; Hamada, Y; Ishiguchi, H; Kato, T; Kobayashi, S; Kono, M; Nakamura, Y; Nanno, T; Oda, T; Okamoto, Y; Okuda, S; Uchinoumi, H; Yamamoto, T; Yano, M1
A, P; K G, R; M, PR; P, SR1
Cheng, M; Hu, S; Huang, CX; Jiang, H; Liu, BL; Tu, X; Wang, L; Wang, S; Wu, G1
Beak, JY; Bowles, DE; Huang, W; Jensen, BC; Jetten, AM; Kang, HS; Myers, PH1
Alenina, N; Bader, M1
Chen, N; Gao, L; Li, L; Liu, Y; Wang, X; Xiao, L; Yang, L; Zhang, J; Zhao, X1
Brenes-Castro, D; Castillo, EC; García-Rivas, G; Torre-Amione, G; Vázquez-Garza, E1
Gao, L; Guo, S; Liang, C; Liu, Y; Wang, X; Xiao, L1
Cheng, WP; Chua, SK; Lo, HM; Shyu, KG; Wang, BW1
Chen, C; Li, HH; Liu, Y; Xia, YL; Yan, X; Zhang, L; Zhang, YL; Zou, LX1
Shah, AM; Zoccarato, A1
Wang, DX; Xiong, T; Yang, XQ1
Armesilla, ÁL; Jiménez-Borreguero, LJ; López-Maderuelo, MD; Lozano-Vidal, N; Martínez-Martínez, S; Redondo, JM1
Chen, T; Han, J; Huang, W; Jiang, L; Li, J; Liang, G; Wang, J; Wang, Y; Xu, J; Ye, S; Zou, C1
Wang, M; Zhang, A; Zhuo, P1
Fernández-Solà, J; Ferrer-Curriu, G; Garrabou, G; Guitart-Mampel, M; Mas-Stachurska, A; Planavila, A; Redondo-Angulo, I; Ruperez, C; Sitges, M; Villarroya, F1
Avery, EG; Balogh, A; Bartolomaeus, H; Dechend, R; Eckardt, KU; Fielitz, J; Forslund, SK; Gollasch, M; Grandoch, M; Haase, N; Hering, L; Höges, S; Homann, S; Kempa, S; Kozhakhmetov, S; Kräker, K; Krannich, A; Kusche-Vihrog, K; Kushugulova, A; Maase, M; Markó, L; Müller, DN; Rump, LC; Stegbauer, J; Tsvetkov, D; Wilck, N; Wundersitz, S; Yakoub, M; Zhumadilov, Z1
Ba, L; Cao, Y; E, M; Fu, B; Qi, H; Ren, J; Shi, P; Song, C; Sun, H; Zhang, Q1
Chen, P; Deng, Y; Feng, H; Huang, L; Ouyang, W; Wang, J; Wu, J; Xian, J; Zhu, G1
Peng, L; Yan, K; Zhang, H; Zheng, N; Zhou, K1
Imai, Y; Ito, H; Kadowaki, A; Kuba, K; Sato, T; Suzuki, T; Watanabe, H1
Cao, R; Qi, B; Wang, Y; Yang, W1
Bao, P; Chen, D; Chen, M; Hu, X; Ji, C; Li, Z; Sanchis, D; Xu, Y; Yan, F; Ye, J; Zhang, M; Zhang, Y1
Chen, D; Fu, M; Gao, P; Grossfeld, P; Han, W; Ostrowski, MC; Xu, L; Ye, M1
Chen, G; Cong, W; Jin, L; Li, S; Liang, J; Liang, Y; Niu, C; Shen, Y; Wang, Y; Xue, M; Yi, X; Zhang, H; Zhao, C; Zheng, J; Zhu, Z1
Cheng, M; Guo, X; Hu, S; Huang, C; Jiang, H; Liu, B; Wang, S; Wu, G1
Chen, W; Fassett, J; Li, W; Liu, Z; Lu, Y; Qi, X; Tang, K; Weng, X; Xu, D; Xu, Y; Zhang, Y; Zhao, Y; Zheng, J1
Huang, T; Li, F; Lu, P; Sheng, Z; Wang, S; Xu, Y1
Ge, Z; Lin, J; Lin, Z; Liu, J; Wang, Y; Yuan, X; Zhang, C1
Chen, H; He, J; Jiang, W; Lan, J; Li, H; Li, R; Li, X; Tang, CS; Wang, X; Wu, S; Wu, Y; Xin, J; Xue, K; Zhuo, C1
Abboud, FM; Chapleau, MW; Cicha, MZ; Meyerholz, DK; Nunez, S; Singh, MV1
Abdisalaam, S; Asaithamby, A; Bhattacharya, S; Gillette, TG; Hill, JA; Lam, NT; Mukherjee, S; Nakada, Y; Nhi Nguyen, NU; Sadek, HA; Savla, JJ; Xiao, F1
Jiang, Y; Liu, R; Men, H; Shao, W; Shu, S; Zhang, W1
Astani, A; Jahanifar, F; Jamhiri, M; Safari, F; Shekarforoosh, S; Zarei, F1
Hu, Y; Li, J; Li, S; Li, Y; Ma, Y; Wen, J; Wu, J; Zhang, J; Zhang, L1
Abraham, D; Acar, E; Costantino, S; Gonçalves, IF; Hallström, S; Hamza, O; Kiss, A; Klein, KU; Paneni, F; Podesser, BK; Szabo, PL; Tretter, EV; Trojanek, S1
Gao, L; Lu, HQ; Qin, XP; Yan, QJ; Yang, L; Zeng, SY1
Gao, T; Wang, F; Wang, J; Xie, M; Xue, J; Ye, H1
Chen, Y; Li, W; Ni, H; Shen, G; Wang, F; Wang, Y; Xu, S; Zhuge, Y1
Azushima, K; Fujikawa, T; Haku, S; Haruhara, K; Ishigami, T; Kinguchi, S; Kobayashi, R; Koguchi, T; Matsuda, M; Minegishi, S; Ohki, K; Tamura, K; Uneda, K; Wakui, H; Yamada, T; Yamaji, T; Yamashita, A1
Ba, L; Cao, Y; Chen, Y; Dong, C; Gao, J; Guan, X; Pan, H; Qi, H; Shi, P; Song, C; Sun, H; Zhang, Q1
Chen, R; Liu, P; Lu, Y; Qiao, C; Shao, C; Song, J; Wang, L; Wang, Z; Xie, Q; Yan, J; Yang, P1
Jing, L; Li, S; Wang, J; Zhang, G1
Andrades, ME; Biolo, A; Caetano, DSL; Clausell, N; Leitão, SAT; Lopes, A; Nascimento, TG; Pinto, GH; Rohde, LEP; Soares, DDS1
Chen, X; Li, P; Liu, C; Wang, L1
Henderson, J; Krishnamurthy, P; Luong, HT; Narasimhan, G; Qin, G; Rajasekaran, NS; Zhang, J1
Jia, CH; Wang, F; Xie, ML; Zhu, ZY1
Bi, HL; Cao, HJ; Han, L; Lai, S; Li, HH; Li, N; Wang, HX; Xie, X; Zhang, YL1
Gao, Y; Ma, ZC; Tan, HL; Wang, J; Wang, NN; Wang, YG1
Arad, M; Aravot, D; Hochhauser, E; Kornwoski, R; Nudelman, V; Peterson, SJ; Shainberg, A; Waldman, M; Zemel, R1
Becirovic-Agic, M; Hultström, M; Jönsson, S1
Deng, W; Fan, D; Huang, SH; Ma, ZG; Tang, QZ; Wan, CX; Wang, HB; Wu, HM; Wu, QQ; Xu, M1
Tang, L; Wang, J; Wen, Q; Zou, X1
Li, Q; Lin, L; Liu, X; Ni, Y; Qin, S; Wei, J; Zhang, C1
Chen, Y; Liang, J; Pan, R; Wu, F; Wu, G; Wu, Z; Xu, W; Yan, W; Zhang, H; Zhang, K1
Cao, C; Chang, J; Chen, X; Gao, E; Han, D; Li, J; Shen, D; Tang, J; Wang, B; Xiao, Y; Zhang, J; Zhao, W1
Duan, MX; Huang, R; Huang, SH; Liu, LB; Ma, ZG; Tang, QZ; Wan, CX; Wang, HB; Wu, QQ; Xu, M; Yang, J1
Hong, L; Lin, C; Lin, L; Liu, GY; Pan, YX; Peng, WW; Wang, SZ; Zhao, XL1
Feng, YQ; Geng, QS; Hu, ZQ; Huang, L; Huang, YQ; Shan, ZX; Yu, XJ; Zhu, JN1
Ding, J; Han, L; Hao, M; Li, M; Lin, L; Luo, B; Tang, Q; Yu, L; Zhang, L1
Han, Q; Li, H; Qin, D; Shi, H; Wang, L; Zhang, Y1
Chao, X; Chen, J; Geng, B; Le, K; Liu, P; Liu, Z; Luo, J; Xu, S; Ye, J; Zeng, S; Zou, J1
Itoh, N; Kinoshita, H; Kito, T; Konishi, M; Kuwahara, K; Matsumoto, E; Nakao, K; Ohta, H; Sasaki, S1
Fukumoto, Y; Kudo, S; Liao, JK; Minami, T; Nochioka, K; Shiba, N; Shimokawa, H; Takai, Y; Tanaka, S; Williams, CL1
Andersen, DC; Bie, P; Eskildsen, TV; Hansen, ML; Hansen, PB; Jensen, CH; Jeppesen, PL; Marcussen, N; Nossent, AY; Rasmussen, LM; Sandberg, MB; Schneider, M; Sheikh, SP1
Hirose, M; Ishigami, A; Kobayashi, A; Kubota, I; Misaka, T; Miyata, M; Saitoh, S; Shishido, T; Suzuki, S; Takeishi, Y1
Barreto-Chaves, ML; da Silva, IB; Gomes, DA; Tavares, FM1
Carretero, OA; Dai, X; González, GE; Leung, P; Liao, TD; Liu, Y; Nakagawa, P; Rhaleb, NE; Yang, XP1
Chu, ML; Dong, H; Khan, SA; Tsuda, T; Wu, J; Zhang, H1
Cao, WW; Chen, SR; Chen, X; Gao, H; Li, Q; Liu, PQ; Luo, JN; Wang, YH; Zeng, SY; Zou, J1
Herichová, I; Mravec, B; Neupauerová, D; Šoltésová, D; Szántóová, K; Veselá, A; Zeman, M1
Bu, L; Cheng, Z; Dong, D; Huang, T; Shen, B; Tu, Y; Wan, L; Zhao, D1
Amrit, B; Chen, H; Chen, X; Deng, X; Gong, L; He, S; Liu, K; Wang, S1
Henze, M; Monasky, MM; Soergel, DG; Solaro, RJ; Taglieri, DM; Utter, MS; Violin, JD; Warren, CM1
Currie, S; Grieve, DJ; Lawan, A; Martin, TP; Paul, A; Plevin, R; Robinson, E1
Aiello, EA; Cingolani, HE; Ennis, IL; Perez, NG2
Ishigami, A; Kobayashi, A; Kubota, I; Misaka, T; Miyata, M; Saitoh, S; Shishido, T; Suzuki, S; Takeishi, Y1
Bhuiyan, MS; Fukunaga, K; Tagashira, H1
Du, J; Han, QY; Jiang, X; Li, HH; Li, N; Tian, C; Wang, HX; Yang, H1
Allen, AM; Bassi, JK; Carter, DA; Chen, D; Choong, YT; Connelly, A; Head, GA; Jancovski, N; Lukoshkova, EV; Menuet, C; Nguyen, TP1
Du, Z; Gao, X; Han, H; Hang, P; Huo, R; Jiang, Y; Liu, Y; Lu, Y; Song, H; Sun, L; Wang, C; Wang, S; Wei, L1
Gao, PJ; Jin, HY; Lu, L; Oudit, GY; Penninger, JM; Shang, QH; Song, B; Xu, YL; Zhang, ZZ; Zhong, JC; Zhou, T; Zhu, DL1
Chien, WM; Chin, MT; Liu, Y; Luchtel, DL; Medvedev, IO; Rosenfeld, ME; Weldy, CS1
Gan, XT; Karmazyn, M; Thomas, A; Zeidan, A1
Abdul-Ghani, M; Brunette, S; Dick, SA; Fernando, P; Megeney, LA; Putinski, C; Stiles, R1
Chang, SK; Guo, LR; Liu, KX; Liu, Q; Sun, CW; Xuan, CL; Yao, FR1
Dalton, JT; Levin, ER; McKinsey, TA; Narayanan, R; Pedram, A; Razandi, M1
Banach, K; Burmeister, BT; Carnegie, GK; Conklin, BR; DeSantiago, J; Johnson, KR; Monasky, MM; Spindler, MJ; Taglieri, DM1
Sadoshima, J; Zablocki, D1
Hikoso, S; Murakawa, T; Nakayama, H; Nishida, K; Oka, T; Omiya, S; Otsu, K; Oyabu, J; Shah, AM; Takeda, T; Taneike, M; Ueda, H; Yamaguchi, O; Yasui, H1
Li, ZY; Xing, L; Yang, YH1
Aiello, EA; Caldiz, CI; Ciancio, MC; De Giusti, VC; Orlowski, A1
Chen, Y; Fan, GC; Jiang, DS; Jiang, XL; Li, H; Liu, Y; Yang, Q; Zhang, R; Zhang, XD; Zhang, Y1
Caldiz, CI; Cingolani, HE; Correa, MV; de Cingolani, GE; Ennis, IL; Nolly, MB1
Kang, YM; Qi, J; Qin, DN; Su, Q; Suo, YP; Yang, Q; Yu, XJ; Yue, LY; Zhang, DM; Zhu, GQ1
Bhuiyan, MS; Fukunaga, K; Shioda, N; Tagashira, H1
Čertíková Chábová, V; Červenka, L; Husková, Z; Kompanowska-Jezierska, E; Kramer, HJ; Kujal, P; Sadowski, J; Škaroupková, P; Tesař, V; Vaněčková, I; Vernerová, Z; Walkowska, A1
Hu, C; Huang, Y; Jiang, M; Lin, J; Tang, J; Wu, D; Wu, L; Zhang, X1
Chen, K; Chen, Y; Fan, GC; Gao, L; Gong, H; Jiang, DS; Li, H; Liu, PP; Liu, Y; Peng, J; Yang, Q; Zhang, XD; Zhang, XF; Zhang, Y; Zhou, H; Zou, Y1
Ku, HC; Su, MJ1
Du, J; Li, Y; Wang, C; Wu, Y; Zhang, C1
Barreto-Torres, G; Hernández, JS; Javadov, S; Khuchua, Z; Kuznetsov, AV1
Huang, F; Huang, H; Liu, Y; Tang, W; Wang, J; Wang, MH; Wang, T; Zhang, H; Zhang, K; Zhu, X1
Chen, XJ; Du, XN; Si, M; Wang, C; Xu, JX; Zhang, HL; Zhang, HR; Zhang, XD1
Chen, S; Chen, X; Fang, W; Gao, H; Gao, S; Geng, B; Li, H; Li, Z; Liu, M; Liu, P; Ma, Y; Ye, J; Yue, Z; Zhang, L; Zou, J1
Fujishima, Y; Funahashi, T; Hirata, A; Komura, N; Maeda, N; Matsuda, K; Mori, T; Nishizawa, H; Sekimoto, R; Shimomura, I; Tsushima, Y1
Chiu, CZ; Shyu, KG; Wang, BW1
Burger, D; Chibale, K; Mahajan, A; Reudelhuber, TL; Sturrock, ED; Touyz, RM1
Li, PF; Liu, CY; Liu, F; Long, B; Sun, T; Wang, K; Wang, Y; Yuan, SM; Zhang, XJ; Zhou, LY1
Ge, J; Lin, L; Liu, X; Tang, C; Wei, W; Weng, L; Xu, J; Ye, Y; Zou, Y1
Bezzerides, VJ; Rosenzweig, A; Ryall, KA; Saucerman, JJ1
Agarwal, D; Dange, RB; Francis, J; Masson, GS; Nair, A; Vila, J; Wilson, B1
Bai, Y; Han, JY; He, K; Huo, ZJ; Li, Q; Li, ZG; Pan, CS; Tian, GH; Wang, CS; Wei, XH; Yang, L; Zhang, YY; Zhou, CM1
Basu, R; Fan, D; Kandalam, V; Kassiri, Z; Lee, J; Oudit, GY; Patel, V; Takawale, A; Wang, X1
Dechend, R; Haase, N; Müller, DN; Przybyl, L; Qadri, F; Rugor, J1
Ai, D; Hammock, BD; Li, L; Li, N; Pang, W; Zhang, X; Zhu, Y1
Fan, YY; Li, N; Li, PF; Liu, CY; Liu, F; Long, B; Murtaza, I; Wang, K; Zhou, QY1
Cheng, C; Huang, H; Huang, J; Liu, B; Liu, S; Pan, W; Sun, W; Xiong, L; Ye, J; You, X; Zhong, Y1
Prathapan, A; Raghu, KG; Vineetha, VP1
Gong, H; Wang, S; Wu, J; You, J; Zhang, L; Zou, Y1
Charles, RL; Eaton, P; Freeman, BA; Hammock, BD; Kamynina, A; Morisseau, C; Prysyazhna, O; Rudyk, O; Yang, J1
Cavasin, MA; Chen, B; Demos-Davies, KM; Ferguson, BS; Ferrara, C; Horn, TR; Jeong, MY; Mahaffey, JH; McKinsey, TA; Piroddi, N; Poggesi, C; Scellini, B; Schuetze, KB; Spiltoir, JI; Tesi, C; Williams, SM1
Chen, GW; Li, Z; Li, ZM; Liu, M; Liu, PQ; Luo, HB; Wang, LP; Ye, JT1
Heymans, S; Westermann, D1
de Boer, RA; Frenay, AR; Hillebrands, JL; Leuvenink, HG; Pasch, A; Snijder, PM; van Goor, H1
Castro-Chaves, C; Einicker-Lamas, M; Lara, LS; Luna-Leite, MA; Luzardo, R; Madeira, C; Medei, E; Monnerat-Cahli, G; Paixão, AD; Panizzutti, R; Pereira-Acácio, A; Ribeiro, VS; Sampaio, LS; Silva, PA; Vieira-Filho, LD; Vieyra, A1
Huang, K; Ke, Y; Lei, M; Lin, WK; Liu, W; Solaro, RJ; Terrar, DA; Wang, R; Wang, X; Wang, Y; Zhang, Y1
Han, F; Lou, XF; Lu, YM; Sun, MM; Wang, P; Xie, YY; Zhang, BY; Zhang, C1
Aranega, AE; Franco, D; Hernandez-Torres, F1
Caluwé, E; Dymarkowski, S; Herijgers, P; Hermans, H; Herregods, MC; Janssens, S; Pokreisz, P; Swinnen, M1
Bin, J; Cao, S; Chen, C; Huang, X; Kitakaze, M; Li, G; Li, X; Liao, Y; Shen, L; Xu, D; Xuan, W; Zhang, J1
Cao, K; Cao, T; Chen, M; Gao, Z; Gu, L; Huang, H; Li, M; Yang, B1
Hayashi, M; Horimai, C; Yamashita, M; Yoshida, T1
Dopona, EP; Furukawa, LN; Heimann, JC; Katayama, IA; Oliveira, IB; Pereira, RC; Shimizu, MH1
Beavo, JA; Blaich, A; Desch, M; Domes, K; Hofmann, F; Lukowski, R; Patrucco, E; Rybalkin, SD; Sbroggió, M; Schlossmann, J1
Feng, X; Gao, S; Liu, P; Liu, Z; Wang, J; Xu, S1
Dasgupta, M; Karnik, SS; Stark, GR; Unal, H; Willard, B; Yang, J1
Li, J; Russell, B; Tanhehco, EJ1
Lin, L; Shan, H; Tan, W; Wei, J; Yan, R; Zhang, M; Zhang, R; Zhu, Y1
Chai, E; Qi, Y; Zhang, L; Zhang, Y; Zou, J1
Carretero, OA; D'Ambrosio, MA; Dai, X; González, GE; Leung, P; Liu, Y; Nakagawa, P; Peterson, EL; Rhaleb, NE; Yang, XP1
Shen, JH; Tan, JH; Wang, H; Xu, MC; Ying, H; Zhang, DF1
Chen, D; Chen, Q; Cheng, X; Fang, M; Gao, Y; Li, L; Liang, P; Weng, X; Wu, X; Xu, H; Xu, Y; Yang, Y; Yu, L; Zhang, T; Zhou, B1
Tan, Y; Yao, F; Zhang, N; Zhang, Q1
Du, J; Han, QY; Li, HH; Li, N; Li, WJ; Wang, HX; Xia, YL; Zhang, YL1
Aoki, Y; Imaizumi, T; Kai, H; Kudo, H; Takayama, N; Yasuoka, S1
Bian, Y; Cao, Y; Ding, L; Dou, L; Li, J; Lin, Y; Lu, Y; Man, Y; Qin, W; Ruan, Y; Shen, T; Wang, S; Xi, C; Xiao, C; Zhu, Y1
Chen, Q; Dai, X; Fang, M; Li, L; Liang, P; Weng, X; Wu, X; Xu, H; Xu, Y; Yu, L; Zhou, B1
Che, W; Guo, H; Hou, L; Jie, Q; Li, G; Liu, B; The, E; Wang, D; Wei, Y1
Fukai, T; Itoh, S; Matsuda, S; Matsuzaki, M; Murata, T; Umemoto, S; Yoshimura, K1
Guo, LR; Liu, KX; O'Rourke, ST; Sun, CW; Sun, WZ; Yan, W; Zhang, Q1
Sandgren, J; Scholz, TD; Segar, JL1
Chen, Q; Fan, Z; Fang, M; Ji, Y; Li, J; Li, L; Li, Y; Liang, P; Tian, W; Weng, X; Wu, X; Xu, H; Xu, Y; Yang, G; Yu, L1
Bian, ZY; Dai, J; Deng, W; Fang, Y; Li, FF; Tang, QZ; Wu, QQ; Xu, M; Yuan, Y; Zhang, JY; Zhou, H; Zong, J1
Chang, H; Sheng, JJ; Yu, ZB1
Cha, SA; Gao, S; Kim, SH; Park, BM1
Estes, AM; Gonzalez, FJ; Kara, M; Khan, NS; Li, W; Lin, Z; Malik, KU; Pingili, AK1
Eskurza, I; Hosooka, T; Jiang, H; Kahn, BB; Kraus, BJ; Lee, SA; Michel, T; Polak, P; Sartoretto, JL; Shiroto, T1
Andrés, V; Díez, J; González-Gómez, C; Guzmán-Martínez, G; Maraver, A; Orbe, J; Rivera-Torres, J; Serrano, M; Villa-Bellosta, R1
Deng, KQ; Gao, L; Jiang, DS; Jiang, X; Li, H; Luo, Y; Zhang, P; Zhang, XF; Zhao, GN; Zhu, X1
Flockerzi, V; Freichel, M; Jacobs, G; Kecskés, M; Kerselaers, S; Menigoz, A; Syam, N; Vangheluwe, P; Vennekens, R; Voets, T1
Birnbaumer, L; Camacho Londoño, J; Camacho Londoño, JE; Dietrich, A; Flockerzi, V; Freichel, M; Hammer, K; He, T; Kaestner, L; Laufs, U; Lipp, P; Mannebach, S; Mathar, I; Oberhofer, M; Philipp, SE; Reil, JC; Schröder, L; Schweda, F; Tabellion, W; Tian, Q1
Ma, N; Mei, J; Si, Y; Zhang, Y1
Chang, L; Guo, B; Jin, X; Li, Y; Liu, S; Miao, C; Wang, Y; Yan, J; Yang, R; Zhang, H1
Bork, N; Dünnes, S; Friebe, A; Gawaz, M; Lukowski, R; Nemer, M; Nikolaev, VO; Russwurm, M; Schöttle, V; Straubinger, J; Subramanian, H1
Chen, P; Li, X; Luo, J; Patterson, AJ; Xue, Q; Zhang, G1
Chong, S; Gang, C; Lihong, L; Qiang, C; Shifen, P; Xiangli, C1
August, BK; Balijepalli, RC; Hacker, TA; Keefe, AM; Markandeya, YS; Patel, HH; Phelan, LJ; Reynolds, CR; Roth, DM; Woon, MT1
Abboud, FM; Chapleau, MW; Cicha, MZ; Meyerholz, DK; Singh, MV1
Bian, ZY; Feng, H; Liao, HH; Ma, ZG; Tang, QZ; Yang, Z; Yuan, Y; Zhang, N1
Li, Q; Liu, P; Shen, P; Zeng, S1
Chen, X; Chen, Y; Dai, W; Huang, J; Lin, Y; Ou, D; Pan, W1
Chen, Y; Dong, P; Li, D; Li, L; Meng, F; Song, J; Wang, J; Yang, B; Zhang, L; Zhang, X1
Francis, J; Sriramula, S1
de la Serna, IL; Joe, B; Kumarasamy, S; Liu, L; Mehta, G; Walsh, A; Williams, K; Wu, J1
Chilton, L; Constantinoiu, C; Haleagrahara, N; Kinobe, R; Newton, P; Phie, J; Sarnyai, Z1
Böhm, M; Devaux, Y; Fries, P; Kazakov, A; Maack, C; Müller, A; Puhl, SL; Wagner, DR1
Alitalo, K; Andersson, LC; Anisimov, A; Cenni, B; Holopainen, T; Hulmi, JJ; Kivelä, R; Mervaala, E; Räsänen, M; Tavi, P; Tuomainen, T; Tvorogov, D; Zheng, W1
Bethmann, D; Gekle, M; Heise, C; Hünerberg, M; Mildenberger, S; Offermanns, S; Rabe, S; Schreier, B; Sibilia, M1
Abdelhamid, G; El-Kadi, AO; El-Sherbeni, AA; Elkhatali, S; Elshenawy, OH1
Cui, T; Janicki, JS; Li, B; Lyu, L; Nagarkatti, M; Nagarkatti, P; Qi, L; Qin, Q; Wang, H; Wang, XL1
Ge, J; Lin, L; Liu, X; Ren, J; Weng, L; Xu, J; Zou, Y1
Benedict, C; Garikipati, VN; Gumpert, AM; Johnson, J; Khan, M; Kishore, R; Koch, WJ; Krishnamurthy, P; Nickoloff, E; Verma, SK1
Ma, N; Si, Y; Zhang, Y1
Baker, KM; Guleria, RS; Gupta, S; Li, L; Pan, J; Thakur, S; Zhang, CL1
Cao, TN; Cordero-Reyes, AM; Gupte, AA; Hamilton, DJ; Li, S; Smith, JA; Torre-Amione, G; Vedula, I; Youker, KA; Zhang, A1
Li, X; Liang, G; Liu, Z; Peng, K; Qian, Y; Skibba, M; Tian, X; Wang, J; Xu, Z; Zou, C1
Dawn, B; Samanta, A1
Cha, HN; Choi, JH; Heo, JY; Jang, BI; Kwon, WY; Lee, IK; Park, SY1
Bian, ZY; Deng, W; Guo, H; Ni, J; Tang, QZ; Yuan, Y; Zhou, H1
Cai, X; Fu, Y; Gao, X; Guan, Y; Li, Y; Su, G; Wang, L; Wang, S1
Bloch, DB; Bloch, KD; Buys, ES; Cheng, J; Ernande, L; Kolodziej, SA; Leyton, PA; Mayeur, C; Rhee, DK; Scherrer-Crosbie, M; Shahid, M; Spagnolli, E; Tainsh, RE; Thoonen, R; Wu, MX; Zapol, WM1
Chen, L; Deng, K; Huang, J; Ji, Y; Jiang, X; Li, H; Ma, G; Wang, P; Zhang, X1
Chen, YH; Guo, K; Hou, JW; Li, CY; Li, YG; Wang, YP; Yang, LC; Zhou, Q1
Bai, J; Ding, L; Gu, R; Li, Q; Li, R; Wang, B; Wang, L; Xie, J; Xu, B1
Beqqali, A; Bitsch, N; de Windt, LJ; Hermans-Beijnsberger, S; Heymans, S; Nakagawa, S; Peters, T; Prasanth, KV; Schroen, B; van Oort, RJ1
Antunes, TT; Callera, GE; He, Y; Ryazanov, AG; Ryazanova, LV; Shrier, A; Stewart, DJ; Touyz, RM; Yogi, A; Zhai, A1
Han, CG; Liu, YX; Sheng, L; Yang, X; Ye, P1
Bakker, EN; Palao, T; Rippe, C; Swärd, K; van Veen, H; VanBavel, E1
Du, YM; Luo, J; Zhang, WD1
Cheng, M; Ding, J; Meng, W; Yu, L1
Fang, J; Gong, J; Guo, JH; Ji, YX; Li, H; Liu, HY; Wei, X; Zhao, GN; Zhu, X1
An, XZ; Chen, HZ; Chen, XF; Hao, DL; Liu, DP; Luo, YX; Tang, X; Xie, XM; Zhao, X1
Bao, JZ; Cao, Y; Gao, W; Liu, ZX; Lu, X; Wang, H; Wang, LS; Yang, Q; Zhang, L1
Chu, ML; Dong, H; Joyce, J; Khan, SA; Sasaki, T; Tsuda, T1
Ding, Z; Ge, J; Gong, H; Jiang, Q; Kang, L; Li, Y; Wang, S; Wang, X; Wu, J; Ye, Y; Yin, P; Yuan, J; Zhang, W; Zou, Y1
Levin, ER; Narayanan, R; Pedram, A; Razandi, M1
Dorri Mashhadi, F; Hafizi, Z; Jamhiri, M; Safari, F; Zare Mehrjardi, F; Zavvar Reza, J1
Hirano, T; Hiromura, M; Kawashima, H; Kogure, M; Kohashi, K; Kushima, H; Mori, Y; Nakano, Y; Negoro, T; Sato, K; Shinmura, K; Terasaki, M; Tomoyasu, M; Wachi, T; Watanabe, R; Watanabe, T; Yamada, Y1
Chen, YH; Hou, JW; Li, CY; Li, YG; Wang, H; Wang, Q; Wang, YP1
Chen, S; Ding, Y; He, P; Jiang, J; Li, Z; Liu, P; Lu, X; Ma, Y; You, J; Yue, Z1
Haag, M; Miteva, K; Müller, I; Pappritz, K; Ringe, J; Sittinger, M; Spillmann, F; Stachelscheid, H; Tschöpe, C; Van Linthout, S1
Ait-Aissa, K; Belmadani, S; Gabani, M; Haddox, S; Irani, K; Kassan, M; Mali, V; Matrougui, K; Radwan, E; Trebak, M; Zhang, W1
Eguchi, S; Elliott, KJ; Forrester, SJ; Kawai, T; Kwok, HF; Nuti, E; Obama, T; Rizzo, V; Rossello, A; Scalia, R; Takayanagi, T; Tsuji, T1
Billia, F; Grothe, D; Hauck, L1
Ding, H; Ding, S; Gao, L; He, B; Pu, J; Xu, L; Yao, T; Ying, X; Yuan, A; Zhao, Y1
Chen, HZ; Cui, SS; Liu, DP; Pei, JF; Tang, X; Yan, YF; Zhang, Y; Zhang, ZQ1
De Meyer, GR; Martinet, W; Roth, L; Schrijvers, DM1
Chang, CP; Chen, HS; Cheng, W; Feng, X; Han, P; Lin, CH; Quertermous, T; Shang, C; Yang, J; Zhou, Q1
Han, X; Ma, B; Zhou, L1
Ferro, A; Gu, Y; Han, Y; Ji, Y; Liu, J; Ma, Y; Meng, G; Moore, PK; Park, CM; Tang, X; Wang, H; Wang, R; Wang, X; Xian, M; Xiao, Y; Xie, L; Yu, Y; Zhang, Z1
Rao, SL; Wang, P; Yuan, YX; Zhu, XH1
Carrón, R; Gómez-Roso, M; Montero, MJ; Sevilla, MA1
Choi, YS; de Mattos, AB; Kim, M; Kolwicz, SC; Li, T; Nabben, M; Shao, D; Tian, R; Wang, W1
Bian, ZY; Deng, W; Jin, YG; Li, H; Shen, DF; Tang, QZ; Wang, SS; Wu, QQ; Yan, L; Yang, Z; Yuan, Y; Zeng, XF; Zhou, H1
Cheng, JD; Deng, CY; Fu, YH; Hu, ZQ; Lin, QX; Liu, FZ; Shan, ZX; Tang, CM; Wu, SL; Yang, H; Zheng, XL; Zhu, JN1
Bai, H; Ben, J; Chen, Q; Fang, R; Li, J; Li, K; Li, X; Lu, Y; Wang, Z; Yang, Q; Zhang, H; Zhang, J; Zhu, X1
Bu, P; Chen, T; Guo, X; Li, J; Li, N; Liu, H; Su, H; Wang, S; Xiao, M; Yan, F; Yang, Y; Zhang, Y1
Antoniak, S; Buczek, LJ; Cardenas, JC; Church, FC; Mackman, N; Pawlinski, R1
Geng, J; Liu, Q; Lu, D; Shan, Q; Wang, K; Wang, S; Zhang, B; Zhang, Q1
Li, F; Tang, Q; Wu, Q; Yang, Z; Yuan, Y; Zhang, N; Zhou, M; Zhu, J1
A, P; K G, R; Mathew, AK; Nair, A; Nair, RH; P, SR; S, A; Varghese, MV1
Gao, Y; Han, R; He, J; Kang, L; Li, C; Li, Y; Tian, J; Wang, J1
Ji, Y; Jing, H; Wang, D; Zhai, G1
Ding, F; Gao, M; Lu, R; Lu, Y; Luo, S; Mu, W; Shu, Y; Sun, F; Xu, C; Yang, T; Zhang, G; Zhao, W; Zhou, X; Zhuang, Y1
Boldt, K; Bork, N; Deng, L; Desch, M; Feil, R; Feil, S; Just, S; Krattenmacher, D; Kuret, A; Lukowski, R; Nemer, M; Ruth, P; Straubinger, J; Ueffing, M1
Huang, H; Kong, B; Li, Q; Liu, Y; Mei, Y; Peng, J; Quan, D; Wang, G; Wang, Z; Xiong, L; Xiong, X; Zhong, P1
Du, B; Gao, L; Huang, Z; Liu, Y; Wang, Z; Wu, L; Xiao, L; Yao, R; Zhang, D; Zhang, Y1
Chen, SR; Feng, GS; He, P; Huang, Y; Li, ZM; Liu, M; Liu, PQ; Lou, LL; Wang, PX; Zhu, CG1
Deng, ZR; Guang, GC; Yan, H; Zhang, Y1
Egashira, T; Fukuda, K; Hashimoto, H; Hayashi, K; Hayashiji, N; Ito, S; Kashimura, S; Kodaira, M; Kunitomi, A; Kusumoto, D; Lachmann, M; Motoda, C; Nagai, T; Nakanishi, C; Sakata, K; Seki, T; Shimojima, M; Takei, M; Tohyama, S; Yamagishi, M; Yozu, G; Yuasa, S1
Aiello, EA; Caldiz, CI; Chiappe de Cingolani, G; Cingolani, HE; Correa, MV; Dulce, RA; Ennis, IL; Garciarena, CD; Nolly, MB; Perez, NG; Villa-Abrille, MC; Yeves, AM1
Caglayan, E; Collins, AR; Erdmann, E; Hsueh, WA; Liu, J; Lyon, CJ; Peterson, LE; Rosenkranz, S; Ross, RS; Stauber, B; Tangirala, RK; Yin, F1
Bousquet, P; de Champlain, J; Jaffré, F; Laplante, MA; Maroteaux, L; Monassier, L1
He, XX; Liang, QS; Zhan, CY; Zhou, DX1
Hosoya, T; Ikeda, K; Ishikawa, M; Kawamura, M; Nakao, K; Otsubo, C; Tajima, N; Tojo, K; Tokudome, G; Udagawa, T1
Cui, W; Du, H; Li, N; Mao, W1
Bharadwaj, KG; Goldberg, IJ; Ikeda, S; Park, TS; Yamashita, H1
Aragon, AC; Carbett, E; Goens, MB; Walker, MK1
Ebrahimian, T; Sairam, MR; Schiffrin, EL; Touyz, RM1
Busk, PK; Hansen, AH; Haunsø, S; Hinrichsen, R1
Ainscough, JF; Ball, SG; Balmforth, AJ; Brooke, DA; Drinkhill, MJ; Sedo, A; Turner, NA1
Antonello, M; Ceolotto, G; Garbisa, S; Montemurro, D; Papparella, I; Rossi, G; Semplicini, A1
Chae, JK; Gul, R; Jang, KY; Kim, SY; Kim, UH; Ko, JK; Park, JH1
Alitalo, K; Andersson, LC; Bry, M; Hassinen, IE; Helkamaa, T; Jeltsch, M; Karpanen, T; Kivelä, R; Leskinen, H; Liimatta, E; Merentie, M; Mervaala, E; Ollila, HM; Oresic, M; Paavonen, K; Seppänen-Laakso, T; Ylä-Herttuala, S1
Bader, M; Baltatu, OC; Campos, LA; Iliescu, R; Oliveira, ML; Popova, E; Rentzsch, B; Santos, RA; Todiras, M1
Nattel, S; Van Wagoner, DR1
Borges, GR; Fazan, R; Prado, CM; Rossi, MA; Salgado, HC; Silva, CA1
Aranha, AB; Bader, M; Callera, GE; Ferreira, AJ; Mercure, C; Reudelhuber, TL; Santos, RA; Touyz, RM; Walther, T; Yogi, A1
He, X; Liang, Q; Zhan, C; Zhou, D1
Epstein, JA; Levin, MD; Liu, F; Lu, MM; Patel, VV; Petrenko, NB; Stout, AL; Wang, T; Yuan, LJ1
Li, H; Li, HZ; Li, QF; Shi, S; Sun, YH; Wang, R; Xu, CQ; Zhao, YJ1
Higashikuni, Y; Hirata, Y; Koibuchi, N; Kugiyama, K; Nagai, R; Nakamura, K; Nishimatsu, H; Sata, M1
Lazartigues, E; Lucchesi, PA; Stewart, JA1
Bian, Z; Cai, J; Lan, J; Ma, WZ; Shen, D; Tang, Q; Wang, W; Wang, YX; Yan, L; Zhuang, GQ1
Gu, ZL; Guo, CY; Sheng, R; Xie, ML; Zhou, WX1
Shyu, KG1
Campbell, KP; Chang, D; Chang, YT; Chen, CC; Chen, JJ; Chen, YC; Chen, YH; Chiang, CS; Chieng, H; Huang, CH; Shin, HS1
Ai, D; Chiamvimonvat, N; Hammock, BD; Jones, PD; Li, N; Pang, W; Shyy, JY; Xu, M; Yang, J; Zhang, Y; Zhu, Y1
Caldiz, CI; Chiappe de Cingolani, GE; Ennis, IL; Garciarena, CD; Portiansky, EL1
Ehrlich, BE; Heidrich, FM1
Bian, ZY; Cai, J; Ghosh, AK; Li, A; Li, H; Shen, DF; Tang, QZ; Yan, L; Yang, L; Yang, Q; Yang, XC; Yi, FF1
Brook, RD; Chen, LC; Mikolaj, M; Rajagopalan, S; Sun, Q; Wang, A; Xu, X; Ying, Z; Yue, P; Zhong, M1
Aplin, M; Christensen, GL; Hansen, JL1
Hong, LF; Lu, ZH; Ma, YX; Wen, Y; Xu, XJ; Zhang, XJ1
Chen, CX; Gao, JP; Gu, WL; Lü, J; Wang, Y1
Dechend, R; Elitok, S; Fischer, R; Gratze, P; Kleinewietfeld, M; Kvakan, H; Luft, FC; Muller, DN; Park, JK; Plehm, R; Qadri, F; Rahn, HP; Schwarz, I; Wellner, M1
Delbridge, LM; Domenighetti, AA; Egger, M; Gusev, K; Niggli, E; Pedrazzini, T1
Ernest, R; Li, Y; Luo, J; Wu, S; Yang, Q; Yang, Y; Yin, R; Zhelyabovska, O1
Bauersachs, J; Ertl, G; Fraccarollo, D; Galuppo, P; Hansen, JM; Jones, DP; Widder, JD1
Guo, WG; Li, RY; Liu, XT; Lu, ZF; Shi, XQ; Shu, Q; Su, FF; Yang, GD; Yuan, LJ; Zheng, QS1
Gondi, CS; Gopinath, S; Rao, JS; Vanamala, SK1
Granger, JP; Stec, DE; Vera, T1
Chilton, RJ; Lindsey, ML; Zamilpa, R1
Chow, FL; Cooper, SB; Fernandez-Patron, C; Kassiri, Z; Lopaschuk, GD; Odenbach, J; Oka, T; Wang, X1
Bader, M; Bürgelová, M; Cervenka, L; Dvorák, P; Kramer, HJ; Malý, J; Opocenský, M; Thumová, M; Vanourková, Z; Zelízko, M1
Dong, YF; Fukuda, M; Kaneko, T; Kataoka, K; Kim-Mitsuyama, S; Matsuba, S; Nakagata, N; Nakamura, T; Nako, H; Ogawa, H; Tokutomi, Y; Yamamoto, E1
Bergmann, MW; de Windt, L; Dietz, R; Gehrke, C; Noack, C; Renger, A; van der Nagel, R; Zafiriou, MP; Zelarayan, L1
Anderson, RH; Berger, F; Bodhey, NK; Falkenberg, J; Fedarava, K; Kozerke, S; Kuehne, T; Lunkenheimer, PP; Reischauer, C; Rothaus, K; Schmitt, B; Schnackenburg, B; Westermann, D1
Aizawa, Y; Gurusamy, N; Kodama, M; Muslin, AJ; Suzuki, K; Tachikawa, H; Thandavarayan, RA; Watanabe, K; Zhang, S1
Alenina, N; Bader, M; Dietz, R; Erdmann, B; Geier, C; Ghadge, SK; Morano, I; Morano, RD; Ozcelik, C; Panek, AN; Perrot, A; Popova, E; Posch, MG1
Hu, SJ; Li, L; Ye, Y1
Abdullah, MH; Abdullah, NA; Anand Swarup, KR; Fathihah, B; Johns, EJ; Khan, AH; Munavvar, AS; NurJannah, MH; Raisa, NA; Rathore, HA; Salman, IM1
Kurose, H; Nakaya, M; Nishida, M; Sato, Y1
Ahmad, S; Cesana, F; Gavras, H; Lamperti, E; Yu, J1
Fan, D; Li, L; Wang, C; Wu, LL; Zhang, ZG; Zhu, Y1
Akie, Y; Aritomi, S; Nakamura, Y; Nakayama, A; Satoh, Y; Sugiyama, A; Takahara, A; Wagatsuma, H1
Du, X; Liang, Y; Mao, Z; Sun, Z1
Abe, J; Beavo, JA; Blaxall, BC; Cai, Y; Chen, YF; Florio, V; Li, JD; Miller, CL; Nagel, DJ; Oikawa, M; Rybalkin, SD; Wojtovich, AP; Xu, H; Xu, X; Yan, C1
McLemore, GR; Ryan, MJ; Stec, DE; Storm, MV; Vera, T1
Ai, D; Shyy, JY; Zhu, Y1
Born, W; Brain, SD; Clark, N; Fischer, JA; Husmann, K; Keeble, J; Liang, L; Poston, R; Pozsgai, G; Shah, A; Siow, R; Tam, CW1
Takimoto, E1
Ardanaz, N; Carretero, OA; Cifuentes, ME; Haurani, MJ; Jackson, KW; Liao, TD; Pagano, PJ; Yang, XP1
Cheng, X; Furukawa, M; Li, P; Murohara, T; Nagata, K; Ohashi, T; Ouchi, N; Shibata, R; Shimano, M; Unno, K1
Almeida, PW; Bader, M; Campagnole-Santos, MJ; Gomes, ER; Guatimosim, S; Guimarães, D; Lara, AA; Resende, RR; Santos, RA1
Hu, D; Li, Y; Liu, N; Ren, L; Sheng, Z; Tang, R1
Brower, GL; Janicki, JS; Levick, SP; Murray, DB1
Biala, A; Eriksson, O; Finckenberg, P; Kaheinen, P; Lapatto, R; Lempiäinen, J; Louhelainen, M; Luft, FC; Martonen, E; Mattila, I; Merasto, S; Mervaala, E; Muller, DN; Oresic, M1
Ahmad, S; Davidoff, KS; Desjardins, DM; Ewen, EP; Gavras, H; Kielbasa, OM; Mathew, M; McCalmon, SA; Naya, FJ; Ohashi, K; Sato, K; Snyder, CM; Walsh, K1
Adler, GK; Coutinho, P; Guo, C; Lapointe, N; Loutraris, P; Pojoga, LH; Ricchiuti, V; Romero, JR; Stone, JR; Williams, GH; Yao, TM1
Crowley, SD; Griffiths, R; Kim, HS; Lin, EE; Ruiz, P; Song, YS1
Aihara, K; Akaike, M; Ikeda, Y; Ishikawa, K; Iwase, T; Matsumoto, T; Sata, M; Soeki, T; Sumitomo-Ueda, Y; Yagi, S; Yoshida, S1
Bai, Y; Dejima, T; Hirawa, N; Horiuchi, M; Ichihara, N; Ishigami, T; Kobayashi, Y; Maeda, A; Masuda, S; Matsuda, M; Minamisawa, S; Mogi, M; Shigenaga, A; Tamura, K; Tanaka, Y; Toya, Y; Umemura, S; Wakui, H; Yabana, M1
Anwar, MM; Euler, G; Heger, J; Piper, HM; Schiegnitz, E; von Waldthausen, D1
Chappell, MC; Ferrario, CM; Gallagher, PE; Ganten, D; Groban, L; Trask, AJ; Varagic, J; Westwood, BM1
Cai, Y; Ma, CG; Pan, CS; Qi, YF; Tang, CS; Yang, JH; Zhao, J1
Abramowitz, J; Baba, HA; Birnbaumer, L; Dietrich, A; Feil, R; Feil, S; Freichel, M; Gerling, A; Klaiber, M; Kruse, M; Kuhn, M; Londoño, JE; Penninger, JM; Pongs, O; Schröter, J; Völker, K1
Hu, Z; Liu, Y; Ma, C; Shi, H; Wu, D; Zhou, J1
Chen, C; Fu, Y; Wang, W; Wang, X; Yu, W1
Apablaza, F; Chiong, M; Godoy, I; Gonzalez, L; Hernandez, C; Jalil, JE; Lavandero, S; Lopez, R; Moya, J; Novoa, U; Ocaranza, MP; Pinto, M; Varas, M; Verdejo, H1
Biala, A; Finckenberg, P; Louhelainen, M; Martonen, E; Merasto, S; Mervaala, E; Muller, DN; Shi, J; Siltanen, A; Tauriainen, E1
Berké, B; Imam, G; Kerim, P; Moore, N; Tohti, I; Umar, A; Yimin, W1
Bruneval, P; Campbell, DJ; Karam, H; Ménard, J; Mullins, JJ1
Cheng, J; Du, J; Entman, ML; Haudek, SB; Hermosillo-Rodriguez, J; Taffet, GE; Trial, J; Wang, Y1
Adrahtas, A; Bertucci, MC; Cheung, RY; Krum, H; Ma, JY; Wang, BH1
Jiang, SY; Ma, XW; Xiao, H; Xu, M; Zhang, YY1
Alvin, Z; Haddad, GE; Laurence, G; Li, C; Zhao, A1
Gai, Y; Gao, W; Li, Z; Liu, F; Liu, X; Xu, M; Zhang, Y1
Cai, WF; Hu, ZW; Lv, XX; Ma, YG; Wang, QQ; Wang, XX; Wang, ZY; Xin, BM; Yan, HM; Yan, J; Yang, HZ; Zhang, XW1
Ai, W; Bai, X; Bian, ZY; Huang, H; Li, H; Liu, C; Tang, QZ; Yan, L; Yin, L; Zhang, Y1
Ge, J; Gong, H; Li, L; Niu, Y; Sun, A; Wu, J; Zhou, N; Zou, Y1
Bers, DM; Blatter, LA; Bodi, I; DeSantiago, J; Domeier, TL; Lorenz, JN; Maillet, M; Mikoshiba, K; Molkentin, JD; Nakayama, H1
An, W; Lin, Y; Liu, J; Yang, Y; Zang, W; Zhou, J1
Aihara, K; Akaike, M; Hirata, Y; Ikeda, Y; Ise, T; Ishikawa, K; Iwase, T; Kato, S; Matsumoto, T; Sata, M; Sumitomo-Ueda, Y; Uemoto, R; Yagi, S; Yoshida, S1
Cervenka, L; Husková, Z; Kramer, HJ; Kujal, P; Mrázová, I; Rakusan, D; Thumová, M; Vanecková, I; Vanourková, Z; Vernerová, Z1
Chen, SL; Chen, YL; Dong, YG; He, JG; Huang, YY; Ma, H1
Basu, R; Byrns, S; Chow, FL; Guo, D; Kassiri, Z; Loibner, H; Oudit, GY; Penninger, JM; Schuster, M; Wang, XH; Zhong, J1
Cao, Y; Duan, H; He, L; Zhan, Y; Zhang, Y1
Bestvater, BP; Fandrich, RR; Kardami, E; Ma, X; McNaughton, LJ; Netticadan, T; Nickel, BE; Santiago, JJ; Yu, L1
Casarini, DE; Coelho, MS; Ferreira, DN; Furukawa, LN; Heimann, JC; Katayama, IA; Oliveira, IB; Rosa, KT1
Dai, W; He, W; Jiang, J; Kong, W; Shang, G; Wang, Y1
Das, K; Estes, AM; Fang, XR; Farjana, N; Gonzalez, FJ; Jennings, BL; Malik, KU; Sahan-Firat, S1
Chang, H; Che, HL; Guo, WG; Song, Z; Wang, T; Wang, YY; Xie, MJ; Yu, ZB; Zhang, L1
Cervenka, L; Chábová, VČ; Husková, Z; Kompanowska-Jezierska, E; Kopkan, L; Kramer, HJ; Kujal, P; Malý, J; Netuka, I; Opočenský, M; Rakušan, D; Sadowski, J; Schejbalová, S; Skaroupková, P; Vaněčková, I; Vaňourková, Z; Vernerová, Z; Walkowska, A1
Bai, B; Chen, GP; Hu, SJ; Li, L; Mou, Y; Ye, Y1
Bian, ZY; Chen, M; Li, H; Liu, C; Liu, PP; Moon, M; Nghiem, MP; Tang, QZ; Wang, AB; Yan, L; Zhang, Y1
Ali, NN; Földes, G; Gorelik, J; Harding, SE; Liu, AQ; Merkely, B; Mioulane, M; Novak, P; Schneider, MD; Wright, JS1
Chow, FL; Cooper, S; Fernandez-Patron, C; Kassiri, Z; Lopaschuk, G; Odenbach, J; Oka, T; Wang, X1
Arthur, HM; Borthwick, GM; Watkins, SJ1
Ge, J; Gong, H; Jiang, G; Li, L; Lin, L; Ye, Y; Zhang, G; Zhou, N; Zou, Y1
Gao, W; Guo, Y; Li, L; Mi, L; Wang, X; Yu, H1
Domenighetti, AA; Egger, M1
Kaye, DM; Kelly, RA; Smith, TW2
Etienne-Selloum, N; Kane, MO; Keravis, T; Lugnier, C; Mokni, W; Schini-Kerth, VB; Walter, A1
Hu, YE; Wu, Y1
Chen, WY; Dai, G; Leng, XY; Li, CL; Sun, XT; Tang, LL; Zeng, WT1
Abdellatif, M; Ago, T; Sadoshima, J; Yang, Y; Zhai, P1
Harding, P; He, Q; Lapointe, MC; Yang, XP1
Cui, T; Janicki, JS; Li, J; Tang, DQ; Wang, XL; Xing, Y; Yamamoto, M; Zhang, C1
Audibert, F; Boivin, A; Fouron, JC; Le Ray, C; Leduc, L; Mercanti, I; Nuyt, AM; Vlieghe, V; Wo, B1
Imai, Y; Manabe, I; Nagai, R; Nakajima, A; Ohba, Y; Osawa, T; Takaoka, A; Taniguchi, T; Tsushima, K; Yanai, H1
Ai, D; Guan, YF; Li, N; Niu, XL; Pang, W; Zhu, Y1
Sun, H; Wang, Y1
Chen, T; Chin, MT; Dai, DF; Dorn, GW; Johnson, SC; Kang, YJ; Marcinek, DJ; Nieves-Cintrón, M; Prolla, TA; Rabinovitch, PS; Santana, LF; Villarin, JJ1
Berk, BC; Blaxall, BC; Cui, Z; Jaffré, F; Lu, Y; Menon, P; Mohan, A; Nigro, P; O'Dell, MR; Oikawa, M; Satoh, K; Soe, NN; Yan, C; Zeidan, A1
Chang, MH; Chu, CH; Hu, WS; Huang, CY; Lo, JF; Lu, RB; Tsai, CH; Tsai, FJ; Tzang, BS; Weng, YS1
Alvin, Z; Coleman, BR; Haddad, GE; Hajj-Moussa, M; Laurence, GG; Zhao, A1
Booz, GW; Kurdi, M1
Dai, DF; Rabinovitch, P1
Chen, J; Entman, ML; Lin, SC; Miao, Y; Taffet, GE; Wang, Y; Xu, J1
Jing, Q; Li, Q; Qin, YW; Song, XW; Wang, GK; Xu, XD1
Böhm, M; Maack, C1
Essick, EE; Ghobrial, J; Ohashi, K; Ouchi, N; Pimentel, DR; Sam, F; Shibata, R; Wilson, RM1
Alvin, ZV; Coleman, BR; Haddad, GE; Hajj-Moussa, M; Laurence, GG; Zhao, A1
Hoit, BD; Lee, HG; Liner, A; Richardson, SL; Smith, MA; Wolfram, JA; Zhu, X1
Chatterjee, A; Dutta, D; Mir, SA; Mitra, A; Pathak, K; Sarkar, S1
Coffman, TM; Crowley, SD; Griffiths, R; Herrera, M; Ruiz, P; Zhang, J1
Hanatani, A; Iwao, H; Izumi, Y; Muro, T; Nakamura, Y; Shimada, K; Shiota, M; Yamashita, N; Yamazaki, T; Yoshiyama, M1
Li, L; Li, ZZ; Su, DF; Wang, ZB; Wei, X; Yu, YS; Zhang, LC1
Chen, CX; Huang, XY; Li, YM; Liu, Y; Wu, XM; Zhang, XM1
Jiao, X; Jin, Z; Wang, J; Zhang, G; Zhang, W; Zhi, J1
Baumann, M; Eriksson, O; Finckenberg, P; Haasio, K; Kytö, V; Lalowski, MM; Levijoki, J; Luft, FC; Merasto, S; Mervaala, E; Muller, DN; Oresic, M1
Arthur, HM; Borthwick, GM; Oakenfull, R; Robson, A; Watkins, SJ1
Cartwright, EJ; Gui, J; Jin, J; Ke, Y; Lei, M; Liu, W; Naumann, R; Neyses, L; Prehar, S; Solaro, RJ; Taglieri, DM; Tsui, H; Ulm, S; Wang, X; Xiao, RP; Zi, M1
Barrick, CJ; Caron, KM; Dackor, RT; Lenhart, PM; Nagle, E1
Ann Tallant, E; Gallagher, PE; McCollum, LT1
Huang, J; Huang, X; Jin, H; Wang, D; Zheng, J1
An, L; Guo, X; He, L; Jia, J; Wu, J; Zhao, X; Zhu, H; Zou, Y1
Galatioto, J; Kamran, H; Lazar, JM; Liu, F; Mascareno, E; Pedrazzini, T; Rozenberg, I; Salciccioli, L; Siddiqui, MA1
Bustelo, XR; Campuzano, V; Coustets, M; Francke, U; Menacho-Márquez, M; Nevado, J; Pérez-Jurado, LA; Sánchez-Rodríguez, C; Segura-Puimedon, M; Terrado, V1
Cai, Y; Chen, SR; Ji, Y; Liu, PQ; Pi, RB; Shen, XY; Ye, JT; Yu, SS1
Adiarto, S; Emoto, N; Heiden, S; Nakayama, K; Vignon-Zellweger, N; Yagi, K; Yanagisawa, M1
Kato, J; Kida, N; Kitamura, K; Komatsu, Y; Kuwasako, K; Nagata, S; Nozaki, N1
Backs, J; Dierck, F; Frank, D; Frey, N; Katus, HA; Krebs, J; Kuhn, C; Lehmann, LH; Oehl, U; Will, R1
Cai, Y; Chen, SR; Gao, S; Li, H; Liu, PQ; Pi, RB; Ye, JT; Yu, SS1
Alexander, AE; Cao, AH; Irvine, JC; Kaye, DM; Kemp-Harper, BK; Lin, EQ; Love, JE; McMullen, JR; Patel, R; Ritchie, RH1
Ding, R; Frank, GD; Inagami, T; Landon, EJ; Pandolfi, PP; Rachakonda, A; Senbonmatsu, T; Tan, Z; Wang, N1
Du, ZM; Han, HM; Hang, PZ; Jiang, YN; Liu, Y; Pan, ZW; Song, HX; Sun, LH; Wang, S1
Chandrasekar, B; Clark, RA; Siddesha, JM; Siebenlist, U; Valente, AJ1
Chuah, M; Creemers, EE; Hiller, M; Leenders, JJ; Pinto, YM; Swinnen, M; van der Made, I; Vandendriessche, T; Wijnen, WJ1
Azibani, F; Chatziantoniou, C; Delcayre, C; Fazal, L; Samuel, JL1
Basu, R; Das, SK; Kassiri, Z; Lopaschuk, GD; McLean, BA; Mori, J; Oudit, GY; Patel, VB; Wagg, CS; Zhang, L1
Aoki, H; Imaizumi, T; Kyogoku, S; Minami, T; Nagata, T; Oba, T; Ohmura, H; Ohshima, H; Sugi, Y; Yasukawa, H1
Bartolomé, MV; Cachofeiro, V; Cordova, C; Delgado, C; Gómez-Hurtado, N; Jurado-López, R; Lahera, V; Martín, R; Martínez-Martínez, E; Miana, M; Nieto, ML; San Román, JA1
Binger, KJ; Bowman, EP; Dechend, R; Fokuhl, V; Kleinewietfeld, M; Kvakan, H; Markó, L; Müller, DN; Park, JK; Qadri, F; Spallek, B1
Aiello, EA; De Giusti, VC1
Feng, Y; Hans, C; Lazartigues, E; McIlwain, E; Varner, KJ1
Chang, C; Chen, HZ; Du, XD; Han, J; He, JP; Luo, J; Shan, ZG; Su, ML; Wang, RH; Wang, WJ; Wang, Y; Wu, Q; Xu, M; Zhang, N; Zhao, BX; Zhao, WX1
Chen, C; Dong, DL; Guo, WT; Huo, R; Li, CB; Li, N; Li, Y; Liu, HB; Sheng, Y; Sun, B; Xie, X; Yang, BF; Zhu, JX1
Cai, Y; Gao, S; Geng, B; Liu, M; Liu, P; Lu, J; Ye, J; Yu, S; Zhang, L; Zou, J1
Hiroi, Y; Ito, M; Li, Y; Liao, JK; Liu, PY; Noma, K; Okamoto, R; Taniguchi, M1
Chen, GP; Hu, SJ; Mou, Y; Yang, J; Ye, Y; Zhao, CZ; Zhu, HH1
Fujita, S; Hiroe, M; Hosotani, N; Imanaka-Yoshida, K; Ishizaka, N; Kitaura, Y; Kohda, Y; Nishioka, T; Otsuka, K; Shimojo, N; Tanaka, T; Terasaki, F; Yoshida, T1
Chu, SL; Gao, PJ; Guo, SJ; Jia, N; Li, XB; Li, YQ; Niu, WQ; Zhu, DL1
Crawford, JR; Duerrschmid, C; Entman, ML; Haudek, SB; Reineke, E; Taffet, GE; Trial, J1
Fu, FY; Lei, H; Li, L; Wang, C; Wang, JY; Wu, LL; Wu, LP; Zhang, ZG; Zhu, WG1
Booz, GW; Fuseler, JW; Hall, JE; Hamza, S; Kurdi, M; Lopez-Ruiz, A; Soljancic, A; Zgheib, C; Zouein, FA1
Alrob, OA; Harris, RA; Lopaschuk, GD; Mori, J; Oudit, GY; Wagg, CS1
Ban, T; Komeda, M; Nagata, K; Nakai, A; Nishizawa, J1
Dell'Italia, LJ; Husain, A1
Ichihara, S; Iwase, M; Izawa, H; Nagasaka, T; Nagata, K; Nakashima, N; Obata, K; Odashima, M; Somura, F; Yamada, Y; Yokota, M1
Azuma, J; Baba, A; Hattori, M; Komatsu, K; Nakamura, N; Ouyang, X; Takahashi, K2
Adachi, Y; Fukamizu, A; Garbers, DL; Harada, M; Izumi, T; Kawakami, R; Kishimoto, I; Kuwahara, K; Li, Y; Nakagawa, Y; Nakanishi, M; Nakao, K; Saito, Y; Takahashi, N; Tanimoto, K1
Inagaki, K; Iwanaga, Y; Kihara, Y; Mochly-Rosen, D; Onozawa, Y; Sarai, N; Takenaka, H1
Eckhart, AD; Greene, EA; Keys, JR; Koch, WJ1
Bader, M1
Chen, LY; Chen, PM; Li, P; Wang, SW1
Kobalava, ZhD; Korovina, EP; Kotovskaia, IuV; Moiseev, VS; Nosikov, VV; Timofeeva, SG1
Altruda, F; Brancaccio, M; De Acetis, M; Fratta, L; Guazzone, S; Hirsch, E; Lembo, G; Marino, G; Notte, A; Poulet, R; Silengo, L; Tarone, G; Vecchione, C1
Fu, MG; Tang, CS1
Araujo, RC; Bader, M; Borges, JC; Gomes, MA; Leite, KM; Lomez, ES; Pesquero, JB; Pesquero, JL; Silva, JA1
Dusting, GJ; Ritchie, RH; Rosenkranz, AC; Woods, RL1
Cheng, L; Jiang, MX; Li, XH; Xia, GJ; Yao, WX1
Cheng, ZJ; Finckenberg, P; Louhelainen, M; Merasto, S; Mervaala, EM; Tikkanen, I; Vapaatalo, H1
Cristol, JP; Delbosc, S; Jover, B; Mimran, A; Rugale, C1
Matsuoka, S; Nagaoka, M; Okamoto, H; Shimazu, E; Takano, M; Yayama, K1
De Smet, HR; Menadue, MF; Oliver, JR; Phillips, PA1
Adams, MA; Angelis, E; Pak, BJ; Pang, SC; Sangaralingham, SJ; Smallegange, C; Tse, MY1
Catt, KJ; Shah, BH1
Liao, JK; Nakagami, H; Takemoto, M1
Dechend, R; Finckenberg, P; Ganten, D; Lapatto, R; Luft, FC; Mervaala, E; Müller, DN; Park, JK; Vapaatalo, H1
Bond, R; Brinsa, TA; Dell'Italia, L; Diwan, A; Evans, K; Flesch, M; Höper, A; Mann, DL; Peshock, R; Sivasubramanian, N; Spinale, FG; Wei, CC1
Sweitzer, NK1
Fu, M; Liu, N; Pang, Y; Tang, C; Xu, S; Zhang, J1
Hattori, T; Higashi, M; Hiroki, J; Ichiki, T; Morikawa, K; Mukai, Y; Shimokawa, H; Takahashi, S; Takeshita, A1
Chamorro, V; Duarte, J; O'Valle, F; Osuna, A; Sainz, J; Vargas, F; Wangensteen, R1
Bendall, JK; Byrne, JA; Cave, AC; Gove, C; Grieve, DJ; Lambeth, JD; Li, JM; Shah, AM1
Ichijo, H; Iwao, H; Izumi, Y; Izumiya, Y; Kim, S; Matsuzawa, A; Yoshida, K; Yoshiyama, M1
Grayburn, PA; Hammer, RE; Kedzierski, RM; Kisanuki, YY; Richardson, JA; Schneider, MD; Williams, CS; Yanagisawa, M1
Delbridge, LM; Domenighetti, AA; Huggins, CE; Pedrazzini, T; Pepe, S1
Capuano, V; Coulombe, A; Deroubaix, E; Ferron, L; Renaud, JF; Ruchon, Y1
Ebihara, A; Hirata, Y; Iimuro, S; Iwata, H; Nagai, R; Niu, P; Shindo, T; Suematsu, Y; Takeda, N; Zhang, Y1
Cheng, ZJ; Finckenberg, P; Helkamaa, T; Lapatto, R; Louhelainen, M; Luft, FC; Männistö, P; Merasto, S; Mervaala, EM; Müller, DN; Rauhala, P; Reenilä, I1
Ding, B; Guo, ZG; Li, YX; Zhang, SQ1
Ahn, HY; Kim, CH; Kim, EG; Kim, HS; Sachinidis, A; Song, HJ; Zheng, Y1
Athirakul, K; Coffman, TM; Francois, H; Mao, L; Rockman, H1
Chan, P; Chen, JJ; Chen, YL; Cheng, TH; Lee, HM; Lee, WS; Liu, JC; Shih, NL1
Bai, H; Liu, J; Wu, LL; Xing, DQ; Zhao, YL1
Bedigian, MP; Lu, L; Robinson, AD; Sun, Y; Weber, KT; Zhang, J1
Asanuma, M; Emori, T; Kakishita, M; Kusano, K; Matsubara, H; Morita, H; Nakamura, K; Nakamura, Y; Ogawa, N; Ohe, T; Saito, H; Sugaya, T1
Ebihara, A; Hirata, Y; Iimuro, S; Iwata, H; Kangawa, K; Nagai, R; Niu, P; Shindo, T; Suematsu, Y; Takeda, N; Zhang, Y1
Sarkar, S; Sen, S; Vellaichamy, E; Young, D1
Dusting, GJ; Huynh, LP; Kaye, DM; Ritchie, RH; Rosenkranz, AC; Stephenson, T1
Shen, FM; Su, DF; Tao, X; Zhang, SH1
Hara, Y; Imaki, T; Naruse, M; Nishikawa, T; Sato, A; Takano, K; Tanabe, A; Tsuchiya, K1
Bruemmer, D; Collins, AR; Fishbein, MC; Hsueh, WA; Kim, S; Law, RE; Nicholas, S; Ross, RS; Schnee, J; Wang, W1
Cupesi, M; Gannon, J; Huang, H; Lee, RT; MacGillivray, C; Schulze, PC; Sylvan, JD; Yoshioka, J1
Akino, M; Denhardt, D; Jia, N; Kitabatake, A; Kon, S; Liu, L; Matsui, Y; Morimoto, J; Okamoto, H; Onozuka, H; Rittling, SR; Uede, T1
Takeda, Y1
Chen, CX; Shen, YH1
Akazawa, H; Fujita, T; Fukamizu, A; Iiri, T; Iwanaga, K; Kihara, M; Komuro, I; Kudoh, S; Makita, N; Minamino, T; Nagai, T; Qin, Y; Sano, M; Takano, H; Tamura, K; Toko, H; Umemura, S; Zhu, W; Zou, Y1
Iwasaka, T; Okigaki, M1
Davisson, RL; Lazartigues, E; Sharma, RV; Zimmerman, MC1
Chau, LY; Chen, YH; Chiang, MT; Hu, CM1
Mascareno, E; Mathew, S; Siddiqui, MA1
Cattini, PA; Hirst, CJ; Jiang, ZS; Jimenez, SK; Kardami, E; Sheikh, F; Zahradka, P1
Fujita, M; Hirata, A; Hori, M; Kitakaze, M; Liao, Y; Minamino, T; Nagamachi, Y; Nakatani, T; Ogawa, S; Okada, K; Ozawa, K; Takashima, S; Tomoike, H; Tsukamoto, O; Tsukamoto, Y; Yutani, C1
Eto, T; Kato, J; Tsuruda, T1
Hasegawa, H; Komuro, I1
Gómez-Fernández, P1
Black, MJ; Jones, ES; Widdop, RE1
Chan, HW; Hannan, RD; Osborne, JE; Smith, NJ; Thomas, WG1
Hao, DL; Huang, Y; Hui, RT; Li, HL; Liang, CC; Lin, M; Liu, DP; Liu, G; Liu, YQ; Wang, AB; Wei, C; Williams, GM; Zhang, CN1
Allessie, M; Blaauw, Y; Eijsbouts, S; Neuberger, HR; Schotten, U; van Hunnik, A; Verheule, S1
Wang, YX1
Hoshijima, M; Iwata, M; Kuroda, S; Maturana, A; Okajima, T; Tanizawa, K; Tatematsu, K; Van Lint, J; Vandenheede, JR1
Finckenberg, P; Lindgren, L; Louhelainen, M; Luft, FC; Merasto, S; Mervaala, EM; Müller, DN; Vapaatalo, H1
Li Volti, G1
Callera, GE; He, Y; Javeshghani, D; Lochard, N; Mercure, C; Reudelhuber, TL; Touyz, RM; Yao, G; Yogi, A1
Goldberg, AL; Izumiya, Y; Lecker, S; Maatz, H; Pimentel, D; Razeghi, P; Sandri, M; Sato, K; Schiekofer, S; Shiojima, I; Skurk, C; Taegtmeyer, H; Walsh, K; Zeng, L1
Curl, CI; Delbridge, LM; Domenighetti, AA; Huggins, CE; Morgan, TO; Pedrazzini, T; Porrello, ER1
du Toit, EF; Lochner, A; Nabben, M1
Choy, DF; da Cunha, V; Dole, WP; Halks-Miller, M; Johns, A; Li, W; Light, DR; Mahmoudi, M; Martin-McNulty, B; Schroeder, M; Vincelette, J; Wang, YX1
de Champlain, J; Laplante, MA; Wu, R1
Baurand, A; Bergmann, MW; Dietz, R; Dunger, S; El-Jamali, A; Freund, C; Loser, P; Scheidereit, C; Schmidt-Ullrich, R; Schneider, W1
Pagliaro, P; Penna, C1
Guo, ZQ; Wang, SR; Zhu, LQ1
Madeddu, P1
Hashikabe, Y; Hattori, Y; Kase, H; Nakanishi, N; Uchida, K1
Aihara, K; Akaike, M; Azuma, H; Fujimura, M; Hashizume, S; Ikeda, Y; Izawa, Y; Kato, M; Kato, S; Kawano, H; Matsumoto, T; Sato, T; Suzaki, Y; Tamaki, T; Yagi, S; Yoshizumi, M1
Ishida, H; Ito, H; Takemori, K1
Asai, T; Fujita, H; Kanmatsuse, K; Kushiro, T1
Booz, GW1
Delbridge, LM; Domenighetti, AA; Egger, M; Pedrazzini, T; Richards, SM; Wang, Q1
Averill, DB; Brosnihan, KB; Ferrario, CM; Schiffrin, EL; Smith, RD; Yokoyama, H1
Goens, MB; Lund, AK; Nuñez, BA; Walker, MK1
Li, T; Liu, X; Sun, S; Wang, Y; Xu, F1
Arimoto, T; Konta, T; Koyama, Y; Kubota, I; Niizeki, T; Shishido, T; Takahashi, H; Takeishi, Y1
Aiqun, M; Geru, W; Tao, G; Xiaojun, B; Yutao, X1
Carretero, OA; Liao, TD; Motivala, A; Peng, H; Peterson, EL; Rhaleb, NE; Vuljaj, N1
Feng, B; He, ZY; Liu, W; Xu, J; Yang, HB1
Iwao, H; Izumi, Y; Izumiya, Y; Kim-Mitsuyama, S; Namba, M; Wake, R; Yoshida, K; Yoshiyama, M1
Kim, HH; Liao, JK; Noma, K; Oyama, N; Rikitake, Y; Satoh, M; Wang, CY1
Akimoto, K; Hattori, Y; Kasai, K; Matsuoka, H; Nishikimi, T1
Abe, J; Arimoto, T; Endoh, M; Goto, K; Koyama, Y; Kubota, I; Nakajima, O; Niizeki, T; Nishimaru, K; Nozaki, N; Shiga, R; Shishido, T; Takahashi, H; Takeishi, Y; Walsh, RA1
Ahn, Y; Bang, YJ; Epstein, JA; Jeong, MH; Kee, HJ; Kim, JK; Kim, KK; Kim, N; Kook, H; Nam, KI; Park, JE; Qian, YR; Sohn, IS; Yin, Z1
Fujioka, D; Kawabata, K; Kitta, Y; Kobayashi, T; Kodama, Y; Kugiyama, K; Nakamura, T; Obata, JE; Saito, Y; Takano, H; Umetani, K1
Cui, W; Han, C; Jia, X; Li, N; Liu, C; Liu, Z; Mao, W; Song, Y; Wang, W; Zhang, W; Zhang, X1
Han, Z; Xiang, J; Yang, Y; Zhang, K1
Ikushima, M; Ito, N; Kaibe, M; Katsuya, T; Ogihara, T; Ohishi, M; Rakugi, H; Shiota, A; Sugano, S; Takeda, S; Tatara, Y; Yamamoto, K1
Aizawa, Y; Gurusamy, N; Hirabayashi, K; Kodama, M; Ma, M; Muslin, AJ; Prakash, P; Watanabe, K; Zhang, S1
Liu, ZP; Liu, ZQ; Song, Y; Zhang, XP1
Liu, YX; Sheng, L; Ye, P1
Gupta, M; Gupta, MP; Lang, R; Pillai, JB; Rajamohan, SB; Raman, J1
Kwiatkowski, DJ; Liao, JK; Mukai, Y; Ogita, H; Satoh, M; Takeshita, K1
Böhm, M; Custodis, F; Eberl, M; Kilter, H; Laufs, U1
Adachi, S; Isobe, M; Ito, H; Kitajima, S; Maejima, Y; Morikawa-Futamatsu, K; Suzuki, J; Tamamori-Adachi, M1
Abdallah, Y; Helmig, S; Piper, HM; Schäfer, C; Schlüter, KD; Wenzel, S1
Huang, Y; Hui, RT; Li, HL; Liang, CC; Liu, DP; Liu, G; Liu, YQ; Wang, AB; Wei, C; Wei, YS; Williams, GM; Zhang, CN1
Guo, WG; Xie, MJ; Yu, ZB1
Javadov, S; Karmazyn, M; Kirshenbaum, LA; Purdham, DM; Rajapurohitam, V1
Chappell, MC; Westwood, BM; Yamaleyeva, LM1
Tian, Y; Wang, J; Yu, LJ; Zhou, YZ; Zhu, SJ; Zhu, ZM1
Kim-Mitsuyama, S1
Galeotti, J; Holle, E; Liu, J; Sadoshima, J; Wagner, T; Yu, X; Zhai, P1
Iwanaga, Y; Kihara, Y; Kita, T; Takenaka, H1
Evangelista, FS; Krieger, JE1
Berenji, K; Castrillon, DH; Cheng, J; Dey, A; Gerard, RD; Hill, JA; Lu, G; Morris, DJ; Ni, YG; Oh, M; Rothermel, BA; Sachan, N; Wang, N1
Asada, Y; Eto, T; Imamura, T; Kato, J; Kitamura, K; Masuyama, H; Stasch, JP; Tsuruda, T1
Abriel, H; Boixel, C; Cefai, D; Domenighetti, AA; Pedrazzini, T1
Inoue, R; Kobayashi, H; Kurose, H; Mori, Y; Nagao, T; Nishida, M; Onohara, N; Sato, Y; Sumimoto, H1
Coles, JG; Dai, X; Du, C; Fedak, PW; Hannigan, G; Henkelman, M; Hinek, A; Husain, M; Lau, A; Lu, H; Mongroo, PS; Yamabi, H; Zhou, YQ1
Coffman, TM; Crowley, SD; Griffiths, R; Gurley, SB; Herrera, MJ; Kim, HS; Kumar, AP; Le, TH; Ruiz, P; Smithies, O1
Bolton, TA; Grobe, JL; Katovich, MJ; Lingis, M; Machado, JM; Mecca, AP; Raizada, MK; Shenoy, V; Speth, RC1
Alvarez, BV; Casey, JR; Johnson, DE; Karmazyn, M; Light, PE; Soliman, D; Sowah, D; Xia, Y1
Bu, DF; Li, YG; Liu, BG; Pang, YZ; Tan, XR; Tang, CS; Wang, DM; Wei, RH; Zhang, YG1
Sheng, L; Wu, SM; Yang, W; Ye, P1
Griffin, AJ; Gupta, M; Kumbar, DH; Muangmingsuk, S; Ocampo, C; VanBergen, A1
Cervenka, L; Husková, Z; Kolský, A; Kramer, H; Malý, J; Opocenský, M; Skaroupková, P; Thumová, M; Vanourková, Z; Vernerová, Z1
Averill, DB; Chappell, MC; Ferrario, CM; Ganten, D; Trask, AJ1
Ahuja, P; Ehler, E; Pedrazzini, T; Perriard, E; Perriard, JC; Satoh, S1
Chen, S; Huang, H; Li, R; Liu, P; Tang, F; Wang, P; Zhang, H1
Chen, H; Feng, J; Li, S; Liang, Q; Wang, Z; Yan, L; Yang, L; Yao, S; Zheng, Z; Zhou, D; Zou, X1
Cingolani, HE; Ennis, IL1
Baurand, A; Bergmann, MW; Betney, R; Birchmeier, W; Busjahn, A; Dietz, R; Dunger, S; Gehrke, C; Huelsken, J; Noack, C; Taketo, MM; Zelarayan, L1
Dechend, R; Dietz, R; Fiebeler, A; Fischer, R; Gapelyuk, A; Gratze, P; Gruner, A; Gruner, K; Luft, FC; Muller, DN; Qadri, F; Schirdewan, A; Shagdarsuren, E; Wellner, M1
Li, HL; Li, TB; Liu, DP; She, ZG; Wang, AB; Wang, YG; Wei, YS; Yang, Q1
Anning, PB; Baalasubramanian, S; Coles, B; Lewis, R; Morgan, BP; Morton, J; O'Donnell, VB1
Chen, H; Cheng, Y; Dean, DB; Ji, R; Liu, X; Yang, J; Yue, J; Zhang, C1
Pandey, KN; Somanna, N; Vellaichamy, E; Zhao, D1
Coles, B; Fielding, CA; Jones, SA; O'Donnell, VB; Rose-John, S; Scheller, J1
Delbosc, S; Jover, B; Mimran, A; Rugale, C1
Gao, GD; Lin, YX; Liu, JJ; Xu, X; Zhou, J1
Fukunaga, K; Han, F; Kasahara, J; Lu, YM; Moriguchi, S; Qin, ZH; Shioda, N; Shirasaki, Y1
Anéas, I; Carmo, EC; Frimm, C; Hashimoto, NY; Krieger, JE; Negrão, CE; Oliveira, EM; Rocha, FL; Roque, FR; Rossoni, LV1
Bak, S; Coleman, T; Osher, E; Semenkovich, CF; Stern, N; Tordjman, KM; Vechoropoulos, M; Yudovich, R1
Ishikawa, K; Kamiyama, Y; Kimura, S; Kobayashi, A; Maruyama, Y; Matsumoto, H1
Frank, D; Frey, N; Gehring, D; Hanselmann, C; Katus, HA; Kuhn, C; Lippl, S; van Eickels, M; Will, R1
Bernstein, EA; Bernstein, KE; Campbell, DJ; Fuchs, S; Li, P; Xiao, HD1
Akazawa, H; Komuro, I; Qin, Y; Yasuda, N; Zou, Y1
Carretero, OA; Harding, P; Peng, H; Pokharel, S; Rasoul, S; Rhaleb, NE; Sharma, U1
Yang, L; Yao, SL; Zou, XJ1
Baker, KM; Kumar, R; Singh, VP1
Han, CG; Liu, YX; Sheng, L; Ye, P; Zhang, ZY1
Li, HZ; Lin, Y; Lv, YJ; Tian, Y; Wang, C; Wang, LN; Xi, YH; Xu, CQ; Yang, BF; Zhang, WH; Zhao, YJ1
An, J; Dietz, R; Endres, M; Gertz, K; Harms, C; Hauck, L; Rohne, J; von Harsdorf, R1
Balestrasse, KB; Gorzalczany, S; Noriega, GO; Polizio, AH; Taira, C; Tomaro, ML; Yannarelli, GG1
Chang, H; Kuan, P; Shyu, KG; Wang, BW1
Levin, ER; Liu, J; Lubahn, D; Pedram, A; Razandi, M; Vannan, M1
Francis, J; Haque, M; Majid, DS; Sriramula, S1
Leenen, FH; Liang, B1
Ehrlich, BE; Estrada, M; Giordano, FJ; Heidrich, FM; Huang, Y; Zhang, K1
Hou, Y; Matsuo, O; Okada, K; Okamoto, C; Ueshima, S1
Burchette, JL; Coffman, TM; Crowley, SD; Frey, CW; Gould, SK; Griffiths, R; Howell, DN; Kim, HS; Makhanova, N; Ruiz, P; Tharaux, PL; Yan, M1
Khairallah, P; Saragoca, M; Sen, S; Tarazi, RC1
Abrahams, JM; Johnston, CI; Woods, RL1
Berglund, G; Hartford, M; Ljungman, S; Wallentin, I; Wikstrand, J; Wilhelmsen, L1
Greenlees, KJ; Migally, N; Tucker, A; Wright, ML1
Hill, NS; Ou, LC1
Doussau, MP; Giudicelli, JF; Richer, C1
Ishiye, M; Nakashima, M; Uematsu, T; Umemura, K2
Lee, YA; Lindpaintner, K; Raman, VK1
Fareh, J; Schiffrin, EL; Thibault, G; Touyz, RM2
Kawamura, K; Kubota, J; Mori, T; Nishimura, H; Ueyama, M1
Fronhoffs, S; Luyken, J; Neyses, L; Nouskas, J; Oberdorf, S; Pfeifer, U; Sukhatme, VP; Vetter, H; Williams, RS1
Rabkin, SW1
Abassi, ZA; Cuda, G; Golomb, E; Keiser, HR; Panchal, VR; Stylianou, M; Trachewsky, D1
Rabkin, SW; Sunga, PS3
Dillmann, WH; Kim, NN; Lee, AA; Printz, MP; Villarreal, FJ1
Parker, TG1
Ikenouchi, H; Kinugawa, K; Kohmoto, O; Serizawa, T; Takahashi, T; Yao, A1
Izumo, S; Sadoshima, J3
Iwai, N; Kinoshita, M; Shimoike, H1
Hiroi, Y; Komuro, I; Kudoh, S; Mizuno, T; Shiojima, I; Takano, H; Tobe, K; Ueki, K; Yamazaki, T; Zou, Y2
Rao, MR; Tao, L; Wang, HX1
Lorell, BH3
Xu, S; Zhang, Y1
Chatani, F; Hamaguchi, A; Inada, Y; Ishimura, Y; Iwao, H; Kim, S; Miura, K; Ohta, K; Omura, T; Yukimura, T1
Li, JS; Schiffrin, EL1
Besse, P; Bonoron-Adèle, S; Gouverneur, G; Sempé, S; Stuyvers, B; Tariosse, L1
Chien, KR; Hunter, JJ; Lembo, G1
Bezstarosti, K; De Jonge, HW; Lamers, JM; Sharma, HS; Van Heugten, HA; Verdouw, PD1
Liu, LS; Zhang, YH1
Hamaguchi, A; Iwao, H; Kim, S; Miura, K; Ohta, K; Yukimura, T1
Bertram, JF; Black, MJ; Bobik, A; O'Sullivan, JB1
Cao, ZP; Gao, GD; Liu, J; Lu, X; Tian, B1
Pollack, PS1
Cade, JR; Fregly, MJ; Hegland, D; Rossi, F; Sun, Z; Tümer, N; Yürekli, M1
Eguchi, S; Hirata, Y; Kanno, K; Kano, H1
Dohi, K; Iwano, M; Kagoshima, T; Konishi, N; Masuda, J; Nakamura, Y; Sakaguchi, Y; Sutani, T; Tsuchihashi, M; Tsuruta, S1
Hughes, AD; Ibrahim, J; Schachter, M; Sever, PS1
Falkenhahn, M; Gohlke, P; Paul, M; Stoll, M; Unger, T1
Fish, AF1
Haneda, T; Miyata, S1
Diamant, D; Ingelfinger, JR; Lopez, JJ; Lorell, BH; Schunkert, H; Tang, SS; Weinberg, EO1
Sano, H1
Brecher, P; Chobanian, AV; Crawford, DC1
Pouleur, H1
Everett, AD; Fisher, A; Gomez, RA; Tufro-McReddie, A1
Chiu, AT; Herblin, WF; Smith, RD; Timmermans, PB; Wong, PC1
Leenen, FH; Ruzicka, M1
Izumo, S; Sadoshima, J; Slayter, HS; Xu, Y1
Dillmann, WH; Kim, NN; Printz, MP; Ungab, GD; Villarreal, FJ1
Andreasen, F; Böttcher, M; Christiansen, EH; Tian, R1
Adachi, S; Hirata, Y; Hiroe, M; Ito, H; Koike, A; Murumo, F; Nogami, A; Tanaka, M; Tsujino, M1
Inada, M; Matsubara, H; Suzuki, J; Urakami, M1
Sakata, Y1
Dzau, VJ1
Casley, DJ; Doyle, AE; Harrap, SB; Mirakian, C; Mitchell, GA1
Harmsen, E; Leenen, FH; Ruzicka, M; Yuan, B1
Dillmann, WH; Lee, AA; McCulloch, AD; Villarreal, FJ1
Komuro, I; Kudoh, S; Takano, H; Yamazaki, T; Yazaki, Y; Zou, Y1
Anderson, NH; Bohr, DF; Devlin, AM; Dominiczak, AF; Lee, WK; Reid, JL1
Adachi, S; Akimoto, H; Fujisaki, H; Hata, M; Hiroe, M; Ito, H; Lin, M; Marumo, F; Tanaka, M1
Fitzpatrick, F; Goulet, JL; Höper, M; Koller, BH; Lepley, RA; Tuder, RM; Voelkel, NF; Wade, K1
Ganten, D; Nishimura, H; Urata, H1
Damen, JE; Goutsouliak, V; Krystal, G; Rabkin, SW1
Brunner, HR; Waeber, B1
Batlouni, M1
Sesin, J; Tamargo, J1
Heagerty, AM; Hollis, S; MacDiarmaid-Gordon, A; Ohanian, V; Roffe, C1
Iyer, SN; Katovich, MJ1
Haneda, T; Kikuchi, K; Miyata, S; Osaki, J1
Baker, KM; Booz, GW2
Lee, MA; Lee, YA; Liang, CS; Lindpaintner, K1
Perryman, MB; Raynolds, MV1
Fukamizu, A; Horiguchi, H; Ishida, J; Murakami, K; Sugiyama, F; Takimoto, E1
Carl, LL; Giger, KE; Hannan, R; Watson, PA1
Kawaguchi, H; Kitabatake, A1
Komuro, I; Shiojima, I; Yamazaki, T; Yazaki, Y3
Bauer, B; Bauer, WR; Ertl, G; Hu, K1
Abe, K; Jiang, ZL; Johnston, CI; Kamimoto, M; Kanazawa, M; Kohzuki, M; Sato, T; Wu, XM; Yasujima, M; Yoshida, K1
Barry, WH; Ito, N; Kagaya, Y; Lorell, BH; Weinberg, EO1
Gallagher, AM; Klett, CP; Palmer, A; Printz, MP; Rioseco-Camacho, N1
Boddi, M; Modesti, PA; Neri Serneri, GG1
Böhm, MP; Knorr, A; Laufs, U; Nickenig, G; Paul, M; Schnabel, P1
Bertram, JF; Black, MJ; Briscoe, T; Jackson, B; Johnston, CI1
Anderson, PG; Berecek, KH; Bishop, SP; Regan, CP1
Arai, M; Iso, T; Kogure, K; Nagai, R; Suzuki, T; Wada, A1
Balcells, E; Bishop, SP; Cartee, RE; Dell'italia, LJ; Dillon, R; Hankes, GH; Machida, N; Meng, QC; Oparil, S; Schultz, D; Straeter-Knowlen, IM; Su, X1
Bezstarosti, K; Dekkers, DH; Eskildsen-Helmond, YE; Lamers, JM; van Heugten, HA1
Arnold, G; Böhm, M; Flesch, M; Hirth-Dietrich, C; Paul, M; Pinto, Y; Rosenkranz, S; Schiffer, F; Zolk, O1
Black, MJ; Bobik, A; Kanellakis, P1
Cavaillon, JM; Charlemagne, D; Corda, S; Fitting, C; Gandolfini, MP; Marotte, F; Mebazaa, A; Payen, D; Peynet, J; Rappaport, L; Samuel, JL1
Harada, M; Igaki, T; Itoh, H; Kuwahara, K; Masuda, I; Miyamoto, Y; Nakagawa, O; Nakao, K; Ogawa, E; Ogawa, Y; Saito, Y; Tanaka, I; Yamashita, J; Yoshimasa, T1
Borg, TK; Carver, W; Fu, L; Price, RL; Simpson, DG; Terracio, L; Zhao, J1
Pelech, SL; Rabkin, SW; Sanghera, JS; Sunga, PS1
Fukuda, K; Hori, S; Kodama, H; Makino, S; Ogawa, S; Pan, J; Sano, M; Takahashi, T1
Kimura, M; Nakashima, M; Ohashi, K; Umemura, K1
Iwao, H; Kim, S1
Aikawa, R; Komuro, I; Kudoh, S; Nagai, R; Uozumi, H; Yamazaki, T; Yazaki, Y; Zou, Y1
Carabello, BA; Coffman, TM; Cooper, G; DeFreyte, G; Hamawaki, M; Koide, M; Lashus, A; Oliverio, MI; Zile, MR1
Iizuka, K; Kawaguchi, H; Kitabatake, A; Murakami, T; Okamoto, H; Sano, H1
Harada, K; Kijima, K; Komuro, I; Kudoh, S; Matsubara, H; Murakami, K; Sugaya, T; Yazaki, Y; Zou, Y1
Antos, CL; Grant, SR; Lu, JR; Markham, B; Molkentin, JD; Olson, EN; Richardson, J; Robbins, J1
Dhar, M; Mascareno, E; Siddiqui, MA1
Fukamizu, A; Goto, K; Kobayashi, T; Maeda, S; Maki, S; Miyauchi, T; Murakami, K; Sakai, S; Sugishita, Y; Sugiyama, F; Takata, Y1
Harada, K; Hayashi, D; Kijima, K; Komuro, I; Kudoh, S; Matsubara, H; Mizuno, T; Murakami, K; Shiojima, I; Sugaya, T; Yazaki, Y1
Aubert, JF; Brunner, DB; Brunner, HR; Gabbiani, G; Mazzolai, L; Nussberger, J; Pedrazzini, T1
Anversa, P; Cheng, W; Kajstura, J; Leri, A; Li, B; Liu, Y; Wang, X1
Azuma, J; Azuma, M; Baba, A; Schaffer, S; Takahahsi, K1
Rao, MR; Tao, L1
Aass, H; Bishopric, N; Fowler, M; Geiran, O; Gullestad, L; Haywood, G; Kjekshus, J; Ross, H; Simonsen, S; Ueland, T; Yee, G1
Fushimi, K; Kouchi, H; Mihara, K; Miyazaki, M; Nakamura, K; Namba, M; Ohe, T1
Beardslee, MA; Beyer, EC; Darrow, BJ; Dodge, SM; Green, KG; Saffitz, JE1
LaPointe, MC; Marsh, JD; Ritchie, RH; Schiebinger, RJ1
Iwao, H; Izumi, Y; Kim, S; Yamanaka, S; Yano, M1
Baker, KM; Dostal, DE2
Gorodetskaya, EA; Kalenikova, EI; Medvedev, OS; Shechter, AB; Zacharova, NV1
Sasayama, S1
Holtz, J1
Hayashi, M; Ichihara, A; Kobori, H; Miyashita, Y; Saruta, T1
Komuro, I; Yamazaki, T; Yazaki, Y2
Fukamizu, A; Ishikawa, K; Kai, T; Kurooka, A; Murakami, K; Shimada, S; Sugimura, K; Takenaka, T1
Delbridge, LM; Morgan, TO1
Gray, MO; Kalinyak, JE; Karliner, JS; Li, HT; Long, CS1
Cardinal, R; de Champlain, J; K-Laflamme, A; Oster, L1
Meissner, A; Min, JY; Simon, R1
Aikawa, R; Kadowaki, T; Komuro, I; Kudoh, S; Yamazaki, T; Yazaki, Y; Zhu, W; Zou, Y1
Carraway, JW; Holycross, BJ; McCune, SA; Park, S; Radin, MJ1
Ishikawa, K; Kai, T; Kurooka, A; Shimada, S; Sugimura, K1
Anastasopoulos, F; Briscoe, TA; Campbell, DJ; Duncan, AM; James, GM; Kladis, A1
Khirmanov, VN; Moiseeva, OM; Pinaev, GP; Polevaia, EV; Selivanova, GV; Semenova, EG; Vlasova, TD1
Bradley, WE; Dell'Italia, LJ; Durand, J; Farrell, DM; Hageman, GR; Hankes, GH; Meng, QC; Oparil, S; Palmer, R; Wei, CC1
Aupetit-Faisant, B; Carayon, A; Delcayre, C; Heymes, C; Oubénaïssa, A; Robert, V; Silvestre, JS; Swynghedauw, B1
Fukuda, K; Kato, T; Kodama, H; Matsuzaki, J; Ogawa, S; Pan, J; Saito, M; Sano, M; Takahashi, T1
Balaev, VV; Drozdova, GA; Frolov, VA; Mustiatsa, VF; Rieger, P1
Phillips, PA1
Dusting, GJ; Ritchie, RH; Rosenkranz, AC1
Haneda, T; Kashiwagi, Y; Kawabe, J; Kikuchi, K; Nakamura, Y; Oi, S; Osaki, J1
Ghatpande, S; Goswami, S; Mascareno, E; Siddiqui, MA1
Bastien, NR; Gutkowska, J; Lambert, C; Meloche, S; Servant, MJ1
Drexler, H; Wollert, KC1
Cody, RJ; Goetze, S; Graf, K; Hsueh, WA; Kawano, H; Kawano, Y; Law, RE; Schnee, J1
Bader, M; Baltatu, O; Ganten, D; Silva, JA1
Aoki, H; Izumo, S; Sadoshima, J1
De Windt, LJ; Lim, HW; Molkentin, JD; Taigen, T1
Bader, M; Breu, V; Ganten, D; Gross, V; Haller, H; Luft, FC; Mervaala, E; Müller, DN; Park, JK; Schmidt, F1
Cingolani, HE1
Hata, T; Makino, N; Ohtsuka, S; Sawada, S; Sugano, M1
Aoki, H; Izumo, S; Richmond, M; Sadoshima, J1
Hsueh, WA; Schnee, JM1
Demura, M; Mabuchi, H; Miyamori, I; Takeda, Y; Yoneda, T2
Bristow, J; Friddle, CJ; Koga, T; Rubin, EM1
Fukuda, K; Kato, T; Kodama, H; Makino, S; Matsuzaki, J; Ogawa, S; Pan, J; Saito, M; Sano, M; Takahashi, T1
Ferrario, CM; Gelband, CH; Katovich, MJ; Pachori, AS; Raizada, MK; Wang, H1
Oriji, GK1
Gerdes, AM; Harris, J; Lu, W; Said, S; Tamura, T1
Fu, M; Liu, N; Pang, Y; Su, J; Tang, C; Xu, S; Zhang, J1
Breu, V; Dechend, R; Ganten, D; Genersch, E; Haller, H; Löffler, BM; Luft, FC; Mervaala, EM; Muller, DN; Park, JK; Schmidt, F; Schneider, W1
Azuma, J; Lombardini, JB; Schaffer, SW1
Abe, S; Adachi, S; Hiroe, M; Ito, H; Marumo, F; Nozato, T; Tamamori, M1
Azuma, J; Azuma, M; Fukuda, T; Iwao, H; Kim, S; Ohyabu, Y; Schaffer, SW; Takahashi, K; Yamamoto, I1
Boer, P; Braam, B; Gröne, H; Hohbach, J; Joles, JA; Koomans, HA; Verhagen, AM1
Belabbas, H; Herizi, A; Jover, B; Mimran, A1
Bandinelli, B; Bertolozzi, I; Boddi, M; Cecioni, I; Galanti, G; Liguori, P; Modesti, PA; Paniccia, R; Perna, A; Polidori, G; Serneri, GG; Vanni, S1
Aubert, JF; Brunner, HR; Pedrazzini, T; Pellieux, C; Sauthier, T1
Leenen, FH; Van Huysse, J; White, R; Zhao, X1
Brunner, HR; Murat, A; Pedrazzini, T; Pellieux, C1
Iwao, H; Izumi, Y; Kim, S; Namba, M; Yasumoto, H; Zhan, Y1
Braunwald, E; Bristow, MR1
Dixon, IM; Hao, J; Jassal, DS; Jones, SC; Wang, B1
Mascareno, E; Siddiqui, MA1
Aikawa, R; Komuro, I; Nagai, R; Yazaki, Y1
Anversa, P; Chimenti, C; Frustaci, A; Jakoniuk, I; Kajstura, J; Leri, A; Maseri, A; Nadal-Ginard, B1
Brede, M; Hein, L1
Beyersdorf, F; Breyer, T; Burkard, T; Dohrmann, U; Dragu, A; Füchtbauer, EM; Holubarsch, CJ; Radicke, D; Schmidt-Schweda, S; Wakili, R; Wiese, S1
Harada, M; Hosoya, T; Ikeda, K; Nakao, K; Tojo, K; Tokudome, G1
Chen, YF; Dell'Italia, LJ; Lucchesi, P; Mori, T; Oparil, S; Perry, GJ; Wei, CC; Xu, XY1
Hayashi, M; Nakaya, H; Saruta, T; Sasamura, H1
Ruwhof, C; Schrier, PI; van der Laarse, A; van der Valk-Kokshoom, LE; van Wamel, AJ1
He, KL; Li, TC; Mu, SC; Pang, YZ; Tang, CS; Zheng, QF1
DiDonato, JA; Lin, A; Mercurio, F; Purcell, NH; Tang, G; Yu, C1
Lorell, BH; Schneider, MD1
Pan, JY; Wang, TH; Zhan, CD1
Fu, MG; Jiang, ZS; Liu, NK; Pang, YZ; Tang, CS; Wang, XH1
Piper, HM; Schlüter, KD; Taimor, G; Wenzel, S1
Paull, JR; Widdop, RE1
Basso, N; González Bosc, LV; Kurnjek, ML; Müller, A; Terragno, NA1
Ikeda, U; Lee, RT; Ohki, R; Shimada, K; Yamamoto, K1
Aubert, JF; Brunner, H; Morgan, T1
Buikema, H; Ganten, D; Hoffmann, S; Inagami, T; Krause, T; Lindschau, C; Pagel, I; Paul, M; Pinto, YM; Urata, H; van Geel, PP; van Gilst, WH; Willenbrock, R1
Bedell, KA; Dalshaug, GB; Scholz, TD; Segar, JL; Smith, OM1
Leenen, FH; White, R; Yuan, B1
Wang, Y1
Grimm, M; Kitakaze, M; Liao, JK; Liao, Y; Nakagami, H; Node, K; Takemoto, M; Takemoto, Y1
Inagami, T; Senbonmatsu, T1
Aubert, JF; Beermann, F; Brunner, HR; Foletti, A; Nussberger, J; Pedrazzini, T; Peduto, G; Pellieux, C1
Chen, L; Gu, ZL; Qin, TC; Yu, LX1
Eskelinen, S; Luodonpää, M; Ruskoaho, H; Vuolteenaho, O1
Buttrick, PM; Geenen, DL; Goldspink, PH; Kimball, VA; McKinney, RD1
Asakura, M; Asanuma, H; Beppu, S; Higashiyama, S; Hori, M; Ishiguro, H; Ishikura, F; Kitakaze, M; Liao, Y; Matsumura, Y; Node, K; Ohmoto, H; Sanada, S; Tada, M; Takashima, S; Takeda, H; Yoshinaka, T; Yoshino, K1
Bishop, SP; Dell'Italia, LJ; Dillon, AR; Hankes, GH; Ideker, R; Powell, P; Rynders, P; Schultz, D; Spinale, FG; Su, X; Walcott, G; Wei, CC1
Cristol, JP; Delbosc, S; Jover, B; Mimran, A1
Bendall, JK; Cave, AC; Gall, N; Heymes, C; Shah, AM1
Piper, M; Ruf, S; Schlüter, KD1
Greenberg, B1
Force, T; Haq, S; Kilter, H; Michael, A1
Higuchi, Y; Hirotani, S; Hori, M; Mano, T; Matsumura, Y; Morita, T; Nakayama, H; Nishida, K; Otsu, K; Tada, M; Ueno, H; Yamaguchi, O1
Barta, P; Dechend, R; Dietz, R; Fiebeler, A; Ganten, D; Haller, H; Luft, FC; Muller, DN; Park, JK; Theuer, J1
Eskelinen, S; Kerkelä, R; Majalahti-Palviainen, T; Pikkarainen, S; Pöntinen, J; Ruskoaho, H; Tokola, H; Vuolteenaho, O1
Asakawa, M; Hasegawa, H; Kadowaki, T; Komuro, I; Kubota, N; Masuda, Y; Nagai, T; Saito, T; Takano, H; Uozumi, H1
Schneider, MD1
Doetschman, T; Glascock, BJ; Kimball, TR; Nieman, ML; Nix, SL; Reiser, PJ; Schultz, Jel J; Witt, SA1
Morgan, T1
Doi, H; Katoh, M; Kurosawa, Y; Narita, H1
Böhm, M; Kilter, H; Konkol, C; Laufs, U; Nickenig, G; Wassmann, S1
Agabiti-Rosei, E; Cotecchia, S; Frati, G; Fratta, L; Guelfi, D; Lembo, G; Mulvany, MJ; Notte, A; Porteri, E; Poulet, R; Rizzoni, D; Trimarco, B; Trimarco, V; Vecchione, C1
Liu, PQ; Lu, W; Pan, JY; Wang, TH1
Wang, HJ; Yao, T; Zhu, YC1
Bikhazi, AB; Birbari, AE; Bitar, KM; El-Sabban, ME; Hassan, KA1
Akazawa, H; Komuro, I; Mizukami, M; Nagai, T; Takano, H; Zou, Y1
Guo, Z; Lai, W; Li, J; Li, S; Liu, Y; Wu, P; Xiu, JC; Xu, JP; Zhang, Y1
Liu, PQ; Lu, W; Pan, JY1
Bhatnagar, RK; Lund, DD; McNamara, RF; Schmid, PG; Schmidt, JA1
Alexander, JK; Gaasch, WH; Quinones, MA; Thiel, HG; Waisser, E1
Coleman, TG; Cowley, AW; DeClue, JW; Guyton, AC; Hall, JE; Young, DB1
Hollander, W1
Abboud, FM; Heistad, DD; Mark, AL; Mayer, HE; Schmid, PG1
Arakawa, K; Doi, Y; Hiroki, T; Kanaya, H1
McMurtry, IF; Petrun, MD; Reeves, JT; Tucker, A1
Bumpus, FM; Sen, S; Tarazi, RC1
Bumpus, FM1
Linz, W; Schölkens, BA1
Adachi, S; Hirata, Y; Hiroe, M; Ito, H; Marumo, F; Tujino, M1
Fernandez-Alfonso, MS; Ganten, D; Paul, M1
Paul, M; Schunkert, H1
Ganten, D; Paul, M1
Fukuchi, S; Hashimoto, S; Mizuno, K; Niimura, S; Ohtsuki, M; Sanada, H; Tani, M; Watanabe, H1
Folkow, B; Lever, AF; Lyall, F; Morton, JJ1
Bobik, A; Dilley, RJ; Oddie, CJ1
Brilla, CG; Weber, KT1
Higaki, J; Higashimori, K; Mikami, H; Nagano, M; Nagano, N; Nakamura, F; Ogihara, T1
Brilla, C; Tan, LB; Weber, KT1
Higaki, J; Higashimori, K; Katahira, K; Mikami, H; Moriguchi, A; Nagano, M; Nakamaru, M; Nakamura, F; Ogihara, T; Tabuchi, Y1
Casley, D; Johnston, CI; Katopothis, A; Mooser, V1
Brilla, CG; Janicki, JS; Pick, R; Tan, LB; Weber, KT1
Baker, KM; Morgan, HE1
Bann, J; Baur, LH; Bruschke, AV; Buis, B; Manger Cats, V; Schipperheyn, JJ; van der Laarse, A; van der Wall, EE; van Dijk, AD1
Jalil, JE; Janicki, JS; Pick, R; Tan, LB; Weber, KT1
Fregly, MJ1
Higaki, J; Higashimori, K; Katahira, K; Mikami, H; Morishita, R; Nagano, M; Nakamura, F; Ogihara, T1
Henning, R; Linz, W; Schölkens, BA1
Neyses, L; Vetter, H2
Gohlke, P; Unger, T1
Fouad, FM; Hanna, MK; Khairallah, PA; Upsher, ME; Yoshida, K1
Ganten, D; Linz, W; Schölkens, BA1
Honda, M; Ishinaga, Y; Kobayashi, S; Matsuno, Y; Morioka, S; Moriyama, K; Murakami, Y; Ohoka, M; Tanabe, K; Yamada, S1
Honda, M; Morioka, S; Moriyama, K; Ohoka, M; Yamada, S; Yamori, Y1
Fernandes, A1
Chobanian, AV; Herrera, VL; Ruiz-Opazo, N1
Ganten, D; Gohlke, P; Lang, RE; Unger, T1
Ganey, PE; Hadley, KB; Roth, RA; Sprugel, KH1
Altiere, RJ; Gillespie, MN; O'Connor, WN; Olson, JW; Reinsel, CN1
Fregly, MJ; Lockley, OE; Sumners, C1
Khairallah, PA; Upsher, ME1
Cody, RJ; Devereux, RB; Laragh, JH; Pickering, TG1
Tatsumi, S1
Krovetz, LJ; McLoughlin, TG; Schiebler, GL1
Davis, JO; Hartroft, PM; Johnston, CI; Robb, CA1
Barold, SS; Hildner, FJ; Linhart, JW; Samet, P1
Gomez, J; McCabe, RE; Zintel, HA1
Chiavaro, A; Cosentino, F; Gambelli, G; Saponaro, A; Strano, A1
Baum, GL; Castillo, C; Llamas, R; Schwartz, A1
Dabels, J; Kochan, E; Sievers, P; Wendel, H1
Frohlich, ED1
Bumpus, FM; Khairallah, PA; Sen, S; Tarazi, RC1
Branche, G; Chiles, B; Garnier, C; Kilcoyne, MM; Soland, T; Thomson, GE; Williams, M1
Jorgensen, H; Sundsfjord, JA1

Reviews

88 review(s) available for angiotensin ii and Cardiomegaly

ArticleYear
Angiotensin II-Induced Signal Transduction Mechanisms for Cardiac Hypertrophy.
    Cells, 2022, 10-22, Volume: 11, Issue:21

    Topics: Angiotensin II; Cardiomegaly; Fibroblasts; Humans; Myocytes, Cardiac; Signal Transduction

2022
The endocrinological component and signaling pathways associated to cardiac hypertrophy.
    Molecular and cellular endocrinology, 2020, 12-01, Volume: 518

    Topics: Angiotensin II; Animals; Cardiomegaly; Disease Progression; Endocrine System; Humans; Insulin; Signal Transduction; Thyroid Hormones

2020
The role of Thymosin β4 in angiotensin II-induced cardiomyocytes growth.
    Expert opinion on biological therapy, 2018, Volume: 18, Issue:sup1

    Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cell Differentiation; Cell Proliferation; Humans; Myocytes, Cardiac; Rats; Signal Transduction; Thymosin

2018
Chronic heart failure: a disease of the brain.
    Heart failure reviews, 2019, Volume: 24, Issue:2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Baroreflex; Brain; Cardiomegaly; Chronic Disease; Heart; Heart Failure; Humans; Inflammation; Natriuretic Peptide, Brain; Neuroimmunomodulation; Norepinephrine; Oxidative Stress; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Renin-Angiotensin System; Sympathetic Nervous System; Vagus Nerve Stimulation

2019
ACE2 in Brain Physiology and Pathophysiology: Evidence from Transgenic Animal Models.
    Neurochemical research, 2019, Volume: 44, Issue:6

    Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Animals, Genetically Modified; Brain; Brain Diseases; Cardiomegaly; Models, Animal; Peptide Fragments; Peptidyl-Dipeptidase A; Phenotype; Serotonin; Stress, Psychological; Tryptophan

2019
Temporal Frame of Immune Cell Infiltration during Heart Failure Establishment: Lessons from Animal Models.
    International journal of molecular sciences, 2018, Nov-22, Volume: 19, Issue:12

    Topics: Angiotensin II; Animals; Aorta; B-Lymphocytes; Cardiomegaly; Cell Movement; Constriction, Pathologic; Cytokines; Disease Models, Animal; Endomyocardial Fibrosis; Heart Failure; Humans; Hypertension; Mice; Monocytes; T-Lymphocytes; Time Factors; Ventricular Dysfunction, Left

2018
The autocrine/paracrine loop after myocardial stretch: mineralocorticoid receptor activation.
    Current cardiology reviews, 2013, Volume: 9, Issue:3

    Topics: Angiotensin II; Autocrine Communication; Calcium; Cardiomegaly; Cardiovascular Diseases; Heart Failure; Humans; Myocardial Contraction; Myocardium; Paracrine Communication; Reactive Oxygen Species; Receptors, Mineralocorticoid; Sodium-Calcium Exchanger; Sodium-Hydrogen Exchangers; Thyroid Hormones

2013
Insights into the activation and inhibition of angiotensin II type 1 receptor in the mechanically loaded heart.
    Circulation journal : official journal of the Japanese Circulation Society, 2014, Volume: 78, Issue:6

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Arrestin; Cardiomegaly; Humans; Myocardial Contraction; Myocardium; Receptor, Angiotensin, Type 1

2014
Molecular mechanism of aggravation of hypertensive organ damages by short-term blood pressure variability.
    Current hypertension reviews, 2014, Volume: 10, Issue:3

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Disease Models, Animal; Fibrosis; Humans; Hypertension; Myocarditis; Myocardium; Rats; Receptors, Mineralocorticoid; Renin-Angiotensin System; Risk Factors; Signal Transduction; Time Factors; Ventricular Dysfunction

2014
The role of autophagy in angiotensin II-induced pathological cardiac hypertrophy.
    Journal of molecular endocrinology, 2016, Volume: 57, Issue:4

    Topics: Adiponectin; Angiotensin II; Animals; Autophagosomes; Autophagy; Autophagy-Related Proteins; Cardiomegaly; Humans; MicroRNAs; Oxidative Stress; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Signal Transduction; TOR Serine-Threonine Kinases

2016
Early signals after stretch leading to cardiac hypertrophy. Key role of NHE-1.
    Frontiers in bioscience : a journal and virtual library, 2008, May-01, Volume: 13

    Topics: Adult; Angiotensin II; Biomechanical Phenomena; Cardiomegaly; Heart Ventricles; Humans; Hypertrophy, Right Ventricular; Obesity; Pressoreceptors; Reactive Oxygen Species; Signal Transduction; Sodium-Hydrogen Exchangers; Ventricular Function

2008
Pharmacologic perspectives of functional selectivity by the angiotensin II type 1 receptor.
    Trends in cardiovascular medicine, 2008, Volume: 18, Issue:8

    Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Cardiomegaly; Cardiovascular Diseases; Feasibility Studies; GTP-Binding Proteins; Humans; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Signal Transduction

2008
Role of 14-3-3 protein and oxidative stress in diabetic cardiomyopathy.
    Acta physiologica Hungarica, 2009, Volume: 96, Issue:3

    Topics: 14-3-3 Proteins; Angiotensin II; Animals; Apoptosis; Cardiomegaly; Cardiomyopathies; Diabetes Complications; Fibrosis; Humans; Myocardium; Oxidative Stress; Signal Transduction

2009
Regulation of cardiac hypertrophy by the formation of G protein-coupled receptor--TRPC channel protein complex.
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2009, Volume: 134, Issue:3

    Topics: Angiotensin II; Animals; Calcium; Calcium Signaling; Cardiomegaly; Diglycerides; Drug Design; Heart Failure; Humans; Multiprotein Complexes; Receptors, G-Protein-Coupled; TRPC Cation Channels; TRPC6 Cation Channel

2009
Linking an insect enzyme to hypertension: angiotensin II-epoxide hydrolase interactions.
    Kidney international, 2010, Volume: 77, Issue:2

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Down-Regulation; Epoxide Hydrolases; Insecta; Vasoconstriction

2010
Insulin signaling: a possible pathogenesis of cardiac hypertrophy.
    Cardiovascular therapeutics, 2010, Volume: 28, Issue:2

    Topics: Angiotensin II; Animals; Cardiomegaly; Humans; Insulin; Myocardium; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction

2010
Adaptive and maladaptive remodeling of cardiomyocyte excitation-contraction coupling by angiotensin II.
    Trends in cardiovascular medicine, 2010, Volume: 20, Issue:3

    Topics: Adaptation, Physiological; Angiotensin II; Animals; Cardiomegaly; Excitation Contraction Coupling; Heart Failure; Humans; Mice; Mice, Knockout; Myocytes, Cardiac; Renin-Angiotensin System; Ventricular Remodeling

2010
Cytokines and cardiac hypertrophy: roles of angiotensin II and basic fibroblast growth factor.
    Clinical and experimental pharmacology & physiology, 1996, Volume: 23 Suppl 3

    Topics: Angiotensin II; Animals; Cardiomegaly; Cytokines; Fibroblast Growth Factor 2; Heart; Humans; Myocardium; Myocytes, Cardiac

1996
Role of autocrine/paracrine mechanisms in response to myocardial strain.
    Pflugers Archiv : European journal of physiology, 2011, Volume: 462, Issue:1

    Topics: Angiotensin II; Animals; Autocrine Communication; Calcium; Cardiomegaly; Endothelins; ErbB Receptors; Humans; Myocardial Contraction; Myocardium; Paracrine Communication; Reactive Oxygen Species; Signal Transduction; Sodium-Calcium Exchanger; Sodium-Hydrogen Exchangers; Stress, Mechanical

2011
Regulation of the cardiac sodium/bicarbonate cotransporter by angiotensin II: potential Contribution to structural, ionic and electrophysiological myocardial remodelling.
    Current cardiology reviews, 2013, Feb-01, Volume: 9, Issue:1

    Topics: Angiotensin II; Calcium; Cardiomegaly; Electrophysiological Phenomena; Heart; Heart Diseases; Humans; Sodium; Sodium-Bicarbonate Symporters; Ventricular Remodeling

2013
Dissecting the role of chymase in angiotensin II formation and heart and blood vessel diseases.
    Current opinion in cardiology, 2002, Volume: 17, Issue:4

    Topics: Angiotensin I; Angiotensin II; Arteriosclerosis; Cardiomegaly; Cardiovascular Diseases; Chymases; Heart Diseases; Heart Failure; Humans; Hypertension; Peptidyl-Dipeptidase A; Serine Endopeptidases

2002
Role of the local renin-angiotensin system in cardiac damage: a minireview focussing on transgenic animal models.
    Journal of molecular and cellular cardiology, 2002, Volume: 34, Issue:11

    Topics: Angiotensin II; Animals; Animals, Genetically Modified; Cardiomegaly; Fibrosis; Heart; Hypertension; Mice; Mice, Knockout; Mice, Transgenic; Models, Biological; Myocardial Infarction; Myocardium; Organ Specificity; Peptidyl-Dipeptidase A; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System; Stress, Mechanical; Ventricular Remodeling

2002
[Signal transduction pathways in cardiac myocyte hypertrophy].
    Sheng li ke xue jin zhan [Progress in physiology], 2000, Volume: 31, Issue:1

    Topics: Angiotensin II; Animals; Calcium; Cardiomegaly; Catecholamines; Endothelial Growth Factors; Humans; Signal Transduction

2000
A central role of EGF receptor transactivation in angiotensin II -induced cardiac hypertrophy.
    Trends in pharmacological sciences, 2003, Volume: 24, Issue:5

    Topics: Angiotensin II; Animals; Cardiomegaly; ErbB Receptors; Gene Expression Regulation; Humans; Transcriptional Activation

2003
[The bioactivity of angiotensin II and the effects of related Chinese Herbs].
    Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2003, Volume: 28, Issue:5

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Drugs, Chinese Herbal; Heart Failure; Humans; Hypertension; Myocardial Reperfusion Injury; Plants, Medicinal; Receptor, Angiotensin, Type 2

2003
[Involvement of angiotensin II in pathogenesis of hypertension and target organ damage].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 3

    Topics: Angioplasty, Balloon, Coronary; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Cardiomegaly; Clinical Trials as Topic; Coronary Restenosis; Humans; Hypertension; Hypertension, Renal; Insulin Resistance; Losartan; Ramipril; Receptor, Angiotensin, Type 1

2004
Fibroblast growth factor 2 isoforms and cardiac hypertrophy.
    Cardiovascular research, 2004, Aug-15, Volume: 63, Issue:3

    Topics: Angiotensin II; Animals; Cardiomegaly; Fibroblast Growth Factor 2; Humans; Myocardium; Protein Isoforms; Signal Transduction

2004
[Effect of adrenomedullin on cardiac myocytes and fibroblasts].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 9

    Topics: Adrenomedullin; Angiotensin II; Animals; Apoptosis; Calcium; Cardiomegaly; Cell Division; Cyclic AMP; Endothelin-1; Heart Failure; Humans; Myoblasts, Cardiac; Myocardial Contraction; Myocytes, Cardiac; Nitric Oxide; Peptides; Protein Kinase C; Signal Transduction; Tumor Necrosis Factor-alpha; Ventricular Remodeling

2004
[Role of endothelin in the development of cardiac hypertrophy].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 9

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Communication; Endothelin-1; GTP-Binding Protein alpha Subunits, Gq-G11; Hemodynamics; Humans; Receptor, Endothelin A; Stress, Mechanical; Ventricular Remodeling

2004
[Modulation of renin-angiotensin system for vascular protection in hypertensive patients and in patients with diabetic nephropathy].
    Revista clinica espanola, 2004, Volume: 204, Issue:11

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cardiomegaly; Coronary Artery Disease; Diabetic Nephropathies; Humans; Hypertension; Renin

2004
Hijacking epidermal growth factor receptors by angiotensin II: new possibilities for understanding and treating cardiac hypertrophy.
    Cellular and molecular life sciences : CMLS, 2004, Volume: 61, Issue:21

    Topics: Angiotensin II; Animals; Cardiomegaly; ErbB Receptors; Humans; Reactive Oxygen Species; Signal Transduction; Transcriptional Activation

2004
Cardiovascular functional phenotypes and pharmacological responses in apolipoprotein E deficient mice.
    Neurobiology of aging, 2005, Volume: 26, Issue:3

    Topics: Angiotensin II; Animals; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Cardiac Output, High; Cardiomegaly; Cardiovascular System; Enzyme Inhibitors; Estradiol; Hypercholesterolemia; Hyperglycemia; Mice; Mice, Knockout; NG-Nitroarginine Methyl Ester; Phenotype; Simvastatin

2005
Rethinking the renin-angiotensin system and its role in cardiovascular regulation.
    Cardiovascular drugs and therapy, 2005, Volume: 19, Issue:1

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Cardiovascular System; Humans; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Signal Transduction

2005
[Role of renin-angiotensin system in cardiovascular remodeling].
    Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64 Suppl 5

    Topics: Angiotensin II; Animals; Cardiomegaly; Humans; Hypertension; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase Kinase 5; Oxidative Stress; Reactive Oxygen Species; Renin-Angiotensin System; Transcription Factor AP-1; Ventricular Remodeling

2006
Sodium-hydrogen exchanger, cardiac overload, and myocardial hypertrophy.
    Circulation, 2007, Mar-06, Volume: 115, Issue:9

    Topics: Amiloride; Angiotensin II; Animals; Calcium Signaling; Carbonic Anhydrase II; Cardiomegaly; Cation Transport Proteins; Cells, Cultured; Endothelins; Heart Failure; Hormones; Humans; Hydrogen; Hydrogen-Ion Concentration; Hypertrophy, Left Ventricular; MAP Kinase Signaling System; Mice; Mitochondria, Heart; Models, Cardiovascular; Myocytes, Cardiac; Phosphorylation; Protein Processing, Post-Translational; Rabbits; Rats; Rats, Inbred SHR; Reactive Oxygen Species; Signal Transduction; Sodium; Sodium-Hydrogen Exchanger 1; Sodium-Hydrogen Exchangers; Stress, Mechanical; Swine

2007
A novel mechanism of mechanical stress-induced angiotensin II type 1-receptor activation without the involvement of angiotensin II.
    Naunyn-Schmiedeberg's archives of pharmacology, 2008, Volume: 377, Issue:4-6

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Cardiomegaly; Drug Inverse Agonism; Extracellular Signal-Regulated MAP Kinases; Humans; Receptor, Angiotensin, Type 1; Stress, Mechanical; Tetrazoles

2008
The intracellular renin-angiotensin system: implications in cardiovascular remodeling.
    Current opinion in nephrology and hypertension, 2008, Volume: 17, Issue:2

    Topics: Angiotensin II; Animals; Cardiomegaly; Cardiovascular Agents; Extracellular Fluid; Fibrosis; Humans; Intracellular Fluid; Myocardium; Renin-Angiotensin System; Signal Transduction; Ventricular Remodeling

2008
The multifactorial role of catecholamines in hypertensive cardiac hypertrophy.
    European heart journal, 1982, Volume: 3 Suppl A

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Catecholamines; Coronary Circulation; Heart Ventricles; Humans; Hypertension; Myocardial Contraction; Norepinephrine; Rats; Rats, Inbred Strains

1982
The cardiac renin-angiotensin-aldosterone system and hypertensive cardiac hypertrophy.
    The American journal of cardiology, 1995, Nov-02, Volume: 76, Issue:13

    Topics: Adaptation, Physiological; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Cardiomegaly; Humans; Hypertension; Myocardial Infarction; Myocardium; Renin-Angiotensin System

1995
Molecular biology of myocardial hypertrophy and failure: gene expression and trophic signaling.
    New horizons (Baltimore, Md.), 1995, Volume: 3, Issue:2

    Topics: Angiotensin II; Animals; Calcium; Cardiomegaly; Fibroblast Growth Factors; Gene Expression; Heart Failure; Hemodynamics; Humans; Muscle Proteins; Proto-Oncogenes; Signal Transduction; Transcription Factors; Transforming Growth Factors

1995
Signaling pathways for cardiac growth and hypertrophy. Recent advances and prospects for growth factor therapy.
    Annals of the New York Academy of Sciences, 1995, Mar-27, Volume: 752

    Topics: Angiotensin II; Animals; Cardiomegaly; Endothelins; Growth Substances; Heart; Humans; Insulin-Like Growth Factor I; Signal Transduction; Transforming Growth Factor beta

1995
Proto-oncogenes and the cardiovascular system.
    Chest, 1995, Volume: 107, Issue:3

    Topics: Angiotensin II; Animals; Cardiomegaly; Cardiovascular Physiological Phenomena; Gene Expression; Heart; Hemodynamics; Humans; Myocardium; Proto-Oncogenes

1995
The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects.
    Journal of cardiovascular pharmacology, 1994, Volume: 24 Suppl 2

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Coronary Disease; Endothelium, Vascular; Heart Failure; Humans; Hypertension; Myocardial Infarction; Myocardium; Peptidyl-Dipeptidase A; Renin-Angiotensin System

1994
Angiotensin converting enzyme inhibitors: inhibition of growth, a novel mechanism of action.
    The Journal of cardiovascular nursing, 1994, Volume: 8, Issue:4

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cardiomegaly; Coronary Disease; Heart; Humans; Hyperplasia; Hypertension; Muscle Development; Muscle, Smooth, Vascular; Tunica Intima

1994
Role of neurohormones in ventricular adaptation and failure.
    The American journal of cardiology, 1994, Apr-07, Volume: 73, Issue:10

    Topics: Adaptation, Physiological; Aldosterone; Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Hormones; Humans; Myocardial Infarction; Ventricular Function, Left

1994
New perspectives in angiotensin system control.
    Journal of human hypertension, 1993, Volume: 7 Suppl 2

    Topics: Amino Acid Sequence; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Cardiomegaly; Hemodynamics; Humans; Imidazoles; Losartan; Molecular Sequence Data; Pyridines; Renin-Angiotensin System; Tetrazoles

1993
Local expression and pathophysiological role of renin-angiotensin in the blood vessels and heart.
    Basic research in cardiology, 1993, Volume: 88 Suppl 1

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Endothelium, Vascular; Heart; Humans; Muscle, Smooth, Vascular; Myocardial Infarction; Peptidyl-Dipeptidase A; Renin-Angiotensin System

1993
Mechanisms of angiotensin II formation in humans.
    European heart journal, 1995, Volume: 16 Suppl N

    Topics: Angiotensin II; Animals; Cardiomegaly; Cardiovascular System; Chymases; Heart Failure; Hemodynamics; Homeostasis; Humans; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Serine Endopeptidases; Species Specificity; Tissue Distribution

1995
Cardiovascular hypertrophy: role of angiotensin II and bradykinin.
    Journal of cardiovascular pharmacology, 1996, Volume: 27 Suppl 2

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Cardiomegaly; Humans; Hypertension; Rats

1996
The role of genetic variants in angiotensin I converting enzyme, angiotensinogen and the angiotensin II type-1 receptor in the pathophysiology of heart muscle disease.
    European heart journal, 1995, Volume: 16 Suppl K

    Topics: Angiotensin II; Angiotensinogen; Bradykinin; Cardiac Output, Low; Cardiomegaly; Genetic Variation; Heart Diseases; Humans; Peptidyl-Dipeptidase A; Receptors, Angiotensin; Renin-Angiotensin System

1995
The role of the renin-angiotensin system in the pathophysiology of cardiac remodeling.
    Blood pressure. Supplement, 1996, Volume: 2

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Division; Cells, Cultured; Humans; Renin-Angiotensin System

1996
The renin-angiotensin system and cardiac hypertrophy.
    Heart (British Cardiac Society), 1996, Volume: 76, Issue:3 Suppl 3

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Heart; Myocardium; Rats; Renin-Angiotensin System; Signal Transduction

1996
The renin-angiotensin system and coronary vasomotion.
    Heart (British Cardiac Society), 1996, Volume: 76, Issue:3 Suppl 3

    Topics: Angiotensin I; Angiotensin II; Animals; Blood Flow Velocity; Cardiomegaly; Coronary Vessels; Dogs; Humans; Hypoxia; In Vitro Techniques; Myocardial Ischemia; Peptidyl-Dipeptidase A; Rats; Renin-Angiotensin System; Swine

1996
Cytokines and cardiac hypertrophy: roles of angiotensin II and basic fibroblast growth factor.
    Clinical and experimental pharmacology & physiology. Supplement, 1996, Volume: 3

    Topics: Angiotensin II; Animals; Cardiomegaly; Epidermal Growth Factor; Fibroblast Growth Factors; Heart; Heparin; Heparin-binding EGF-like Growth Factor; Intercellular Signaling Peptides and Proteins; Molecular Weight; Myocardium; Phenotype; Receptors, Angiotensin

1996
[The cardiac autocrine-paracrine system in the development of hypertrophy].
    Cardiologia (Rome, Italy), 1997, Volume: 42, Issue:1

    Topics: Angiotensin II; Animals; Cardiomegaly; Endothelin-1; Heart; Humans; Renin-Angiotensin System

1997
Involvement of angiotensin II in cardiovascular and renal injury: effects of an AT1-receptor antagonist on gene expression and the cellular phenotype.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1997, Volume: 15, Issue:6

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cardiomegaly; Fibronectins; Gene Expression; Humans; Hypertension; Nephrosclerosis; Proto-Oncogene Proteins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Tetrazoles

1997
[Mechanism involved in the onset of heart failure].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1998, Sep-10, Volume: 87, Issue:9

    Topics: Angiotensin II; Animals; Calcium; Cardiomegaly; Endothelin-1; Heart Failure; Humans; Interleukin-1; Neurotransmitter Agents; Receptors, Adrenergic, beta; Ventricular Remodeling

1998
Role of ACE inhibition or AT1 blockade in the remodeling following myocardial infarction.
    Basic research in cardiology, 1998, Volume: 93 Suppl 2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Cardiomegaly; Humans; Myocardial Infarction; Myocardium; Renin-Angiotensin System

1998
Signalling pathways for cardiac hypertrophy.
    Cellular signalling, 1998, Volume: 10, Issue:10

    Topics: Angiotensin II; Animals; Cardiomegaly; Heart; Humans; Phosphorylation; Signal Transduction

1998
Angiotensin blocking drugs and the heart beyond 2000.
    Journal of the American Society of Nephrology : JASN, 1999, Volume: 10 Suppl 11

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Bradykinin; Cardiomegaly; Forecasting; Hypertension; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System

1999
The molecular mechanism of cardiac hypertrophy and failure.
    Annals of the New York Academy of Sciences, 1999, Jun-30, Volume: 874

    Topics: Angiotensin II; Animals; Cardiac Output, Low; Cardiomegaly; Endothelin-1; Hypertension; Myocardium; Renin-Angiotensin System; Signal Transduction; Sodium-Hydrogen Exchangers; Stress, Mechanical

1999
Signal transduction and transcriptional adaptation in embryonic heart development and during myocardial hypertrophy.
    Molecular and cellular biochemistry, 1999, Volume: 196, Issue:1-2

    Topics: Adaptation, Physiological; Angiotensin II; Animals; Cardiomegaly; Gene Expression Regulation, Developmental; Heart; Humans; Signal Transduction; Transcription, Genetic

1999
The renin-angiotensin system and experimental heart failure.
    Cardiovascular research, 1999, Volume: 43, Issue:4

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve Stenosis; Cardiomegaly; Coronary Disease; Heart Failure; Mice; Mice, Transgenic; Myocardium; Rats; Receptors, Angiotensin; Renin-Angiotensin System; Signal Transduction

1999
Na+/H+ exchange hyperactivity and myocardial hypertrophy: are they linked phenomena?
    Cardiovascular research, 1999, Volume: 44, Issue:3

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Antiporters; Cardiomegaly; Erythrocytes; Humans; Hydrogen-Ion Concentration; Hypertension; Myocardium; Signal Transduction; Sodium-Hydrogen Exchangers

1999
Role of the renin-angiotensin system in cardiac hypertrophy.
    The American journal of cardiology, 1999, Jun-17, Volume: 83, Issue:12A

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cardiomegaly; Cell Division; Cells, Cultured; Hydralazine; Hypertension; Mitogen-Activated Protein Kinases; Myocardium; Protein-Tyrosine Kinases; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System; Signal Transduction; Sodium-Hydrogen Exchangers; Tetrazoles

1999
Role of angiotensin AT1, and AT2 receptors in cardiac hypertrophy and disease.
    The American journal of cardiology, 1999, Jun-17, Volume: 83, Issue:12A

    Topics: Angiotensin II; Animals; Aortic Valve Stenosis; Cardiomegaly; Cell Division; Humans; Hypertension; Myocardium; Proto-Oncogene Mas; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Signal Transduction

1999
Angiotensin II, adhesion, and cardiac fibrosis.
    Cardiovascular research, 2000, Volume: 46, Issue:2

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Adhesion; Extracellular Matrix; Fibrosis; Humans; Integrins; Myocardium; Osteopontin; Sialoglycoproteins

2000
Interaction between the actions of taurine and angiotensin II.
    Amino acids, 2000, Volume: 18, Issue:4

    Topics: Angiotensin II; Animals; Calcium; Cardiomegaly; Cell Size; Diuretics; Heart Failure; Humans; MAP Kinase Signaling System; Myocardium; Receptors, Angiotensin; Sodium-Calcium Exchanger; Taurine

2000
The role of Jak/STAT signaling in heart tissue renin-angiotensin system.
    Molecular and cellular biochemistry, 2000, Volume: 212, Issue:1-2

    Topics: Angiotensin II; Animals; Cardiomegaly; DNA-Binding Proteins; Heart; Heart Diseases; Humans; Myocardium; Protein-Tyrosine Kinases; Signal Transduction; Trans-Activators

2000
Transgenic mouse models of angiotensin receptor subtype function in the cardiovascular system.
    Regulatory peptides, 2001, Jan-12, Volume: 96, Issue:3

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cardiovascular System; Kidney; Mice; Mice, Transgenic; Receptors, Angiotensin; Signal Transduction

2001
Signal transduction in cardiac hypertrophy--dissecting compensatory versus pathological pathways utilizing a transgenic approach.
    Current opinion in pharmacology, 2001, Volume: 1, Issue:2

    Topics: Angiotensin II; Animals; Animals, Genetically Modified; Antigens, CD; Calcineurin; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomegaly; Cytokine Receptor gp130; GTP-Binding Protein alpha Subunits, Gq-G11; Heart Failure; Heterotrimeric GTP-Binding Proteins; Membrane Glycoproteins; Mitogen-Activated Protein Kinases; Monomeric GTP-Binding Proteins; Myocardial Contraction; Protein Kinase C; Receptor Protein-Tyrosine Kinases; Receptors, Angiotensin; Signal Transduction; Transcription, Genetic

2001
Dual effects of angiotensin II type 2 receptor on cardiovascular hypertrophy.
    Trends in cardiovascular medicine, 2001, Volume: 11, Issue:8

    Topics: Angiotensin II; Animals; Cardiomegaly; Forecasting; Humans; Mice; Receptors, Angiotensin; Renin-Angiotensin System; Ventricular Remodeling

2001
Molecular and cellular mechanisms of mechanical stress-induced cardiac hypertrophy.
    Endocrine journal, 2002, Volume: 49, Issue:1

    Topics: Angiotensin II; Calcineurin; Calcium; Cardiomegaly; Endothelin-1; Hemodynamics; Humans; Protein Kinases; Signal Transduction; Stress, Mechanical

2002
Integration and control of circulatory function.
    International review of physiology, 1976, Volume: 9

    Topics: Angiotensin II; Animals; Blood Circulation; Blood Pressure; Blood Volume; Body Fluids; Cardiac Output; Cardiomegaly; Cardiovascular Physiological Phenomena; Cardiovascular System; Dogs; Hemodynamics; Homeostasis; Humans; Kidney; Oxygen Consumption; Reflex; Regional Blood Flow; Renin

1976
Role of hypertension in atherosclerosis and cardiovascular disease.
    The American journal of cardiology, 1976, Nov-23, Volume: 38, Issue:6

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Arteriosclerosis; Blood Platelets; Capillary Permeability; Cardiomegaly; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Disease; Death, Sudden; Endothelium; Histamine; Humans; Hypertension; Lipids; Lysosomes; Muscle, Smooth; Renin; Serotonin; Thrombosis

1976
Mechanisms and sites of action of newer angiotensin agonists and antagonists in terms of activity and receptor.
    Federation proceedings, 1977, Volume: 36, Issue:8

    Topics: Adrenal Glands; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Blood Pressure; Cardiomegaly; Catecholamines; Protein Biosynthesis; Protein Conformation; Receptors, Angiotensin; Receptors, Cell Surface; Structure-Activity Relationship

1977
Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitors.
    Journal of cardiovascular pharmacology, 1992, Volume: 20 Suppl 9

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Cardiomegaly; Epoprostenol; Heart; Kallikrein-Kinin System; Nitric Oxide; Renin-Angiotensin System; Reperfusion Injury

1992
Mechanisms of cardiac growth. The role of the renin-angiotensin system.
    Basic research in cardiology, 1992, Volume: 87 Suppl 2

    Topics: Angiotensin II; Animals; Cardiomegaly; Humans; Hypertension; Myocardium; Renin-Angiotensin System

1992
Diastolic dysfunction in pressure-overload hypertrophy and its modification by angiotensin II: current concepts.
    Basic research in cardiology, 1992, Volume: 87 Suppl 2

    Topics: Angiotensin II; Animals; Cardiomegaly; Diastole; Enzyme Activation; Heart; Humans; Hypertension; Myocardium; Peptidyl-Dipeptidase A

1992
The molecular basis of cardiovascular hypertrophy: the role of the renin-angiotensin system.
    Journal of cardiovascular pharmacology, 1992, Volume: 19 Suppl 5

    Topics: Angiotensin II; Animals; Blood Vessels; Cardiomegaly; Cell Division; Cells, Cultured; Gene Expression; Growth Substances; Hypertension; Hypertrophy; Muscle, Smooth, Vascular; Proto-Oncogenes; Renin-Angiotensin System

1992
Angiotensin II, vascular structure and blood pressure.
    Kidney international. Supplement, 1992, Volume: 37

    Topics: Angiotensin II; Animals; Blood Pressure; Blood Vessels; Cardiomegaly; Growth Substances; Hypertension; Hypertrophy; Models, Cardiovascular; Rats

1992
Prevention of structural changes in the heart in hypertension by angiotensin converting enzyme inhibition.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1992, Volume: 10, Issue:1

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Diastole; Heart Failure; Humans; Hypertension; Myocardium; Rats; Rats, Inbred SHR

1992
Cardiac hypertrophy. Mechanical, neural, and endocrine dependence.
    Circulation, 1991, Volume: 83, Issue:1

    Topics: Angiotensin II; Animals; Cardiomegaly; Heart; Humans; Myocardial Contraction; Receptors, Adrenergic; Signal Transduction; Stress, Mechanical; Thyroid Hormones

1991
Tissue renin-angiotensin systems in the heart and vasculature: possible involvement in the cardiovascular actions of converting enzyme inhibitors.
    The American journal of cardiology, 1990, May-22, Volume: 65, Issue:19

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cardiomegaly; Cardiovascular Physiological Phenomena; Cardiovascular System; Heart Failure; Humans; Peptidyl-Dipeptidase A; Renin-Angiotensin System

1990
[Physiopathology of arterial hypertension. Significance of the renin-angiotensin-aldosterone system and structural changes].
    Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 1989, Volume: 8, Issue:4

    Topics: Angiotensin II; Cardiomegaly; Coronary Disease; Humans; Hypertension; Hypertrophy; Renin-Angiotensin System

1989
[The renin-angiotensin system: systemic and local function].
    Zeitschrift fur Kardiologie, 1988, Volume: 77 Suppl 3

    Topics: Angiotensin II; Cardiomegaly; Coronary Disease; Heart Failure; Humans; Hypertension; Peptidyl-Dipeptidase A; Renin-Angiotensin System

1988
Relation of renin-angiotensin system activity to left ventricular hypertrophy and function in experimental and human hypertension.
    Journal of clinical hypertension, 1987, Volume: 3, Issue:1

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cardiomegaly; Humans; Hypertension; Rats; Rats, Inbred SHR; Renin-Angiotensin System

1987
Clinical significance of hemodynamic findings in hypertension.
    Chest, 1973, Volume: 64, Issue:1

    Topics: Angiotensin II; Blood Pressure; Blood Viscosity; Blood Volume; Cardiac Output; Cardiomegaly; Diuretics; Heart Rate; Hemodynamics; Humans; Hypertension; Hypertension, Renal; Propranolol; Receptors, Adrenergic; Renin

1973

Trials

1 trial(s) available for angiotensin ii and Cardiomegaly

ArticleYear
Statins exert the pleiotropic effects through small GTP-binding protein dissociation stimulator upregulation with a resultant Rac1 degradation.
    Arteriosclerosis, thrombosis, and vascular biology, 2013, Volume: 33, Issue:7

    Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Atorvastatin; Biomarkers; Cardiomegaly; Cells, Cultured; Cholesterol; Cholesterol, LDL; Coronary Vessels; Cross-Over Studies; Cytoskeletal Proteins; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrosis; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Guanine Nucleotide Exchange Factors; Heptanoic Acids; Human Umbilical Vein Endothelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Japan; Male; Mice; Mice, Knockout; Neuropeptides; Oxidative Stress; Phosphatidylinositol 3-Kinase; Pravastatin; Proto-Oncogene Proteins c-akt; Pyrroles; Quinolines; rac GTP-Binding Proteins; rac1 GTP-Binding Protein; RNA Interference; Signal Transduction; Transfection

2013

Other Studies

1059 other study(ies) available for angiotensin ii and Cardiomegaly

ArticleYear
Circ_nuclear factor I X (circNfix) attenuates pressure overload-induced cardiac hypertrophy via regulating miR-145-5p/ATF3 axis.
    Bioengineered, 2021, Volume: 12, Issue:1

    Topics: Activating Transcription Factor 3; Angiotensin II; Animals; Cardiomegaly; Humans; Mice; Mice, Inbred C57BL; MicroRNAs; Myocytes, Cardiac; RNA, Circular; Signal Transduction

2021
Angiotensin-(3-7) alleviates isoprenaline-induced cardiac remodeling via attenuating cAMP-PKA and PI3K/Akt signaling pathways.
    Amino acids, 2021, Volume: 53, Issue:10

    Topics: Angiotensin II; Animals; Cardiomegaly; Cardiovascular Agents; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Fibrosis; Isoproterenol; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Peptide Fragments; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Signal Transduction; Ventricular Remodeling

2021
Capn4 aggravates angiotensin II-induced cardiac hypertrophy by activating the IGF-AKT signalling pathway.
    Journal of biochemistry, 2022, Jan-07, Volume: 171, Issue:1

    Topics: Angiotensin II; Animals; Calpain; Cardiomegaly; Mice; Myocytes, Cardiac; Proto-Oncogene Proteins c-akt; Signal Transduction; Somatomedins

2022
Clitoria ternatea (Linn.) flower extract attenuates vascular dysfunction and cardiac hypertrophy via modulation of Ang II/AT
    Journal of the science of food and agriculture, 2022, Volume: 102, Issue:6

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Clitoria; Flowers; Plant Extracts; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Signal Transduction; Transforming Growth Factor beta1

2022
Alarin moderated myocardial hypertrophy via inhibiting cyclic adenosine monophosphate/protein kinase A signaling pathway to attenuate autophagy.
    Peptides, 2021, Volume: 146

    Topics: Angiotensin II; Animals; Autophagy; Cardiomegaly; Cell Line; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Galanin-Like Peptide; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Receptors, Galanin; Signal Transduction

2021
Aqueous extract of Solanum nigrum attenuates Angiotensin-II induced cardiac hypertrophy and improves cardiac function by repressing protein kinase C-ζ to restore HSF2 deSUMOlyation and Mel-18-IGF-IIR signaling suppression.
    Journal of ethnopharmacology, 2022, Feb-10, Volume: 284

    Topics: Angiotensin II; Animals; Cardiomegaly; Cardiotonic Agents; Cell Line; Disease Models, Animal; Dose-Response Relationship, Drug; Heat-Shock Proteins; Hypertension; Male; Myoblasts, Cardiac; Plant Extracts; Protein Kinase C; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, IGF Type 2; Solanum nigrum; Transcription Factors

2022
Low-intensity pulsed ultrasound ameliorates angiotensin II-induced cardiac fibrosis by alleviating inflammation via a caveolin-1-dependent pathway.
    Journal of Zhejiang University. Science. B, 2021, Oct-15, Volume: 22, Issue:10

    Topics: Angiotensin II; Animals; Cardiomegaly; Caveolin 1; Cells, Cultured; Fibrosis; Inflammation; Male; Mice; Mice, Inbred C57BL; Myocardium; Rats; Rats, Sprague-Dawley; Signal Transduction; Ultrasonic Waves

2021
Downregulation of miR-128 Ameliorates Ang II-Induced Cardiac Remodeling via SIRT1/PIK3R1 Multiple Targets.
    Oxidative medicine and cellular longevity, 2021, Volume: 2021

    Topics: Angiotensin II; Animals; Cardiomegaly; Mice, Inbred C57BL; MicroRNAs; Myocardium; Myocytes, Cardiac; Oxidative Stress; Sirtuin 1; Ventricular Remodeling

2021
STING protects against cardiac dysfunction and remodelling by blocking autophagy.
    Cell communication and signaling : CCS, 2021, 11-08, Volume: 19, Issue:1

    Topics: Angiotensin II; Animals; Apoptosis; Autophagy; Autophagy-Related Protein-1 Homolog; Cardiomegaly; Disease Models, Animal; Gene Expression Regulation; Heart Failure; Humans; Membrane Proteins; Mice; Myocytes, Cardiac; Protective Agents; Signal Transduction; Sirolimus

2021
Ventricular SK2 upregulation following angiotensin II challenge: Modulation by p21-activated kinase-1.
    Journal of molecular and cellular cardiology, 2022, Volume: 164

    Topics: Angiotensin II; Animals; Apamin; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; Fingolimod Hydrochloride; Mice; Myocytes, Cardiac; p21-Activated Kinases; Protein Serine-Threonine Kinases; Rats; RNA, Small Interfering; Up-Regulation

2022
NLRC5 enhances autophagy via inactivation of AKT/mTOR pathway and ameliorates cardiac hypertrophy.
    International journal of experimental pathology, 2022, Volume: 103, Issue:1

    Topics: Angiotensin II; Animals; Autophagy; Cardiomegaly; Myocytes, Cardiac; NLR Proteins; Proto-Oncogene Proteins c-akt; Rats; TOR Serine-Threonine Kinases

2022
RNA binding Motif protein-38 regulates myocardial hypertrophy in LXR-α-dependent lipogenesis pathway.
    Bioengineered, 2021, Volume: 12, Issue:2

    Topics: Angiotensin II; Cardiomegaly; Humans; Lipogenesis; Liver X Receptors; Myocytes, Cardiac; RNA-Binding Proteins; Signal Transduction

2021
S-nitrosylation of Hsp90 promotes cardiac hypertrophy in mice through GSK3β signaling.
    Acta pharmacologica Sinica, 2022, Volume: 43, Issue:8

    Topics: Angiotensin II; Animals; Cardiomegaly; Glycogen Synthase Kinase 3 beta; Heart Failure; HSP90 Heat-Shock Proteins; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Rats; Signal Transduction

2022
Angiotensin Type 2 and Mas Receptor Activation Prevents Myocardial Fibrosis and Hypertrophy through the Reduction of Inflammatory Cell Infiltration and Local Sympathetic Activity in Angiotensin II-Dependent Hypertension.
    International journal of molecular sciences, 2021, Dec-20, Volume: 22, Issue:24

    Topics: Angiotensin I; Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Fibrosis; Hypertension; Imidazoles; Injections, Intraperitoneal; Losartan; Male; Peptide Fragments; Proto-Oncogene Mas; Rats; Rats, Sprague-Dawley; Sulfonamides; Thiophenes; Tyrosine 3-Monooxygenase

2021
MiR-410-3p facilitates Angiotensin II-induced cardiac hypertrophy by targeting Smad7.
    Bioengineered, 2022, Volume: 13, Issue:1

    Topics: 3' Untranslated Regions; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Disease Models, Animal; HEK293 Cells; Humans; MicroRNAs; Myocytes, Cardiac; Primary Cell Culture; Rats; Smad7 Protein; Up-Regulation

2022
Zyxin protects from hypertension-induced cardiac dysfunction.
    Cellular and molecular life sciences : CMLS, 2022, Jan-24, Volume: 79, Issue:2

    Topics: Angiotensin II; Animals; Apoptosis; Blood Pressure; Cardiomegaly; Fibrosis; Hypertension; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Zyxin

2022
[Effect and mechanism of leonurine on pressure overload-induced cardiac hypertrophy in rats].
    Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2022, Volume: 47, Issue:2

    Topics: Angiotensin II; Animals; Cardiomegaly; Gallic Acid; Hypertrophy, Left Ventricular; Myocardium; Rats

2022
FTZ protects against cardiac hypertrophy and oxidative injury via microRNA-214 / SIRT3 signaling pathway.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 148

    Topics: Angiotensin II; Animals; Cardiomegaly; Drugs, Chinese Herbal; Mice; Mice, Inbred C57BL; MicroRNAs; Myocytes, Cardiac; Oxidative Stress; Signal Transduction; Sirtuin 3

2022
Osteocrin alleviates cardiac hypertrophy via attenuating oxidative stress.
    Peptides, 2022, Volume: 152

    Topics: Angiotensin II; Animals; Cardiomegaly; Fibrosis; Mice; Muscle Proteins; Myocytes, Cardiac; Oxidative Stress; Rats; Transcription Factors

2022
Angiotensin II Induces Cardiac Edema and Hypertrophic Remodeling through Lymphatic-Dependent Mechanisms.
    Oxidative medicine and cellular longevity, 2022, Volume: 2022

    Topics: Angiotensin II; Animals; Cardiomegaly; Edema, Cardiac; Endothelial Cells; Lymphangiogenesis; Lymphatic Vessels; Mice; Mice, Knockout; Myocardium; Permeability; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Vascular Endothelial Growth Factor Receptor-3

2022
Inhibition of Src improves cardiac fibrosis in AngII-induced hypertrophy by regulating the expression of galectin-3.
    Microvascular research, 2022, Volume: 142

    Topics: Angiotensin II; Animals; Cardiomegaly; Fibrosis; Galectin 3; Mice; Mice, Knockout; Myocytes, Cardiac; src-Family Kinases

2022
LongShengZhi alleviated cardiac remodeling via upregulation microRNA-150-5p with matrix metalloproteinase 14 as the target.
    Journal of ethnopharmacology, 2022, Jun-12, Volume: 291

    Topics: Angiotensin II; Animals; Cardiomegaly; Drugs, Chinese Herbal; Fibrosis; Matrix Metalloproteinase 14; MicroRNAs; Myocytes, Cardiac; Rats; Up-Regulation; Ventricular Remodeling

2022
Circular RNA circ_0001006 aggravates cardiac hypertrophy via miR-214-3p/PAK6 axis.
    Aging, 2022, 03-06, Volume: 14, Issue:5

    Topics: 3' Untranslated Regions; Angiotensin II; Animals; Cardiomegaly; Cell Proliferation; Mice; MicroRNAs; Myocytes, Cardiac; RNA, Circular

2022
Hydrogen Attenuates Thyroid Hormone-Induced Cardiac Hypertrophy in Rats by regulating angiotensin II type 1 receptor and NADPH oxidase 2 mediated oxidative stress.
    European journal of pharmacology, 2022, May-05, Volume: 922

    Topics: Angiotensin II; Animals; Antioxidants; Cardiomegaly; Hydrogen; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Rats; Receptor, Angiotensin, Type 1; Thyroid Hormones; Thyroxine

2022
MicroRNA miR-27a-3p accelerates cardiac hypertrophy by targeting neuro-oncological ventral antigen 1.
    Bioengineered, 2022, Volume: 13, Issue:4

    Topics: Angiotensin II; Animals; Cardiomegaly; Mice; MicroRNAs; Myocytes, Cardiac; Neuro-Oncological Ventral Antigen

2022
Ginkgolide A alleviates cardiac remodeling in mice with myocardial infarction via binding to matrix metalloproteinase-9 to attenuate inflammation.
    European journal of pharmacology, 2022, May-15, Volume: 923

    Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cardiotonic Agents; Fibronectins; Fibrosis; Ginkgolides; Heart Diseases; Inflammation; Lactones; Matrix Metalloproteinase 9; Mice; Myocardial Infarction; Myocytes, Cardiac; Rats; Ventricular Remodeling

2022
The Prevention Role of Theaflavin-3,3'-digallate in Angiotensin II Induced Pathological Cardiac Hypertrophy via CaN-NFAT Signal Pathway.
    Nutrients, 2022, Mar-26, Volume: 14, Issue:7

    Topics: Angiotensin II; Antioxidants; Biflavonoids; Calcineurin; Cardiomegaly; Catechin; Heart Failure; Humans; Myocytes, Cardiac; Signal Transduction

2022
Sodium Ferulate Inhibits Rat Cardiomyocyte Hypertrophy Induced by Angiotensin II Through Enhancement of Endothelial Nitric Oxide Synthase/Nitric Oxide/Cyclic Guanosine Monophosphate Signaling Pathway.
    Journal of cardiovascular pharmacology, 2022, 08-01, Volume: 80, Issue:2

    Topics: Angiotensin II; Animals; Cardiomegaly; Coumaric Acids; Cyclic GMP; Esters; Guanosine Monophosphate; Myocytes, Cardiac; Nitric Oxide; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Signal Transduction

2022
Targeting of midkine alleviates cardiac hypertrophy via attenuation of oxidative stress and autophagy.
    Peptides, 2022, Volume: 153

    Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Autophagy; Cardiomegaly; Mice; Midkine; Myocytes, Cardiac; Natriuretic Peptide, Brain; Oxidative Stress

2022
MicroRNA-384-5p protects against cardiac hypertrophy via the ALPK3 signaling pathway.
    Journal of biochemical and molecular toxicology, 2022, Volume: 36, Issue:8

    Topics: Angiotensin II; Animals; Cardiomegaly; Heart Failure; Humans; MicroRNAs; Muscle Proteins; Myocytes, Cardiac; Protein Kinases; Signal Transduction

2022
Up-regulation of Nrf2/HO-1 and inhibition of TGF-β1/Smad2/3 signaling axis by daphnetin alleviates transverse aortic constriction-induced cardiac remodeling in mice.
    Free radical biology & medicine, 2022, Volume: 186

    Topics: Angiotensin II; Animals; Cardiomegaly; Collagen; Heme Oxygenase-1; Membrane Proteins; Mice; NF-E2-Related Factor 2; Reactive Oxygen Species; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta1; Umbelliferones; Up-Regulation; Ventricular Remodeling

2022
Tumor Necrosis Factor-
    Oxidative medicine and cellular longevity, 2022, Volume: 2022

    Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Inflammation; Intracellular Signaling Peptides and Proteins; Macrophages; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Rats; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha

2022
Sulfasalazine exacerbates angiotensin II-induced cardiac remodelling by activating Akt signal pathway.
    Clinical and experimental pharmacology & physiology, 2022, Volume: 49, Issue:7

    Topics: Angiotensin II; Animals; Cardiomegaly; Fibrosis; Hypertrophy; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Proto-Oncogene Proteins c-akt; Signal Transduction; Sulfasalazine; Ventricular Remodeling

2022
Circ-TLR4 promotes cardiac hypertrophy through recruiting FUS to stabilize TLR4 mRNA.
    Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2022, Volume: 65, Issue:1

    Topics: Angiotensin II; Atrial Natriuretic Factor; Cardiomegaly; Humans; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; RNA-Binding Protein FUS; RNA, Circular; RNA, Messenger; Toll-Like Receptor 4

2022
Downregulation of lncRNA MALAT1 Inhibits Angiotensin II-induced Hypertrophic Effects of Cardiomyocytes by Regulating SIRT4 via miR-93-5p.
    International heart journal, 2022, Volume: 63, Issue:3

    Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Down-Regulation; Mice; Mice, Inbred C57BL; MicroRNAs; Mitochondrial Proteins; Myocytes, Cardiac; Neoplasms; RNA, Long Noncoding; Sirtuins

2022
CCL17 acts as a novel therapeutic target in pathological cardiac hypertrophy and heart failure.
    The Journal of experimental medicine, 2022, 08-01, Volume: 219, Issue:8

    Topics: Angiotensin II; Animals; Cardiomegaly; Chemokine CCL17; Chemokines; Fibrosis; Heart Failure; Humans; Ligands; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Proteomics

2022
Tabersonine attenuates Angiotensin II-induced cardiac remodeling and dysfunction through targeting TAK1 and inhibiting TAK1-mediated cardiac inflammation.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2022, Volume: 103

    Topics: Angiotensin II; Animals; Cardiomegaly; Fibrosis; Heart Failure; Indole Alkaloids; Inflammation; MAP Kinase Kinase Kinases; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Quinolines; Rats; Signal Transduction; Ventricular Remodeling

2022
PKN2 deficiency leads both to prenatal 'congenital' cardiomyopathy and defective angiotensin II stress responses.
    The Biochemical journal, 2022, 07-15, Volume: 479, Issue:13

    Topics: Angiotensin II; Animals; Cardiomegaly; Cardiomyopathies; Female; Hypertension; Mice; Mice, Knockout; Myocardium; Myocytes, Cardiac; Pregnancy; Protein Kinase C

2022
Postnatal Deletion of Bmal1 in Cardiomyocyte Promotes Pressure Overload Induced Cardiac Remodeling in Mice.
    Journal of the American Heart Association, 2022, 07-05, Volume: 11, Issue:13

    Topics: Angiotensin II; Animals; ARNTL Transcription Factors; Cardiomegaly; Disease Models, Animal; Fibrosis; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Ventricular Remodeling

2022
Targeting miR-30d reverses pathological cardiac hypertrophy.
    EBioMedicine, 2022, Volume: 81

    Topics: Angiotensin II; Animals; Cardiomegaly; China; Heart Failure; Humans; Intracellular Signaling Peptides and Proteins; Mice; MicroRNAs; Myocytes, Cardiac; Protein Serine-Threonine Kinases; Rats

2022
Angiotensin II Mediates Cardiomyocyte Hypertrophy in Atrial Cardiomyopathy via Epigenetic Transcriptional Regulation.
    Computational and mathematical methods in medicine, 2022, Volume: 2022

    Topics: Angiotensin II; Atrial Fibrillation; Cardiomegaly; Cardiomyopathies; Chromatin; Epigenesis, Genetic; Humans; Myocytes, Cardiac; Signal Transduction

2022
METTL3 mediates Ang-II-induced cardiac hypertrophy through accelerating pri-miR-221/222 maturation in an m6A-dependent manner.
    Cellular & molecular biology letters, 2022, Jul-14, Volume: 27, Issue:1

    Topics: Angiotensin II; Animals; beta Catenin; Cardiomegaly; Methyltransferases; Mice; Mice, Inbred C57BL; MicroRNAs; Myocytes, Cardiac; Rats; RNA-Binding Proteins

2022
ANGPTL8 is a negative regulator in pathological cardiac hypertrophy.
    Cell death & disease, 2022, 07-18, Volume: 13, Issue:7

    Topics: Angiopoietin-Like Protein 8; Angiopoietin-like Proteins; Angiotensin II; Animals; Antigens, CD; Cardiomegaly; Disease Models, Animal; Glycogen Synthase Kinase 3 beta; Heart Failure; Humans; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Peptide Hormones; Proto-Oncogene Proteins c-akt; Rats; Receptors, Immunologic; Signal Transduction

2022
Angiotensin II Receptor Blockers and Arrhythmias in Ventricular Hypertrophy.
    Journal of the American Heart Association, 2022, 08-02, Volume: 11, Issue:15

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Arrhythmias, Cardiac; Cardiomegaly; Humans; Receptor, Angiotensin, Type 1

2022
miR-21 upregulation exacerbates pressure overload-induced cardiac hypertrophy in aged hearts.
    Aging, 2022, Jul-28, Volume: 14, Issue:14

    Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Humans; Hypertension; Mice; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Myocytes, Cardiac; Up-Regulation; Ventricular Remodeling

2022
Genetic Deletion of Galectin-3 Exacerbates Age-Related Myocardial Hypertrophy and Fibrosis in Mice.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2022, Aug-12, Volume: 56, Issue:4

    Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Fibrosis; Galectin 3; Gene Deletion; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Sirtuin 1; Transforming Growth Factor beta; Ventricular Remodeling

2022
BMAL1 plays a critical role in the protection against cardiac hypertrophy through autophagy in vitro.
    BMC cardiovascular disorders, 2022, 08-22, Volume: 22, Issue:1

    Topics: Angiotensin II; Animals; Apoptosis; Autophagy; Cardiomegaly; Humans; Myocytes, Cardiac; Rats

2022
Downregulation of amphiregulin improves cardiac hypertrophy via attenuating oxidative stress and apoptosis.
    Biology direct, 2022, 08-22, Volume: 17, Issue:1

    Topics: Amphiregulin; Angiotensin II; Animals; Apoptosis; Cardiomegaly; Down-Regulation; Mice; Oxidative Stress; Rats

2022
Diacerein alleviates Ang II-induced cardiac inflammation and remodeling by inhibiting the MAPKs/c-Myc pathway.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2022, Volume: 106

    Topics: Angiotensin II; Animals; Anthraquinones; Cardiomegaly; Cardiomyopathies; Fibrosis; Heart Failure; Hypertension; Inflammation; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; RNA; Ventricular Remodeling

2022
Self-limiting bidirectional positive feedback between P53 and P21 is involved in cardiac hypertrophy.
    European journal of pharmacology, 2022, Oct-15, Volume: 932

    Topics: Angiotensin II; Animals; Cardiomegaly; Feedback, Physiological; Myocytes, Cardiac; Proto-Oncogene Proteins p21(ras); Rats; Tumor Suppressor Protein p53

2022
miR-212 Promotes Cardiomyocyte Hypertrophy through Regulating Transcription Factor 7 Like 2.
    Mediators of inflammation, 2022, Volume: 2022

    Topics: Angiotensin II; Animals; Cardiomegaly; MicroRNAs; Myocytes, Cardiac; Rats; Transcription Factor 7-Like 2 Protein

2022
GSDMD (Gasdermin D) Mediates Pathological Cardiac Hypertrophy and Generates a Feed-Forward Amplification Cascade via Mitochondria-STING (Stimulator of Interferon Genes) Axis.
    Hypertension (Dallas, Tex. : 1979), 2022, Volume: 79, Issue:11

    Topics: Angiotensin II; Animals; Cardiomegaly; Humans; Interferons; Intracellular Signaling Peptides and Proteins; Mice; Mitochondria; Myocytes, Cardiac; Phosphate-Binding Proteins

2022
Dock10 Regulates Cardiac Function under Neurohormonal Stress.
    International journal of molecular sciences, 2022, Aug-25, Volume: 23, Issue:17

    Topics: Angiotensin II; Animals; Cardiomegaly; Guanine Nucleotide Exchange Factors; JNK Mitogen-Activated Protein Kinases; Mice; Myocardium; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Signal Transduction

2022
G-protein coupled receptor 30 attenuates myocardial hypertrophy by reducing oxidative stress and apoptosis in Ang II-treated mice.
    Peptides, 2022, Volume: 157

    Topics: Angiotensin II; Animals; Apoptosis; Atrial Natriuretic Factor; Cardiomegaly; Female; Fibrosis; GTP-Binding Proteins; Mice; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; Oxidative Stress; Peptide Hormones; Rats; Receptors, Estrogen; Receptors, G-Protein-Coupled

2022
Secreted frizzled-related protein 3 alleviated cardiac remodeling induced by angiotensin II via inhibiting oxidative stress and apoptosis in mice.
    European journal of pharmacology, 2022, Nov-05, Volume: 934

    Topics: Angiotensin II; Animals; Apoptosis; Cardiomegaly; Fibrosis; Hypertrophy; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Oxidative Stress; Rats; Ventricular Remodeling

2022
IRX2 activated by jumonji domain-containing protein 2A is crucial for cardiac hypertrophy and dysfunction in response to the hypertrophic stimuli.
    International journal of cardiology, 2023, Jan-15, Volume: 371

    Topics: Angiotensin II; Animals; beta Catenin; Cardiomegaly; Cardiomyopathy, Hypertrophic; Homeodomain Proteins; Jumonji Domain-Containing Histone Demethylases; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Transcription Factors; Ventricular Dysfunction

2023
Heart-targeting exosomes from human cardiosphere-derived cells improve the therapeutic effect on cardiac hypertrophy.
    Journal of nanobiotechnology, 2022, Oct-04, Volume: 20, Issue:1

    Topics: Angiotensin II; Animals; Cardiomegaly; Cytokine Receptor gp130; Exosomes; Humans; Lysosomal Membrane Proteins; Mice; MicroRNAs; Myocytes, Cardiac; Peptides; Proto-Oncogene Proteins c-akt; Rats

2022
Cardiomyocyte p38 MAPKα suppresses a heart-adipose tissue-neutrophil crosstalk in heart failure development.
    Basic research in cardiology, 2022, 10-07, Volume: 117, Issue:1

    Topics: Adipose Tissue; Angiotensin II; Animals; Cardiomegaly; Fatty Acids; Heart Failure; Inflammation; Lipase; Lipids; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Neutrophils; p38 Mitogen-Activated Protein Kinases; Tamoxifen

2022
Development of non-bias phenotypic drug screening for cardiomyocyte hypertrophy by image segmentation using deep learning.
    Biochemical and biophysical research communications, 2022, 12-03, Volume: 632

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Cholesterol; Deep Learning; Drug Evaluation, Preclinical; Endothelin-1; Ezetimibe; Heart Failure; Mice; Myocytes, Cardiac; Rats

2022
Inhibition of intermittent calcium-activated potassium channel (SK4) attenuates Ang II-induced hypertrophy of human-induced stem cell-derived cardiomyocytes via targeting Ras-Raf-MEK1/2-ERK1/2 and CN-NFAT signaling pathways.
    Cell biology international, 2023, Volume: 47, Issue:2

    Topics: Angiotensin II; Cardiomegaly; Humans; MAP Kinase Kinase 1; MAP Kinase Signaling System; Myocytes, Cardiac; NFATC Transcription Factors; RNA, Messenger; Signal Transduction; Stem Cells

2023
Membrane Estrogen Receptor β Is Sufficient to Mitigate Cardiac Cell Pathology.
    Endocrinology, 2022, 12-19, Volume: 164, Issue:2

    Topics: Angiotensin II; Animals; Cardiomegaly; Cricetinae; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Mice; Myocytes, Cardiac; Rats

2022
A novel circ_0018553 protects against angiotensin-induced cardiac hypertrophy in cardiomyocytes by modulating the miR-4731/SIRT2 signaling pathway.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2023, Volume: 46, Issue:2

    Topics: Angiotensin II; Cardiomegaly; Humans; MicroRNAs; Myocytes, Cardiac; RNA, Circular; Signal Transduction; Sirtuin 2

2023
MiR-423-5p Inhibition Exerts Protective Effects on Angiotensin II-Induced Cardiomyocyte Hypertrophy.
    The Tohoku journal of experimental medicine, 2023, Feb-17, Volume: 259, Issue:3

    Topics: Angiotensin II; Cardiomegaly; Humans; MicroRNAs; Myocytes, Cardiac

2023
Angiotensin II Type 1A Receptor Expressed in Smooth Muscle Cells is Required for Hypertensive Vascular Remodeling in Mice Infused With Angiotensin II.
    Hypertension (Dallas, Tex. : 1979), 2023, Volume: 80, Issue:3

    Topics: Angiotensin II; Animals; Cardiomegaly; Fibrosis; Hypertension; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Smooth Muscle; Receptor, Angiotensin, Type 1; Vascular Remodeling

2023
Increased angiotensin II coupled with decreased Adra1a expression enhances cardiac hypertrophy in pregnancy-associated hypertensive mice.
    The Journal of biological chemistry, 2023, Volume: 299, Issue:3

    Topics: Angiotensin II; Animals; Cardiomegaly; Female; Humans; Hypertension, Pregnancy-Induced; Mice; Myocardium; Pregnancy; Receptors, Adrenergic, alpha-1; Renin-Angiotensin System

2023
HypERlnc attenuates angiotensin II-induced cardiomyocyte hypertrophy via promoting SIRT1 SUMOylation-mediated activation of PGC-1α/PPARα pathway in AC16 cells.
    Cell biology international, 2023, Volume: 47, Issue:6

    Topics: Angiotensin II; Cardiomegaly; Heart Failure; Humans; Myocytes, Cardiac; Peptide Hormones; PPAR alpha; Sirtuin 1; Sumoylation

2023
Circ_0001052 promotes cardiac hypertrophy via elevating Hipk3.
    Aging, 2023, 02-14, Volume: 15, Issue:4

    Topics: Angiotensin II; Aortic Valve Stenosis; Biological Assay; Cardiomegaly; Cell Proliferation; Humans; Intracellular Signaling Peptides and Proteins; MicroRNAs; Peptide Hormones; Protein Serine-Threonine Kinases; RNA, Circular; Serine-Arginine Splicing Factors

2023
Herpud1 modulates hypertrophic signals independently of calmodulin nuclear translocation in rat myocardium-derived H9C2 cells.
    Biochemical and biophysical research communications, 2023, 04-16, Volume: 652

    Topics: Angiotensin II; Animals; Calmodulin; Cardiomegaly; Cell Line; Cells, Cultured; Myocytes, Cardiac; Rats; RNA, Small Interfering; Transcription Factors

2023
Serum exosomes derived from spontaneously hypertensive rats induce cardiac hypertrophy in vitro and in vivo by increasing autocrine release of angiotensin II in cardiomyocytes.
    Biochemical pharmacology, 2023, Volume: 210

    Topics: Angiotensin II; Animals; Cardiomegaly; Exosomes; Hypertension; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Rats; Rats, Inbred SHR; Renin; Renin-Angiotensin System

2023
Silicate Ions Derived from Calcium Silicate Extract Decelerate Ang II-Induced Cardiac Remodeling.
    Tissue engineering and regenerative medicine, 2023, Volume: 20, Issue:5

    Topics: Angiotensin II; Animals; Calcium; Cardiomegaly; Mice; Silicates; Ventricular Remodeling

2023
Baicalin inhibits pressure overload-induced cardiac hypertrophy by regulating the SIRT3-dependent signaling pathway.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2023, Volume: 114

    Topics: Angiotensin II; Animals; Cardiomegaly; Flavonoids; Mice; Myocytes, Cardiac; Proteasome Endopeptidase Complex; Rats; Signal Transduction; Sirtuin 3

2023
Discovery of 14-3-3 zeta as a potential biomarker for cardiac hypertrophy.
    BMB reports, 2023, Volume: 56, Issue:6

    Topics: 14-3-3 Proteins; Angiotensin II; Biomarkers; Cardiomegaly; Humans; Myocardial Infarction; Myocytes, Cardiac; Proteomics

2023
Gramine protects against pressure overload-induced pathological cardiac hypertrophy through Runx1-TGFBR1 signaling.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2023, Volume: 114

    Topics: Angiotensin II; Animals; Cardiomegaly; Core Binding Factor Alpha 2 Subunit; Disease Models, Animal; Indole Alkaloids; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Rats; Receptor, Transforming Growth Factor-beta Type I; Signal Transduction; Transforming Growth Factor beta

2023
SLC26A4-AS1 Aggravates AngII-induced Cardiac Hypertrophy by Enhancing SLC26A4 Expression.
    Arquivos brasileiros de cardiologia, 2023, Volume: 120, Issue:4

    Topics: Angiotensin II; Animals; Cardiomegaly; Mice; MicroRNAs; Myocytes, Cardiac; RNA, Antisense; Sulfate Transporters

2023
Angiotensin II-induced calcium overload affects mitochondrial functions in cardiac hypertrophy by targeting the USP2/MFN2 axis.
    Molecular and cellular endocrinology, 2023, 07-01, Volume: 571

    Topics: Angiotensin II; Animals; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium, Dietary; Cardiomegaly; Mitochondria; Myocytes, Cardiac

2023
TRIM-containing 44 aggravates cardiac hypertrophy via TLR4/NOX4-induced ferroptosis.
    Journal of molecular medicine (Berlin, Germany), 2023, Volume: 101, Issue:6

    Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Ferroptosis; Mice; Mice, Knockout; Myocytes, Cardiac; NADPH Oxidase 4; Toll-Like Receptor 4

2023
6-Formylindolo[3,2-b]carbazole Protects Against Angiotensin II-Induced Cellular Hypertrophy through the Induction of Cytochrome P450 1A1 and Its Associated 19(S)-HETE Metabolite In Vitro.
    Drug metabolism and disposition: the biological fate of chemicals, 2023, Volume: 51, Issue:7

    Topics: Angiotensin II; Arachidonic Acid; Carbazoles; Cardiomegaly; Cytochrome P-450 CYP1A1; Cytochrome P-450 Enzyme System; Humans; Hydroxyeicosatetraenoic Acids; Receptors, Aryl Hydrocarbon

2023
CMTM3 deficiency induces cardiac hypertrophy by regulating MAPK/ERK signaling.
    Biochemical and biophysical research communications, 2023, 07-30, Volume: 667

    Topics: Angiotensin II; Animals; Cardiomegaly; Chemokines; Gene Knockout Techniques; Heart; MARVEL Domain-Containing Proteins; Mice; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Phenylephrine; Phosphorylation; Rats; Up-Regulation

2023
Long non-coding RNA KCND1 protects hearts from hypertrophy by targeting YBX1.
    Cell death & disease, 2023, 05-30, Volume: 14, Issue:5

    Topics: Angiotensin II; Animals; Cardiomegaly; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; RNA, Long Noncoding; Shal Potassium Channels; Transcription Factors

2023
Pristimerin protects against pathological cardiac hypertrophy through improvement of PPARα pathway.
    Toxicology and applied pharmacology, 2023, Aug-15, Volume: 473

    Topics: Angiotensin II; Animals; Cardiomegaly; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; PPAR alpha; Rats; Signal Transduction

2023
Cardiac-specific BACH1 ablation attenuates pathological cardiac hypertrophy by inhibiting the Ang II type 1 receptor expression and the Ca2+/CaMKII pathway.
    Cardiovascular research, 2023, 08-07, Volume: 119, Issue:9

    Topics: Angiotensin II; Animals; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; Fibrosis; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Myocytes, Cardiac

2023
Sesamin suppresses angiotensin-II-enhanced oxidative stress and hypertrophic markers in H9c2 cells.
    Environmental toxicology, 2023, Volume: 38, Issue:9

    Topics: Angiotensin II; Cardiomegaly; Cardiovascular Diseases; Humans; Myocytes, Cardiac; Oxidative Stress; Reactive Oxygen Species

2023
Integrin beta-like 1 mediates fibroblast-cardiomyocyte crosstalk to promote cardiac fibrosis and hypertrophy.
    Cardiovascular research, 2023, 08-19, Volume: 119, Issue:10

    Topics: Angiotensin II; Animals; Cardiomegaly; Fibroblasts; Fibrosis; Heart Failure; Integrins; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Rats; Ventricular Remodeling

2023
Dapagliflozin attenuates myocardial hypertrophy via activating the SIRT1/HIF-1α signaling pathway.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 165

    Topics: Angiotensin II; Animals; Cardiomegaly; Fibrosis; Mice; Myocytes, Cardiac; Signal Transduction; Sirtuin 1; Stroke Volume; Ventricular Function, Left

2023
Cardioprotective Effects of Sodium Glucose Cotransporter 2 Inhibition in Angiotensin II-Dependent Hypertension Are Mediated by the Local Reduction of Sympathetic Activity and Inflammation.
    International journal of molecular sciences, 2023, Jun-27, Volume: 24, Issue:13

    Topics: Angiotensin II; Animals; Blood Glucose; Blood Pressure; Cardiomegaly; Fibrosis; Hypertension; Inflammation; Rats; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Tyrosine 3-Monooxygenase

2023
Transmembrane protein 117 knockdown protects against angiotensin-II-induced cardiac hypertrophy.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2023, Volume: 46, Issue:10

    Topics: Angiotensin II; Animals; Cardiomegaly; Mice; Mitochondria; Myocytes, Cardiac; Oxidative Stress

2023
Nuclear import of Mas-related G protein-coupled receptor member D induces pathological cardiac remodeling.
    Cell communication and signaling : CCS, 2023, 07-24, Volume: 21, Issue:1

    Topics: Active Transport, Cell Nucleus; Angiotensin II; Cardiomegaly; Humans; Ligands; Receptors, G-Protein-Coupled; Ventricular Remodeling

2023
Effects of Angiotensin 1-7 and Mas Receptor Agonist on Renal System in a Rat Model of Heart Failure.
    International journal of molecular sciences, 2023, Jul-14, Volume: 24, Issue:14

    Topics: Angiotensin I; Angiotensin II; Animals; Cardiomegaly; Heart Failure; Kidney; Peptide Fragments; Rats; Renin-Angiotensin System

2023
Resveratrol prevents Ang II-induced cardiac hypertrophy by inhibition of NF-κB signaling.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 165

    Topics: Angiotensin II; Animals; Cardiomegaly; Heart Failure; Mice; Myocytes, Cardiac; NF-kappa B; Rats; Resveratrol; Signal Transduction

2023
Paeoniflorin alleviates AngII-induced cardiac hypertrophy in H9c2 cells by regulating oxidative stress and Nrf2 signaling pathway.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 165

    Topics: Angiotensin II; Animals; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Cardiomegaly; Myocytes, Cardiac; NF-E2-Related Factor 2; Oxidative Stress; Protein Kinases; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Superoxide Dismutase

2023
The novel peptide athycaltide-1 attenuates Ang II-induced pathological myocardial hypertrophy by reducing ROS and inhibiting the activation of CaMKII and ERK1/2.
    European journal of pharmacology, 2023, Oct-15, Volume: 957

    Topics: Angiotensin II; Animals; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; Cells, Cultured; MAP Kinase Signaling System; Mice; Myocytes, Cardiac; Peptides; Reactive Oxygen Species

2023
Inhibition of miR-25 Ameliorates Cardiac Dysfunction and Fibrosis by Restoring Krüppel-like Factor 4 Expression.
    International journal of molecular sciences, 2023, Aug-04, Volume: 24, Issue:15

    Topics: Angiotensin II; Animals; Calcium; Cardiomegaly; Cardiomyopathies; Fibrosis; Hypertension; Kruppel-Like Factor 4; Mice; Mice, Inbred C57BL; MicroRNAs; Myocytes, Cardiac

2023
Effect of pharmacological heart failure drugs and gene therapy on Danon's cardiomyopathy.
    Biochemical pharmacology, 2023, Volume: 215

    Topics: Angiotensin II; Animals; Cardiomegaly; Fibrosis; Genetic Therapy; Glycogen Storage Disease Type IIb; Heart Failure; Humans; Mice; Ramipril; Reactive Oxygen Species; Spironolactone

2023
Visfatin aggravates transverse aortic constriction-induced cardiac remodelling by enhancing macrophage-mediated oxidative stress in mice.
    Journal of cellular and molecular medicine, 2023, Volume: 27, Issue:17

    Topics: Angiotensin II; Animals; Aortic Valve Stenosis; Cardiomegaly; Constriction; Fibrosis; Macrophages; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Nicotinamide Phosphoribosyltransferase; Oxidative Stress; Ventricular Remodeling

2023
Pregnancy-induced physiological hypertrophic preconditioning attenuates pathological myocardial hypertrophy by activation of FoxO3a.
    Cellular and molecular life sciences : CMLS, 2023, Aug-26, Volume: 80, Issue:9

    Topics: Angiotensin II; Animals; Aortic Valve Stenosis; Cardiomegaly; Female; Glycogen Synthase Kinase 3 beta; Heart; Heart Failure; Mice; Peptide Hormones; Pregnancy

2023
Early-life exposure to lead changes cardiac development and compromises long-term cardiac function.
    The Science of the total environment, 2023, Dec-15, Volume: 904

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Female; Humans; Lead; Mice; Mice, Inbred ICR; Myocytes, Cardiac; Pregnancy

2023
SOX4 as a potential therapeutic target for pathological cardiac hypertrophy.
    European journal of pharmacology, 2023, Nov-05, Volume: 958

    Topics: Angiotensin II; Animals; Cardiomegaly; Heart Failure; Mice; Myocytes, Cardiac; Rats; Sirtuin 3; SOXC Transcription Factors

2023
Exosomes derived from cardiac fibroblasts with angiotensin II stimulation provoke hypertrophy and autophagy inhibition in cardiomyocytes.
    Biochemical and biophysical research communications, 2023, 11-19, Volume: 682

    Topics: Angiotensin II; Animals; Autophagy; Cardiomegaly; Exosomes; Fibroblasts; Mice; Myocytes, Cardiac; Rats

2023
PKD knockdown mitigates Ang II-induced cardiac hypertrophy and ferroptosis via the JNK/P53 signaling pathway.
    Cellular signalling, 2024, Volume: 113

    Topics: Angiotensin II; Cardiomegaly; Ferroptosis; Humans; Myocytes, Cardiac; Signal Transduction; Tumor Suppressor Protein p53

2024
Repurposing an anti-cancer agent for the treatment of hypertrophic heart disease.
    The Journal of pathology, 2019, Volume: 249, Issue:4

    Topics: Angiotensin II; Animals; Cardiomegaly; Cardiovascular Agents; Case-Control Studies; Cells, Cultured; Disease Models, Animal; Drug Repositioning; Fibrosis; Gene Expression Regulation; Heart Failure; Humans; Integrin alphaVbeta3; Male; Mice; Myocytes, Cardiac; Neovascularization, Physiologic; Recovery of Function; Signal Transduction; Snake Venoms; Transcriptome

2019
β-catenin/LEF1/IGF-IIR Signaling Axis Galvanizes the Angiotensin-II- induced Cardiac Hypertrophy.
    International journal of molecular sciences, 2019, Sep-02, Volume: 20, Issue:17

    Topics: Angiotensin II; Animals; beta Catenin; Biomarkers; Cardiomegaly; Cell Nucleus; GATA4 Transcription Factor; GTP-Binding Protein alpha Subunits, Gq-G11; Lymphoid Enhancer-Binding Factor 1; Myocytes, Cardiac; NFATC Transcription Factors; Promoter Regions, Genetic; Protein Kinase C-alpha; Rats, Inbred SHR; Receptor, IGF Type 2; Signal Transduction

2019
Hexarelin protects cardiac H9C2 cells from angiotensin II-induced hypertrophy
    Die Pharmazie, 2019, 08-01, Volume: 74, Issue:8

    Topics: Angiotensin II; Animals; Autophagosomes; Autophagy; Cardiomegaly; Cell Line; Cell Survival; Metabolic Networks and Pathways; Myocytes, Cardiac; Oligopeptides; Oxidative Stress; Protective Agents; Rats; Signal Transduction; TOR Serine-Threonine Kinases

2019
A knock-in mutation at cysteine 144 of TRIM72 is cardioprotective and reduces myocardial TRIM72 release.
    Journal of molecular and cellular cardiology, 2019, Volume: 136

    Topics: Angiotensin II; Animals; Cardiomegaly; Coronary Artery Disease; Cysteine; Disease Models, Animal; Gene Knock-In Techniques; Insulin Resistance; Membrane Proteins; Mice, Inbred C57BL; Mice, Mutant Strains; Mutation; Myocardial Reperfusion Injury; Myocardium

2019
Interleukin enhancement binding factor 3 inhibits cardiac hypertrophy by targeting asymmetric dimethylarginine-nitric oxide.
    Nitric oxide : biology and chemistry, 2019, 12-01, Volume: 93

    Topics: Amidohydrolases; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arginine; Cardiomegaly; Down-Regulation; Gene Knockdown Techniques; Losartan; Male; Myocytes, Cardiac; Nitric Oxide; Nuclear Factor 90 Proteins; Rats, Sprague-Dawley

2019
MicroRNA-122 promotes cardiomyocyte hypertrophy via targeting FoxO3.
    Biochemical and biophysical research communications, 2019, 11-19, Volume: 519, Issue:4

    Topics: Angiotensin II; Animals; Animals, Newborn; Calcineurin; Cardiomegaly; Cell Size; Cells, Cultured; Forkhead Box Protein O3; Gene Expression Regulation; MicroRNAs; Myocytes, Cardiac; Rats, Sprague-Dawley; Signal Transduction; Vasoconstrictor Agents

2019
Sodium butyrate attenuates angiotensin II-induced cardiac hypertrophy by inhibiting COX2/PGE2 pathway via a HDAC5/HDAC6-dependent mechanism.
    Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:12

    Topics: Angiotensin II; Animals; Butyric Acid; Cardiomegaly; Cell Line; Cyclooxygenase 2; Dinoprostone; Gene Expression; Gene Knockdown Techniques; Histone Deacetylase 6; Histone Deacetylases; Hypertension; Myocytes, Cardiac; Rats, Sprague-Dawley; Signal Transduction

2019
miR-154-5p Functions as an Important Regulator of Angiotensin II-Mediated Heart Remodeling.
    Oxidative medicine and cellular longevity, 2019, Volume: 2019

    Topics: Angiotensin II; Animals; Apoptosis; Cardiomegaly; Disease Models, Animal; Male; Mice; MicroRNAs; Myocytes, Cardiac

2019
Deficiency of MicroRNA miR-1954 Promotes Cardiac Remodeling and Fibrosis.
    Journal of the American Heart Association, 2019, 11-05, Volume: 8, Issue:21

    Topics: Actins; Angiotensin II; Animals; bcl-2 Homologous Antagonist-Killer Protein; Cardiomegaly; Caspase 3; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type III; Collagen Type IV; Connective Tissue Growth Factor; Disease Models, Animal; Fibrosis; High-Throughput Nucleotide Sequencing; Interleukin-6; Mice, Transgenic; MicroRNAs; Myocardium; Organ Size; S100 Calcium-Binding Protein A4; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Thrombospondin 1; Transforming Growth Factor beta1; Up-Regulation; Ventricular Remodeling

2019
BRD4 blockage alleviates pathological cardiac hypertrophy through the suppression of fibrosis and inflammation via reducing ROS generation.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 121

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Line; Fibrosis; Heart; Heme Oxygenase-1; Humans; Inflammation; Male; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; NF-kappa B; Nuclear Proteins; Oxidative Stress; Protective Agents; Reactive Oxygen Species; Signal Transduction; Transcription Factors; Transforming Growth Factor beta1; Up-Regulation

2020
MiR-21, MiR-29a, GATA4, and MEF2c Expression Changes in Endothelin-1 and Angiotensin II Cardiac Hypertrophy Stimulated Isl-1
    Cells, 2019, 11-09, Volume: 8, Issue:11

    Topics: Angiotensin II; Animals; Antigens, Surface; Biomarkers; Cardiomegaly; Cells, Cultured; Cellular Reprogramming; Connexin 43; Disease Susceptibility; Endothelin-1; GATA4 Transcription Factor; Genetic Predisposition to Disease; Immunophenotyping; MEF2 Transcription Factors; MicroRNAs; Myoblasts, Cardiac; Phenotype; Swine; Ventricular Remodeling

2019
Effect of endostatin overexpression on angiotensin II-induced cardiac hypertrophy in rats.
    Chinese medical journal, 2019, Nov-20, Volume: 132, Issue:22

    Topics: Angiotensin II; Animals; Blotting, Western; Cardiomegaly; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Echocardiography; Endostatins; Fluorescent Antibody Technique; Male; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Signal Transduction

2019
Corosolic acid ameliorates cardiac hypertrophy via regulating autophagy.
    Bioscience reports, 2019, 12-20, Volume: 39, Issue:12

    Topics: AMP-Activated Protein Kinase Kinases; Angiotensin II; Animals; Autophagosomes; Autophagy; Cardiomegaly; Disease Models, Animal; Gene Expression Regulation; Humans; Mice; Microtubule-Associated Proteins; Myocytes, Cardiac; Protein Kinases; Rats; Signal Transduction; Triterpenes

2019
Steroidogenic acute regulatory protein/aldosterone synthase mediates angiotensin II-induced cardiac fibrosis and hypertrophy.
    Molecular biology reports, 2020, Volume: 47, Issue:2

    Topics: Adrenal Glands; Angiotensin II; Animals; Biomarkers; Biopsy; Cardiomegaly; Cardiomyopathies; Collagen; Cytochrome P-450 CYP11B2; Disease Models, Animal; Disease Susceptibility; Fibrosis; Immunohistochemistry; Macrophages; Male; Models, Biological; Myocardium; Myofibroblasts; Phosphoproteins; Rats; Receptor, Angiotensin, Type 1; Signal Transduction; Smad2 Protein; Smad3 Protein

2020
Long Noncoding RNA FTX Reduces Hypertrophy of Neonatal Mouse Cardiac Myocytes and Regulates the PTEN/PI3K/Akt Signaling Pathway by Sponging MicroRNA-22.
    Medical science monitor : international medical journal of experimental and clinical research, 2019, Dec-16, Volume: 25

    Topics: Actins; Angiotensin II; Animals; Animals, Newborn; Apoptosis; Cardiomegaly; Cells, Cultured; Heart Failure; Mice; Mice, Inbred C57BL; MicroRNAs; Myocardium; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; RNA, Long Noncoding; Signal Transduction

2019
MicroRNA302-367-PI3K-PTEN-AKT-mTORC1 pathway promotes the development of cardiac hypertrophy through controlling autophagy.
    In vitro cellular & developmental biology. Animal, 2020, Volume: 56, Issue:2

    Topics: Angiotensin II; Animals; Autophagosomes; Autophagy; Base Sequence; Cardiomegaly; Cell Line; Mechanistic Target of Rapamycin Complex 1; MicroRNAs; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Rats; Signal Transduction

2020
Involvement of phosphatase and tensin homolog-induced putative kinase 1/Parkin-mediated autophagy in angiotensin II-induced cardiac hypertrophy in C57BL/6 mice.
    The Journal of international medical research, 2020, Volume: 48, Issue:5

    Topics: Angiotensin II; Animals; Apoptosis; Autophagy; Cardiomegaly; Disease Models, Animal; Echocardiography; Heart Ventricles; Humans; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Mitochondria, Heart; Myocardium; Myocytes, Cardiac; Protein Kinases; Ubiquitin-Protein Ligases

2020
NRF1-enhanced miR-4458 alleviates cardiac hypertrophy through releasing TTP-inhibited TFAM.
    In vitro cellular & developmental biology. Animal, 2020, Volume: 56, Issue:2

    Topics: Angiotensin II; Animals; Base Sequence; Cardiomegaly; Cell Line; Male; Mice, Inbred C57BL; MicroRNAs; Nuclear Respiratory Factor 1; Phenotype; Protein Stability; Rats; Transcription Factors; Transcription, Genetic; Tristetraprolin

2020
Complement component C3 and the TLR co-receptor CD14 are not involved in angiotensin II induced cardiac remodelling.
    Biochemical and biophysical research communications, 2020, 03-19, Volume: 523, Issue:4

    Topics: Angiotensin II; Animals; Biomarkers; Blood Pressure; Cardiomegaly; Complement C3; Fibrosis; Hypertrophy; Interleukin-6; Lipopolysaccharide Receptors; Mice; Myocardium; Myocytes, Cardiac; Organ Size; RNA, Messenger; Systole; Toll-Like Receptors; Ventricular Remodeling

2020
MiR-326 targets MDK to regulate the progression of cardiac hypertrophy through blocking JAK/STAT and MAPK signaling pathways.
    European journal of pharmacology, 2020, Apr-05, Volume: 872

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Line; Disease Models, Animal; Disease Progression; Down-Regulation; Humans; Janus Kinases; Male; MAP Kinase Signaling System; Mice; MicroRNAs; Midkine; Myocytes, Cardiac; Rats; STAT Transcription Factors

2020
Neuron-derived orphan receptor-1 modulates cardiac gene expression and exacerbates angiotensin II-induced cardiac hypertrophy.
    Clinical science (London, England : 1979), 2020, 02-14, Volume: 134, Issue:3

    Topics: Angiotensin II; Animals; Biomarkers; Cardiomegaly; Collagen; Collagen Type I, alpha 1 Chain; Disease Models, Animal; Disease Progression; Electrocardiography; Fibroblasts; Fibrosis; Gene Expression Regulation; Humans; Inflammation; Mice, Inbred C57BL; Mice, Transgenic; Myocardium; Myocytes, Cardiac; Nuclear Receptor Subfamily 4, Group A, Member 3; Transcription, Genetic; Ventricular Remodeling

2020
Aliskiren attenuates cardiac dysfunction by modulation of the mTOR and apoptosis pathways.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2020, Volume: 53, Issue:2

    Topics: Amides; Angiotensin II; Animals; Apoptosis; Blotting, Western; Cardiomegaly; Disease Models, Animal; Fibrosis; Flow Cytometry; Fumarates; Isoproterenol; Male; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; TOR Serine-Threonine Kinases

2020
Emodin and emodin-rich rhubarb inhibits histone deacetylase (HDAC) activity and cardiac myocyte hypertrophy.
    The Journal of nutritional biochemistry, 2020, Volume: 79

    Topics: Acetylation; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cardiotonic Agents; Disease Models, Animal; Emodin; Female; Gene Expression; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Rheum

2020
High content screening identifies licoisoflavone A as a bioactive compound of Tongmaiyangxin Pills to restrain cardiomyocyte hypertrophy via activating Sirt3.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2020, Volume: 68

    Topics: Acetylation; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Isoflavones; Isoproterenol; Male; Mice, Inbred C57BL; Mitochondria, Heart; Myocytes, Cardiac; Phenylephrine; Rats; Sirtuin 3

2020
Resveratrol suppresses interleukin-6 expression through activation of sirtuin 1 in hypertrophied H9c2 cardiomyoblasts.
    Journal of cellular physiology, 2020, Volume: 235, Issue:10

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Survival; Cells, Cultured; Gene Expression; Inflammation; Interleukin-6; Myocytes, Cardiac; Rats; Resveratrol; RNA, Messenger; Sirtuin 1; Transcription, Genetic

2020
The association between microRNA-21 and hypertension-induced cardiac remodeling.
    PloS one, 2020, Volume: 15, Issue:2

    Topics: Aged; Angiotensin II; Animals; Animals, Newborn; Apoptosis Regulatory Proteins; Cardiomegaly; Disease Models, Animal; Female; Fibrosis; Humans; Hypertension; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Middle Aged; Myocardium; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; RNA-Binding Proteins; Signal Transduction; Transcription Factor AP-1; Transforming Growth Factor beta1

2020
LncRNA AK045171 protects the heart from cardiac hypertrophy by regulating the SP1/MG53 signalling pathway.
    Aging, 2020, 02-21, Volume: 12, Issue:4

    Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Down-Regulation; Membrane Proteins; Mice; Myocardium; Myocytes, Cardiac; RNA, Long Noncoding; Signal Transduction; Sp1 Transcription Factor

2020
B38-CAP is a bacteria-derived ACE2-like enzyme that suppresses hypertension and cardiac dysfunction.
    Nature communications, 2020, 02-26, Volume: 11, Issue:1

    Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Carboxypeptidases; Cardiomegaly; Disease Models, Animal; Fibrosis; Heart Failure; Hypertension; Male; Mice; Mice, Inbred C57BL; Paenibacillus; Peptidyl-Dipeptidase A; Recombinant Proteins

2020
STING is an essential regulator of heart inflammation and fibrosis in mice with pathological cardiac hypertrophy via endoplasmic reticulum (ER) stress.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 125

    Topics: Angiotensin II; Animals; Biomarkers; Cardiomegaly; Disease Models, Animal; Disease Susceptibility; Echocardiography; Endoplasmic Reticulum Stress; Fibrosis; Gene Expression; Gene Knockdown Techniques; Immunohistochemistry; Inflammation; Male; Membrane Proteins; Mice; Myocytes, Cardiac; Rats; Signal Transduction

2020
Inhibition of histone demethylase JMJD1C attenuates cardiac hypertrophy and fibrosis induced by angiotensin II.
    Journal of receptor and signal transduction research, 2020, Volume: 40, Issue:4

    Topics: Aminopyridines; Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Heart; Humans; Hydrazones; Jumonji Domain-Containing Histone Demethylases; Myocardium; Myocytes, Cardiac; Oxidoreductases, N-Demethylating; Rats; RNA, Small Interfering; Signal Transduction; Tissue Inhibitor of Metalloproteinase-1

2020
DPP (Dipeptidyl Peptidase)-4 Inhibitor Attenuates Ang II (Angiotensin II)-Induced Cardiac Hypertrophy via GLP (Glucagon-Like Peptide)-1-Dependent Suppression of Nox (Nicotinamide Adenine Dinucleotide Phosphate Oxidase) 4-HDAC (Histone Deacetylase) 4 Pathw
    Hypertension (Dallas, Tex. : 1979), 2020, Volume: 75, Issue:4

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Heart Rate; Histone Deacetylases; Mice; Myocytes, Cardiac; NADPH Oxidase 4; Oxidative Stress; Pyrazoles; Rats; Signal Transduction; Thiazolidines

2020
Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway.
    Aging, 2020, 03-25, Volume: 12, Issue:6

    Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Anthocyanins; Cardiomegaly; Fibrosis; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; NADPH Oxidases; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Reactive Oxygen Species; Signal Transduction

2020
TBC1D25 Regulates Cardiac Remodeling Through TAK1 Signaling Pathway.
    International journal of biological sciences, 2020, Volume: 16, Issue:8

    Topics: Angiotensin II; Animals; Aorta; Cardiomegaly; Echocardiography; Gene Expression Regulation; GTPase-Activating Proteins; Heart Failure; Hypertrophy; Male; MAP Kinase Kinase Kinases; MAP Kinase Signaling System; Mice; Mice, Knockout; Myocytes, Cardiac; Phosphorylation; Protein Domains; Rats; Rats, Sprague-Dawley; Signal Transduction; Ventricular Remodeling

2020
Fluconazole Represses Cytochrome P450 1B1 and Its Associated Arachidonic Acid Metabolites in the Heart and Protects Against Angiotensin II-Induced Cardiac Hypertrophy.
    Journal of pharmaceutical sciences, 2020, Volume: 109, Issue:7

    Topics: Angiotensin II; Animals; Arachidonic Acid; Cardiomegaly; Cytochrome P-450 Enzyme System; Fluconazole; Rats; Rats, Sprague-Dawley

2020
Polyphyllin I attenuates pressure over-load induced cardiac hypertrophy via inhibition of Wnt/β-catenin signaling pathway.
    Life sciences, 2020, Jul-01, Volume: 252

    Topics: Angiotensin II; Animals; Cardiomegaly; Diosgenin; Disease Models, Animal; Echocardiography; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Rats; Wnt Signaling Pathway

2020
Wnt-C59 Attenuates Pressure Overload-Induced Cardiac Hypertrophy via Interruption of Wnt Pathway.
    Medical science monitor : international medical journal of experimental and clinical research, 2020, Apr-12, Volume: 26

    Topics: Angiotensin II; Animals; Aorta; Benzeneacetamides; Cardiomegaly; Cells, Cultured; Constriction; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Pyridines; Rats; Wnt Signaling Pathway

2020
VSMC-Specific Deletion of FAM3A Attenuated Ang II-Promoted Hypertension and Cardiovascular Hypertrophy.
    Circulation research, 2020, 06-05, Volume: 126, Issue:12

    Topics: Adenosine Triphosphate; Angiotensin II; Animals; Arteries; Blood Pressure; Cardiomegaly; Cells, Cultured; Cytokines; Female; Gene Deletion; Heat Shock Transcription Factors; Humans; Hypertension; Male; Mice; Mice, Inbred C57BL; Middle Aged; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Rats; Receptors, Purinergic P2; Vasoconstriction; Vasoconstrictor Agents

2020
Extracellular vesicular MicroRNA-27a* contributes to cardiac hypertrophy in chronic heart failure.
    Journal of molecular and cellular cardiology, 2020, Volume: 143

    Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Biological Transport; Biomarkers; Cardiomegaly; Cells, Cultured; Coculture Techniques; Disease Susceptibility; Extracellular Vesicles; Fibroblasts; Gene Expression; Gene Expression Regulation; MicroRNAs; Myocytes, Cardiac; Organogenesis; Rats

2020
DSCAM-AS1 mediates pro-hypertrophy role of GRK2 in cardiac hypertrophy aggravation via absorbing miR-188-5p.
    In vitro cellular & developmental biology. Animal, 2020, Volume: 56, Issue:4

    Topics: Angiotensin II; Animals; Base Sequence; Cardiomegaly; Cell Line; G-Protein-Coupled Receptor Kinase 2; Gene Knockdown Techniques; Mice, Inbred C57BL; MicroRNAs; RNA, Long Noncoding; Up-Regulation

2020
Quercetin Dihydrate inhibition of cardiac fibrosis induced by angiotensin II in vivo and in vitro.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 127

    Topics: Angiotensin II; Animals; Cardiomegaly; Cardiomyopathies; Collagen Type I; Collagen Type III; Disease Models, Animal; Disease Progression; Fibroblasts; Fibrosis; Male; Mice; Mice, Inbred C57BL; Myocardium; Quercetin; Rats

2020
SP1-induced SNHG14 aggravates hypertrophic response in in vitro model of cardiac hypertrophy via up-regulation of PCDH17.
    Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:13

    Topics: Angiotensin II; Animals; Base Sequence; Cadherins; Cardiomegaly; Gene Silencing; Male; Mice, Inbred C57BL; MicroRNAs; Models, Biological; Myocytes, Cardiac; Protocadherins; RNA, Long Noncoding; Sp1 Transcription Factor; Up-Regulation

2020
Effects of Sirt3‑autophagy and resveratrol activation on myocardial hypertrophy and energy metabolism.
    Molecular medicine reports, 2020, Volume: 22, Issue:2

    Topics: Acyl-CoA Dehydrogenase; Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Autophagy; Beclin-1; Cardiomegaly; Cells, Cultured; Energy Metabolism; Female; Gene Silencing; Male; Microtubule-Associated Proteins; Myocytes, Cardiac; Natriuretic Peptide, Brain; Pyruvate Kinase; Rats, Sprague-Dawley; Resveratrol; Sirtuins

2020
Activated FMS-like tyrosine kinase 3 ameliorates angiotensin II-induced cardiac remodelling.
    Acta physiologica (Oxford, England), 2020, Volume: 230, Issue:2

    Topics: Angiotensin II; Animals; Cardiomegaly; fms-Like Tyrosine Kinase 3; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Rats; Ventricular Remodeling

2020
Puerarin ameliorated pressure overload-induced cardiac hypertrophy in ovariectomized rats through activation of the PPARα/PGC-1 pathway.
    Acta pharmacologica Sinica, 2021, Volume: 42, Issue:1

    Topics: Angiotensin II; Animals; Aorta, Abdominal; Cardiomegaly; Cardiotonic Agents; Constriction, Pathologic; Energy Metabolism; Female; Isoflavones; Myocardium; Myocytes, Cardiac; Ovariectomy; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR alpha; Rats, Sprague-Dawley; Signal Transduction

2021
Paired box 6 inhibits cardiac fibroblast differentiation.
    Biochemical and biophysical research communications, 2020, 07-30, Volume: 528, Issue:3

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Differentiation; Chemokine CXCL10; Disease Models, Animal; Extracellular Matrix Proteins; Fibroblasts; Fibrosis; Gene Expression Regulation; Gene Knockdown Techniques; Introns; Male; Mice; Mice, Inbred C57BL; Myocardium; PAX6 Transcription Factor; Promoter Regions, Genetic; Protein Binding; Receptors, Interleukin-1 Type II; RNA, Messenger; RNA, Small Interfering; Transforming Growth Factor beta1

2020
Resveratrol attenuates angiotensin II-induced cellular hypertrophy through the inhibition of CYP1B1 and the cardiotoxic mid-chain HETE metabolites.
    Molecular and cellular biochemistry, 2020, Volume: 471, Issue:1-2

    Topics: Angiotensin II; Antioxidants; Atrial Natriuretic Factor; Cardiomegaly; Cardiotoxicity; Cell Line; Cytochrome P-450 CYP1B1; Humans; Hydroxyeicosatetraenoic Acids; Myosin Heavy Chains; Protective Agents; Resveratrol; Vasoconstrictor Agents

2020
MiR-30e-5p is sponged by Kcnq1ot1 and represses Angiotensin II-induced hypertrophic phenotypes in cardiomyocytes by targeting ADAM9.
    Experimental cell research, 2020, 09-15, Volume: 394, Issue:2

    Topics: ADAM Proteins; Angiotensin II; Animals; Animals, Newborn; Base Sequence; Cardiomegaly; Cell Line; Down-Regulation; Membrane Proteins; Mice; MicroRNAs; Myocytes, Cardiac; Phenotype; Protein Binding; RNA, Long Noncoding; Up-Regulation

2020
Sophocarpine ameliorates cardiac hypertrophy through activation of autophagic responses.
    Bioscience, biotechnology, and biochemistry, 2020, Volume: 84, Issue:10

    Topics: Alkaloids; Angiotensin II; Animals; Autophagy; Cardiomegaly; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Myocardium; Ventricular Remodeling

2020
TRIF/EGFR signalling mediates angiotensin-II-induced cardiac remodelling in mice.
    Journal of molecular endocrinology, 2020, Volume: 65, Issue:2

    Topics: Adaptor Proteins, Vesicular Transport; Angiotensin II; Animals; Cardiomegaly; ErbB Receptors; Inflammation; Male; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; RNA, Messenger; Signal Transduction; Ventricular Remodeling

2020
GJA1-20k attenuates Ang II-induced pathological cardiac hypertrophy by regulating gap junction formation and mitochondrial function.
    Acta pharmacologica Sinica, 2021, Volume: 42, Issue:4

    Topics: Angiotensin II; Animals; Cardiomegaly; Connexin 43; Down-Regulation; Gap Junctions; Janus Kinase 2; Male; Membrane Potential, Mitochondrial; Mitochondria; Myocardium; Organelle Biogenesis; Rats, Inbred WKY; Reactive Oxygen Species; Signal Transduction; Tyrphostins; Valsartan

2021
Sulfated N-acetylglucosamino-glucuronopyranosyl-arabinopyranan from seafood Amphioctopus neglectus attenuates angiotensin-II prompted cardiac hypertrophy.
    International journal of biological macromolecules, 2020, Nov-15, Volume: 163

    Topics: Acetylglucosamine; Angiotensin II; Animals; Antihypertensive Agents; Antioxidants; Cardiomegaly; Cephalopoda; Disease Susceptibility; Humans; Magnetic Resonance Spectroscopy; Molecular Docking Simulation; Molecular Dynamics Simulation; Monosaccharides; Peptidyl-Dipeptidase A; Polysaccharides; Seafood; Structure-Activity Relationship; Sulfates

2020
Senolytic Agent Navitoclax Inhibits Angiotensin II-Induced Heart Failure in Mice.
    Journal of cardiovascular pharmacology, 2020, Volume: 76, Issue:4

    Topics: Angiotensin II; Aniline Compounds; Animals; Apoptosis; Cardiac Pacing, Artificial; Cardiomegaly; Cells, Cultured; Cellular Senescence; Disease Models, Animal; Fibrosis; Heart Failure; Inflammation Mediators; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Rats, Sprague-Dawley; Stroke Volume; Sulfonamides; Tachycardia, Ventricular; Ventricular Function, Left; Ventricular Remodeling

2020
Ca
    Hypertension (Dallas, Tex. : 1979), 2020, Volume: 76, Issue:3

    Topics: Acetylcysteine; Angiotensin II; Animals; Cardiomegaly; Free Radical Scavengers; Gene Expression Regulation; Humans; Isoenzymes; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinase Kinases; Myocytes, Cardiac; NADPH Oxidase 5; Oxidative Stress; Phagocytes; Rats; Reactive Oxygen Species; Signal Transduction; Vasoconstrictor Agents; Ventricular Myosins

2020
Bone marrow mesenchymal stem cell-derived exosomes attenuate cardiac hypertrophy and fibrosis in pressure overload induced remodeling.
    In vitro cellular & developmental biology. Animal, 2020, Volume: 56, Issue:7

    Topics: Angiotensin II; Animals; Apoptosis; Cardiomegaly; Exosomes; Fibrosis; Male; Mesenchymal Stem Cells; Mice, Inbred C57BL; Myocytes, Cardiac; Myofibroblasts; Pressure; Ventricular Remodeling

2020
Ubiquitin-specific protease 19 blunts pathological cardiac hypertrophy via inhibition of the TAK1-dependent pathway.
    Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:18

    Topics: Angiotensin II; Animals; Animals, Newborn; Aortic Valve Stenosis; Cardiomegaly; CRISPR-Cas Systems; Disease Models, Animal; Endopeptidases; Fibrosis; Inflammation; Male; MAP Kinase Kinase Kinases; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Phenylephrine; Pressure; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Ubiquitin-Protein Ligases; Ventricular Remodeling

2020
MicroRNA-183 as a Novel Regulator Protects Against Cardiomyocytes Hypertrophy via Targeting TIAM1.
    American journal of hypertension, 2022, 01-05, Volume: 35, Issue:1

    Topics: Angiotensin II; Animals; Cardiomegaly; Gene Expression Regulation; Heart Ventricles; MicroRNAs; Myocytes, Cardiac; Rats; T-Lymphoma Invasion and Metastasis-inducing Protein 1

2022
CSN6 aggravates Ang II-induced cardiomyocyte hypertrophy via inhibiting SIRT2.
    Experimental cell research, 2020, 11-01, Volume: 396, Issue:1

    Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cell Size; COP9 Signalosome Complex; Gene Expression Regulation; Homeobox Protein Nkx-2.2; Homeodomain Proteins; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Proteasome Endopeptidase Complex; Protein Stability; Proteolysis; Rats; Rats, Sprague-Dawley; Signal Transduction; Sirtuin 2; Ubiquitin; Zebrafish Proteins

2020
Mitochondrial pyruvate carrier abundance mediates pathological cardiac hypertrophy.
    Nature metabolism, 2020, Volume: 2, Issue:11

    Topics: Angiotensin II; Animals; Anion Transport Proteins; Cardiomegaly; Cell Proliferation; Citric Acid Cycle; Constriction, Pathologic; Female; Heart Failure; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Monocarboxylic Acid Transporters; Myocardium; Myocytes, Cardiac; Pyruvic Acid

2020
Inhibition of lncRNA Gm15834 Attenuates Autophagy-Mediated Myocardial Hypertrophy via the miR-30b-3p/ULK1 Axis in Mice.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2021, 03-03, Volume: 29, Issue:3

    Topics: Angiotensin II; Animals; Autophagy; Autophagy-Related Protein-1 Homolog; Cardiomegaly; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Myocytes, Cardiac; NF-kappa B; RNA, Long Noncoding; Signal Transduction; Vasoconstrictor Agents

2021
Deubiquitinase Ubiquitin-Specific Protease 10 Deficiency Regulates Sirt6 signaling and Exacerbates Cardiac Hypertrophy.
    Journal of the American Heart Association, 2020, 11-17, Volume: 9, Issue:22

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Culture Techniques; Disease Models, Animal; Male; Mice; Mice, Transgenic; Myocytes, Cardiac; Signal Transduction; Sirtuins; Ubiquitin Thiolesterase

2020
Transcribed ultraconserved region uc.242 is a novel regulator of cardiomyocyte hypertrophy induced by angiotensin II.
    Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2021, Volume: 69, Issue:3

    Topics: Angiotensin II; Cardiomegaly; Cells, Cultured; Humans; Myocytes, Cardiac; RNA, Long Noncoding; RNA, Messenger

2021
MicroRNA-214 contributes to Ang II-induced cardiac hypertrophy by targeting SIRT3 to provoke mitochondrial malfunction.
    Acta pharmacologica Sinica, 2021, Volume: 42, Issue:9

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Line; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Mitochondria, Heart; Myocardium; Myocytes, Cardiac; Rats, Sprague-Dawley; Sirtuin 3

2021
Melatonin alleviates angiotensin-II-induced cardiac hypertrophy via activating MICU1 pathway.
    Aging, 2020, 11-26, Volume: 13, Issue:1

    Topics: Angiotensin II; Animals; Antioxidants; Calcium-Binding Proteins; Cardiomegaly; Disease Models, Animal; Gene Knockdown Techniques; Heart; In Vitro Techniques; Melatonin; Mice; Mitochondria; Mitochondrial Membrane Transport Proteins; Myocardium; Myocytes, Cardiac; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Reactive Oxygen Species; Vasoconstrictor Agents

2020
Mep1a contributes to Ang II-induced cardiac remodeling by promoting cardiac hypertrophy, fibrosis and inflammation.
    Journal of molecular and cellular cardiology, 2021, Volume: 152

    Topics: Angiotensin II; Animals; Cardiomegaly; Cytokines; Fibrosis; Inflammation; Macrophages; Male; Metalloendopeptidases; Mice; Mice, Inbred C57BL; Mice, Knockout; Signal Transduction; Ventricular Remodeling

2021
Tranilast prevents doxorubicin-induced myocardial hypertrophy and angiotensin II synthesis in rats.
    Life sciences, 2021, Feb-15, Volume: 267

    Topics: Angiotensin II; Animals; Antioxidants; Cardiomegaly; Doxorubicin; Fibrosis; Heart Diseases; Male; Mast Cells; Myocardium; ortho-Aminobenzoates; Oxidative Stress; Rats; Rats, Wistar

2021
Direct Actions of AT
    Hypertension (Dallas, Tex. : 1979), 2021, Volume: 77, Issue:2

    Topics: Angiotensin II; Animals; Cardiomegaly; Hypertension; Mice; Mice, Knockout; Mice, Transgenic; Myocardium; Myocytes, Cardiac; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Vascular Resistance

2021
Cardioprotective potential of amygdalin against angiotensin II induced cardiac hypertrophy, oxidative stress and inflammatory responses through modulation of Nrf2 and NF-κB activation.
    Environmental toxicology, 2021, Volume: 36, Issue:5

    Topics: Amygdalin; Angiotensin II; Animals; Cardiomegaly; Molecular Docking Simulation; Myocytes, Cardiac; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress

2021
Angiotensin II Increases HMGB1 Expression in the Myocardium Through AT1 and AT2 Receptors When Under Pressure Overload.
    International heart journal, 2021, Jan-30, Volume: 62, Issue:1

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Cardiomegaly; Case-Control Studies; Constriction; HMGB1 Protein; Imidazoles; Losartan; Male; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Pyridines; Up-Regulation; Vasoconstrictor Agents

2021
Angiotensin II-induced cardiomyocyte hypertrophy: A complex response dependent on intertwined pathways.
    Revista portuguesa de cardiologia, 2021, Volume: 40, Issue:3

    Topics: Angiotensin II; Cardiomegaly; Humans; Myocytes, Cardiac; Receptor, Angiotensin, Type 1

2021
Piperlongumine attenuates angiotensin-II-induced cardiac hypertrophy and fibrosis by inhibiting Akt-FoxO1 signalling.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2021, Volume: 82

    Topics: Angiotensin II; Animals; Apoptosis; Cardiomegaly; Cardiomyopathies; Dioxolanes; Disease Models, Animal; Fibroblasts; Fibrosis; Heart Failure; Kruppel-Like Factor 4; Myocytes, Cardiac; Nerve Tissue Proteins; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction

2021
GRK5 is a regulator of fibroblast activation and cardiac fibrosis.
    Proceedings of the National Academy of Sciences of the United States of America, 2021, 02-02, Volume: 118, Issue:5

    Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cell Transdifferentiation; Fibroblasts; Fibrosis; G-Protein-Coupled Receptor Kinase 5; Mice, Knockout; Models, Biological; Myocardial Ischemia; Myocardium; Myofibroblasts; Rats

2021
LRRC8A contributes to angiotensin II-induced cardiac hypertrophy by interacting with NADPH oxidases via the C-terminal leucine-rich repeat domain.
    Free radical biology & medicine, 2021, Volume: 165

    Topics: Angiotensin II; Animals; Cardiomegaly; Leucine; Membrane Proteins; Mice; NADPH Oxidases; Reactive Oxygen Species

2021
Scoparone alleviates Ang II-induced pathological myocardial hypertrophy in mice by inhibiting oxidative stress.
    Journal of cellular and molecular medicine, 2021, Volume: 25, Issue:6

    Topics: Angiotensin II; Animals; Antioxidants; Biomarkers; Biopsy; Blood Pressure; Cardiomegaly; Collagen; Coumarins; Disease Management; Disease Models, Animal; Disease Susceptibility; Echocardiography; Fibroblasts; Immunohistochemistry; Male; Mice; Myocytes, Cardiac; Oxidative Stress; Rats

2021
PHD Finger Protein 19 Promotes Cardiac Hypertrophy via Epigenetically Regulating SIRT2.
    Cardiovascular toxicology, 2021, Volume: 21, Issue:6

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Disease Models, Animal; DNA Methylation; DNA-Binding Proteins; Epigenesis, Genetic; Gene Expression Regulation, Enzymologic; Humans; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Rats, Sprague-Dawley; Sirtuin 2; Transcription Factors; Ventricular Remodeling

2021
Exosomes Derived From Hypertrophic Cardiomyocytes Induce Inflammation in Macrophages
    Frontiers in immunology, 2020, Volume: 11

    Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cell Communication; Cellular Microenvironment; Exosomes; Humans; Inflammation; Inflammation Mediators; Interleukin-6; Interleukin-8; Macrophages; Mice; MicroRNAs; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Phosphorylation; Rats, Wistar; RAW 264.7 Cells; Signal Transduction

2020
The Angiotensin II Type 1(AT1) Receptor and Cardiac Hypertrophy: Did We Have It Wrong All Along?
    Journal of cardiovascular pharmacology, 2021, 05-01, Volume: 77, Issue:5

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Hypertension; Mice; Receptor, Angiotensin, Type 1

2021
Ndufs1 Deficiency Aggravates the Mitochondrial Membrane Potential Dysfunction in Pressure Overload-Induced Myocardial Hypertrophy.
    Oxidative medicine and cellular longevity, 2021, Volume: 2021

    Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Biomarkers; Cardiomegaly; Constriction, Pathologic; Down-Regulation; Male; Membrane Potential, Mitochondrial; Mice, Inbred C57BL; Mitochondria, Heart; Myocardium; Myocytes, Cardiac; Myosin Heavy Chains; NADH Dehydrogenase; Natriuretic Peptide, Brain; Pressure; Rats; RNA-Seq; Single-Cell Analysis

2021
Cardiac Oxidative Signaling and Physiological Hypertrophy in the Na/K-ATPase α1
    International journal of molecular sciences, 2021, Mar-27, Volume: 22, Issue:7

    Topics: Angiotensin II; Animals; Cardiac Glycosides; Cardiomegaly; Disease Models, Animal; Echocardiography; Heart; Male; Mice; Mutation; Myocardium; Ouabain; Protein Isoforms; Reactive Oxygen Species; RNA-Seq; Signal Transduction; Sodium-Potassium-Exchanging ATPase

2021
Prevention of Fibrosis and Pathological Cardiac Remodeling by Salinomycin.
    Circulation research, 2021, 05-28, Volume: 128, Issue:11

    Topics: Angiotensin II; Animals; Antifibrotic Agents; Cardiomegaly; Cell Survival; Disease Models, Animal; Extracellular Matrix; Fibrosis; Gene Expression; Heart Failure; Humans; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Myofibroblasts; NIH 3T3 Cells; p38 Mitogen-Activated Protein Kinases; Pyrans; rho-Associated Kinases; Ventricular Remodeling

2021
Serum microRNA-30d is a sensitive biomarker for angiotensin II-induced cardiovascular complications in rats.
    Heart and vessels, 2021, Volume: 36, Issue:10

    Topics: Angiotensin II; Animals; Biomarkers; Cardiomegaly; Hypertension; MicroRNAs; Myocytes, Cardiac; Natriuretic Peptide, Brain; Rats

2021
miR-145-5p targets paxillin to attenuate angiotensin II-induced pathological cardiac hypertrophy via downregulation of Rac 1, pJNK, p-c-Jun, NFATc3, ANP and by Sirt-1 upregulation.
    Molecular and cellular biochemistry, 2021, Volume: 476, Issue:9

    Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Gene Expression Regulation; MAP Kinase Kinase 4; MicroRNAs; Myoblasts, Cardiac; NFATC Transcription Factors; Paxillin; Proto-Oncogene Proteins c-jun; rac1 GTP-Binding Protein; Rats; Sirtuin 1; Vasoconstrictor Agents

2021
Rap1GAP Mediates Angiotensin II-Induced Cardiomyocyte Hypertrophy by Inhibiting Autophagy and Increasing Oxidative Stress.
    Oxidative medicine and cellular longevity, 2021, Volume: 2021

    Topics: Angiotensin II; Animals; Autophagy; Cardiomegaly; GTPase-Activating Proteins; Oxidative Stress; Rats; Rats, Sprague-Dawley; Rats, Wistar

2021
Neuregulin-1 compensates for endothelial nitric oxide synthase deficiency.
    American journal of physiology. Heart and circulatory physiology, 2021, 06-01, Volume: 320, Issue:6

    Topics: Angiotensin II; Animals; Cardiomegaly; Diastole; Endothelial Cells; Fibrosis; Gene Expression Regulation; Heart; Heart Rate; Kidney; Mice; Mice, Knockout; MicroRNAs; Myocardium; Neuregulin-1; Nitric Oxide; Nitric Oxide Synthase Type III; Random Allocation; Vasoconstrictor Agents

2021
Lutein attenuates angiotensin II- induced cardiac remodeling by inhibiting AP-1/IL-11 signaling.
    Redox biology, 2021, Volume: 44

    Topics: Angiotensin II; Animals; Cardiomegaly; Fibrosis; Interleukin-11; Lutein; Mice; Mice, Inbred C57BL; Myocardium; Rats; Transcription Factor AP-1; Ventricular Remodeling

2021
MicroRNA-17-5p Promotes Cardiac Hypertrophy by Targeting Mfn2 to Inhibit Autophagy.
    Cardiovascular toxicology, 2021, Volume: 21, Issue:9

    Topics: Angiotensin II; Animals; Autophagy; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Gene Expression Regulation; GTP Phosphohydrolases; Male; MicroRNAs; Mitochondrial Proteins; Myocytes, Cardiac; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Signal Transduction; TOR Serine-Threonine Kinases

2021
Prostaglandin E1 attenuates AngII-induced cardiac hypertrophy via EP3 receptor activation and Netrin-1upregulation.
    Journal of molecular and cellular cardiology, 2021, Volume: 159

    Topics: Alprostadil; Angiotensin II; Animals; Cardiomegaly; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Netrin-1; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin E, EP3 Subtype; Signal Transduction; Up-Regulation

2021
Lp-PLA2 inhibition prevents Ang II-induced cardiac inflammation and fibrosis by blocking macrophage NLRP3 inflammasome activation.
    Acta pharmacologica Sinica, 2021, Volume: 42, Issue:12

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Angiotensin II; Animals; Anti-Inflammatory Agents; Benzaldehydes; Cardiomegaly; Cardiotonic Agents; Enzyme Inhibitors; Fibrosis; Heart; Inflammasomes; Inflammation; Macrophages; Male; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Oximes

2021
Schisandra chinensis polysaccharides prevent cardiac hypertrophy by dissociating thioredoxin-interacting protein/thioredoxin-1 complex and inhibiting oxidative stress.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 139

    Topics: Angiotensin II; Animals; Antioxidants; Cardiomegaly; Cells, Cultured; Male; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Myocytes, Cardiac; Oxidative Stress; Polysaccharides; Rats; Schisandra; Thioredoxins

2021
Ginkgolide B Protects Cardiomyocytes from Angiotensin II-Induced Hypertrophy via Regulation of Autophagy through SIRT1-FoxO1.
    Cardiovascular therapeutics, 2021, Volume: 2021

    Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Autophagy; Cardiomegaly; Cell Line; Ginkgolides; Lactones; Myocytes, Cardiac; Nerve Tissue Proteins; Protective Agents; Rats; Signal Transduction; Sirtuin 1; Transcription, Genetic; Ventricular Myosins

2021
SLC7A11/xCT Prevents Cardiac Hypertrophy by Inhibiting Ferroptosis.
    Cardiovascular drugs and therapy, 2022, Volume: 36, Issue:3

    Topics: Amino Acid Transport System y+; Amino Acid Transport Systems, Acidic; Angiotensin II; Animals; Cardiomegaly; Ferroptosis; Mice; Mice, Knockout; Myocytes, Cardiac; Rats

2022
Fibroblast-specific IKK-β deficiency ameliorates angiotensin II-induced adverse cardiac remodeling in mice.
    JCI insight, 2021, 09-22, Volume: 6, Issue:18

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cell Differentiation; Cell Movement; Cell Proliferation; Cells, Cultured; Collagen Type I; Fibroblasts; Fibrosis; Gene Knockdown Techniques; Heart Rate; Hypertension; I-kappa B Kinase; Inflammation; Macrophages; Male; Mice; Myocarditis; Myocardium; Organ Size; Protective Factors; Signal Transduction; Ventricular Remodeling

2021
De-ubiquitination of p300 by USP12 Critically Enhances METTL3 Expression and Ang II-induced cardiac hypertrophy.
    Experimental cell research, 2021, 09-01, Volume: 406, Issue:1

    Topics: Adenosine; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; E1A-Associated p300 Protein; Gene Expression Regulation; Male; Methyltransferases; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Signal Transduction; Ubiquitin Thiolesterase; Ubiquitination

2021
Azilsartan ameliorates ventricular hypertrophy in rats suffering from pressure overload-induced cardiac hypertrophy by activating the Keap1-Nrf2 signalling pathway.
    The Journal of pharmacy and pharmacology, 2021, Dec-07, Volume: 73, Issue:12

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antioxidants; Benzimidazoles; Cardiomegaly; Female; Heart Ventricles; Kelch-Like ECH-Associated Protein 1; Male; Myocardium; Myocytes, Cardiac; NF-E2-Related Factor 2; Oxadiazoles; Oxidative Stress; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Up-Regulation

2021
Glucagon-like peptide-1 attenuates cardiac hypertrophy via the AngII/AT1R/ACE2 and AMPK/mTOR/p70S6K pathways.
    Acta biochimica et biophysica Sinica, 2021, Aug-31, Volume: 53, Issue:9

    Topics: Adenylate Kinase; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Cardiomegaly; Cardiotonic Agents; Cell Line; Disease Models, Animal; Glucagon-Like Peptide 1; Hypertension; Liraglutide; Male; Morpholines; Myocytes, Cardiac; Piperidines; Rats; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; TOR Serine-Threonine Kinases; Triazines; Uracil

2021
MicroRNA-27b-3p down-regulates FGF1 and aggravates pathological cardiac remodelling.
    Cardiovascular research, 2022, 07-20, Volume: 118, Issue:9

    Topics: Angiotensin II; Animals; Cardiomegaly; Fibroblast Growth Factor 1; Fibrosis; Mice; Mice, Knockout; MicroRNAs; Myocytes, Cardiac; Ventricular Remodeling

2022
MiR-26a-5p alleviates cardiac hypertrophy and dysfunction via targeting ADAM17.
    Cell biology international, 2021, Volume: 45, Issue:11

    Topics: ADAM17 Protein; Angiotensin II; Animals; Autophagy; Cardiomegaly; Cell Line; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Myocytes, Cardiac; Signal Transduction

2021
Resolvin-D1 attenuation of angiotensin II-induced cardiac inflammation in mice is associated with prevention of cardiac remodeling and hypertension.
    Biochimica et biophysica acta. Molecular basis of disease, 2021, 12-01, Volume: 1867, Issue:12

    Topics: Angiotensin II; Animals; Cardiomegaly; Chemokine CCL2; Disease Models, Animal; Docosahexaenoic Acids; Gene Expression Regulation; Humans; Hypertension; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-1beta; Interleukin-6; Mice; Renin-Angiotensin System; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1; Ventricular Remodeling

2021
Roxadustat prevents Ang II hypertension by targeting angiotensin receptors and eNOS.
    JCI insight, 2021, 09-22, Volume: 6, Issue:18

    Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Cardiomegaly; Cells, Cultured; Electrolytes; Endothelial Cells; Glycine; Hypertension; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Isoquinolines; Kidney Glomerulus; Male; Mice; Myocytes, Smooth Muscle; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphorylation; Proteinuria; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Thiobarbituric Acid Reactive Substances; Urine; Vascular Remodeling

2021
MiR-590-5p inhibits pathological hypertrophy mediated heart failure by targeting RTN4.
    Journal of molecular histology, 2021, Volume: 52, Issue:5

    Topics: Angiotensin II; Animals; Apoptosis; Base Sequence; Biomarkers; Cardiomegaly; Cell Line; Disease Models, Animal; Down-Regulation; Heart Failure; Mice, Inbred C57BL; MicroRNAs; Nogo Proteins; Protein Binding

2021
Comparative beneficial effects of nebivolol and nebivolol/valsartan combination against mitochondrial dysfunction in angiotensin II-induced pathology in H9c2 cardiomyoblasts.
    The Journal of pharmacy and pharmacology, 2021, Oct-07, Volume: 73, Issue:11

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cardiomegaly; Cell Culture Techniques; Drug Combinations; Heart; Hypertension; Inflammation; Mechanistic Target of Rapamycin Complex 1; Mitochondria; Myoblasts, Cardiac; Myocardium; Nebivolol; Organelle Biogenesis; Oxidative Stress; Rats; Reactive Oxygen Species; Valsartan

2021
Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis.
    Cardiovascular drugs and therapy, 2017, Volume: 31, Issue:2

    Topics: Angiotensin II; Animals; Cardiomegaly; Cardiomyopathies; Cell Proliferation; Cells, Cultured; Cyclic Nucleotide Phosphodiesterases, Type 1; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Matrix; Extracellular Matrix Proteins; Fibroblasts; Fibrosis; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Phosphodiesterase Inhibitors; Signal Transduction; Ventricular Remodeling; Vinca Alkaloids

2017
Critical Role of ADAMTS2 (A Disintegrin and Metalloproteinase With Thrombospondin Motifs 2) in Cardiac Hypertrophy Induced by Pressure Overload.
    Hypertension (Dallas, Tex. : 1979), 2017, Volume: 69, Issue:6

    Topics: ADAMTS Proteins; Angiotensin II; Animals; Biopsy, Needle; Cardiomegaly; Disease Models, Animal; Disintegrins; Gene Expression Regulation; Humans; Metalloproteases; Mice; Mice, Transgenic; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Random Allocation; Signal Transduction; Thrombospondins; Tissue Culture Techniques; Up-Regulation; Ventricular Dysfunction, Left; Ventricular Remodeling

2017
Angiotensin-(1-7) attenuates angiotensin II-induced cardiac hypertrophy via a Sirt3-dependent mechanism.
    American journal of physiology. Heart and circulatory physiology, 2017, May-01, Volume: 312, Issue:5

    Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cardiomegaly; Cardiotonic Agents; Cell Size; Fibrosis; Male; Myocytes, Cardiac; Peptide Fragments; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Sirtuins; Superoxide Dismutase

2017
(-)-Epicatechin Suppresses Angiotensin II-induced Cardiac Hypertrophy via the Activation of the SP1/SIRT1 Signaling Pathway.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2017, Volume: 41, Issue:5

    Topics: Angiotensin II; Animals; Cardiomegaly; Catechin; Mice; Myocytes, Cardiac; Signal Transduction; Sirtuin 1; Sp1 Transcription Factor

2017
Inhibition of Mid-chain HETEs Protects Against Angiotensin II-induced Cardiac Hypertrophy.
    Journal of cardiovascular pharmacology, 2017, Volume: 70, Issue:1

    Topics: Angiotensin II; Animals; Cardiomegaly; Cardiotonic Agents; Cells, Cultured; Cytochrome P-450 CYP1B1; Humans; Hydroxyeicosatetraenoic Acids; Male; Myocytes, Cardiac; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Stilbenes

2017
Crucial Role of ROCK2-Mediated Phosphorylation and Upregulation of FHOD3 in the Pathogenesis of Angiotensin II-Induced Cardiac Hypertrophy.
    Hypertension (Dallas, Tex. : 1979), 2017, Volume: 69, Issue:6

    Topics: Amides; Analysis of Variance; Angiotensin II; Animals; Blotting, Western; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Formins; Male; Microfilament Proteins; Myocytes, Cardiac; Phosphorylation; Pyridines; Random Allocation; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; rho-Associated Kinases; Signal Transduction; Up-Regulation

2017
Role of microRNA-124 in cardiomyocyte hypertrophy inducedby angiotensin II.
    Cellular and molecular biology (Noisy-le-Grand, France), 2017, Apr-29, Volume: 63, Issue:4

    Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Calreticulin; Cardiomegaly; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Gene Expression Regulation; Heat-Shock Proteins; Humans; MicroRNAs; Myocytes, Cardiac; Natriuretic Peptide, Brain; Rats; Ventricular Myosins

2017
Stachydrine Protects Against Pressure Overload-Induced Cardiac Hypertrophy by Suppressing Autophagy.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2017, Volume: 42, Issue:1

    Topics: Angiotensin II; Animals; Autophagy; Cardiomegaly; Cell Line; Heart; Male; Membrane Glycoproteins; Microtubule-Associated Proteins; Myocardium; NADH, NADPH Oxidoreductases; NADPH Oxidase 2; NADPH Oxidases; Phosphorylation; Pressure; Proline; Protective Agents; Rats, Wistar; Reactive Oxygen Species

2017
Hydrogen sulfide pretreatment improves mitochondrial function in myocardial hypertrophy via a SIRT3-dependent manner.
    British journal of pharmacology, 2018, Volume: 175, Issue:8

    Topics: Angiotensin II; Animals; Cardiomegaly; Hydrogen Sulfide; Male; Membrane Potential, Mitochondrial; Mice, Knockout; Mitochondria, Heart; Myocardium; Myocytes, Cardiac; Oxidative Stress; Rats, Sprague-Dawley; Sirtuin 3

2018
Exogenous cathepsin V protein protects human cardiomyocytes HCM from angiotensin Ⅱ-Induced hypertrophy.
    The international journal of biochemistry & cell biology, 2017, Volume: 89

    Topics: Angiotensin II; Biomarkers; Cardiomegaly; Cardiotonic Agents; Cathepsins; Cell Line; Cysteine Endopeptidases; Gene Expression Regulation; Humans; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases

2017
Lysyl oxidase overexpression accelerates cardiac remodeling and aggravates angiotensin II-induced hypertrophy.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2017, Volume: 31, Issue:9

    Topics: Angiotensin II; Animals; Cardiomegaly; Fibroblasts; Gene Expression Regulation, Enzymologic; Humans; Inflammation; Mice; Mice, Transgenic; Myocardium; Protein-Lysine 6-Oxidase; Signal Transduction; Ventricular Remodeling

2017
Plasminogen Activator Inhibitor Type I Controls Cardiomyocyte Transforming Growth Factor-β and Cardiac Fibrosis.
    Circulation, 2017, Aug-15, Volume: 136, Issue:7

    Topics: Angiotensin II; Animals; Bone Morphogenetic Protein 7; Cardiomegaly; Cells, Cultured; Female; Frameshift Mutation; Humans; Magnetic Resonance Imaging, Cine; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Plasminogen Activator Inhibitor 1; RNA; Sequence Analysis, RNA; Smad6 Protein; Transcription, Genetic; Transforming Growth Factor beta

2017
Differential Effects of Myocardial Afadin on Pressure Overload-Induced Compensated Cardiac Hypertrophy.
    Circulation journal : official journal of the Japanese Circulation Society, 2017, Nov-24, Volume: 81, Issue:12

    Topics: Angiotensin II; Animals; Apoptosis; Cardiomegaly; Fibrosis; Humans; Mice; Mice, Knockout; Microfilament Proteins; Myocardium; Pressure; Stress, Mechanical

2017
Melatonin protects against the pathological cardiac hypertrophy induced by transverse aortic constriction through activating PGC-1β: In vivo and in vitro studies.
    Journal of pineal research, 2017, Volume: 63, Issue:3

    Topics: Angiotensin II; Animals; Antioxidants; Cardiomegaly; Disease Models, Animal; Drug Evaluation, Preclinical; Fibrosis; Heart; Lung Diseases; Male; Melatonin; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Primary Cell Culture; Transcriptional Activation

2017
The Inhibitory Effect of WenxinKeli on H9C2 Cardiomyocytes Hypertrophy Induced by Angiotensin II through Regulating Autophagy Activity.
    Oxidative medicine and cellular longevity, 2017, Volume: 2017

    Topics: Angiotensin II; Animals; Autophagy; Cardiomegaly; Heart Failure; Humans; Medicine, Chinese Traditional; Myocytes, Cardiac; Rats

2017
Augmented sphingosine 1 phosphate receptor-1 signaling in cardiac fibroblasts induces cardiac hypertrophy and fibrosis through angiotensin II and interleukin-6.
    PloS one, 2017, Volume: 12, Issue:8

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Cardiomegaly; Cells, Cultured; Fibroblasts; Heart Ventricles; Humans; Interleukin-6; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardium; Myocytes, Cardiac; Peptidyl-Dipeptidase A; Phosphorylation; Plasmids; Receptors, Lysosphingolipid; Signal Transduction; Tetrazoles

2017
The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
    Aging cell, 2017, Volume: 16, Issue:5

    Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Cardiomegaly; Cerebrovascular Disorders; Echocardiography; Gene Expression Regulation; Hypertension; Hypertrophy, Left Ventricular; Male; Mechanistic Target of Rapamycin Complex 1; Mice, Transgenic; Myocardium; Myocytes, Cardiac; Pressure; Primary Cell Culture; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; Valosin Containing Protein; Ventricular Remodeling

2017
Tanshinone-induced ERs suppresses IGFII activation to alleviate Ang II-mediated cardiac hypertrophy.
    Journal of receptor and signal transduction research, 2017, Volume: 37, Issue:5

    Topics: Abietanes; Angiotensin II; Animals; Cardiomegaly; Cell Line; Drugs, Chinese Herbal; Gene Expression; Heat Shock Transcription Factors; Humans; Insulin-Like Growth Factor II; Mitogen-Activated Protein Kinase Kinases; Myocytes, Cardiac; Rats; Receptor, IGF Type 2; Receptors, Estrogen; Signal Transduction; Sirtuin 1

2017
Lercanidipine attenuates angiotensin II-induced cardiomyocyte hypertrophy by blocking calcineurin-NFAT3 and CaMKII-HDAC4 signaling.
    Molecular medicine reports, 2017, Volume: 16, Issue:4

    Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Calcineurin; Calcium Channel Blockers; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; Cells, Cultured; Dihydropyridines; Gene Expression Regulation; Histone Deacetylases; Myocytes, Cardiac; Natriuretic Peptide, Brain; NFATC Transcription Factors; Rats; Signal Transduction

2017
A Systems Biology Approach to Investigating Sex Differences in Cardiac Hypertrophy.
    Journal of the American Heart Association, 2017, Aug-19, Volume: 6, Issue:8

    Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Female; Gene Expression Regulation; Gene Regulatory Networks; Male; Mice, Inbred C57BL; MicroRNAs; Myocardium; Oxazoles; PPAR alpha; Protein Interaction Maps; RNA, Messenger; Sex Characteristics; Sex Factors; Signal Transduction; Systems Biology; Time Factors; Tyrosine

2017
Sirtuin 3 Deficiency Accelerates Hypertensive Cardiac Remodeling by Impairing Angiogenesis.
    Journal of the American Heart Association, 2017, Aug-19, Volume: 6, Issue:8

    Topics: Acetylation; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Collagen Type I; Collagen Type III; Disease Models, Animal; Disease Progression; Fibrosis; Genetic Predisposition to Disease; Hypertension; Mice, 129 Strain; Mice, Knockout; Mitochondria, Heart; Mitophagy; Myocardium; Neovascularization, Physiologic; Oxidative Stress; Phenotype; Protein Kinases; Signal Transduction; Sirtuin 3; Time Factors; Tissue Culture Techniques; Ubiquitin-Protein Ligases; Ventricular Remodeling

2017
Dipeptidyl Peptidase-4 Inhibition With Saxagliptin Ameliorates Angiotensin II-Induced Cardiac Diastolic Dysfunction in Male Mice.
    Endocrinology, 2017, 10-01, Volume: 158, Issue:10

    Topics: Adamantane; Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Aorta; Blood Pressure; Cardiomegaly; CD4-Positive T-Lymphocytes; CD8 Antigens; Diastole; Dipeptides; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Echocardiography; Fibrosis; Gene Expression; Heart; Inflammation; Interleukin-17; Interleukin-18; Lymphocytes; Macrophages; Male; Mice; Proto-Oncogene Proteins c-jun; Signal Transduction; Vascular Stiffness; Vasoconstrictor Agents

2017
Zinc-finger protein 418 overexpression protects against cardiac hypertrophy and fibrosis.
    PloS one, 2017, Volume: 12, Issue:10

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Down-Regulation; Humans; Male; Mice; Mice, Knockout; Rats; Rats, Sprague-Dawley; Repressor Proteins; Transcription Factor AP-1

2017
Kaempferol Alleviates Angiotensin II-Induced Cardiac Dysfunction and Interstitial Fibrosis in Mice.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2017, Volume: 43, Issue:6

    Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cell Survival; Cells, Cultured; Collagen Type I; Collagen Type II; Echocardiography; Fibroblasts; Fibrosis; Heart Ventricles; Human Umbilical Vein Endothelial Cells; Humans; Kaempferols; Male; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Mitogen-Activated Protein Kinases; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; Rats; Signal Transduction; Transforming Growth Factor beta1; Ventricular Remodeling

2017
Nox4 genetic inhibition in experimental hypertension and metabolic syndrome.
    Archives of cardiovascular diseases, 2018, Volume: 111, Issue:1

    Topics: Angiotensin II; Animals; Biomarkers; Blood Glucose; Blood Pressure; Cardiomegaly; Diet, High-Fat; Disease Models, Animal; Female; Fibrosis; Genetic Predisposition to Disease; Heart Rate; Hypertension; Male; Metabolic Syndrome; Mice, Inbred C57BL; Mice, Knockout; Myocardium; NADPH Oxidase 4; Phenotype; Reactive Oxygen Species; Time Factors; Triglycerides; Ventricular Remodeling

2018
Estrogen receptor beta maintains expression of KLF15 to prevent cardiac myocyte hypertrophy in female rodents.
    Molecular and cellular endocrinology, 2018, 07-15, Volume: 470

    Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Estrogen Receptor beta; Female; Gene Expression Regulation; Kruppel-Like Transcription Factors; Male; MAP Kinase Kinase Kinases; Models, Biological; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Rats; Signal Transduction; Transforming Growth Factor beta

2018
Oleanonic acid ameliorates pressure overload-induced cardiac hypertrophy in rats: The role of PKCζ-NF-κB pathway.
    Molecular and cellular endocrinology, 2018, 07-15, Volume: 470

    Topics: Angiotensin II; Animals; Aorta; Cardiomegaly; Constriction, Pathologic; Gene Knockdown Techniques; Male; Myocytes, Cardiac; NF-kappa B; Phenylephrine; Phosphorylation; Pressure; Protein Kinase C; Rats, Sprague-Dawley; Signal Transduction; Transcription Factor RelA; Transcription, Genetic; Triterpenes

2018
Gallic Acid Reduces Blood Pressure and Attenuates Oxidative Stress and Cardiac Hypertrophy in Spontaneously Hypertensive Rats.
    Scientific reports, 2017, Nov-15, Volume: 7, Issue:1

    Topics: Angiotensin II; Animals; Blood Pressure; Blood Pressure Determination; Cardiomegaly; Gallic Acid; GATA4 Transcription Factor; Gene Expression Regulation; Heart; Homeobox Protein Nkx-2.5; Humans; Hypertension; Male; NADPH Oxidase 2; Oxidative Stress; Rats; Rats, Inbred SHR

2017
Inhibition of HSF2 SUMOylation via MEL18 upregulates IGF-IIR and leads to hypertension-induced cardiac hypertrophy.
    International journal of cardiology, 2018, 04-15, Volume: 257

    Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Dose-Response Relationship, Drug; Female; Heat-Shock Proteins; HEK293 Cells; Humans; Hypertension; Polycomb Repressive Complex 1; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Receptor, IGF Type 2; Sumoylation; Transcription Factors; Up-Regulation

2018
DKK3 overexpression attenuates cardiac hypertrophy and fibrosis in an angiotensin-perfused animal model by regulating the ADAM17/ACE2 and GSK-3β/β-catenin pathways.
    Journal of molecular and cellular cardiology, 2018, Volume: 114

    Topics: ADAM17 Protein; Adaptor Proteins, Signal Transducing; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Animals, Newborn; Apoptosis; beta Catenin; Cardiomegaly; Cell Proliferation; Disease Models, Animal; Fibroblasts; Fibrosis; Glycogen Synthase Kinase 3 beta; Inflammation; Intercellular Signaling Peptides and Proteins; Matrix Metalloproteinases; Mice, Inbred C57BL; Peptide Fragments; Peptidyl-Dipeptidase A; Perfusion; Phosphorylation; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1

2018
MiR-208a-3p aggravates autophagy through the PDCD4-ATG5 pathway in Ang II-induced H9c2 cardiomyoblasts.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 98

    Topics: Angiotensin II; Animals; Apoptosis Regulatory Proteins; Autophagy; Autophagy-Related Protein 5; Cardiomegaly; Cell Line; Down-Regulation; Humans; MicroRNAs; Myoblasts; Myocytes, Cardiac; Rats; RNA-Binding Proteins; Up-Regulation

2018
MiR-181a mediates Ang II-induced myocardial hypertrophy by mediating autophagy.
    European review for medical and pharmacological sciences, 2017, Volume: 21, Issue:23

    Topics: Adenine; Angiotensin II; Animals; Autophagy; Autophagy-Related Protein 5; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Down-Regulation; Male; MicroRNAs; Microtubule-Associated Proteins; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley

2017
Angiotensin II Facilitates Matrix Metalloproteinase-9-Mediated Myosin Light Chain Kinase Degradation in Pressure Overload-Induced Cardiac Hypertrophy.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2017, Volume: 44, Issue:6

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Humans; Male; Matrix Metalloproteinase 9; Myocytes, Cardiac; Myosin-Light-Chain Kinase; Proteolysis; Rats, Sprague-Dawley

2017
A new miRNA regulator, miR-672, reduces cardiac hypertrophy by inhibiting JUN expression.
    Gene, 2018, Mar-30, Volume: 648

    Topics: 3' Untranslated Regions; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Gene Expression Profiling; Gene Expression Regulation; Gene Ontology; Mice, Inbred ICR; MicroRNAs; Myocytes, Cardiac; Proto-Oncogene Proteins c-jun; Rats, Sprague-Dawley

2018
Anti-Interleukin-22-Neutralizing Antibody Attenuates Angiotensin II-Induced Cardiac Hypertrophy in Mice.
    Mediators of inflammation, 2017, Volume: 2017

    Topics: Angiotensin II; Animals; Antibodies, Neutralizing; Cardiomegaly; Cells, Cultured; Cytokines; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Interleukin-22; Interleukins; Male; Mice; Mice, Inbred C57BL; Myocardium; RNA, Messenger; STAT3 Transcription Factor

2017
Glycosylated CD147 reduces myocardial collagen cross-linking in cardiac hypertrophy.
    Journal of cellular biochemistry, 2018, Volume: 119, Issue:10

    Topics: Angiotensin II; Animals; Basigin; Cardiomegaly; Collagen; Echocardiography; Male; Myocardium; Rats; Rats, Sprague-Dawley

2018
Osteoglycin attenuates cardiac fibrosis by suppressing cardiac myofibroblast proliferation and migration through antagonizing lysophosphatidic acid 3/matrix metalloproteinase 2/epidermal growth factor receptor signalling.
    Cardiovascular research, 2018, 04-01, Volume: 114, Issue:5

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Movement; Cell Proliferation; Cells, Cultured; Disease Models, Animal; ErbB Receptors; Fibrosis; Hypertension; Intercellular Signaling Peptides and Proteins; Matrix Metalloproteinase 14; Matrix Metalloproteinase 2; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Myofibroblasts; Receptor Cross-Talk; Receptors, Lysophosphatidic Acid; rho GTP-Binding Proteins; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Ventricular Remodeling

2018
Alamandine acts via MrgD to induce AMPK/NO activation against ANG II hypertrophy in cardiomyocytes.
    American journal of physiology. Cell physiology, 2018, 06-01, Volume: 314, Issue:6

    Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Enzyme Activation; Male; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Nerve Tissue Proteins; Nitric Oxide; Oligopeptides; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction

2018
CXCL1-CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation of monocyte infiltration.
    European heart journal, 2018, 05-21, Volume: 39, Issue:20

    Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Animals; Cardiomegaly; Cell Movement; Chemokine CXCL1; Female; Fibrosis; Heart Failure; Humans; Male; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Monocytes; Myocardium; Receptors, Interleukin-8B; Signal Transduction; Up-Regulation

2018
CXCL1-CXCR2 lead monocytes to the heart of the matter.
    European heart journal, 2018, 05-21, Volume: 39, Issue:20

    Topics: Angiotensin II; Cardiomegaly; Chemokine CXCL1; Humans; Monocytes; Receptors, Interleukin-8B

2018
MicroRNA-19a/b-3p protect the heart from hypertension-induced pathological cardiac hypertrophy through PDE5A.
    Journal of hypertension, 2018, Volume: 36, Issue:9

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Cyclic Nucleotide Phosphodiesterases, Type 5; Gene Expression Regulation; Humans; Hypertension; Mice, Transgenic; MicroRNAs; Myocytes, Cardiac; Signal Transduction

2018
C1QTNF1 attenuates angiotensin II-induced cardiac hypertrophy via activation of the AMPKa pathway.
    Free radical biology & medicine, 2018, Volume: 121

    Topics: Adipokines; AMP-Activated Protein Kinase Kinases; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Fibrosis; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Phosphorylation; Protein Kinases; Rats; Rats, Sprague-Dawley; Signal Transduction; Vasoconstrictor Agents

2018
Astragaloside IV protects against the pathological cardiac hypertrophy in mice.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 97

    Topics: Angiotensin II; Animals; Apoptosis; Cardiomegaly; Cardiotonic Agents; Enzyme Activation; Inflammation; Intracellular Signaling Peptides and Proteins; Male; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Phosphorylation; Pressure; Protein Serine-Threonine Kinases; Saponins; Signal Transduction; Triterpenes

2018
sRAGE attenuates angiotensin II-induced cardiomyocyte hypertrophy by inhibiting RAGE-NFκB-NLRP3 activation.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2018, Volume: 67, Issue:8

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Line; Extracellular Signal-Regulated MAP Kinases; HMGB1 Protein; Interleukin-1beta; Myocytes, Cardiac; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Protein Kinase C; Rats; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; RNA, Small Interfering

2018
Leflunomide counter
    Clinical science (London, England : 1979), 2018, 05-31, Volume: 132, Issue:10

    Topics: Angiotensin II; Aniline Compounds; Animals; Cardiomegaly; Crotonates; Fibrosis; Hydroxybutyrates; Leflunomide; Mice; Nitriles; Proto-Oncogene Proteins c-akt; Toluidines

2018
Overexpression of SARAF Ameliorates Pressure Overload-Induced Cardiac Hypertrophy Through Suppressing STIM1-Orai1 in Mice.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2018, Volume: 47, Issue:2

    Topics: Angiotensin II; Animals; Aorta, Abdominal; Atrial Natriuretic Factor; Cardiomegaly; Cell Line; Echocardiography; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; ORAI1 Protein; Pressure; Stromal Interaction Molecule 1; Up-Regulation; Ventricular Function, Left

2018
N‑terminal truncated peroxisome proliferator‑activated receptor‑γ coactivator‑1α alleviates phenylephrine‑induced mitochondrial dysfunction and decreases lipid droplet accumulation in neonatal rat cardiomyocytes.
    Molecular medicine reports, 2018, Volume: 18, Issue:2

    Topics: Adenosine Triphosphate; Angiotensin II; Animals; Cardiomegaly; Energy Metabolism; Lipid Droplets; Mitochondria, Heart; Myocytes, Cardiac; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phenylephrine; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species

2018
EndophilinA2 protects against angiotensin II-induced cardiac hypertrophy by inhibiting angiotensin II type 1 receptor trafficking in neonatal rat cardiomyocytes.
    Journal of cellular biochemistry, 2018, Volume: 119, Issue:10

    Topics: Acyltransferases; Adenoviridae; Angiotensin II; Animals; Animals, Newborn; Apoptosis; Cardiomegaly; Endoplasmic Reticulum Stress; Gene Expression Regulation; Genetic Vectors; Heat-Shock Proteins; Myocytes, Cardiac; Primary Cell Culture; Protein Transport; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; RNA, Small Interfering; Signal Transduction; Transfection

2018
CD1d-dependent natural killer T cells attenuate angiotensin II-induced cardiac remodelling via IL-10 signalling in mice.
    Cardiovascular research, 2019, 01-01, Volume: 115, Issue:1

    Topics: Adoptive Transfer; Angiotensin II; Animals; Antigens, CD1d; Cardiomegaly; Cells, Cultured; Coculture Techniques; Dendritic Cells; Disease Models, Animal; Fibrosis; Galactosylceramides; Hypertension; Inflammation Mediators; Interleukin-10; Male; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Natural Killer T-Cells; NF-kappa B; Signal Transduction; STAT3 Transcription Factor; Transforming Growth Factor beta1; Ventricular Remodeling

2019
Eriobotrya japonica ameliorates cardiac hypertrophy in H9c2 cardiomyoblast and in spontaneously hypertensive rats.
    Environmental toxicology, 2018, Volume: 33, Issue:11

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cells, Cultured; Drugs, Chinese Herbal; Echocardiography; Eriobotrya; Heart; Hypertension; Male; Myocytes, Cardiac; Phytotherapy; Rats; Rats, Inbred SHR; Rats, Inbred WKY

2018
Network-based predictions of in vivo cardiac hypertrophy.
    Journal of molecular and cellular cardiology, 2018, Volume: 121

    Topics: Angiotensin II; Animals; Cardiomegaly; Computational Biology; Disease Models, Animal; Heart Failure; Humans; Mice; Mice, Transgenic; Myocardium; Myocytes, Cardiac; Signal Transduction

2018
PARP1 interacts with HMGB1 and promotes its nuclear export in pathological myocardial hypertrophy.
    Acta pharmacologica Sinica, 2019, Volume: 40, Issue:5

    Topics: Active Transport, Cell Nucleus; Angiotensin II; Animals; Cardiomegaly; Cell Nucleus; HMGB1 Protein; Isoproterenol; Male; Myocytes, Cardiac; Phenylephrine; Poly (ADP-Ribose) Polymerase-1; Rats, Sprague-Dawley

2019
Irisin alleviates pressure overload-induced cardiac hypertrophy by inducing protective autophagy via mTOR-independent activation of the AMPK-ULK1 pathway.
    Journal of molecular and cellular cardiology, 2018, Volume: 121

    Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Autophagy; Autophagy-Related Protein-1 Homolog; Benzamides; Cardiomegaly; Fibronectins; Heart Failure; Humans; Mice; Mice, Transgenic; Myocytes, Cardiac; Phenylephrine; Pressure; Pyrimidines; Signal Transduction; TOR Serine-Threonine Kinases

2018
Crosstalk between FGF23- and angiotensin II-mediated Ca
    Cellular and molecular life sciences : CMLS, 2018, Volume: 75, Issue:23

    Topics: Angiotensin II; Animals; Animals, Newborn; Calcium; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; Cells, Cultured; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Gene Expression; Histone Deacetylases; Myocytes, Cardiac; Rats; Receptor, Angiotensin, Type 1

2018
Testosterone plays a permissive role in angiotensin II-induced hypertension and cardiac hypertrophy in male rats.
    Biology of reproduction, 2019, 01-01, Volume: 100, Issue:1

    Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Hypertension; Male; Mesenteric Arteries; Orchiectomy; Rats; Rats, Wistar; Receptors, Androgen; Receptors, Angiotensin; Renin-Angiotensin System; Testosterone

2019
Dioscin ameliorates cardiac hypertrophy through inhibition of the MAPK and Akt/GSK3β/mTOR pathways.
    Life sciences, 2018, Sep-15, Volume: 209

    Topics: Angiotensin II; Animals; Cardiomegaly; Diosgenin; Glycogen Synthase Kinase 3 beta; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases; Vasoconstrictor Agents

2018
Hydroxysafflor yellow A protects against angiotensin II‑induced hypertrophy.
    Molecular medicine reports, 2018, Volume: 18, Issue:4

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Line; Chalcone; Disease Models, Animal; Heme Oxygenase-1; Male; Myocardial Infarction; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Protective Agents; Quinones; Rats; Rats, Sprague-Dawley; Signal Transduction

2018
Effects of high- and low-dose aspirin on adaptive immunity and hypertension in the stroke-prone spontaneously hypertensive rat.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2019, Volume: 33, Issue:1

    Topics: Adaptive Immunity; Angiotensin II; Animals; Aspirin; Biomarkers; Blood Pressure; Blood Vessels; Cardiomegaly; Cyclooxygenase 1; Cyclooxygenase 2; Cytokines; Disease Susceptibility; Dose-Response Relationship, Drug; Epoprostenol; Hypertension; Kidney; Mice; Rats; Rats, Inbred SHR; Real-Time Polymerase Chain Reaction; RNA, Messenger; Stroke; Systole; T-Lymphocytes; Thromboxanes

2019
The Effects of Dracocephalum Heterophyllum Benth Flavonoid on Hypertrophic Cardiomyocytes Induced by Angiotensin II in Rats.
    Medical science monitor : international medical journal of experimental and clinical research, 2018, Sep-10, Volume: 24

    Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cardiomegaly; Cardiomyopathy, Hypertrophic; Cells, Cultured; China; Flavonoids; Heart Ventricles; Medicine, Tibetan Traditional; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Signal Transduction

2018
Bakuchiol protects against pathological cardiac hypertrophy by blocking NF-κB signaling pathway.
    Bioscience reports, 2018, 10-31, Volume: 38, Issue:5

    Topics: Administration, Oral; Angiotensin II; Animals; Aorta; Atrial Natriuretic Factor; Cardiomegaly; Cardiotonic Agents; Collagen; Connective Tissue Growth Factor; Constriction, Pathologic; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Natriuretic Peptide, Brain; NF-kappa B; Phenols; Plant Extracts; Primary Cell Culture; Psoralea; Signal Transduction

2018
Effect of the Shensong Yangxin Capsule on Energy Metabolism in Angiotensin II-Induced Cardiac Hypertrophy.
    Chinese medical journal, 2018, Oct-05, Volume: 131, Issue:19

    Topics: Angiotensin II; Animals; Cardiomegaly; Energy Metabolism; Medicine, Chinese Traditional; Myocardium; Myocytes, Cardiac; Rats

2018
Administration of ubiquitin-activating enzyme UBA1 inhibitor PYR-41 attenuates angiotensin II-induced cardiac remodeling in mice.
    Biochemical and biophysical research communications, 2018, 10-20, Volume: 505, Issue:1

    Topics: Angiotensin II; Animals; Benzoates; Blood Pressure; Cardiomegaly; Fibrosis; Furans; Gene Expression; Heart; Hypertension; Male; Mice; Myocardium; Pyrazoles; Signal Transduction; Ubiquitin-Activating Enzymes; Ventricular Remodeling

2018
Angiotensin II requires an intact cardiac thyrotropin-releasing hormone (TRH) system to induce cardiac hypertrophy in mouse.
    Journal of molecular and cellular cardiology, 2018, Volume: 124

    Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Disease Susceptibility; Drinking; Fibrosis; Gene Expression Profiling; Hypertrophy, Left Ventricular; Immunohistochemistry; Mice; Myocardium; NIH 3T3 Cells; Phenotype; Rats; RNA Interference; RNA, Small Interfering; Thyrotropin-Releasing Hormone

2018
AdipoRon, an adiponectin receptor agonist, attenuates cardiac remodeling induced by pressure overload.
    Journal of molecular medicine (Berlin, Germany), 2018, Volume: 96, Issue:12

    Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cell Differentiation; Fibroblasts; Humans; Male; Mice, Inbred C57BL; Mice, Knockout; Piperidines; Rats, Sprague-Dawley; Receptors, Adiponectin; Transforming Growth Factor beta1; Ventricular Remodeling

2018
Nuclear translocation of calmodulin in pathological cardiac hypertrophy originates from ryanodine receptor bound calmodulin.
    Journal of molecular and cellular cardiology, 2018, Volume: 125

    Topics: Angiotensin II; Animals; Biological Transport; Calmodulin; Cardiomegaly; Cell Nucleus; Cells, Cultured; Dantrolene; Histone Deacetylases; Mice; Nuclear Localization Signals; Phenylephrine; Receptors, G-Protein-Coupled; Ryanodine Receptor Calcium Release Channel; Suramin

2018
Apoptosis in angiotensin II-stimulated hypertrophic cardiac cells -modulation by phenolics rich extract of Boerhavia diffusa L.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 108

    Topics: Angiotensin II; Animals; Apoptosis; bcl-2-Associated X Protein; Biomarkers; Cardiomegaly; Caspases; Cell Survival; Cytochromes c; Interleukin-10; Nyctaginaceae; p38 Mitogen-Activated Protein Kinases; Phenols; Plant Extracts; Rats; RNA, Messenger; Staining and Labeling; Tumor Necrosis Factor-alpha

2018
Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 108

    Topics: Angiotensin II; Animals; Apoptosis; Atrial Natriuretic Factor; Cardiomegaly; Carrier Proteins; Cells, Cultured; Heart Failure; Intracellular Signaling Peptides and Proteins; Male; MicroRNAs; Mitochondria, Heart; Myocardium; Natriuretic Peptide, Brain; Rats; Rats, Sprague-Dawley

2018
The nuclear receptor RORα protects against angiotensin II-induced cardiac hypertrophy and heart failure.
    American journal of physiology. Heart and circulatory physiology, 2019, 01-01, Volume: 316, Issue:1

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Female; Fibroblasts; Heart Failure; Humans; Interleukin-6; Loss of Function Mutation; Mice; Mice, Inbred C57BL; Middle Aged; Mitochondria, Heart; Myocardial Contraction; Myocytes, Cardiac; Nuclear Receptor Subfamily 1, Group F, Member 1; Rats; Rats, Sprague-Dawley; STAT3 Transcription Factor

2019
Hyperoside Protects Against Pressure Overload-Induced Cardiac Remodeling via the AKT Signaling Pathway.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2018, Volume: 51, Issue:2

    Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Interleukin-1beta; Male; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Oxidative Stress; Protective Agents; Proto-Oncogene Proteins c-akt; Quercetin; Rats; Signal Transduction; Superoxide Dismutase; Ventricular Remodeling

2018
Testin protects against cardiac hypertrophy by targeting a calcineurin-dependent signalling pathway.
    Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:1

    Topics: Adult; Aged; Angiotensin II; Animals; Calcineurin; Cardiomegaly; Cardiomyopathy, Dilated; Case-Control Studies; Cytoskeletal Proteins; Disease Models, Animal; Female; Humans; Male; Mice, Inbred C57BL; Mice, Transgenic; Myocytes, Cardiac; NFATC Transcription Factors; RNA-Binding Proteins

2019
Macrocyclic lactones from seafood Amphioctopus neglectus: Newly described natural leads to attenuate angiotensin-II induced cardiac hypertrophy.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 110

    Topics: Angiotensin II; Animals; Antioxidants; Biological Products; Cardiomegaly; Cell Line; Lactones; Molecular Docking Simulation; Myocytes, Cardiac; Octopodiformes; Structure-Activity Relationship

2019
Effect of atorvastatin on cardiomyocyte hypertrophy through suppressing MURC induced by volume overload and cyclic stretch.
    Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:2

    Topics: Angiotensin II; Animals; Anticholesteremic Agents; Arteriovenous Shunt, Surgical; Atorvastatin; Cardiomegaly; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Male; Muscle Proteins; Myocytes, Cardiac; Rats; Rats, Wistar; Signal Transduction; Stress, Mechanical

2019
Gallic Acid Suppresses Cardiac Hypertrophic Remodeling and Heart Failure.
    Molecular nutrition & food research, 2019, Volume: 63, Issue:5

    Topics: Angiotensin II; Animals; Autophagy; Cardiomegaly; Cardiotonic Agents; Cell Enlargement; Cells, Cultured; Gallic Acid; Heart Failure; Male; Mice, Inbred C57BL; Myocarditis; Myocytes, Cardiac; Oxidative Stress; Rats, Sprague-Dawley; Signal Transduction

2019
RORα nuclear receptors in protection against angiotensin II-induced cardiac hypertrophy.
    American journal of physiology. Heart and circulatory physiology, 2019, 02-01, Volume: 316, Issue:2

    Topics: Angiotensin II; Cardiomegaly; Heart Failure; Humans

2019
Macrophage: beyond cardiac structural remodelling.
    European heart journal, 2019, 03-21, Volume: 40, Issue:12

    Topics: Angiotensin II; Cardiomegaly; Chemokine CXCL1; Heart; Humans; Macrophages; Monocytes

2019
Cardiomyocyte calcineurin is required for the onset and progression of cardiac hypertrophy and fibrosis in adult mice.
    The FEBS journal, 2019, Volume: 286, Issue:1

    Topics: Angiotensin II; Animals; Calcineurin; Cardiomegaly; Disease Progression; Fibrosis; Gene Expression Profiling; Mice; Mice, Knockout; Myocytes, Cardiac; Signal Transduction; Vasoconstrictor Agents

2019
Angiotensin II Causes Biphasic STAT3 Activation Through TLR4 to Initiate Cardiac Remodeling.
    Hypertension (Dallas, Tex. : 1979), 2018, Volume: 72, Issue:6

    Topics: Angiotensin II; Animals; Atrial Remodeling; Cardiomegaly; Cell Line; Interleukin-6; Mice; Mice, Knockout; Myocytes, Cardiac; Rats; Receptors, Interleukin-6; Signal Transduction; STAT3 Transcription Factor; Toll-Like Receptor 4

2018
Unc-51 like autophagy activating kinase 1 accelerates angiotensin II-induced cardiac hypertrophy through promoting oxidative stress regulated by Nrf-2/HO-1 pathway.
    Biochemical and biophysical research communications, 2019, 01-29, Volume: 509, Issue:1

    Topics: Angiotensin II; Animals; Autophagy; Autophagy-Related Protein-1 Homolog; Cardiomegaly; Cardiomyopathy, Dilated; Cells, Cultured; Heme Oxygenase-1; Humans; Male; Mice, Inbred C57BL; Myocardium; NF-E2-Related Factor 2; Oxidative Stress; Signal Transduction

2019
Fibroblast growth factor-21 protects against fibrosis in hypertensive heart disease.
    The Journal of pathology, 2019, Volume: 248, Issue:1

    Topics: Angiotensin II; Animals; Biopsy; Blood Pressure; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Fibroblast Growth Factors; Fibrosis; Gene Expression Regulation; Heart Rate; Heart Ventricles; Humans; Hypertension; Mice, Knockout; Myocardium; Rats, Sprague-Dawley; RNA, Messenger

2019
Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage.
    Circulation, 2019, 03-12, Volume: 139, Issue:11

    Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Aortic Diseases; Arrhythmias, Cardiac; Arterial Pressure; Atherosclerosis; Cardiomegaly; Disease Models, Animal; Hypertension; Male; Mice, Knockout, ApoE; Plaque, Atherosclerotic; Propionates; T-Lymphocytes, Regulatory; Th17 Cells

2019
MiR-103 inhibiting cardiac hypertrophy through inactivation of myocardial cell autophagy via targeting TRPV3 channel in rat hearts.
    Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:3

    Topics: Angiotensin II; Animals; Autophagy; Beclin-1; Cardiomegaly; Cells, Cultured; Down-Regulation; Heart; Heart Failure; Male; MicroRNAs; Myocytes, Cardiac; Rats; Rats, Wistar; Signal Transduction; TRPV Cation Channels; Up-Regulation

2019
MicroRNA-375-3p inhibitor suppresses angiotensin II-induced cardiomyocyte hypertrophy by promoting lactate dehydrogenase B expression.
    Journal of cellular physiology, 2019, Volume: 234, Issue:8

    Topics: Angiotensin II; Animals; Aorta; Cardiomegaly; Disease Models, Animal; Gene Expression Regulation; Gene Knockdown Techniques; Heart Failure; Humans; Isoenzymes; L-Lactate Dehydrogenase; MicroRNAs; Myocardium; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; Primary Cell Culture; Rats; Signal Transduction

2019
Effect of muscarinic receptors agonist in the rat model of coronary heart disease: A potential therapeutic target in cardiovascular diseases.
    Pakistan journal of pharmaceutical sciences, 2018, Volume: 31, Issue:6(Special)

    Topics: Acetylcholine; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Electrocardiography; Hemodynamics; Hypertrophy; Male; Muscarinic Agonists; Rats; Receptor, Muscarinic M3; Ventricular Function, Left; Ventricular Myosins

2018
Loss of Apelin Augments Angiotensin II-Induced Cardiac Dysfunction and Pathological Remodeling.
    International journal of molecular sciences, 2019, Jan-09, Volume: 20, Issue:2

    Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Apelin; Biopsy; Cardiomegaly; Disease Models, Animal; Echocardiography; Fibrosis; Heart Failure; Hypertension; Mice; Mice, Knockout; Myocardial Contraction; Myocytes, Cardiac; Peptidyl-Dipeptidase A; Ventricular Dysfunction; Ventricular Remodeling

2019
SP1-SYNE1-AS1-miR-525-5p feedback loop regulates Ang-II-induced cardiac hypertrophy.
    Journal of cellular physiology, 2019, Volume: 234, Issue:8

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Proliferation; Cytoskeletal Proteins; Disease Models, Animal; Disease Progression; Gene Expression Regulation; Humans; Mice; MicroRNAs; Myocytes, Cardiac; Nerve Tissue Proteins; RNA, Long Noncoding; Sp1 Transcription Factor; Transcriptional Activation

2019
Nrf2 deficiency aggravates Angiotensin II-induced cardiac injury by increasing hypertrophy and enhancing IL-6/STAT3-dependent inflammation.
    Biochimica et biophysica acta. Molecular basis of disease, 2019, 06-01, Volume: 1865, Issue:6

    Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Inflammation; Interleukin-6; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; NF-E2-Related Factor 2; Rats, Sprague-Dawley; Signal Transduction; STAT3 Transcription Factor

2019
Endothelial-specific deletion of Ets-1 attenuates Angiotensin II-induced cardiac fibrosis via suppression of endothelial-to-mesenchymal transition.
    BMB reports, 2019, Volume: 52, Issue:10

    Topics: Angiotensin II; Animals; Cardiomegaly; Epithelial-Mesenchymal Transition; Fibrosis; Gene Expression Regulation; HEK293 Cells; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Proto-Oncogene Protein c-ets-1; Signal Transduction; Transforming Growth Factor beta1; Twist Transcription Factors; Zinc Finger E-box-Binding Homeobox 1

2019
Fibroblast growth factor 21 protects the heart from angiotensin II-induced cardiac hypertrophy and dysfunction via SIRT1.
    Biochimica et biophysica acta. Molecular basis of disease, 2019, 06-01, Volume: 1865, Issue:6

    Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Animals, Newborn; Apoptosis; Cardiomegaly; Cell Line; Cells, Cultured; Fibroblast Growth Factors; Gene Expression; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Protein Binding; Protein Serine-Threonine Kinases; Rats; Reactive Oxygen Species; Sirtuin 1; Superoxide Dismutase

2019
Down-regulation of miR-200c attenuates AngII-induced cardiac hypertrophy via targeting the MLCK-mediated pathway.
    Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:4

    Topics: Angiotensin II; Animals; Antagomirs; Aorta; Apoptosis; Cardiomegaly; Constriction, Pathologic; Disease Models, Animal; Echocardiography; Gene Expression Regulation; Male; MicroRNAs; Myocytes, Cardiac; Myosin-Light-Chain Kinase; Oligoribonucleotides; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction

2019
Novel role of mitochondrial GTPases 1 in pathological cardiac hypertrophy.
    Journal of molecular and cellular cardiology, 2019, Volume: 128

    Topics: Angiotensin II; Animals; Cardiomegaly; Cardiomyopathy, Dilated; GTP Phosphohydrolases; Heart Failure; Humans; MAP Kinase Kinase Kinases; Mice; Mice, Knockout; Mitochondria; Myocytes, Cardiac; Oxidative Stress

2019
CSN5 attenuates Ang II-induced cardiac hypertrophy through stabilizing LKB1.
    Experimental cell research, 2019, 03-01, Volume: 376, Issue:1

    Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Angiotensin II; Animals; Cardiomegaly; COP9 Signalosome Complex; Disease Models, Animal; Gene Expression Regulation; Humans; Mice; Myocytes, Cardiac; Peptide Hydrolases; Protein Binding; Protein Interaction Maps; Protein Kinases; Protein Serine-Threonine Kinases

2019
GDF11 Attenuated ANG II-Induced Hypertrophic Cardiomyopathy and Expression of ANP, BNP and Beta-MHC Through Down- Regulating CCL11 in Mice.
    Current molecular medicine, 2018, Volume: 18, Issue:10

    Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Bone Morphogenetic Proteins; Cardiomegaly; Chemokine CCL11; Down-Regulation; Growth Differentiation Factors; Mice; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain

2018
Irisin ameliorates angiotensin II-induced cardiomyocyte apoptosis through autophagy.
    Journal of cellular physiology, 2019, Volume: 234, Issue:10

    Topics: Angiotensin II; Animals; Apoptosis; Autophagy; Cardiomegaly; Cells, Cultured; Down-Regulation; Fibronectins; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Recombinant Proteins; RNA, Messenger; Signal Transduction

2019
Angiotensin II-induced hypertension and cardiac hypertrophy are differentially mediated by TLR3- and TLR4-dependent pathways.
    American journal of physiology. Heart and circulatory physiology, 2019, 05-01, Volume: 316, Issue:5

    Topics: Adaptor Proteins, Vesicular Transport; Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Hypertension; Immunity, Innate; Inflammation Mediators; Kidney; Male; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Receptor, Angiotensin, Type 1; Signal Transduction; Toll-Like Receptor 3; Toll-Like Receptor 4

2019
DNA Damage Response Mediates Pressure Overload-Induced Cardiomyocyte Hypertrophy.
    Circulation, 2019, 02-26, Volume: 139, Issue:9

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Cycle; Disease Models, Animal; DNA Damage; Mice; Myocytes, Cardiac

2019
Monoamine oxidase inhibitors protect against coronary heart disease in rodent rat models: A pilot study.
    Pakistan journal of pharmaceutical sciences, 2019, Volume: 32, Issue:1(Special)

    Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Hemodynamics; Male; Monoamine Oxidase Inhibitors; Myocardium; Oxazoles; Rats, Wistar

2019
1.25 Dihydroxyvitamin D3 Attenuates Hypertrophy Markers in Cardiomyoblast H9c2 Cells: Evaluation of Sirtuin3 mRNA and Protein Level.
    International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition, 2019, Volume: 89, Issue:3-4

    Topics: Angiotensin II; Animals; Calcitriol; Cardiomegaly; Myocytes, Cardiac; Rats; RNA, Messenger

2019
Epigallocatechin-3-gallate inhibits angiotensin II-induced cardiomyocyte hypertrophy via regulating Hippo signaling pathway in H9c2 rat cardiomyocytes.
    Acta biochimica et biophysica Sinica, 2019, Apr-01, Volume: 51, Issue:4

    Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Catechin; Cell Line; Gene Expression Regulation; Molecular Structure; Myocytes, Cardiac; Natriuretic Peptide, Brain; Protein Serine-Threonine Kinases; Rats; Reactive Oxygen Species; Signal Transduction

2019
Epigenetic modulation of tenascin C in the heart: implications on myocardial ischemia, hypertrophy and metabolism.
    Journal of hypertension, 2019, Volume: 37, Issue:9

    Topics: Angiotensin II; Animals; Cardiomegaly; Coronary Artery Disease; DNA Methylation; Energy Metabolism; Epigenesis, Genetic; Extracellular Matrix; Extracellular Matrix Proteins; Fibrosis; Heart Diseases; Humans; Hypertrophy; Hypoxia; Male; Matrix Metalloproteinase 2; MicroRNAs; Myocardial Infarction; Myocardium; Nerve Tissue Proteins; Rats; Tenascin; Ventricular Remodeling

2019
Rutaecarpine prevents hypertensive cardiac hypertrophy involving the inhibition of Nox4-ROS-ADAM17 pathway.
    Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:6

    Topics: ADAM17 Protein; Angiotensin II; Animals; Aorta, Abdominal; Cardiomegaly; Constriction, Pathologic; Gene Expression Regulation; Humans; Hypertension; Indole Alkaloids; MAP Kinase Signaling System; Myocytes, Cardiac; NADPH Oxidase 4; Quinazolines; Rats; Rats, Inbred Dahl; Reactive Oxygen Species

2019
Luteolin improves myocardial cell glucolipid metabolism by inhibiting hypoxia inducible factor-1α expression in angiotensin II/hypoxia-induced hypertrophic H9c2 cells.
    Nutrition research (New York, N.Y.), 2019, Volume: 65

    Topics: Angiotensin II; Animals; Cardiomegaly; Carnitine O-Palmitoyltransferase; Fatty Acids, Nonesterified; Glucose; Glucose Transporter Type 4; Hypertrophy; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Luteolin; Myocardium; Myocytes, Cardiac; Plant Extracts; PPAR alpha; Protein Kinases; Rats

2019
Inhibition of circHIPK3 prevents angiotensin II-induced cardiac fibrosis by sponging miR-29b-3p.
    International journal of cardiology, 2019, 10-01, Volume: 292

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Fibrosis; Intracellular Signaling Peptides and Proteins; Mice; Mice, Inbred C57BL; MicroRNAs; Myocytes, Cardiac; Protein Serine-Threonine Kinases; RNA, Circular

2019
Effects of ATRAP in Renal Proximal Tubules on Angiotensin-Dependent Hypertension.
    Journal of the American Heart Association, 2019, 04-16, Volume: 8, Issue:8

    Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Hypertension; Kidney Tubules, Proximal; Laser Capture Microdissection; Mice; Mice, Knockout; Nephrons; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vasoconstrictor Agents

2019
Allicin attenuates pathological cardiac hypertrophy by inhibiting autophagy via activation of PI3K/Akt/mTOR and MAPK/ERK/mTOR signaling pathways.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2019, Volume: 58

    Topics: Angiotensin II; Animals; Autophagy; Cardiomegaly; Cardiotonic Agents; Disulfides; Male; MAP Kinase Signaling System; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats, Wistar; Signal Transduction; Sulfinic Acids; TOR Serine-Threonine Kinases

2019
The TIR/BB-loop mimetic AS-1 prevents Ang II-induced hypertensive cardiac hypertrophy via NF-κB dependent downregulation of miRNA-143.
    Scientific reports, 2019, 04-23, Volume: 9, Issue:1

    Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Down-Regulation; Gene Expression Regulation; Hypertension; Male; MAP Kinase Signaling System; Mice, Inbred C57BL; MicroRNAs; Myocytes, Cardiac; NF-kappa B; Phosphorylation; Pyrrolidines; Rats; Valine

2019
Long non-coding RNA small nucleolar RNA host gene 7 facilitates cardiac hypertrophy via stabilization of SDA1 domain containing 1 mRNA.
    Journal of cellular biochemistry, 2019, Volume: 120, Issue:9

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Cycle Proteins; ELAV-Like Protein 1; Gene Silencing; Myocytes, Cardiac; Nuclear Proteins; Protein Binding; Rats, Sprague-Dawley; RNA Stability; RNA, Long Noncoding; RNA, Messenger; Up-Regulation

2019
Cardiac hypertrophy in mice submitted to a swimming protocol: influence of training volume and intensity on myocardial renin-angiotensin system.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2019, 06-01, Volume: 316, Issue:6

    Topics: Angiotensin I; Angiotensin II; Animals; Cardiomegaly; Hypertrophy, Left Ventricular; Male; Mice, Inbred BALB C; Myocardium; Peptide Fragments; Physical Conditioning, Animal; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Swimming; Ventricular Remodeling

2019
Alamandine attenuates long‑term hypertension‑induced cardiac fibrosis independent of blood pressure.
    Molecular medicine reports, 2019, Volume: 19, Issue:6

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Collagen Type I; Collagen Type I, alpha 1 Chain; Fibrosis; Heart Ventricles; Hypertension; Imidazoles; Male; Matrix Metalloproteinase 9; Oligopeptides; Proto-Oncogene Proteins c-akt; Pyridines; Rats; Rats, Inbred SHR; Renin-Angiotensin System

2019
OBG-like ATPase 1 inhibition attenuates angiotensin II-induced hypertrophic response in human ventricular myocytes via GSK-3beta/beta-catenin signalling.
    Clinical and experimental pharmacology & physiology, 2019, Volume: 46, Issue:8

    Topics: Adenosine Triphosphatases; Angiotensin II; Animals; beta Catenin; Cardiomegaly; Cell Line; Enzyme Inhibitors; Glycogen Synthase Kinase 3 beta; GTP-Binding Proteins; Heart Ventricles; Humans; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Signal Transduction; Up-Regulation

2019
Apigenin-induced HIF-1α inhibitory effect improves abnormal glucolipid metabolism in AngⅡ/hypoxia-stimulated or HIF-1α-overexpressed H9c2 cells.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2019, Volume: 62

    Topics: Angiotensin II; Animals; Apigenin; Atrial Natriuretic Factor; Cardiomegaly; Cell Hypoxia; Cell Line; Down-Regulation; Glucose; Glucose Transporter Type 4; Hypoxia-Inducible Factor 1, alpha Subunit; Myocytes, Cardiac; PPAR alpha; PPAR gamma; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Rats; Up-Regulation

2019
The immunoproteasome catalytic β5i subunit regulates cardiac hypertrophy by targeting the autophagy protein ATG5 for degradation.
    Science advances, 2019, Volume: 5, Issue:5

    Topics: Aged; Aged, 80 and over; Angiotensin II; Animals; Autophagy; Autophagy-Related Protein 5; Cardiomegaly; Case-Control Studies; Catalytic Domain; Female; Heart Failure; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Middle Aged; Myocardium; Natriuretic Peptide, Brain; Proteasome Endopeptidase Complex; Rats; RNA Interference; RNA, Small Interfering; Up-Regulation

2019
[Aconitine ameliorates cardiomyocyte hypertrophy induced by angiotensin Ⅱ].
    Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2019, Volume: 44, Issue:8

    Topics: Aconitine; Actins; Angiotensin II; Atrial Natriuretic Factor; Cardiac Myosins; Cardiomegaly; Cells, Cultured; Humans; Hypertrophy; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain

2019
The Role of Heme Oxygenase 1 in the Protective Effect of Caloric Restriction against Diabetic Cardiomyopathy.
    International journal of molecular sciences, 2019, May-16, Volume: 20, Issue:10

    Topics: Angiotensin II; Animals; Blood Glucose; Caloric Restriction; Carbazoles; Cardiomegaly; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Heme Oxygenase-1; Male; Malondialdehyde; Mesoporphyrins; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Obesity; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR gamma; Protoporphyrins; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Sirtuin 1

2019
Quantitative trait loci associated with angiotensin II and high-salt diet induced acute decompensated heart failure in Balb/CJ mice.
    Physiological genomics, 2019, 07-01, Volume: 51, Issue:7

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Chromosome Mapping; Diet; Disease Models, Animal; Echocardiography; Female; Genetic Linkage; Genetic Predisposition to Disease; Heart Failure; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred Strains; Oligonucleotide Array Sequence Analysis; Phenotype; Polymorphism, Single Nucleotide; Quantitative Trait Loci; Sodium Chloride, Dietary; Species Specificity; Thiobarbituric Acid Reactive Substances

2019
Oridonin protects against cardiac hypertrophy by promoting P21-related autophagy.
    Cell death & disease, 2019, 05-24, Volume: 10, Issue:6

    Topics: Angiotensin II; Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Autophagy; Cardiomegaly; Cyclin-Dependent Kinase Inhibitor p21; Disease Models, Animal; Diterpenes, Kaurane; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Myocytes, Cardiac; Oxidative Stress; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; RNA, Small Interfering

2019
LncRNA TUG1 contributes to cardiac hypertrophy via regulating miR-29b-3p.
    In vitro cellular & developmental biology. Animal, 2019, Volume: 55, Issue:7

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Line; Gene Expression Regulation; HEK293 Cells; Humans; MicroRNAs; Myocytes, Cardiac; Rats; RNA, Long Noncoding; Transcriptional Activation; Up-Regulation

2019
ERK1/2 communicates GPCR and EGFR signaling pathways to promote CTGF-mediated hypertrophic cardiomyopathy upon Ang-II stimulation.
    BMC molecular and cell biology, 2019, 06-14, Volume: 20, Issue:1

    Topics: Angiotensin II; Animals; Butadienes; Cardiomegaly; Cardiomyopathy, Hypertrophic; Cell Enlargement; Cell Line; Connective Tissue Growth Factor; Disease Models, Animal; ErbB Receptors; Heart Ventricles; MAP Kinase Signaling System; Myocytes, Cardiac; Nitriles; Phosphorylation; Rats; Receptors, G-Protein-Coupled; Signal Transduction

2019
Soluble epoxide hydrolase inhibitor, TUPS, attenuates isoproterenol/angiotensin II-induced cardiac hypertrophy through mammalian target of rapamycin-mediated autophagy inhibition.
    The Journal of pharmacy and pharmacology, 2019, Volume: 71, Issue:8

    Topics: Angiotensin II; Animals; Autophagy; Beclin-1; Cardiomegaly; Cell Line; Cell Survival; Epoxide Hydrolases; Isoproterenol; Male; Microtubule-Associated Proteins; Myocytes, Cardiac; Pyrenes; Rats; Rats, Sprague-Dawley

2019
Sodium (±)-5-bromo-2-(α-hydroxypentyl) benzoate ameliorates pressure overload-induced cardiac hypertrophy and dysfunction through inhibiting autophagy.
    Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:9

    Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Autophagy; Cardiomegaly; Cell Line; Heart Failure; Male; Metformin; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Signal Transduction; TOR Serine-Threonine Kinases; Ventricular Remodeling

2019
Cordycepin ameliorates cardiac hypertrophy via activating the AMPKα pathway.
    Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:8

    Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Cardiomegaly; Cardiotonic Agents; Deoxyadenosines; Fibrosis; Hemodynamics; Male; Mice, Inbred C57BL; Models, Biological; Myocytes, Cardiac; Oxidative Stress; Phosphorylation; Pressure; Signal Transduction

2019
Prehypertension exercise training attenuates hypertension and cardiac hypertrophy accompanied by temporal changes in the levels of angiotensin II and angiotensin (1-7).
    Hypertension research : official journal of the Japanese Society of Hypertension, 2019, Volume: 42, Issue:11

    Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Cardiomegaly; Diastole; Male; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Physical Conditioning, Animal; Prehypertension; Rats, Inbred SHR; Rats, Inbred WKY; Ventricular Remodeling

2019
MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2.
    Life sciences, 2019, Sep-01, Volume: 232

    Topics: 3' Untranslated Regions; Angiotensin II; Animals; Basic Helix-Loop-Helix Transcription Factors; Cardiomegaly; Cardiomyopathy, Hypertrophic; Disease Models, Animal; Heart Defects, Congenital; Heart Failure; Heart Ventricles; Mice; Mice, Inbred C57BL; MicroRNAs; Myocardium; Myocytes, Cardiac; RNA, Small Interfering; Signal Transduction; Up-Regulation

2019
Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway.
    European journal of pharmacology, 2019, Sep-15, Volume: 859

    Topics: Angiotensin II; Animals; Cardiomegaly; Down-Regulation; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibrosis; Glucuronidase; Klotho Proteins; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Myocytes, Cardiac; Signal Transduction; Transforming Growth Factor beta1; Ventricular Remodeling

2019
MiR-195-5p Promotes Cardiomyocyte Hypertrophy by Targeting MFN2 and FBXW7.
    BioMed research international, 2019, Volume: 2019

    Topics: Angiotensin II; Animals; Cardiomegaly; F-Box-WD Repeat-Containing Protein 7; Gene Expression Regulation; GTP Phosphohydrolases; Male; Mice; MicroRNAs; Myocytes, Cardiac

2019
Fenofibrate ameliorates cardiac hypertrophy by activation of peroxisome proliferator-activated receptor-α partly via preventing p65-NFκB binding to NFATc4.
    Molecular and cellular endocrinology, 2013, May-06, Volume: 370, Issue:1-2

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Enzyme Activation; Fenofibrate; Hypolipidemic Agents; Male; Myocytes, Cardiac; Nerve Tissue Proteins; NFATC Transcription Factors; PPAR alpha; PPAR gamma; Protein Binding; Rats; Rats, Sprague-Dawley; Signal Transduction; Transcription Factor RelA

2013
Angiotensin II-induced cardiac hypertrophy and fibrosis are promoted in mice lacking Fgf16.
    Genes to cells : devoted to molecular & cellular mechanisms, 2013, Volume: 18, Issue:7

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Fibroblast Growth Factor 2; Fibroblast Growth Factors; Fibrosis; Mice; Mice, Inbred C57BL; Mice, Knockout

2013
Angiotensin II regulates microRNA-132/-212 in hypertensive rats and humans.
    International journal of molecular sciences, 2013, May-27, Volume: 14, Issue:6

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Cardiomegaly; Disease Models, Animal; Endothelin-1; Female; Fibrosis; Gene Expression Regulation; Humans; Hypertension; Mice; Mice, Inbred C57BL; MicroRNAs; Oligonucleotide Array Sequence Analysis; Organ Specificity; Rats, Sprague-Dawley; Reproducibility of Results; Vasoconstrictor Agents

2013
Deficiency of senescence marker protein 30 exacerbates angiotensin II-induced cardiac remodelling.
    Cardiovascular research, 2013, Aug-01, Volume: 99, Issue:3

    Topics: Aging; Angiotensin II; Animals; Apoptosis; Ascorbic Acid; bcl-2-Associated X Protein; Biomarkers; Calcium-Binding Proteins; Cardiomegaly; Caspase 3; Disease Models, Animal; Fibrosis; Heart Failure; Intracellular Signaling Peptides and Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Ventricular Remodeling

2013
Angiotensin II type 2 receptor (AT2R) is associated with increased tolerance of the hyperthyroid heart to ischemia-reperfusion.
    Cardiovascular drugs and therapy, 2013, Volume: 27, Issue:5

    Topics: AMP-Activated Protein Kinases; Angiotensin I; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Cardiomegaly; Hyperthyroidism; Imidazoles; Male; Myocardial Reperfusion Injury; Myocardium; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Thyroxine; Triiodothyronine; Ventricular Pressure

2013
N-acetyl-seryl-aspartyl-lysyl-proline reduces cardiac collagen cross-linking and inflammation in angiotensin II-induced hypertensive rats.
    Clinical science (London, England : 1979), 2014, Jan-01, Volume: 126, Issue:1

    Topics: Amino Acid Oxidoreductases; Angiotensin II; Animals; Body Weight; Cardiomegaly; CD4-Positive T-Lymphocytes; Collagen; Extracellular Matrix; Hypertension; Inflammation; Lung; Male; NF-kappa B; Oligopeptides; Organ Size; Protein-Lysine 6-Oxidase; Rats; Rats, Inbred Lew; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Ventricular Function, Left; Ventricular Remodeling

2014
Fibulin-2 deficiency attenuates angiotensin II-induced cardiac hypertrophy by reducing transforming growth factor-β signalling.
    Clinical science (London, England : 1979), 2014, Volume: 126, Issue:4

    Topics: Angiotensin II; Animals; Calcium-Binding Proteins; Cardiomegaly; Extracellular Matrix Proteins; Fibrosis; Hypertension; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Myocardium; Signal Transduction; Transforming Growth Factor beta; Vasoconstrictor Agents

2014
Upregulation of Nox4 promotes angiotensin II-induced epidermal growth factor receptor activation and subsequent cardiac hypertrophy by increasing ADAM17 expression.
    The Canadian journal of cardiology, 2013, Volume: 29, Issue:10

    Topics: ADAM Proteins; ADAM17 Protein; Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; ErbB Receptors; Male; Myocardium; NADPH Oxidase 4; NADPH Oxidases; Rats; Rats, Sprague-Dawley; RNA; Signal Transduction; Transcriptional Activation; Tumor Necrosis Factor-alpha; Up-Regulation

2013
Effect of angiotensin II on rhythmic per2 expression in the suprachiasmatic nucleus and heart and daily rhythm of activity in Wistar rats.
    Regulatory peptides, 2013, Sep-10, Volume: 186

    Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; ARNTL Transcription Factors; Blood Pressure; Cardiomegaly; Circadian Rhythm; CLOCK Proteins; DNA-Binding Proteins; Gene Expression; Motor Activity; Myocardium; Nuclear Receptor Subfamily 1, Group D, Member 1; Peptidyl-Dipeptidase A; Period Circadian Proteins; Rats; Rats, Wistar; RNA, Messenger; Suprachiasmatic Nucleus; Transcription Factors

2013
MicroRNA-22 downregulation by atorvastatin in a mouse model of cardiac hypertrophy: a new mechanism for antihypertrophic intervention.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2013, Volume: 31, Issue:6

    Topics: Angiotensin II; Animals; Anticholesteremic Agents; Atorvastatin; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Down-Regulation; Heptanoic Acids; Male; Mice; MicroRNAs; Myocardium; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; Oligonucleotides, Antisense; Phosphoric Monoester Hydrolases; PTEN Phosphohydrolase; Pyrroles; Rats

2013
The effect of intermedin on angiotensin II and endothelin-1 induced ventricular myocyte hypertrophy in neonatal rat.
    Clinical laboratory, 2013, Volume: 59, Issue:5-6

    Topics: Actins; Adrenomedullin; Analysis of Variance; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cell Size; Cells, Cultured; Drug Interactions; Endothelin-1; Gene Expression; Heart Ventricles; Membrane Glycoproteins; Myocytes, Cardiac; Myosin Heavy Chains; NADPH Oxidase 2; NADPH Oxidases; Neuropeptides; Protective Agents; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction

2013
The β-arrestin-biased ligand TRV120023 inhibits angiotensin II-induced cardiac hypertrophy while preserving enhanced myofilament response to calcium.
    American journal of physiology. Heart and circulatory physiology, 2013, Sep-15, Volume: 305, Issue:6

    Topics: Angiotensin II; Animals; Arrestins; beta-Arrestins; Calcium; Cardiomegaly; Cardiotonic Agents; Heart Ventricles; Male; Myocardial Contraction; Myofibrils; Oligopeptides; Organ Size; Rats; Rats, Sprague-Dawley; Treatment Outcome; Up-Regulation

2013
Adult cardiac fibroblast proliferation is modulated by calcium/calmodulin-dependent protein kinase II in normal and hypertrophied hearts.
    Pflugers Archiv : European journal of physiology, 2014, Volume: 466, Issue:2

    Topics: Angiotensin II; Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; Cell Proliferation; Fibroblasts; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac

2014
Senescence marker protein 30 inhibits angiotensin II-induced cardiac hypertrophy and diastolic dysfunction.
    Biochemical and biophysical research communications, 2013, Sep-13, Volume: 439, Issue:1

    Topics: Angiotensin II; Animals; Antioxidants; Ascorbic Acid; Blood Pressure; Calcium-Binding Proteins; Cardiomegaly; Cellular Senescence; Diastole; Echocardiography; Fibrosis; Hypertension; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Transgenic; Oxidative Stress; Promoter Regions, Genetic; Superoxides

2013
Diverse regulation of IP3 and ryanodine receptors by pentazocine through σ1-receptor in cardiomyocytes.
    American journal of physiology. Heart and circulatory physiology, 2013, Oct-15, Volume: 305, Issue:8

    Topics: Adenosine Triphosphate; Angiotensin II; Animals; Anisoles; Calcium; Cardiomegaly; Cells, Cultured; Female; Heart; Hypertrophy, Left Ventricular; Inositol 1,4,5-Trisphosphate Receptors; Mitochondria; Myocardial Contraction; Myocytes, Cardiac; Narcotic Antagonists; Narcotics; Ovariectomy; Pentazocine; Propylamines; Rats; Rats, Wistar; Receptors, sigma; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Sigma-1 Receptor; Vasoconstrictor Agents

2013
NADPH oxidases mediate a cellular "memory" of angiotensin II stress in hypertensive cardiac hypertrophy.
    Free radical biology & medicine, 2013, Volume: 65

    Topics: Angiotensin II; Animals; Apoptosis; Cardiomegaly; Cells, Cultured; Hypertension; Male; Mice, Inbred C57BL; Myocytes, Cardiac; NADPH Oxidases; Oxidative Stress; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction

2013
Stimulation of angiotensin type 1A receptors on catecholaminergic cells contributes to angiotensin-dependent hypertension.
    Hypertension (Dallas, Tex. : 1979), 2013, Volume: 62, Issue:5

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Catecholamines; Hypertension; Mice; Mice, Knockout; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Subfornical Organ; Sympathetic Nervous System

2013
Upregulation of M₃ muscarinic receptor inhibits cardiac hypertrophy induced by angiotensin II.
    Journal of translational medicine, 2013, Sep-12, Volume: 11

    Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Cardiomegaly; Disease Models, Animal; Down-Regulation; Enzyme Activation; Heart Rate; MAP Kinase Signaling System; Mice; Mice, Transgenic; Myocardium; Organ Specificity; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Muscarinic M3; Up-Regulation

2013
Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice.
    Journal of translational medicine, 2013, Sep-25, Volume: 11

    Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Biphenyl Compounds; Cardiomegaly; Cardiotonic Agents; Collagen; Connective Tissue Growth Factor; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Gene Expression Regulation; Irbesartan; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphorylation; PPAR alpha; PPAR delta; PPAR gamma; Receptor, Angiotensin, Type 1; RNA, Messenger; Signal Transduction; Tetrazoles; Transforming Growth Factor beta

2013
Inhalation of diesel exhaust does not exacerbate cardiac hypertrophy or heart failure in two mouse models of cardiac hypertrophy.
    Particle and fibre toxicology, 2013, Oct-05, Volume: 10

    Topics: Air Pollutants; Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Disease Progression; Echocardiography; Heart Failure; Heart Rate; Inhalation Exposure; Male; Mice; Mice, Inbred C57BL; Particle Size; Particulate Matter; Time Factors; Vehicle Emissions

2013
Prevention of RhoA activation and cofilin-mediated actin polymerization mediates the antihypertrophic effect of adenosine receptor agonists in angiotensin II- and endothelin-1-treated cardiomyocytes.
    Molecular and cellular biochemistry, 2014, Volume: 385, Issue:1-2

    Topics: Actin Depolymerizing Factors; Actins; Angiotensin II; Animals; Cardiomegaly; Cell Nucleus; Endothelin-1; Enzyme Activation; Models, Biological; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Polymerization; Protein Transport; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; rhoA GTP-Binding Protein

2014
Intrinsic-mediated caspase activation is essential for cardiomyocyte hypertrophy.
    Proceedings of the National Academy of Sciences of the United States of America, 2013, Oct-22, Volume: 110, Issue:43

    Topics: Angiotensin II; Animals; Animals, Newborn; Apoptosis; Bronchodilator Agents; Cardiomegaly; Caspase 3; Caspase 9; Cells, Cultured; Cysteine Proteinase Inhibitors; Endothelin-1; Enzyme Activation; Fluorescent Antibody Technique; Hypertrophy; In Vitro Techniques; Isoproterenol; Membrane Potential, Mitochondrial; Myocardium; Myocytes, Cardiac; Oligopeptides; Phenylephrine; Rats; Rats, Sprague-Dawley; Signal Transduction; Vasoconstrictor Agents

2013
Comparison of extracts from cooked and raw lentil in antagonizing angiotensin II-induced hypertension and cardiac hypertrophy.
    European review for medical and pharmacological sciences, 2013, Volume: 17, Issue:19

    Topics: Angiotensin II; Animals; Cardiomegaly; Hypertension; Lens Plant; Male; Myocytes, Cardiac; Oxidative Stress; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Ventricular Remodeling

2013
Estrogen regulates histone deacetylases to prevent cardiac hypertrophy.
    Molecular biology of the cell, 2013, Volume: 24, Issue:24

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Estradiol; Estrogen Receptor beta; Estrogens; Female; GATA4 Transcription Factor; Heart; Histone Deacetylase 2; Histone Deacetylases; Isoquinolines; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Phosphorylation; Protein Kinase C-delta; Rats; Repressor Proteins; RNA, Messenger; Transcriptional Activation

2013
The C-terminus of the long AKAP13 isoform (AKAP-Lbc) is critical for development of compensatory cardiac hypertrophy.
    Journal of molecular and cellular cardiology, 2014, Volume: 66

    Topics: A Kinase Anchor Proteins; Angiotensin II; Animals; Aorta; Apoptosis; Cardiomegaly; Collagen; Female; Gene Expression Regulation; Guanine Nucleotide Exchange Factors; Heart Failure; Histone Deacetylases; Male; Mice; Mice, Transgenic; Minor Histocompatibility Antigens; Myocardium; Phenylephrine; Protein Kinase C; Protein Structure, Tertiary; Signal Transduction

2014
Solving the cardiac hypertrophy riddle: The angiotensin II-mechanical stress connection.
    Circulation research, 2013, Nov-08, Volume: 113, Issue:11

    Topics: Angiotensin II; Animals; Cardiomegaly; Humans; Hyperplasia; Myocytes, Cardiac; Proto-Oncogene Proteins c-fos; Receptor, Angiotensin, Type 1; Signal Transduction; Stress, Mechanical

2013
Autophagy-mediated degradation is necessary for regression of cardiac hypertrophy during ventricular unloading.
    Biochemical and biophysical research communications, 2013, Nov-29, Volume: 441, Issue:4

    Topics: Angiotensin II; Animals; Autophagy; Autophagy-Related Protein 5; Cardiomegaly; Disease Models, Animal; Heart Ventricles; Mice; Mice, Mutant Strains; Microtubule-Associated Proteins

2013
[Stimulation of adenosine A1 receptor attenuates angiotensin II induced myocardial hypertrophy in neonatal rats via the extracellular signal-regulated kinase signal pathways].
    Zhonghua xin xue guan bing za zhi, 2013, Volume: 41, Issue:8

    Topics: Adenosine A1 Receptor Agonists; Angiotensin II; Animals; Calcium; Cardiomegaly; Cells, Cultured; Female; Male; MAP Kinase Signaling System; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1

2013
Reduced sarcolemmal expression and function of the NBCe1 isoform of the Na⁺-HCO₃⁻ cotransporter in hypertrophied cardiomyocytes of spontaneously hypertensive rats: role of the renin-angiotensin system.
    Cardiovascular research, 2014, Feb-01, Volume: 101, Issue:2

    Topics: Ammonium Compounds; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Bicarbonates; Cardiomegaly; Disease Models, Animal; Down-Regulation; Endosomes; Hydrogen-Ion Concentration; Hyperkalemia; Hypertension; Losartan; Male; Myocytes, Cardiac; Potassium; Protein Transport; Rats; Rats, Inbred SHR; Rats, Wistar; Renin-Angiotensin System; Sarcolemma; Sodium-Bicarbonate Symporters; Time Factors

2014
Toll-interacting protein (Tollip) negatively regulates pressure overload-induced ventricular hypertrophy in mice.
    Cardiovascular research, 2014, Jan-01, Volume: 101, Issue:1

    Topics: Angiotensin II; Animals; Cardiomegaly; Down-Regulation; Humans; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Proto-Oncogene Proteins c-akt; Signal Transduction; Ventricular Remodeling

2014
Endogenous endothelin 1 mediates angiotensin II-induced hypertrophy in electrically paced cardiac myocytes through EGFR transactivation, reactive oxygen species and NHE-1.
    Pflugers Archiv : European journal of physiology, 2014, Volume: 466, Issue:9

    Topics: Angiotensin II; Animals; Blotting, Western; Cardiomegaly; Cats; Disease Models, Animal; Electric Stimulation; Endothelin-1; ErbB Receptors; Hypertrophy; Myocytes, Cardiac; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Signal Transduction; Sodium-Hydrogen Exchangers; Transcriptional Activation

2014
Chronic infusion of enalaprilat into hypothalamic paraventricular nucleus attenuates angiotensin II-induced hypertension and cardiac hypertrophy by restoring neurotransmitters and cytokines.
    Toxicology and applied pharmacology, 2014, Feb-01, Volume: 274, Issue:3

    Topics: Angiotensin II; Animals; Cardiomegaly; Chemokine CCL2; Enalaprilat; gamma-Aminobutyric Acid; Glutamic Acid; Heart; Hypertension; Interleukin-10; Interleukin-1beta; Interleukin-6; Kidney; Losartan; Male; Neurotransmitter Agents; Norepinephrine; Organ Size; Paraventricular Hypothalamic Nucleus; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System

2014
Fluvoxamine rescues mitochondrial Ca2+ transport and ATP production through σ(1)-receptor in hypertrophic cardiomyocytes.
    Life sciences, 2014, Jan-30, Volume: 95, Issue:2

    Topics: Adenosine Triphosphate; Angiotensin II; Animals; Calcium; Cardiomegaly; Cells, Cultured; Fluvoxamine; Immunohistochemistry; Male; Mice; Mitochondria; Myocytes, Cardiac; Rats; Receptors, sigma; Selective Serotonin Reuptake Inhibitors

2014
Addition of ET(A) receptor blockade increases renoprotection provided by renin-angiotensin system blockade in 5/6 nephrectomized Ren-2 transgenic rats.
    Life sciences, 2014, Nov-24, Volume: 118, Issue:2

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Endothelin Receptor Antagonists; Endothelin-1; Kidney; Kidney Diseases; Nephrectomy; Protective Agents; Rats, Sprague-Dawley; Rats, Transgenic; Receptor, Endothelin A; Renin; Renin-Angiotensin System; Systole

2014
Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.
    Gene, 2014, Feb-25, Volume: 536, Issue:2

    Topics: Angiotensin II; Animals; Aorta; Cardiomegaly; Echocardiography; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heart; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocytes, Cardiac; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; TNF Receptor-Associated Factor 2; Up-Regulation; Ventricular Dysfunction, Left

2014
Interferon regulatory factor 7 functions as a novel negative regulator of pathological cardiac hypertrophy.
    Hypertension (Dallas, Tex. : 1979), 2014, Volume: 63, Issue:4

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Hypertrophy; I-kappa B Kinase; In Vitro Techniques; Interferon Regulatory Factor-7; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Myocytes, Cardiac; NF-kappa B; Signal Transduction

2014
DPP4 deficiency preserved cardiac function in abdominal aortic banding rats.
    PloS one, 2014, Volume: 9, Issue:1

    Topics: Angiotensin II; Animals; Aorta, Abdominal; Cardiomegaly; Collagen; Dipeptidyl Peptidase 4; Glucagon-Like Peptide 1; Heart Function Tests; Hemodynamics; Male; Pressure; Rats; Rats, Inbred F344; Signal Transduction; Up-Regulation

2014
Antagonist of C5aR prevents cardiac remodeling in angiotensin II-induced hypertension.
    American journal of hypertension, 2014, Volume: 27, Issue:6

    Topics: Angiotensin II; Animals; Cardiomegaly; Cardiovascular Agents; Collagen; Connective Tissue Growth Factor; Cytokines; Disease Models, Animal; Fibrosis; Hypertension; Mice, Inbred C57BL; Myocardium; Peptides, Cyclic; Receptor, Anaphylatoxin C5a; RNA, Messenger; Time Factors; Transforming Growth Factor beta1; Ventricular Remodeling

2014
Crosstalk between AMPK activation and angiotensin II-induced hypertrophy in cardiomyocytes: the role of mitochondria.
    Journal of cellular and molecular medicine, 2014, Volume: 18, Issue:4

    Topics: AMP-Activated Protein Kinases; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cardiomegaly; Gene Expression Regulation; Losartan; Metformin; Mitochondria; Myocytes, Cardiac; Nitric Oxide Synthase Type III; Rats; Receptor, Angiotensin, Type 1; Signal Transduction; Sirtuin 1; Tumor Suppressor Protein p53

2014
Deletion of soluble epoxide hydrolase attenuates cardiac hypertrophy via down-regulation of cardiac fibroblasts-derived fibroblast growth factor-2.
    Critical care medicine, 2014, Volume: 42, Issue:5

    Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Epoxide Hydrolases; Fibroblast Growth Factor 2; Fibroblasts; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Confocal; Myocardium; Myocytes, Cardiac; Prospective Studies; Real-Time Polymerase Chain Reaction; Vasoconstrictor Agents

2014
Phosphoinositide kinases play key roles in norepinephrine- and angiotensin II-induced increase in phosphatidylinositol 4,5-bisphosphate and modulation of cardiac function.
    The Journal of biological chemistry, 2014, Mar-07, Volume: 289, Issue:10

    Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Myocytes, Cardiac; Norepinephrine; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositol-4-Phosphate 3-Kinase; Rats; Rats, Sprague-Dawley

2014
Salvianolic acid B protects cardiomyocytes from angiotensin II-induced hypertrophy via inhibition of PARP-1.
    Biochemical and biophysical research communications, 2014, Feb-14, Volume: 444, Issue:3

    Topics: Angiotensin II; Animals; Benzofurans; Cardiomegaly; Cells, Cultured; Myocytes, Cardiac; NAD; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction

2014
Effect of adiponectin on cardiac β-catenin signaling pathway under angiotensin II infusion.
    Biochemical and biophysical research communications, 2014, Feb-07, Volume: 444, Issue:2

    Topics: Adenoviridae; Adiponectin; Angiotensin II; Animals; beta Catenin; Cardiomegaly; Collagen Type I; Collagen Type III; Female; Gene Expression; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Immunoblotting; Infusion Pumps, Implantable; Mice; Mice, Knockout; Myocardium; Phosphorylation; Proto-Oncogene Proteins c-akt; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; TOR Serine-Threonine Kinases

2014
Angiotensin II and the JNK pathway mediate urotensin II expression in response to hypoxia in rat cardiomyocytes.
    The Journal of endocrinology, 2014, Volume: 220, Issue:3

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Collagen; Humans; Hypoxia; MAP Kinase Signaling System; Myocytes, Cardiac; Rats; Rats, Wistar; Reactive Oxygen Species; Urotensins

2014
Effects of a domain-selective ACE inhibitor in a mouse model of chronic angiotensin II-dependent hypertension.
    Clinical science (London, England : 1979), 2014, Volume: 127, Issue:1

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Cardiomegaly; Chronic Disease; Disease Models, Animal; Drug Evaluation, Preclinical; Hypertension; Hypertrophy; Kidney; Lisinopril; Mice; Mice, Transgenic

2014
The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489.
    Circulation research, 2014, Apr-25, Volume: 114, Issue:9

    Topics: Angiotensin II; Animals; Apoptosis; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Endothelial Cells; Fibroblasts; Gene Expression Regulation; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; MicroRNAs; Myeloid Differentiation Factor 88; Oligonucleotides; RNA Interference; RNA, Long Noncoding; Time Factors; Transfection

2014
Mechanical stress triggers cardiomyocyte autophagy through angiotensin II type 1 receptor-mediated p38MAP kinase independently of angiotensin II.
    PloS one, 2014, Volume: 9, Issue:2

    Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Autophagy; Biomechanical Phenomena; Cardiomegaly; Cells, Cultured; Chlorocebus aethiops; COS Cells; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Rats; Stress, Physiological

2014
Phenotypic screen quantifying differential regulation of cardiac myocyte hypertrophy identifies CITED4 regulation of myocyte elongation.
    Journal of molecular and cellular cardiology, 2014, Volume: 72

    Topics: Angiotensin II; Animals; Animals, Newborn; bcl-2-Associated X Protein; Cardiomegaly; CCAAT-Enhancer-Binding Protein-beta; Cell Shape; Connective Tissue Growth Factor; Gene Expression Profiling; Gene Expression Regulation; Myocytes, Cardiac; Neuregulin-1; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Signal Transduction; Tumor Necrosis Factor-alpha

2014
Central blockade of TLR4 improves cardiac function and attenuates myocardial inflammation in angiotensin II-induced hypertension.
    Cardiovascular research, 2014, Jul-01, Volume: 103, Issue:1

    Topics: Angiotensin II; Animals; Blood Pressure; Brain; Cardiomegaly; Hypertension; Interleukin-1beta; Male; Myocarditis; NF-kappa B; Nitric Oxide Synthase; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; RNA, Messenger; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha

2014
The ameliorating effects of long-term electroacupuncture on cardiovascular remodeling in spontaneously hypertensive rats.
    BMC complementary and alternative medicine, 2014, Apr-01, Volume: 14

    Topics: Acupuncture Points; Angiotensin II; Animals; Aorta; Blood Pressure; Cardiomegaly; Collagen; Electroacupuncture; Endothelin-1; Enzyme-Linked Immunosorbent Assay; Hypertension; Male; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar; Receptor, Angiotensin, Type 1; Vascular Remodeling

2014
Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction.
    Cardiovascular research, 2014, Jul-15, Volume: 103, Issue:2

    Topics: Angiotensin II; Animals; Cardiomegaly; Cardiomyopathies; Fibrosis; Heart Failure, Diastolic; Hypertrophy, Left Ventricular; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Tissue Inhibitor of Metalloproteinase-2; Tissue Inhibitor of Metalloproteinase-3; Ventricular Remodeling

2014
Relaxin does not improve Angiotensin II-induced target-organ damage.
    PloS one, 2014, Volume: 9, Issue:4

    Topics: Albuminuria; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Humans; Hypertension; Male; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Recombinant Proteins; Relaxin; Renin

2014
Opposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosis.
    PloS one, 2014, Volume: 9, Issue:4

    Topics: Angiotensin II; Animals; Animals, Newborn; Arachidonic Acids; Biomarkers; Cardiomegaly; Chemokine CCL2; Disease Models, Animal; Epoxide Hydrolases; Fibrosis; Hypertension; Interleukin-6; Male; Metabolome; Mice; Mice, Inbred C57BL; Myocardium; Myofibroblasts; Ventricular Remodeling

2014
Cardiac hypertrophy is negatively regulated by miR-541.
    Cell death & disease, 2014, Apr-10, Volume: 5

    Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Gene Expression Regulation; Male; Mice, Inbred C57BL; Mice, Transgenic; Microphthalmia-Associated Transcription Factor; MicroRNAs; Transcription, Genetic

2014
miR-34a modulates angiotensin II-induced myocardial hypertrophy by direct inhibition of ATG9A expression and autophagic activity.
    PloS one, 2014, Volume: 9, Issue:4

    Topics: Angiotensin II; Animals; Autophagy; Base Sequence; Cardiomegaly; Disease Models, Animal; Gene Expression Regulation; Humans; Male; Membrane Proteins; MicroRNAs; Molecular Sequence Data; Myocardium; Myocytes, Cardiac; Rats, Sprague-Dawley; RNA, Small Interfering; Systole; Vacuoles

2014
Protective effect of Boerhaavia diffusa L. against mitochondrial dysfunction in angiotensin II induced hypertrophy in H9c2 cardiomyoblast cells.
    PloS one, 2014, Volume: 9, Issue:4

    Topics: Angiotensin II; Animals; Calcium; Cardiomegaly; Cell Line; Cell Size; Heart; Membrane Potential, Mitochondrial; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Mitochondrial Swelling; Myocardium; Nyctaginaceae; Oxidative Stress; Plant Extracts; Rats; Reactive Oxygen Species; Superoxides

2014
Protection from hypertension in mice by the Mediterranean diet is mediated by nitro fatty acid inhibition of soluble epoxide hydrolase.
    Proceedings of the National Academy of Sciences of the United States of America, 2014, Jun-03, Volume: 111, Issue:22

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cellulase; Diet, Mediterranean; Disease Models, Animal; Epoxide Hydrolases; Fatty Acids; Gene Knock-In Techniques; Hypertension; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Nitrates; Nitrites; Sulfhydryl Compounds; Vasoconstrictor Agents; Vasodilation

2014
HDAC6 contributes to pathological responses of heart and skeletal muscle to chronic angiotensin-II signaling.
    American journal of physiology. Heart and circulatory physiology, 2014, Jul-15, Volume: 307, Issue:2

    Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Fibrosis; Heart Failure; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Histone Deacetylases; Hydroxamic Acids; Indoles; Male; Mice; Mice, Knockout; Muscle, Skeletal; Muscular Atrophy; Myocardium; Signal Transduction; Stroke Volume; Systole; Time Factors; Ventricular Function, Left; Ventricular Remodeling

2014
AG-690/11026014, a novel PARP-1 inhibitor, protects cardiomyocytes from AngII-induced hypertrophy.
    Molecular and cellular endocrinology, 2014, Jul-05, Volume: 392, Issue:1-2

    Topics: Angiotensin II; Animals; Cardiomegaly; Cardiotonic Agents; Cytoprotection; Drug Evaluation, Preclinical; Enzyme Activation; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Membrane Glycoproteins; Molecular Docking Simulation; Myocytes, Cardiac; NAD; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Rats, Sprague-Dawley; Reactive Oxygen Species; Recombinant Proteins; Sirtuins; Thioglycolates; Up-Regulation; Xanthines

2014
Fibrosis or hypertrophy: let TIMPs decide.
    Cardiovascular research, 2014, Jul-15, Volume: 103, Issue:2

    Topics: Angiotensin II; Animals; Cardiomegaly; Heart Failure, Diastolic; Hypertrophy, Left Ventricular; Tissue Inhibitor of Metalloproteinase-2; Tissue Inhibitor of Metalloproteinase-3

2014
Exogenous administration of thiosulfate, a donor of hydrogen sulfide, attenuates angiotensin II-induced hypertensive heart disease in rats.
    British journal of pharmacology, 2015, Volume: 172, Issue:6

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Disease Models, Animal; Hydrogen Sulfide; Hypertension; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Sulfides; Thiosulfates

2015
Mechanisms involving Ang II and MAPK/ERK1/2 signaling pathways underlie cardiac and renal alterations during chronic undernutrition.
    PloS one, 2014, Volume: 9, Issue:7

    Topics: Adenosine Triphosphatases; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Cardiomegaly; Cation Transport Proteins; Cyclic AMP-Dependent Protein Kinases; Heart; Heart Rate; Kidney Tubules, Proximal; Losartan; Male; Malnutrition; MAP Kinase Signaling System; Myocytes, Cardiac; Plasma Volume; Protein Kinase C; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Sodium-Potassium-Exchanging ATPase

2014
Inhibition of angiotensin II-induced cardiac hypertrophy and associated ventricular arrhythmias by a p21 activated kinase 1 bioactive peptide.
    PloS one, 2014, Volume: 9, Issue:7

    Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Cardiomegaly; Cells, Cultured; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; p21-Activated Kinases; Peptides; Rats

2014
Overexpression of PEP-19 suppresses angiotensin II-induced cardiomyocyte hypertrophy.
    Journal of pharmacological sciences, 2014, Volume: 125, Issue:3

    Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Calcineurin; Calcium; Calcium Signaling; Calcium-Binding Proteins; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calmodulin; Calmodulin-Binding Proteins; Cardiomegaly; Cells, Cultured; Gene Expression; Hypertrophy; Male; Myocytes, Cardiac; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Rats, Sprague-Dawley; Sarcoplasmic Reticulum

2014
Identification of regulatory elements directing miR-23a-miR-27a-miR-24-2 transcriptional regulation in response to muscle hypertrophic stimuli.
    Biochimica et biophysica acta, 2014, Volume: 1839, Issue:9

    Topics: 3T3 Cells; Angiotensin II; Animals; Cardiomegaly; Gene Expression Regulation; Genes, Regulator; Hypertrophy; Mice; MicroRNAs; Muscle, Skeletal; Myocytes, Cardiac; Norepinephrine; Promoter Regions, Genetic; Transcription, Genetic

2014
Murine pressure overload models: a 30-MHz look brings a whole new "sound" into data interpretation.
    Journal of applied physiology (Bethesda, Md. : 1985), 2014, Sep-01, Volume: 117, Issue:5

    Topics: Angiotensin II; Animals; Aorta, Thoracic; Cardiomegaly; Constriction, Pathologic; Data Interpretation, Statistical; Disease Models, Animal; Echocardiography; Echocardiography, Doppler; Mice; Mice, Inbred C57BL; Pressure; Vasoconstrictor Agents

2014
Cytosolic CARP promotes angiotensin II- or pressure overload-induced cardiomyocyte hypertrophy through calcineurin accumulation.
    PloS one, 2014, Volume: 9, Issue:8

    Topics: Adenoviridae; Angiotensin II; Animals; Animals, Newborn; Aorta; Atrial Natriuretic Factor; Calcineurin; Calpain; Cardiomegaly; Constriction, Pathologic; Cyclosporine; Gene Expression Regulation; Genetic Vectors; Glycoproteins; Imidazoles; Mice; Muscle Proteins; Myocytes, Cardiac; Myosin Heavy Chains; Nuclear Proteins; Primary Cell Culture; Protein Transport; Rats; Repressor Proteins; RNA, Small Interfering; Signal Transduction; Tetrazoles

2014
AdipoR1/APPL1 potentiates the protective effects of globular adiponectin on angiotensin II-induced cardiac hypertrophy and fibrosis in neonatal rat atrial myocytes and fibroblasts.
    PloS one, 2014, Volume: 9, Issue:8

    Topics: Adaptor Proteins, Signal Transducing; Adiponectin; AMP-Activated Protein Kinases; Angiotensin II; Animals; Cardiomegaly; Endomyocardial Fibrosis; Fibroblasts; Heart Atria; Myocytes, Cardiac; Nerve Tissue Proteins; NF-kappa B; Phosphatidylinositol 3-Kinases; Rats; Rats, Sprague-Dawley; Receptors, Adiponectin; Signal Transduction; Vasoconstrictor Agents

2014
Kruppel-like factor 4 protein regulates isoproterenol-induced cardiac hypertrophy by modulating myocardin expression and activity.
    The Journal of biological chemistry, 2014, Sep-19, Volume: 289, Issue:38

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Cardiomegaly; Cell Line; Gene Expression; Gene Expression Regulation; Histone Deacetylase Inhibitors; Hydroxamic Acids; Imidazoles; Isoproterenol; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Myocytes, Cardiac; Natriuretic Peptide, C-Type; Nuclear Proteins; Protein Precursors; Tetrazoles; Trans-Activators

2014
High-salt intake induces cardiomyocyte hypertrophy in rats in response to local angiotensin II type 1 receptor activation.
    The Journal of nutrition, 2014, Volume: 144, Issue:10

    Topics: Acetylcysteine; Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Cardiomegaly; Heart Rate; Hematocrit; Hydralazine; Losartan; Male; Myocytes, Cardiac; Potassium; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Sodium; Sodium Chloride, Dietary; Thiobarbituric Acid Reactive Substances

2014
Roles of cGMP-dependent protein kinase I (cGKI) and PDE5 in the regulation of Ang II-induced cardiac hypertrophy and fibrosis.
    Proceedings of the National Academy of Sciences of the United States of America, 2014, Sep-02, Volume: 111, Issue:35

    Topics: Angiotensin II; Animals; Cardiomegaly; Cyclic GMP; Cyclic GMP-Dependent Protein Kinase Type I; Cyclic Nucleotide Phosphodiesterases, Type 5; Fibrosis; Genetic Markers; Hypertension; Mice; Muscle, Smooth; Myocardial Contraction; Myocytes, Cardiac; Nitric Oxide; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vasoconstrictor Agents

2014
Tumor suppressor gene ING3 induces cardiomyocyte hypertrophy via inhibition of AMPK and activation of p38 MAPK signaling.
    Archives of biochemistry and biophysics, 2014, Nov-15, Volume: 562

    Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Animals, Newborn; Aorta, Abdominal; Cardiomegaly; Cell Membrane; Imidazoles; Isoproterenol; Male; MAP Kinase Signaling System; Myocardium; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Phenylephrine; Plasmids; Pyridines; Rats; Rats, Sprague-Dawley; RNA Interference; Tumor Suppressor Proteins

2014
Critical role for lysine 685 in gene expression mediated by transcription factor unphosphorylated STAT3.
    The Journal of biological chemistry, 2014, Oct-31, Volume: 289, Issue:44

    Topics: Acetylation; Angiotensin II; Cardiomegaly; Cell Line; Humans; Interleukin-6; Lysine; Mutation, Missense; Phosphorylation; Protein Processing, Post-Translational; STAT3 Transcription Factor; Transcriptional Activation

2014
Actin dynamics is rapidly regulated by the PTEN and PIP2 signaling pathways leading to myocyte hypertrophy.
    American journal of physiology. Heart and circulatory physiology, 2014, Dec-01, Volume: 307, Issue:11

    Topics: Actins; Angiotensin II; Animals; Cardiomegaly; Cell Size; Enzyme Activation; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositol Phosphates; PTEN Phosphohydrolase; Rats; Rats, Sprague-Dawley; Signal Transduction; Subcellular Fractions

2014
[Calreticulin-induced mitochondrial injury: a novel mechanism of cardiac hypertrophy].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2014, Volume: 34, Issue:9

    Topics: Angiotensin II; Animals; Calreticulin; Cardiomegaly; Cells, Cultured; Membrane Potential, Mitochondrial; Mitochondria; Myocytes, Cardiac; Protein Biosynthesis; Rats; RNA, Small Interfering

2014
Alpha-lipoic acid attenuates cardiac hypertrophy via downregulation of PARP-2 and subsequent activation of SIRT-1.
    European journal of pharmacology, 2014, Dec-05, Volume: 744

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Down-Regulation; Heart; Male; Myocytes, Cardiac; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; Sirtuin 1; Thioctic Acid; Up-Regulation

2014
Deletion of interleukin-6 prevents cardiac inflammation, fibrosis and dysfunction without affecting blood pressure in angiotensin II-high salt-induced hypertension.
    Journal of hypertension, 2015, Volume: 33, Issue:1

    Topics: Albumins; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Echocardiography; Fibrosis; Heart; Heart Rate; Hypertension; Inflammation; Interleukin-6; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Myocytes, Cardiac; Phenotype; Sodium Chloride, Dietary

2015
Pressure overload-induced cardiac hypertrophy response requires janus kinase 2-histone deacetylase 2 signaling.
    International journal of molecular sciences, 2014, Nov-05, Volume: 15, Issue:11

    Topics: Active Transport, Cell Nucleus; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cell Nucleus; Cells, Cultured; Histone Deacetylase 2; Hydroxamic Acids; Janus Kinase 2; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Natriuretic Peptide, Brain; Peptide Fragments; Pressure; Rats; Signal Transduction; Tyrphostins

2014
Endothelial MRTF-A mediates angiotensin II induced cardiac hypertrophy.
    Journal of molecular and cellular cardiology, 2015, Volume: 80

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Line; Disease Models, Animal; Endothelial Cells; Endothelin-1; Endothelium, Vascular; Epigenesis, Genetic; Fibrosis; Gene Expression Regulation; Humans; Mice; Models, Biological; Promoter Regions, Genetic; Protein Binding; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Trans-Activators; Transcriptional Activation

2015
Polydatin prevents angiotensin II-induced cardiac hypertrophy and myocardial superoxide generation.
    Experimental biology and medicine (Maywood, N.J.), 2015, Volume: 240, Issue:10

    Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Body Weight; Cardiomegaly; Cells, Cultured; Glucosides; Male; Myocardium; Myocytes, Cardiac; NADPH Oxidases; Organ Size; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; RNA, Messenger; Signal Transduction; Stilbenes; Superoxides; Ventricular Myosins

2015
Activation of the cardiac proteasome promotes angiotension II-induced hypertrophy by down-regulation of ATRAP.
    Journal of molecular and cellular cardiology, 2015, Volume: 79

    Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Cardiomegaly; Down-Regulation; Enzyme Activation; Fibrosis; Inflammation; Male; Mice, Inbred C57BL; Models, Biological; Myocardium; p38 Mitogen-Activated Protein Kinases; Polyubiquitin; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Subunits; Proteolysis; Receptor, Angiotensin, Type 1; Signal Transduction; STAT3 Transcription Factor; Ubiquitinated Proteins

2015
SIRT1 functions as an important regulator of estrogen-mediated cardiomyocyte protection in angiotensin II-induced heart hypertrophy.
    Oxidative medicine and cellular longevity, 2014, Volume: 2014

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Estradiol; Female; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Random Allocation; Rats; Rats, Sprague-Dawley; Signal Transduction; Sirtuin 1

2014
A crosstalk between chromatin remodeling and histone H3K4 methyltransferase complexes in endothelial cells regulates angiotensin II-induced cardiac hypertrophy.
    Journal of molecular and cellular cardiology, 2015, Volume: 82

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Line, Transformed; Chromatin Assembly and Disassembly; Disease Models, Animal; DNA Helicases; Endothelial Cells; Endothelin-1; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Humans; Male; Mice; Nuclear Proteins; Promoter Regions, Genetic; Protein Binding; Signal Transduction; Trans-Activators; Transcription Factors

2015
The role of mAKAPβ in the process of cardiomyocyte hypertrophy induced by angiotensin II.
    International journal of molecular medicine, 2015, Volume: 35, Issue:5

    Topics: A Kinase Anchor Proteins; Angiotensin II; Animals; Biomarkers; Cardiomegaly; Disease Models, Animal; Gene Expression; Hypertrophy; Male; Mitogen-Activated Protein Kinase 1; Myocytes, Cardiac; Rats; RNA Interference; RNA, Small Interfering

2015
Angiotensin Ⅱ Activates MCP-1 and Induces Cardiac Hypertrophy and Dysfunction via Toll-like Receptor 4.
    Journal of atherosclerosis and thrombosis, 2015, Aug-26, Volume: 22, Issue:8

    Topics: Adrenergic alpha-Agonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Cardiomegaly; Chemokine CCL2; Hypertension; Irbesartan; Male; Mice; Mice, Inbred BALB C; Norepinephrine; Oxidative Stress; Tetrazoles; Toll-Like Receptor 4; Vasoconstrictor Agents

2015
Chronic blockade of class I PI3-kinase attenuates Ang II-induced cardiac hypertrophy and autophagic alteration.
    European review for medical and pharmacological sciences, 2015, Volume: 19, Issue:5

    Topics: Angiotensin II; Animals; Autophagy; Cardiomegaly; Fibrosis; Male; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction

2015
ANG II modulation of cardiac growth and remodeling in immature fetal sheep.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2015, Jun-01, Volume: 308, Issue:11

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Biomarkers; Blood Pressure; Cardiomegaly; Cell Differentiation; Cell Enlargement; Cell Proliferation; Cell Size; Cyclin B1; Cyclin E; Cyclin-Dependent Kinase Inhibitor p21; Fetal Heart; Gestational Age; Hyperplasia; Hypertension; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Nitroprusside; Proliferating Cell Nuclear Antigen; Sheep; Signal Transduction; Time Factors; Vasodilator Agents

2015
Histone Methyltransferase SET1 Mediates Angiotensin II-Induced Endothelin-1 Transcription and Cardiac Hypertrophy in Mice.
    Arteriosclerosis, thrombosis, and vascular biology, 2015, Volume: 35, Issue:5

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Endothelial Cells; Endothelin-1; Epigenomics; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Mice; Myocytes, Cardiac

2015
3,3'-Diindolylmethane attenuates cardiac H9c2 cell hypertrophy through 5'-adenosine monophosphate-activated protein kinase-α.
    Molecular medicine reports, 2015, Volume: 12, Issue:1

    Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cardiotonic Agents; Cell Line; Gene Expression Regulation; Indoles; Models, Biological; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; Phosphorylation; Rats; Signal Transduction; TOR Serine-Threonine Kinases; Vasoconstrictor Agents

2015
Nuclear Translocation of Calpain-2 Mediates Apoptosis of Hypertrophied Cardiomyocytes in Transverse Aortic Constriction Rat.
    Journal of cellular physiology, 2015, Volume: 230, Issue:11

    Topics: Angiotensin II; Animals; Apoptosis; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calpain; Cardiomegaly; Constriction, Pathologic; Gene Expression Regulation; Humans; Myocytes, Cardiac; Rats; Signal Transduction

2015
Attenuation of renovascular hypertension by cyclooxygenase-2 inhibitor partly through ANP release.
    Peptides, 2015, Volume: 69

    Topics: Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Hypertension, Renovascular; Natriuretic Peptide, Brain; Nitrobenzenes; Rats; Sulfonamides

2015
6β-hydroxytestosterone, a cytochrome P450 1B1 metabolite of testosterone, contributes to angiotensin II-induced hypertension and its pathogenesis in male mice.
    Hypertension (Dallas, Tex. : 1979), 2015, Volume: 65, Issue:6

    Topics: Angiotensin II; Animals; Cardiomegaly; Castration; Cytochrome P-450 CYP1B1; Disease Models, Animal; Gene Expression Regulation; Hydroxytestosterones; Hypertension; Male; Mice; Random Allocation; Reactive Oxygen Species; Reference Values

2015
Novel role for retinol-binding protein 4 in the regulation of blood pressure.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2015, Volume: 29, Issue:8

    Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Cardiomegaly; Hypertension; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide Synthase Type III; Obesity; Phosphorylation; Retinol-Binding Proteins, Plasma; Vasodilation

2015
Targeting γ-secretases protect against angiotensin II-induced cardiac hypertrophy.
    Journal of hypertension, 2015, Volume: 33, Issue:4

    Topics: Amyloid Precursor Protein Secretases; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cells, Cultured; Dibenzazepines; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Mice; Middle Aged; Muscle, Smooth, Vascular; Signal Transduction

2015
Tumor necrosis factor receptor-associated factor 3 is a positive regulator of pathological cardiac hypertrophy.
    Hypertension (Dallas, Tex. : 1979), 2015, Volume: 66, Issue:2

    Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Female; Humans; Hypertrophy; Male; Mice; Mice, Knockout; Mice, Transgenic; Myocytes, Cardiac; Phenylephrine; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; TNF Receptor-Associated Factor 3; Up-Regulation

2015
The Ca(2+)-activated cation channel TRPM4 is a negative regulator of angiotensin II-induced cardiac hypertrophy.
    Basic research in cardiology, 2015, Volume: 110, Issue:4

    Topics: Angiotensin II; Animals; Animals, Newborn; Calcium; Cardiomegaly; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Phosphoric Monoester Hydrolases; TRPM Cation Channels

2015
A background Ca2+ entry pathway mediated by TRPC1/TRPC4 is critical for development of pathological cardiac remodelling.
    European heart journal, 2015, Sep-01, Volume: 36, Issue:33

    Topics: Angiotensin II; Angiotensinogen; Animals; Calcium; Calcium Channels; Calcium Signaling; Cardiomegaly; Hemodynamics; Homeostasis; Mice, Knockout; Myocytes, Cardiac; TRPC Cation Channels; Ventricular Remodeling

2015
The RNA-binding protein PCBP2 inhibits Ang II-induced hypertrophy of cardiomyocytes though promoting GPR56 mRNA degeneration.
    Biochemical and biophysical research communications, 2015, Aug-28, Volume: 464, Issue:3

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Enlargement; Cell Line; Cells, Cultured; Down-Regulation; Gene Knockdown Techniques; Humans; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Rats; Receptors, G-Protein-Coupled; RNA Stability; RNA-Binding Proteins; RNA, Messenger

2015
Angiotensin II increases secreted frizzled-related protein 5 (sFRP5) expression through AT1 receptor/Rho/ROCK1/JNK signaling in cardiomyocytes.
    Molecular and cellular biochemistry, 2015, Volume: 408, Issue:1-2

    Topics: Adipokines; Amides; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Eye Proteins; Myocytes, Cardiac; Pyridines; Rats; Tumor Necrosis Factor-alpha

2015
Sildenafil Does Not Prevent Heart Hypertrophy and Fibrosis Induced by Cardiomyocyte Angiotensin II Type 1 Receptor Signaling.
    The Journal of pharmacology and experimental therapeutics, 2015, Volume: 354, Issue:3

    Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Cardiomegaly; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Fibrosis; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocytes, Cardiac; Piperazines; Purines; Receptor, Angiotensin, Type 1; Signal Transduction; Sildenafil Citrate; Sulfonamides; Up-Regulation

2015
Maternal High-Fat Diet Causes a Sex-Dependent Increase in AGTR2 Expression and Cardiac Dysfunction in Adult Male Rat Offspring.
    Biology of reproduction, 2015, Volume: 93, Issue:2

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cardiomegaly; Diet, High-Fat; Female; Fetal Development; Genetic Predisposition to Disease; Heart Diseases; Imidazoles; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Pregnancy; Prenatal Exposure Delayed Effects; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Sex Characteristics

2015
Puerarin Suppresses Angiotensin II-Induced Cardiac Hypertrophy by Inhibiting NADPH Oxidase Activation and Oxidative Stress-Triggered AP-1 Signaling Pathways.
    Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2015, Volume: 18, Issue:2

    Topics: Angiotensin II; Animals; Cardiomegaly; Dose-Response Relationship, Drug; Enzyme Activation; Isoflavones; Mice; Mice, Inbred C57BL; NADPH Oxidases; Oxidative Stress; Reactive Oxygen Species; Signal Transduction; Structure-Activity Relationship; Transcription Factor AP-1

2015
Caveolin-3 Overexpression Attenuates Cardiac Hypertrophy via Inhibition of T-type Ca2+ Current Modulated by Protein Kinase Cα in Cardiomyocytes.
    The Journal of biological chemistry, 2015, Sep-04, Volume: 290, Issue:36

    Topics: Angiotensin II; Animals; Animals, Newborn; Blotting, Western; Calcium Channels, T-Type; Cardiomegaly; Caveolae; Caveolin 3; Cells, Cultured; Gene Expression; Male; Membrane Potentials; Mice, Inbred C57BL; Microscopy, Electron, Transmission; Myocytes, Cardiac; Patch-Clamp Techniques; Protein Kinase C-alpha; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference

2015
Dual Activation of TRIF and MyD88 Adaptor Proteins by Angiotensin II Evokes Opposing Effects on Pressure, Cardiac Hypertrophy, and Inflammatory Gene Expression.
    Hypertension (Dallas, Tex. : 1979), 2015, Volume: 66, Issue:3

    Topics: Adaptor Proteins, Vesicular Transport; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Gene Expression; Inflammation; Mice; Mice, Knockout; Myeloid Differentiation Factor 88

2015
Oleanolic acid alleviated pressure overload-induced cardiac remodeling.
    Molecular and cellular biochemistry, 2015, Volume: 409, Issue:1-2

    Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Antioxidants; Blood Glucose; Cardiomegaly; Diabetic Cardiomyopathies; Echocardiography; Fibrosis; Glucose; Hypertension; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Oleanolic Acid; Proto-Oncogene Proteins c-akt; RNA, Messenger; Signal Transduction; TOR Serine-Threonine Kinases; Ventricular Remodeling

2015
TIEG1 Inhibits Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting Transcription Factor GATA4.
    Journal of cardiovascular pharmacology, 2015, Volume: 66, Issue:2

    Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; DNA-Binding Proteins; GATA4 Transcription Factor; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Transcription Factors

2015
LC3B, a Protein That Serves as an Autophagic Marker, Modulates Angiotensin II-induced Myocardial Hypertrophy.
    Journal of cardiovascular pharmacology, 2015, Volume: 66, Issue:6

    Topics: Angiotensin II; Animals; Animals, Newborn; Autophagy; Biomarkers; Cardiomegaly; Cells, Cultured; Microtubule-Associated Proteins; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley

2015
Pentoxifylline Ameliorates Cardiac Fibrosis, Pathological Hypertrophy, and Cardiac Dysfunction in Angiotensin II-induced Hypertensive Rats.
    Journal of cardiovascular pharmacology, 2016, Volume: 67, Issue:1

    Topics: Angiotensin II; Animals; Cardiomegaly; Fibrosis; Hypertension; Inflammation Mediators; Male; Pentoxifylline; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley

2016
Tumor Necrosis Factor - Alpha Is Essential for Angiotensin II-Induced Ventricular Remodeling: Role for Oxidative Stress.
    PloS one, 2015, Volume: 10, Issue:9

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Collagen Type I; Collagen Type III; Connective Tissue Growth Factor; Fibrosis; Heart; Hypertension; Male; MAP Kinase Signaling System; Mice; Myocardium; NADPH Oxidases; NF-kappa B; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Receptor, Angiotensin, Type 1; RNA, Messenger; Signal Transduction; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Ventricular Remodeling

2015
MITF interacts with the SWI/SNF subunit, BRG1, to promote GATA4 expression in cardiac hypertrophy.
    Journal of molecular and cellular cardiology, 2015, Volume: 88

    Topics: Angiotensin II; Animals; Aorta; Base Sequence; Binding Sites; Cardiomegaly; Cell Line; Constriction, Pathologic; DNA Helicases; GATA4 Transcription Factor; Gene Expression Regulation; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Microphthalmia-Associated Transcription Factor; Molecular Sequence Data; Myocytes, Cardiac; Nuclear Proteins; Primary Cell Culture; Protein Binding; Rats; Signal Transduction; Transcription Factors; Transcription, Genetic

2015
Prolonged Subcutaneous Administration of Oxytocin Accelerates Angiotensin II-Induced Hypertension and Renal Damage in Male Rats.
    PloS one, 2015, Volume: 10, Issue:9

    Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Calcineurin; Cardiomegaly; Hypertension; Injections, Subcutaneous; Kidney; Male; Oxytocin; Rats; Rats, Sprague-Dawley; Renin

2015
Adenosine A1 receptor activation attenuates cardiac hypertrophy and fibrosis in response to α1 -adrenoceptor stimulation in vivo.
    British journal of pharmacology, 2016, Volume: 173, Issue:1

    Topics: Adenosine; Adenosine A1 Receptor Agonists; Adrenergic alpha-1 Receptor Agonists; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cell Culture Techniques; Dose-Response Relationship, Drug; Fibrosis; Insulin-Like Growth Factor I; Male; Matrix Metalloproteinase 2; Mice; Myocytes, Cardiac; Oxidative Stress; Phenylephrine; Rats; Receptor, Adenosine A1; Up-Regulation

2016
Endothelial Bmx tyrosine kinase activity is essential for myocardial hypertrophy and remodeling.
    Proceedings of the National Academy of Sciences of the United States of America, 2015, Oct-20, Volume: 112, Issue:42

    Topics: Angiotensin II; Animals; Cardiomegaly; Cytokines; Endothelium, Vascular; Inflammation Mediators; Mice; Mice, Knockout; Mitochondria, Heart; Myocytes, Cardiac; Protein-Tyrosine Kinases; Signal Transduction

2015
Consequences of postnatal vascular smooth muscle EGFR deletion on acute angiotensin II action.
    Clinical science (London, England : 1979), 2016, Volume: 130, Issue:1

    Topics: Age Factors; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Chemokine CCL2; Disease Models, Animal; Dose-Response Relationship, Drug; ErbB Receptors; Gene Deletion; Humans; Hypertension; Mice, Inbred C57BL; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphorylation; Plasminogen Activator Inhibitor 1; Signal Transduction; Time Factors; Vascular Remodeling; Vasoconstrictor Agents

2016
19-Hydroxyeicosatetraenoic acid and isoniazid protect against angiotensin II-induced cardiac hypertrophy.
    Toxicology and applied pharmacology, 2015, Dec-15, Volume: 289, Issue:3

    Topics: Angiotensin II; Animals; Arachidonic Acid; Cardiomegaly; Cells, Cultured; Cytochrome P-450 Enzyme System; Humans; Hydroxyeicosatetraenoic Acids; Isoniazid; Male; Myocytes, Cardiac; Protective Agents; Rats; Rats, Sprague-Dawley

2015
A critical role of cardiac fibroblast-derived exosomes in activating renin angiotensin system in cardiomyocytes.
    Journal of molecular and cellular cardiology, 2015, Volume: 89, Issue:Pt B

    Topics: Amiloride; Angiotensin II; Aniline Compounds; Animals; Animals, Newborn; Benzylidene Compounds; Cardiomegaly; Exosomes; Fibroblasts; HEK293 Cells; Humans; Mice; Mitogen-Activated Protein Kinases; Models, Biological; Myocardium; Myocytes, Cardiac; Protein Array Analysis; Protein Kinase Inhibitors; Proteomics; Proto-Oncogene Proteins c-akt; Rats; Renin-Angiotensin System; Signal Transduction; Up-Regulation

2015
Mas receptor mediates cardioprotection of angiotensin-(1-7) against Angiotensin II-induced cardiomyocyte autophagy and cardiac remodelling through inhibition of oxidative stress.
    Journal of cellular and molecular medicine, 2016, Volume: 20, Issue:1

    Topics: Angiotensin II; Animals; Autophagy; Cardiomegaly; Cardiotonic Agents; Cells, Cultured; Drug Evaluation, Preclinical; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Oxidative Stress; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled

2016
Interleukin-10 inhibits chronic angiotensin II-induced pathological autophagy.
    Journal of molecular and cellular cardiology, 2015, Volume: 89, Issue:Pt B

    Topics: Angiotensin II; Animals; Animals, Newborn; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Cardiomegaly; Down-Regulation; Enzyme Activation; Gene Deletion; Heart Failure; Heart Ventricles; Interleukin-10; Mechanistic Target of Rapamycin Complex 1; Mice, Inbred C57BL; Mice, Knockout; Models, Biological; Multiprotein Complexes; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Rats, Sprague-Dawley; Signal Transduction; TOR Serine-Threonine Kinases

2015
Meis1 promotes poly (rC)-binding protein 2 expression and inhibits angiotensin II-induced cardiomyocyte hypertrophy.
    IUBMB life, 2016, Volume: 68, Issue:1

    Topics: Angiotensin II; Animals; Cardiomegaly; Gene Expression; Homeodomain Proteins; Humans; Mice, Inbred C57BL; Myeloid Ecotropic Viral Integration Site 1 Protein; Myocytes, Cardiac; Neoplasm Proteins; Promoter Regions, Genetic; Proto-Oncogene Proteins c-akt; RNA-Binding Proteins; Signal Transduction; TOR Serine-Threonine Kinases; Transcriptional Activation

2016
Thymosin β4 Prevents Angiotensin II-Induced Cardiomyocyte Growth by Regulating Wnt/WISP Signaling.
    Journal of cellular physiology, 2016, Volume: 231, Issue:8

    Topics: Active Transport, Cell Nucleus; Angiotensin II; Animals; Animals, Newborn; beta Catenin; Cardiomegaly; CCN Intercellular Signaling Proteins; Cell Size; Cells, Cultured; Gene Expression Regulation; Myocytes, Cardiac; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Thymosin; Transfection; Wnt Signaling Pathway

2016
Combination of angiotensin II and l-NG-nitroarginine methyl ester exacerbates mitochondrial dysfunction and oxidative stress to cause heart failure.
    American journal of physiology. Heart and circulatory physiology, 2016, Mar-15, Volume: 310, Issue:6

    Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; DNA, Mitochondrial; Electron Transport Complex I; Electron Transport Complex II; Enzyme Inhibitors; Gene Expression; Heart; Heart Failure; Hydrogen Peroxide; Mice; Mitochondria, Heart; Myocardium; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Protein Precursors; Pyruvate Dehydrogenase Complex; Reverse Transcriptase Polymerase Chain Reaction; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Vasoconstrictor Agents

2016
Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II.
    Journal of cellular and molecular medicine, 2016, Volume: 20, Issue:3

    Topics: Angiotensin II; Animals; Cardiomegaly; Cardiotonic Agents; Cell Line; Drug Evaluation, Preclinical; Epidermal Growth Factor; ErbB Receptors; Gene Knockdown Techniques; Mice, Inbred C57BL; Myocytes, Cardiac; Quinazolines; Rats; Tyrphostins

2016
IL-10 for cardiac autophagy modulation: New direction in the pursuit of perfection.
    Journal of molecular and cellular cardiology, 2016, Volume: 91

    Topics: Angiotensin II; Animals; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Cardiomegaly; Gene Expression Regulation; Heart Failure; Humans; Interleukin-10; Mice; Myocardium; Myocytes, Cardiac; Proto-Oncogene Proteins c-bcl-2; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Signal Transduction; Stroke Volume

2016
Interleukin-10 deficiency aggravates angiotensin II-induced cardiac remodeling in mice.
    Life sciences, 2016, Feb-01, Volume: 146

    Topics: Angiotensin II; Animals; Cardiomegaly; Collagen; Interleukin-10; Interleukin-6; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Natriuretic Peptide, Brain; Oncogene Protein v-akt; Ultrasonography; Ventricular Remodeling

2016
Pleiotropic and puzzling effects of ATF3 in maladaptive cardiac remodeling.
    International journal of cardiology, 2016, Mar-01, Volume: 206

    Topics: Activating Transcription Factor 3; Angiotensin II; Animals; Cardiomegaly; Gene Expression Regulation; MAP Kinase Signaling System; Mice; Myocytes, Cardiac; Ventricular Remodeling

2016
Adiponectin Upregulates MiR-133a in Cardiac Hypertrophy through AMPK Activation and Reduced ERK1/2 Phosphorylation.
    PloS one, 2016, Volume: 11, Issue:2

    Topics: Adiponectin; AMP-Activated Protein Kinases; Angiotensin II; Animals; Cardiomegaly; Connective Tissue Growth Factor; Disease Models, Animal; Echocardiography; Gene Expression; Gene Expression Regulation; Genetic Vectors; Lentivirus; Male; MicroRNAs; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocytes, Cardiac; Phosphorylation; Rats; Receptors, Adiponectin; Signal Transduction; Transduction, Genetic; Up-Regulation

2016
BMP type I receptor ALK2 is required for angiotensin II-induced cardiac hypertrophy.
    American journal of physiology. Heart and circulatory physiology, 2016, Apr-15, Volume: 310, Issue:8

    Topics: Activin Receptors, Type I; Activin Receptors, Type II; Angiotensin II; Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Protein 4; Bone Morphogenetic Protein Receptors, Type I; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrosis; Inhibitor of Differentiation Protein 1; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; NFATC Transcription Factors; Phenylephrine; Phosphorylation; Pyrazoles; Pyrimidines; Rats, Sprague-Dawley; RNA Interference; Signal Transduction; Smad Proteins; Time Factors; Transfection

2016
Tripartite motif 32 prevents pathological cardiac hypertrophy.
    Clinical science (London, England : 1979), 2016, 05-01, Volume: 130, Issue:10

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Differentiation; Cells, Cultured; Echocardiography; Heart Failure; Humans; Male; Mice, Knockout; Myocytes, Cardiac; Signal Transduction; Transcription Factors; Tripartite Motif Proteins; Ubiquitin-Protein Ligases

2016
Dual-specificity phosphatase 14 protects the heart from aortic banding-induced cardiac hypertrophy and dysfunction through inactivation of TAK1-P38MAPK/-JNK1/2 signaling pathway.
    Basic research in cardiology, 2016, Volume: 111, Issue:2

    Topics: Angiotensin II; Animals; Base Sequence; Cardiomegaly; Case-Control Studies; Cells, Cultured; Dual-Specificity Phosphatases; Heart Failure; HEK293 Cells; Humans; MAP Kinase Kinase Kinases; MAP Kinase Signaling System; Mice, Inbred C57BL; Mice, Transgenic; Mitogen-Activated Protein Kinase Phosphatases; Molecular Sequence Data; Myocytes, Cardiac; Rats

2016
Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.
    PloS one, 2016, Volume: 11, Issue:2

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Enlargement; Cells, Cultured; Disease Models, Animal; Genetic Therapy; Heart Failure; Humans; Isoproterenol; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Myocytes, Cardiac; Signal Transduction; TOR Serine-Threonine Kinases; Up-Regulation

2016
Long Non-Coding RNA Malat-1 Is Dispensable during Pressure Overload-Induced Cardiac Remodeling and Failure in Mice.
    PloS one, 2016, Volume: 11, Issue:2

    Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Aorta, Thoracic; Cardiomegaly; Constriction, Pathologic; Crosses, Genetic; Fetal Proteins; Gene Expression Regulation; Heart Failure; Heterozygote; Ligation; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Pressure; Proteins; RNA Splicing; RNA, Long Noncoding; Ventricular Remodeling

2016
Transient Receptor Potential Melastatin 7 Cation Channel Kinase: New Player in Angiotensin II-Induced Hypertension.
    Hypertension (Dallas, Tex. : 1979), 2016, Volume: 67, Issue:4

    Topics: Analysis of Variance; Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Disease Progression; Gene Expression Regulation; Hypertension; Male; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Random Allocation; Reactive Oxygen Species; Risk Assessment; TRPM Cation Channels; Up-Regulation; Ventricular Dysfunction, Left

2016
Effect of Atorvastatin on Expression of Peroxisome Proliferator-activated Receptor Beta/delta in Angiotensin II-induced Hypertrophic Myocardial Cells In Vitro.
    Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih, 2015, Volume: 30, Issue:4

    Topics: Angiotensin II; Animals; Atorvastatin; Cardiomegaly; Cells, Cultured; Hydroxymethylglutaryl-CoA Reductase Inhibitors; PPAR delta; PPAR-beta; Rats; Rats, Wistar

2015
Thrombospondin-4 knockout in hypertension protects small-artery endothelial function but induces aortic aneurysms.
    American journal of physiology. Heart and circulatory physiology, 2016, 06-01, Volume: 310, Issue:11

    Topics: Angiotensin II; Animals; Aorta; Aortic Aneurysm; Cardiomegaly; Collagen; Dilatation, Pathologic; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Genetic Predisposition to Disease; Hypertension; Mesenteric Arteries; Mice, Knockout; Microscopy, Electron; Phenotype; Thrombospondins; Vascular Resistance; Vasodilation; Vasodilator Agents

2016
Early administration of nifedipine protects against angiotensin II-induced cardiomyocyte hypertrophy through regulating CaMKII-SERCA2a pathway and apoptosis in rat cardiomyocytes.
    Cell biochemistry and function, 2016, Volume: 34, Issue:3

    Topics: Angiotensin II; Animals; Apoptosis; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; Myocytes, Cardiac; Nifedipine; Rats; Rats, Wistar

2016
Klotho inhibits angiotensin II-induced cardiomyocyte hypertrophy through suppression of the AT1R/beta catenin pathway.
    Biochemical and biophysical research communications, 2016, Apr-29, Volume: 473, Issue:2

    Topics: Angiotensin II; Animals; beta Catenin; Cardiomegaly; Cells, Cultured; Glucuronidase; Klotho Proteins; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Signal Transduction

2016
Cardiac-Specific EPI64C Blunts Pressure Overload-Induced Cardiac Hypertrophy.
    Hypertension (Dallas, Tex. : 1979), 2016, Volume: 67, Issue:5

    Topics: Angiotensin II; Animals; Blotting, Western; Calcineurin; Cardiac Output, High; Cardiomegaly; Disease Models, Animal; GTPase-Activating Proteins; Haplorhini; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Myocytes, Cardiac; Pressure; Random Allocation; Recovery of Function; Risk Assessment; Sensitivity and Specificity; Signal Transduction

2016
SIRT4 accelerates Ang II-induced pathological cardiac hypertrophy by inhibiting manganese superoxide dismutase activity.
    European heart journal, 2017, May-07, Volume: 38, Issue:18

    Topics: Angiotensin II; Animals; Cardiomegaly; Gene Knockdown Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitochondria, Heart; Mitochondrial Proteins; Myocytes, Cardiac; Oxidative Stress; Reactive Oxygen Species; Sirtuins; Superoxide Dismutase; Vascular Remodeling; Vasoconstrictor Agents

2017
Retinol-Binding Protein 4 Induces Cardiomyocyte Hypertrophy by Activating TLR4/MyD88 Pathway.
    Endocrinology, 2016, Volume: 157, Issue:6

    Topics: Adipocytes; Angiotensin II; Animals; Blotting, Western; Cardiomegaly; Cells, Cultured; Inflammation; Losartan; Male; Mice; Mice, Inbred C57BL; Myeloid Differentiation Factor 88; Myocytes, Cardiac; Oxidative Stress; Polymerase Chain Reaction; Reactive Oxygen Species; Retinol-Binding Proteins, Plasma; Signal Transduction; Toll-Like Receptor 4

2016
Fibulin-2 is essential for angiotensin II-induced myocardial fibrosis mediated by transforming growth factor (TGF)-β.
    Laboratory investigation; a journal of technical methods and pathology, 2016, Volume: 96, Issue:7

    Topics: Angiotensin II; Animals; Calcium-Binding Proteins; Cardiomegaly; Disease Models, Animal; Extracellular Matrix Proteins; Fibrosis; Heart Failure; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Cardiovascular; Myocardium; Signal Transduction; Transforming Growth Factor beta1; Ventricular Remodeling

2016
The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice.
    Journal of molecular and cellular cardiology, 2016, Volume: 97

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Cardiomegaly; Disease Models, Animal; Echocardiography; Hemodynamics; Hypertension; Male; Mice; Mice, Knockout; Myocardium; Myocytes, Cardiac; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; RNA, Small Interfering; Signal Transduction; Ventricular Remodeling

2016
Estrogen receptor beta signals to inhibition of cardiac fibrosis.
    Molecular and cellular endocrinology, 2016, 10-15, Volume: 434

    Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Collagen Type I; Collagen Type III; Disease Models, Animal; Estrogen Receptor beta; Fibrosis; Male; Mice; Myofibroblasts; Rats; Signal Transduction

2016
The effect of resveratrol on angiotensin II levels and the rate of transcription of its receptors in the rat cardiac hypertrophy model.
    The journal of physiological sciences : JPS, 2017, Volume: 67, Issue:2

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Disease Models, Animal; Heart; Male; Myocardium; Rats; Rats, Wistar; Resveratrol; RNA, Messenger; Stilbenes; Transcription, Genetic

2017
Suppressive Effects of Glucose-Dependent Insulinotropic Polypeptide on Cardiac Hypertrophy and Fibrosis in Angiotensin II-Infused Mouse Models.
    Circulation journal : official journal of the Japanese Circulation Society, 2016, Aug-25, Volume: 80, Issue:9

    Topics: Angiotensin II; Animals; Apolipoproteins E; Cardiomegaly; Cell Line; Fibrosis; Gastric Inhibitory Polypeptide; Gene Expression Regulation; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Knockout; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; Transforming Growth Factor beta1

2016
Partial inhibition of activin receptor-like kinase 4 attenuates pressure overload-induced cardiac fibrosis and improves cardiac function.
    Journal of hypertension, 2016, Volume: 34, Issue:9

    Topics: Activin Receptors, Type I; Angiotensin II; Animals; Aorta; Apoptosis; Blood Pressure; Cardiomegaly; Cell Differentiation; Cell Proliferation; Cells, Cultured; Collagen; Disease Models, Animal; Fibroblasts; Fibrosis; Haploinsufficiency; Heterozygote; Male; Mice; Myocardium; Myocytes, Cardiac; Signal Transduction; Smad2 Protein; Smad3 Protein; Stroke Volume; Transforming Growth Factor beta; Up-Regulation; Ventricular Dysfunction, Left

2016
NMNAT3 is involved in the protective effect of SIRT3 in Ang II-induced cardiac hypertrophy.
    Experimental cell research, 2016, 10-01, Volume: 347, Issue:2

    Topics: Acetylation; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cardiotonic Agents; Down-Regulation; Fluorescent Antibody Technique; Intracellular Space; Male; Mice, Knockout; Mitochondria; Models, Biological; Myocytes, Cardiac; Nicotinamide Phosphoribosyltransferase; Nicotinamide-Nucleotide Adenylyltransferase; Protein Binding; Rats; RNA, Messenger; Sirtuin 3

2016
Human Endomyocardial Biopsy Specimen-Derived Stromal Cells Modulate Angiotensin II-Induced Cardiac Remodeling.
    Stem cells translational medicine, 2016, Volume: 5, Issue:12

    Topics: Adult; Angiotensin II; Animals; Biopsy; Cardiomegaly; Cell Proliferation; Cell Transdifferentiation; Collagen; Female; Fibroblasts; Fibrosis; Humans; Immunomodulation; Male; Mice, Inbred C57BL; Myocardium; Myofibroblasts; Oxidative Stress; Stromal Cells; Vascular Remodeling; Ventricular Function, Left

2016
Essential Role of Smooth Muscle STIM1 in Hypertension and Cardiovascular Dysfunction.
    Arteriosclerosis, thrombosis, and vascular biology, 2016, Volume: 36, Issue:9

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cyclic GMP; Disease Models, Animal; Dose-Response Relationship, Drug; Endoplasmic Reticulum Stress; Fibrosis; Genetic Predisposition to Disease; Hypertension; Male; Mice, Knockout; Muscle, Smooth, Vascular; Myocardium; NADPH Oxidases; Nitric Oxide Synthase Type III; Nitrites; Phenotype; Phosphorylation; Reactive Oxygen Species; Signal Transduction; Stromal Interaction Molecule 1; Time Factors; Transcription Factor CHOP; Transforming Growth Factor beta; Vasodilation; Vasodilator Agents

2016
Vascular ADAM17 as a Novel Therapeutic Target in Mediating Cardiovascular Hypertrophy and Perivascular Fibrosis Induced by Angiotensin II.
    Hypertension (Dallas, Tex. : 1979), 2016, Volume: 68, Issue:4

    Topics: ADAM17 Protein; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Disease Models, Animal; ErbB Receptors; Fibrosis; Humans; Hypertension; Male; Mice; Mice, Inbred C57BL; Molecular Targeted Therapy; Myocytes, Cardiac; Random Allocation; Renin-Angiotensin System; Sensitivity and Specificity; Signal Transduction; Vascular Remodeling; Ventricular Remodeling

2016
p21(CIP1/WAF1)-dependent inhibition of cardiac hypertrophy in response to Angiotensin II involves Akt/Myc and pRb signaling.
    Peptides, 2016, Volume: 83

    Topics: Angiotensin II; Animals; Cardiomegaly; Cyclin-Dependent Kinase Inhibitor p21; Gene Expression Regulation; Heart; Heart Failure; Humans; Mice; Mice, Knockout; Oncogene Protein v-akt; Proto-Oncogene Proteins c-myc; Retinoblastoma Protein

2016
Novel Protective Role for Ubiquitin-Specific Protease 18 in Pathological Cardiac Remodeling.
    Hypertension (Dallas, Tex. : 1979), 2016, Volume: 68, Issue:5

    Topics: Analysis of Variance; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Gene Expression Regulation; Heart Failure; Mice; Mice, Knockout; Myocytes, Cardiac; Random Allocation; Role; Sensitivity and Specificity; Signal Transduction; Ubiquitin Thiolesterase; Ventricular Remodeling

2016
Human paraoxonase gene cluster overexpression alleviates angiotensin II-induced cardiac hypertrophy in mice.
    Science China. Life sciences, 2016, Volume: 59, Issue:11

    Topics: Angiotensin II; Animals; Aryldialkylphosphatase; Blood Pressure; Blotting, Western; Cardiomegaly; Echocardiography; Fibrosis; Gene Expression Regulation, Enzymologic; Heart; Humans; Male; Matrix Metalloproteinases; Mice, Inbred C57BL; Mice, Transgenic; Multigene Family; Myocardium; Reverse Transcriptase Polymerase Chain Reaction; Tissue Inhibitor of Metalloproteinases; Ventricular Remodeling

2016
Angiotensin II increases coronary fibrosis, cardiac hypertrophy and the incidence of myocardial infarctions in ApoE
    Acta cardiologica, 2016, Volume: 71, Issue:4

    Topics: Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Cardiomegaly; Disease Models, Animal; Fibrillin-1; Mice; Myocardial Infarction; Myocardium; Organ Size; Peptide Fragments; Treatment Outcome

2016
Pathological Ace2-to-Ace enzyme switch in the stressed heart is transcriptionally controlled by the endothelial Brg1-FoxM1 complex.
    Proceedings of the National Academy of Sciences of the United States of America, 2016, 09-20, Volume: 113, Issue:38

    Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cardiomegaly; Disease Models, Animal; DNA Helicases; Endothelial Cells; Forkhead Box Protein M1; Heart Failure; Humans; Mice; Multiprotein Complexes; Myocardium; Nuclear Proteins; Peptidyl-Dipeptidase A; Thiostrepton; Transcription Factors

2016
Hydrogen Sulfide Regulates Krüppel-Like Factor 5 Transcription Activity via Specificity Protein 1 S-Sulfhydration at Cys664 to Prevent Myocardial Hypertrophy.
    Journal of the American Heart Association, 2016, 09-16, Volume: 5, Issue:9

    Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cardiomegaly; Case-Control Studies; Cystathionine gamma-Lyase; Gene Expression Regulation; Humans; Hydrogen Sulfide; Kruppel-Like Transcription Factors; Male; Morpholines; Myocardium; Myocytes, Cardiac; Organothiophosphorus Compounds; Platelet-Derived Growth Factor; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; RNA, Messenger; Sp1 Transcription Factor; Transcriptional Activation

2016
LncRNA MIAT enhances cardiac hypertrophy partly through sponging miR-150.
    European review for medical and pharmacological sciences, 2016, Volume: 20, Issue:17

    Topics: Angiotensin II; Animals; Cardiomegaly; Mice; MicroRNAs; Myocardial Infarction; Myocytes, Cardiac; Rats; RNA, Long Noncoding

2016
Zofenopril exerts a cardiovascular protective effect on rats infused with angiotensin II beyond angiotensin-converting enzyme inhibition.
    The Journal of pharmacy and pharmacology, 2016, Volume: 68, Issue:11

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta, Thoracic; Blood Pressure; Captopril; Cardiomegaly; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrosis; Hydroxyproline; Hypertension; Male; Myocardium; Rats, Wistar; Superoxides; Time Factors; Vasodilation; Vasodilator Agents

2016
Preservation of myocardial fatty acid oxidation prevents diastolic dysfunction in mice subjected to angiotensin II infusion.
    Journal of molecular and cellular cardiology, 2016, Volume: 100

    Topics: Acetyl-CoA Carboxylase; Angiotensin II; Animals; Cardiomegaly; Diastole; Disease Models, Animal; Echocardiography; Energy Metabolism; Fatty Acids; Fibrosis; Gene Deletion; Magnetic Resonance Imaging; Male; Mice; Mice, Knockout; Myocardium; Organelle Biogenesis; Oxidation-Reduction; Oxidative Stress; Ventricular Dysfunction

2016
Mnk1 (Mitogen-Activated Protein Kinase-Interacting Kinase 1) Deficiency Aggravates Cardiac Remodeling in Mice.
    Hypertension (Dallas, Tex. : 1979), 2016, Volume: 68, Issue:6

    Topics: Analysis of Variance; Angiotensin II; Animals; Biomarkers; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Protein Serine-Threonine Kinases; Random Allocation; Signal Transduction; Ventricular Remodeling

2016
Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
    Scientific reports, 2016, 10-31, Volume: 6

    Topics: Angiotensin II; Animals; Antagomirs; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Heart Ventricles; Male; MEF2 Transcription Factors; Mice; Mice, Inbred C57BL; MicroRNAs; Myocardium; Myocytes, Cardiac; Myosin Heavy Chains; NF-kappa B; RNA Interference; Signal Transduction; Up-Regulation

2016
Glycine prevents pressure overload induced cardiac hypertrophy mediated by glycine receptor.
    Biochemical pharmacology, 2017, Jan-01, Volume: 123

    Topics: Angiotensin II; Animals; Cardiomegaly; Coculture Techniques; Glycine; Heart; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Rats; Rats, Sprague-Dawley; Receptors, Glycine

2017
Mouse Sirt3 promotes autophagy in AngII-induced myocardial hypertrophy through the deacetylation of FoxO1.
    Oncotarget, 2016, Dec-27, Volume: 7, Issue:52

    Topics: Acetylation; Angiotensin II; Animals; Autophagy; Cardiomegaly; Cells, Cultured; Forkhead Box Protein O1; Mice; Rats; Sirtuin 3

2016
Protease-Activated Receptor 1 Contributes to Angiotensin II-Induced Cardiovascular Remodeling and Inflammation.
    Cardiology, 2017, Volume: 136, Issue:4

    Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Cardiomegaly; Coronary Vessels; Fibrosis; Hypertension; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Receptor, PAR-1; Signal Transduction; Vascular Remodeling

2017
Renal Denervation Attenuates Multi-Organ Fibrosis and Improves Vascular Remodeling in Rats with Transverse Aortic Constriction Induced Cardiomyopathy.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2016, Volume: 40, Issue:3-4

    Topics: Alanine Transaminase; Angiotensin II; Animals; Aorta; Blood Pressure; Carbazoles; Cardiomegaly; Cardiomyopathies; Carvedilol; Constriction; Cystatin C; Denervation; Fibrosis; Heart Rate; Kidney; Malondialdehyde; Natriuretic Peptide, Brain; Organ Specificity; Oxidative Stress; Peptide Fragments; Procollagen; Propanolamines; Rats, Sprague-Dawley; Superoxide Dismutase; Transforming Growth Factor beta1; Vascular Remodeling

2016
Syringin prevents cardiac hypertrophy induced by pressure overload through the attenuation of autophagy.
    International journal of molecular medicine, 2017, Volume: 39, Issue:1

    Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Autophagy; Cardiomegaly; Cardiotonic Agents; Cell Line; Glucosides; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Phenylpropionates; Pressure; Rats; Signal Transduction

2017
Polyphenol rich ethanolic extract from Boerhavia diffusa L. mitigates angiotensin II induced cardiac hypertrophy and fibrosis in rats.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 87

    Topics: Angiotensin II; Animals; Antioxidants; Cardiomegaly; Ethanol; Fibrosis; Glutathione; Heart; Lipid Peroxidation; Male; Myocardium; Nyctaginaceae; Oxidative Stress; Plant Extracts; Plants, Medicinal; Polyphenols; Quercetin; Rats; Rats, Wistar; Reactive Oxygen Species

2017
Pirfenidone controls the feedback loop of the AT1R/p38 MAPK/renin-angiotensin system axis by regulating liver X receptor-α in myocardial infarction-induced cardiac fibrosis.
    Scientific reports, 2017, 01-16, Volume: 7

    Topics: Angiotensin II; Animals; Cardiomegaly; Collagen Type I; Collagen Type III; Feedback, Physiological; Fibrosis; Hemodynamics; Hydroxyproline; Liver X Receptors; Male; Myocardial Infarction; Myocardium; p38 Mitogen-Activated Protein Kinases; Peptidyl-Dipeptidase A; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pyridones; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction; Systole; Ventricular Dysfunction

2017
microRNA-10a Targets T-box 5 to Inhibit the Development of Cardiac Hypertrophy.
    International heart journal, 2017, Feb-07, Volume: 58, Issue:1

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Gene Knockdown Techniques; Male; MicroRNAs; Random Allocation; Rats, Wistar; T-Box Domain Proteins

2017
Let-7a Is an Antihypertrophic Regulator in the Heart via Targeting Calmodulin.
    International journal of biological sciences, 2017, Volume: 13, Issue:1

    Topics: 3' Untranslated Regions; Angiotensin II; Animals; Atrial Natriuretic Factor; Calmodulin; Cardiomegaly; Cells, Cultured; MicroRNAs; Myocytes, Cardiac; Natriuretic Peptide, Brain; Rats; Real-Time Polymerase Chain Reaction; RNA, Messenger

2017
Amplified pathogenic actions of angiotensin II in cysteine-rich LIM-only protein 4-negative mouse hearts.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2017, Volume: 31, Issue:4

    Topics: alpha-Defensins; Angiotensin II; Animals; Cardiomegaly; Carrier Proteins; Cells, Cultured; Cyclic GMP; Heart; LIM Domain Proteins; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Zebrafish

2017
Novel Protective Role of Myeloid Differentiation 1 in Pathological Cardiac Remodelling.
    Scientific reports, 2017, 02-06, Volume: 7

    Topics: Angiotensin II; Animals; Antigens, Surface; Cardiomegaly; Cells, Cultured; Humans; Male; MAP Kinase Signaling System; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocytes, Cardiac; NF-kappa B; Nitriles; Sulfones; Ventricular Remodeling

2017
Isorhamnetin protects against cardiac hypertrophy through blocking PI3K-AKT pathway.
    Molecular and cellular biochemistry, 2017, Volume: 429, Issue:1-2

    Topics: Angiotensin II; Animals; Cardiomegaly; Cardiotonic Agents; Echocardiography; Gene Expression Regulation; Male; Mice; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Quercetin; Rats; Signal Transduction

2017
Synthesis of the novel PARP-1 inhibitor AG-690/11026014 and its protective effects on angiotensin II-induced mouse cardiac remodeling.
    Acta pharmacologica Sinica, 2017, Volume: 38, Issue:5

    Topics: Angiotensin II; Animals; Cardiomegaly; Cardiotonic Agents; Fibrosis; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Poly (ADP-Ribose) Polymerase-1; Sirtuin 1; Thioglycolates; Ventricular Remodeling; Xanthines

2017
Overexpressed connective tissue growth factor in cardiomyocytes attenuates left ventricular remodeling induced by angiotensin II perfusion.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2017, Volume: 39, Issue:2

    Topics: Actins; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Collagen Type I; Connective Tissue Growth Factor; Echocardiography; Fibrosis; Heart; Heart Ventricles; Hypertension; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardium; Myocytes, Cardiac; Reverse Transcriptase Polymerase Chain Reaction; Transforming Growth Factor beta; Vasoconstrictor Agents; Ventricular Remodeling

2017
Emerin plays a crucial role in nuclear invagination and in the nuclear calcium transient.
    Scientific reports, 2017, 03-14, Volume: 7

    Topics: Active Transport, Cell Nucleus; Angiotensin II; Aniline Compounds; Animals; Atrial Remodeling; Calcium; Cardiomegaly; Cytoplasm; Disease Models, Animal; Endothelin-1; Fluorescent Dyes; Gene Expression Regulation; Heterocyclic Compounds, 3-Ring; Humans; Membrane Proteins; Muscular Dystrophy, Emery-Dreifuss; Myocardium; Myocytes, Cardiac; Nuclear Envelope; Nuclear Proteins; Phenylephrine; Primary Cell Culture; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Ventricular Remodeling; Xanthenes

2017
Differential roles of cardiomyocyte and macrophage peroxisome proliferator-activated receptor gamma in cardiac fibrosis.
    Diabetes, 2008, Volume: 57, Issue:9

    Topics: Adiponectin; Angiotensin II; Animals; Cardiomegaly; Chemotaxis; Female; Fibrosis; Hypoglycemic Agents; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Knockout; Myocardium; Myocytes, Cardiac; Pioglitazone; PPAR gamma; Thiazolidinediones; Vasoconstrictor Agents

2008
Serotonin 5-HT(2B) receptor blockade prevents reactive oxygen species-induced cardiac hypertrophy in mice.
    Hypertension (Dallas, Tex. : 1979), 2008, Volume: 52, Issue:2

    Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Echocardiography, Doppler; Indoles; Isoproterenol; Mice; Mice, Inbred Strains; NADP; Probability; Quinolines; Random Allocation; Reactive Oxygen Species; Receptor, Serotonin, 5-HT2B; Reference Values; Sensitivity and Specificity; Serotonin Antagonists; Superoxides

2008
[Changes of c-fos, c-jun mRNA expressions in cardiomyocyte hypertrophy induced by angiotensin II and effects of tanshinone II A].
    Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2008, Volume: 33, Issue:8

    Topics: Abietanes; Angiotensin II; Animals; Cardiomegaly; Gene Expression Regulation; Genes, fos; Genes, jun; Myocytes, Cardiac; Phenanthrenes; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats; Rats, Wistar; RNA, Messenger; Tetrazoles; Valine; Valsartan

2008
Cellular physiology of rat cardiac myocytes in cardiac fibrosis: in vitro simulation using the cardiac myocyte/cardiac non-myocyte co-culture system.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2008, Volume: 31, Issue:4

    Topics: Angiotensin II; Angiotensinogen; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cardiomegaly; Cell Separation; Cells, Cultured; Coculture Techniques; Diuretics, Osmotic; Endothelin-1; Fibrosis; Leucine; Mannitol; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptors, Angiotensin; Renin; Thymidine; Transforming Growth Factor beta1; Tritium

2008
[Inhibitory effect of tea polyphenols and EGCG on cultured hypertrophic myocyte induced by Ang II].
    Wei sheng yan jiu = Journal of hygiene research, 2008, Volume: 37, Issue:3

    Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Catechin; Cells, Cultured; Female; Flavonoids; Male; Myocytes, Cardiac; Phenols; Polyphenols; Rats; Rats, Wistar; Tea

2008
Cardiac metabolic compensation to hypertension requires lipoprotein lipase.
    American journal of physiology. Endocrinology and metabolism, 2008, Volume: 295, Issue:3

    Topics: Adenosine Triphosphate; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Desoxycorticosterone; Fatty Acids; Glucose; Glycogen; Hypertension; Lipid Metabolism; Lipids; Lipoprotein Lipase; Mice; Mice, Knockout; Myocardium; Oxidation-Reduction; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Triglycerides

2008
Perinatal 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure sensitizes offspring to angiotensin II-induced hypertension.
    Cardiovascular toxicology, 2008,Fall, Volume: 8, Issue:3

    Topics: Angiotensin II; Animals; Blood Pressure; Carcinogens, Environmental; Cardiomegaly; Collagen; Disease Models, Animal; Female; Fibroblasts; Fibrosis; Gestational Age; Hypertension; Kidney; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; NADPH Oxidase 2; NADPH Oxidases; Polychlorinated Dibenzodioxins; Pregnancy; Prenatal Exposure Delayed Effects; Procollagen; Renin-Angiotensin System; RNA, Messenger; Telemetry; Time Factors; Ultrasonography

2008
Cardiac hypertrophy is associated with altered thioredoxin and ASK-1 signaling in a mouse model of menopause.
    American journal of physiology. Heart and circulatory physiology, 2008, Volume: 295, Issue:4

    Topics: Angiotensin II; Animals; Apoptosis; Blood Pressure; Blotting, Western; Cardiomegaly; Collagen; Disease Models, Animal; Female; Follicle Stimulating Hormone; Hypertension; MAP Kinase Kinase Kinase 5; Menopause; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocardium; Oxidative Stress; Phosphorylation; Receptor, Angiotensin, Type 1; Signal Transduction; Superoxide Dismutase; Thioredoxins; Time Factors

2008
Phosphorylation of pRb by cyclin D kinase is necessary for development of cardiac hypertrophy.
    Cell proliferation, 2008, Volume: 41, Issue:5

    Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cell Proliferation; Cells, Cultured; Cyclin D; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclins; DNA; DNA Replication; E2F Transcription Factors; Hexanones; Myocytes, Cardiac; Phosphorylation; Protein Biosynthesis; Purines; Rats; Rats, Wistar; Retinoblastoma Protein; Roscovitine; Up-Regulation

2008
Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction.
    Cardiovascular research, 2009, Feb-15, Volume: 81, Issue:3

    Topics: Age Factors; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Fibrosis; Heart Rate; Humans; Hypertension; Infusion Pumps, Implantable; Male; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Transgenic; Mutation; Myocytes, Cardiac; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Stroke Volume; Time Factors; Ventricular Remodeling

2009
Green tea attenuates angiotensin II-induced cardiac hypertrophy in rats by modulating reactive oxygen species production and the Src/epidermal growth factor receptor/Akt signaling pathway.
    The Journal of nutrition, 2008, Volume: 138, Issue:9

    Topics: Angiotensin II; Animals; Cardiomegaly; Enzyme Activation; ErbB Receptors; Isoenzymes; Male; Mitogen-Activated Protein Kinases; NADPH Oxidases; Oncogene Protein v-akt; Protein Kinase C; Protein Subunits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; src-Family Kinases; Tea

2008
Inhibition of ADP-ribosyl cyclase attenuates angiotensin II-induced cardiac hypertrophy.
    Cardiovascular research, 2009, Feb-15, Volume: 81, Issue:3

    Topics: ADP-ribosyl Cyclase; Angiotensin II; Animals; Azo Compounds; Calcium; Calcium Signaling; Cardiomegaly; Cell Size; Cyclic ADP-Ribose; Disease Models, Animal; Enzyme Inhibitors; Hypertension, Renovascular; Male; Myocytes, Cardiac; Nephrectomy; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Renal Artery; src-Family Kinases

2009
Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy.
    Circulation research, 2008, Oct-24, Volume: 103, Issue:9

    Topics: Angiotensin II; Animals; Blood Pressure; Capillaries; Cardiomegaly; Cardiomyopathies; Cell Size; Ceramides; Coronary Vessels; Disease Models, Animal; Heart Rate; Humans; Hypertension; Lipid Metabolism; Mice; Mice, Transgenic; Mitochondria, Heart; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Myosin Heavy Chains; Neovascularization, Physiologic; Oxidation-Reduction; Promoter Regions, Genetic; Skin; Time Factors; Triglycerides; Up-Regulation; Vascular Endothelial Growth Factor B; Ventricular Function, Left; Ventricular Myosins

2008
Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function.
    Hypertension (Dallas, Tex. : 1979), 2008, Volume: 52, Issue:5

    Topics: Acetylcholine; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Animals, Genetically Modified; Blood Pressure; Cardiomegaly; Disease Models, Animal; Endothelium, Vascular; Gene Expression Regulation, Enzymologic; Humans; Hypertension; Muscle, Smooth, Vascular; Nitroprusside; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Vasodilator Agents

2008
Insights into mechanisms linking cardiac hypertrophy and atrial fibrosis: evidence for a role of histone deacetylase in atrial fibrillation pathophysiology and therapy.
    Journal of molecular and cellular cardiology, 2008, Volume: 45, Issue:6

    Topics: Angiotensin II; Animals; Atrial Fibrillation; Cardiomegaly; Connexins; Enzyme Inhibitors; Fibrosis; Gap Junction alpha-5 Protein; Histone Deacetylase Inhibitors; Histone Deacetylases; Homeodomain Proteins; Hydroxamic Acids; Mice; Mice, Transgenic; Time Factors

2008
Changes in hemodynamic and neurohumoral control cause cardiac damage in one-kidney, one-clip hypertensive mice.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2008, Volume: 295, Issue:6

    Topics: Adrenergic beta-Antagonists; Angiotensin II; Animals; Baroreflex; Blood Pressure; Cardiomegaly; Constriction; Disease Models, Animal; Fibrosis; Heart Rate; Hemodynamics; Hypertension, Renovascular; Kidney Cortex; Male; Mice; Muscarinic Antagonists; Renal Artery; Renin; Renin-Angiotensin System; Sympathetic Nervous System; Time Factors; Vagus Nerve

2008
Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart.
    Circulation research, 2008, Nov-21, Volume: 103, Issue:11

    Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Crosses, Genetic; Heart; Hypertension; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Ventricular Remodeling

2008
Changes of c-fos and c-jun mRNA expression in angiotensin II-induced cardiomyocyte hypertrophy and effects of sodium tanshinone IIA sulfonate.
    Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2008, Volume: 28, Issue:5

    Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Drugs, Chinese Herbal; Myocytes, Cardiac; Phenanthrenes; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats; Rats, Wistar; RNA, Messenger

2008
Histone-deacetylase inhibition reverses atrial arrhythmia inducibility and fibrosis in cardiac hypertrophy independent of angiotensin.
    Journal of molecular and cellular cardiology, 2008, Volume: 45, Issue:6

    Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Cardiomegaly; Connexins; Enzyme Inhibitors; Fibrosis; Gap Junction alpha-5 Protein; Histone Deacetylase Inhibitors; Histone Deacetylases; Homeodomain Proteins; Hydroxamic Acids; Mice; Mice, Transgenic; Time Factors

2008
Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.
    Clinical and experimental pharmacology & physiology, 2009, Volume: 36, Issue:3

    Topics: Angiotensin II; Animals; Animals, Newborn; Bromocriptine; Calcium Signaling; Cardiomegaly; Cells, Cultured; Dopamine Agonists; Dopamine Antagonists; Endothelin-1; Haloperidol; Heart Ventricles; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Phosphorylation; Protein Kinase C; Rats; Rats, Wistar; Receptors, Dopamine D2

2009
Candesartan ameliorates cardiac dysfunction observed in angiotensin-converting enzyme 2-deficient mice.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2008, Volume: 31, Issue:10

    Topics: Age Factors; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Benzimidazoles; Biphenyl Compounds; Cardiomegaly; Disease Models, Animal; Echocardiography; Female; Hypertension; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Myocardium; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Tetrazoles

2008
The angiotensin converting enzyme 2/Ang-(1-7) axis in the heart: a role for MAS communication?
    Circulation research, 2008, Nov-21, Volume: 103, Issue:11

    Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cardiomegaly; Female; Heart; Humans; Hypertension; Male; Mice; Mice, Knockout; Models, Animal; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System

2008
Lysosomal cysteine peptidase cathepsin L protects against cardiac hypertrophy through blocking AKT/GSK3beta signaling.
    Journal of molecular medicine (Berlin, Germany), 2009, Volume: 87, Issue:3

    Topics: Angiotensin II; Animals; Animals, Newborn; Apoptosis; Atrial Natriuretic Factor; Blotting, Western; Cardiomegaly; Caspases; Cathepsin L; Cathepsins; Cells, Cultured; Cysteine Endopeptidases; Echocardiography; Female; Gene Expression; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardium; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction

2009
EGCG inhibits proliferation of cardiac fibroblasts in rats with cardiac hypertrophy.
    Planta medica, 2009, Volume: 75, Issue:2

    Topics: Angiotensin II; Animals; Antioxidants; Atrial Natriuretic Factor; Camellia sinensis; Cardiomegaly; Catechin; Cell Proliferation; Disease Models, Animal; DNA-Binding Proteins; Dose-Response Relationship, Drug; Endothelins; Enzyme Inhibitors; Fibroblasts; Fibrosis; Hydroxyproline; Male; Myocardium; Nitric Oxide Synthase Type II; Nitrites; Organ Size; Plant Extracts; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Transcription Factors

2009
Serotonin 5-HT2B receptor in cardiac fibroblast contributes to cardiac hypertrophy: a new therapeutic target for heart failure?
    Circulation research, 2009, Jan-02, Volume: 104, Issue:1

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cardiomegaly; Cytokines; Drug Delivery Systems; ErbB Receptors; Fibroblasts; Heart Failure; Heparin-binding EGF-like Growth Factor; Humans; Intercellular Signaling Peptides and Proteins; Isoproterenol; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Mice, Transgenic; Myocardium; Rats; Receptor, Angiotensin, Type 1; Receptor, Serotonin, 5-HT2B; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Signal Transduction

2009
The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice.
    Circulation research, 2009, Feb-27, Volume: 104, Issue:4

    Topics: Angiotensin II; Animals; Animals, Newborn; Aorta; Blood Pressure; Calcineurin; Calcium Channel Blockers; Calcium Channels, T-Type; Calcium Signaling; Cardiomegaly; Cells, Cultured; Constriction; Disease Models, Animal; Ethosuximide; Genes, Reporter; Hypertension; Male; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; NFATC Transcription Factors; Time Factors

2009
Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy.
    Proceedings of the National Academy of Sciences of the United States of America, 2009, Jan-13, Volume: 106, Issue:2

    Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Epoxide Hydrolases; Mice; Mice, Knockout; Myocardium; Myocytes, Cardiac; Rats; Up-Regulation

2009
Chronic NHE-1 blockade induces an antiapoptotic effect in the hypertrophied heart.
    Journal of applied physiology (Bethesda, Md. : 1985), 2009, Volume: 106, Issue:4

    Topics: Angiotensin II; Animals; Anti-Arrhythmia Agents; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Cardiomegaly; Cell Nucleus; Guanidines; In Situ Nick-End Labeling; Male; Mitochondria, Heart; Myocardium; Myocytes, Cardiac; Rats; Rats, Inbred SHR; Sodium-Hydrogen Exchanger 1; Sodium-Hydrogen Exchangers; Sulfones; Superoxides

2009
Calcium, calpains, and cardiac hypertrophy: a new link.
    Circulation research, 2009, Jan-30, Volume: 104, Issue:2

    Topics: Angiotensin II; Animals; Calcium; Calpain; Cardiomegaly; Humans; Inositol 1,4,5-Trisphosphate Receptors; Myocardium; NF-kappa B; Signal Transduction

2009
Targeted expression of receptor-associated late transducer inhibits maladaptive hypertrophy via blocking epidermal growth factor receptor signaling.
    Hypertension (Dallas, Tex. : 1979), 2009, Volume: 53, Issue:3

    Topics: Adenoviridae; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Collagen; Disease Models, Animal; Echocardiography; ErbB Receptors; Fibrosis; Intracellular Signaling Peptides and Proteins; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardium; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Signal Transduction

2009
Air pollution and cardiac remodeling: a role for RhoA/Rho-kinase.
    American journal of physiology. Heart and circulatory physiology, 2009, Volume: 296, Issue:5

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angiotensin II; Animals; Atmosphere Exposure Chambers; Blood Pressure; Cardiomegaly; Collagen; Disease Models, Animal; Guanine Nucleotide Exchange Factors; Hypertension; Infusion Pumps; Inhalation Exposure; Injections, Intraperitoneal; Male; Matrix Metalloproteinases, Secreted; Mice; Mice, Inbred C57BL; Myocardium; Particulate Matter; Protein Kinase Inhibitors; rho GTP-Binding Proteins; Rho Guanine Nucleotide Exchange Factors; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Vasoconstriction; Vasodilation; Ventricular Remodeling

2009
Erythropoietin attenuates hypertrophy of neonatal rat cardiac myocytes induced by angiotensin-II in vitro.
    Scandinavian journal of clinical and laboratory investigation, 2009, Volume: 69, Issue:4

    Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Base Sequence; Blotting, Western; Cardiomegaly; Cells, Cultured; DNA Primers; Erythropoietin; Heart; In Vitro Techniques; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinases; Polymerase Chain Reaction; Proto-Oncogene Proteins c-akt; Rats; RNA, Messenger

2009
Effect of sodium houttuyfonate on myocardial hypertrophy in mice and rats.
    The Journal of pharmacy and pharmacology, 2009, Volume: 61, Issue:5

    Topics: Alkanes; Angiotensin II; Animals; Captopril; Cardiomegaly; Cyclic AMP; Dose-Response Relationship, Drug; Endothelin-1; Hydroxyproline; Isoproterenol; Male; Mice; Myocardium; Myocytes, Cardiac; Organ Size; Rats; Rats, Sprague-Dawley; Sulfites; Thyroxine

2009
Regulatory T cells ameliorate angiotensin II-induced cardiac damage.
    Circulation, 2009, Jun-09, Volume: 119, Issue:22

    Topics: Adoptive Transfer; Angiotensin II; Animals; Cardiomegaly; Fibrosis; Heart Diseases; Immunosuppression Therapy; Male; Mice; Mice, Inbred Strains; T-Lymphocytes, Regulatory; Treatment Outcome

2009
Angiotensin II-mediated adaptive and maladaptive remodeling of cardiomyocyte excitation-contraction coupling.
    Circulation research, 2009, Jul-02, Volume: 105, Issue:1

    Topics: Angiotensin II; Angiotensinogen; Animals; Calcium; Cardiomegaly; Electrophysiologic Techniques, Cardiac; Mice; Mice, Transgenic; Myocardial Contraction; Myocytes, Cardiac; Sodium-Calcium Exchanger

2009
Liver X receptors are negative regulators of cardiac hypertrophy via suppressing NF-kappaB signalling.
    Cardiovascular research, 2009, Oct-01, Volume: 84, Issue:1

    Topics: Adenoviridae; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; DNA-Binding Proteins; Hydrocarbons, Fluorinated; Inflammation; Lipopolysaccharides; Liver X Receptors; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Orphan Nuclear Receptors; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Sulfonamides; Toll-Like Receptor 4

2009
Attenuation of angiotensin II-induced vascular dysfunction and hypertension by overexpression of Thioredoxin 2.
    Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:2

    Topics: Analysis of Variance; Angiotensin II; Animals; Animals, Newborn; Blood Pressure Determination; Cardiomegaly; Disease Models, Animal; Endothelium, Vascular; Hypertension; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Oxygen Consumption; Random Allocation; Reactive Oxygen Species; Reference Values; Risk Factors; Thioredoxins; Vascular Resistance; Vasoconstriction; Vasodilation

2009
Simvastatin inhibits angiotensin II-induced cardiac cell hypertrophy: role of Homer 1a.
    Clinical and experimental pharmacology & physiology, 2010, Volume: 37, Issue:1

    Topics: Angiotensin II; Animals; Animals, Newborn; Anticholesteremic Agents; Cardiomegaly; Carrier Proteins; Cell Line; Drug Interactions; Drug Therapy, Combination; Extracellular Signal-Regulated MAP Kinases; Homer Scaffolding Proteins; Myocytes, Cardiac; Phosphorylation; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Simvastatin; Transfection; Up-Regulation

2010
Effect of human umbilical cord blood cells on Ang-II-induced hypertrophy in mice.
    Biochemical and biophysical research communications, 2009, Aug-21, Volume: 386, Issue:2

    Topics: Angiotensin II; Animals; Apoptosis; Biomarkers; Cardiomegaly; Cell Differentiation; Coculture Techniques; Fetal Blood; Histocompatibility Antigens Class I; Humans; Mice; Myocytes, Cardiac; Rats; Stem Cell Transplantation; Stem Cells

2009
Inhibition of bilirubin metabolism induces moderate hyperbilirubinemia and attenuates ANG II-dependent hypertension in mice.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2009, Volume: 297, Issue:3

    Topics: Angiotensin II; Animals; Bilirubin; Blood Pressure; Cardiomegaly; Disease Models, Animal; Glucuronosyltransferase; Hyperbilirubinemia; Hypertension; Indinavir; Male; Mice; Mice, Inbred C57BL; Nitrates; Nitrites; Organic Cation Transport Proteins; Oxidative Stress

2009
Tumor necrosis factor-alpha--converting enzyme roles in hypertension-induced hypertrophy: look both ways when crossing the street.
    Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:3

    Topics: ADAM Proteins; ADAM12 Protein; ADAM17 Protein; Angiotensin II; Animals; Cardiomegaly; Fibrosis; Matrix Metalloproteinase 2; Mice; Models, Biological; Myocardium; Rats; RNA Interference; Signal Transduction

2009
Tumor necrosis factor-alpha-converting enzyme is a key regulator of agonist-induced cardiac hypertrophy and fibrosis.
    Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:3

    Topics: ADAM Proteins; ADAM12 Protein; ADAM17 Protein; Angiotensin II; Animals; Blood Pressure; Blotting, Western; Cardiomegaly; Echocardiography; Fibrosis; Male; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; Myocardium; Rats; Rats, Inbred SHR; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Signal Transduction

2009
Impairment of the angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas axis contributes to the acceleration of two-kidney, one-clip Goldblatt hypertension.
    Journal of hypertension, 2009, Volume: 27, Issue:10

    Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Disease Models, Animal; Disease Progression; Hypertension, Renovascular; Infusion Pumps, Implantable; Peptide Fragments; Rats; Rats, Transgenic; Surgical Instruments; Telemetry; Vasodilator Agents

2009
Aliskiren enhances the protective effects of valsartan against cardiovascular and renal injury in endothelial nitric oxide synthase-deficient mice.
    Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:3

    Topics: Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Cardiomegaly; Cardiovascular Diseases; Cardiovascular System; Drug Synergism; Drug Therapy, Combination; Fumarates; Gene Expression; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidases; Nitric Oxide Synthase Type III; Receptor, Angiotensin, Type 1; Renin; RNA, Messenger; Superoxides; Tetrazoles; Tunica Intima; Valine; Valsartan

2009
NF-kappaB activation is required for adaptive cardiac hypertrophy.
    Cardiovascular research, 2009, Dec-01, Volume: 84, Issue:3

    Topics: Angiotensin II; Animals; Apoptosis; Cardiomegaly; Disease Models, Animal; Female; Fibrosis; I-kappa B Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Myocardium; Myocytes, Cardiac; Myosin Heavy Chains; NF-kappa B; NF-KappaB Inhibitor alpha; Receptor, Angiotensin, Type 1; Sex Characteristics; Signal Transduction; Ventricular Remodeling

2009
Three-dimensional alignment of the aggregated myocytes in the normal and hypertrophic murine heart.
    Journal of applied physiology (Bethesda, Md. : 1985), 2009, Volume: 107, Issue:3

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Aggregation; Diffusion Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Ultrasonography; Vasoconstrictor Agents

2009
Connective tissue growth factor overexpression in cardiomyocytes promotes cardiac hypertrophy and protection against pressure overload.
    PloS one, 2009, Aug-25, Volume: 4, Issue:8

    Topics: Angiotensin II; Animals; Base Sequence; Calcium; Cardiomegaly; Connective Tissue Growth Factor; DNA Primers; Enzyme Activation; Humans; Isoproterenol; MAP Kinase Kinase 4; Mice; Mice, Transgenic; Myocardial Ischemia; Myocardium; Polymerase Chain Reaction; Pressure; Proto-Oncogene Proteins c-akt; Rats

2009
Inhibition of farnesylpyrophosphate synthase prevents angiotensin II-induced hypertrophic responses in rat neonatal cardiomyocytes: involvement of the RhoA/Rho kinase pathway.
    FEBS letters, 2009, Sep-17, Volume: 583, Issue:18

    Topics: Alendronate; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Dimethylallyltranstransferase; Hypertrophy; Myocytes, Cardiac; Prenylation; Rats; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction

2009
Interaction between renin-angiotensin and sympathetic nervous systems in a rat model of pressure overload cardiac hypertrophy.
    Autonomic & autacoid pharmacology, 2009, Volume: 29, Issue:4

    Topics: Angiotensin II; Animals; Aortic Valve Stenosis; Blood Pressure; Cardiomegaly; Electrocardiography; Male; Methoxamine; Norepinephrine; Phenylephrine; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Sympathetic Nervous System

2009
Attenuation of angiotensin II-induced hypertension and cardiac hypertrophy in transgenic mice overexpressing a type 1 receptor mutant.
    American journal of hypertension, 2009, Volume: 22, Issue:12

    Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Cardiomegaly; Cells, Cultured; Endothelium, Vascular; Enzyme Activation; Hypertension; Mice; Mice, Transgenic; Protein Kinases; Proto-Oncogene Proteins c-akt; Receptor, Angiotensin, Type 1; rhoA GTP-Binding Protein

2009
Globular adiponectin inhibits angiotensin II-induced nuclear factor kappaB activation through AMP-activated protein kinase in cardiac hypertrophy.
    Journal of cellular physiology, 2010, Volume: 222, Issue:1

    Topics: Adiponectin; AMP-Activated Protein Kinases; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Enzyme Activation; Heart Ventricles; Humans; I-kappa B Proteins; Myocytes, Cardiac; NF-kappa B; Phosphorylation; Rats

2010
Long-term blockade of L/N-type Ca(2+) channels by cilnidipine ameliorates repolarization abnormality of the canine hypertrophied heart.
    British journal of pharmacology, 2009, Volume: 158, Issue:5

    Topics: Action Potentials; Amlodipine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Atrioventricular Block; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Cardiomegaly; Chronic Disease; Dihydropyridines; Dogs; Electrocardiography; Epinephrine; Female; Male; Neurotransmitter Agents; Norepinephrine; Tetrazoles; Time Factors

2009
3,3',4',5,7-Pentamethylquercetin reduces angiotensin II-induced cardiac hypertrophy and apoptosis in rats.
    Canadian journal of physiology and pharmacology, 2009, Volume: 87, Issue:9

    Topics: Angiotensin II; Animals; Apoptosis; Cardiomegaly; Cardiotonic Agents; Down-Regulation; Gene Expression; Male; Molecular Structure; NADPH Oxidases; Quercetin; Rats; Rats, Sprague-Dawley

2009
Role of Ca2+/calmodulin-stimulated cyclic nucleotide phosphodiesterase 1 in mediating cardiomyocyte hypertrophy.
    Circulation research, 2009, Nov-06, Volume: 105, Issue:10

    Topics: Angiotensin II; Animals; Calcium; Calcium Signaling; Calmodulin; Cardiomegaly; Cardiotonic Agents; Cells, Cultured; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 1; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Heart Ventricles; Humans; Isoproterenol; Male; Mice; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Second Messenger Systems

2009
Blood pressure and renal blow flow responses in heme oxygenase-2 knockout mice.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2009, Volume: 297, Issue:6

    Topics: Administration, Oral; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Disease Models, Animal; Female; Heme Oxygenase (Decyclizing); Hypertension; Infusion Pumps, Implantable; Infusions, Subcutaneous; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Renal Circulation; Vascular Resistance; Vasoconstriction

2009
Protection of angiotensin II-induced vascular hypertrophy in vascular smooth muscle-targeted receptor activity-modifying protein 2 transgenic mice.
    Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:6

    Topics: Adrenomedullin; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Female; Hypertension; Hypertrophy; Hypotension; Intracellular Signaling Peptides and Proteins; Lipopolysaccharides; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Muscle, Smooth, Vascular; Receptor Activity-Modifying Proteins; Receptors, Adrenomedullin; Receptors, Peptide; Vasculitis

2009
Controlling myocyte cGMP: phosphodiesterase 1 joins the fray.
    Circulation research, 2009, Nov-06, Volume: 105, Issue:10

    Topics: Angiotensin II; Animals; Calcium; Calcium Signaling; Calmodulin; Cardiomegaly; Cardiotonic Agents; Cells, Cultured; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 1; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Heart Ventricles; Humans; Isoproterenol; Male; Mice; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Second Messenger Systems

2009
Lack of glutathione peroxidase 1 accelerates cardiac-specific hypertrophy and dysfunction in angiotensin II hypertension.
    Hypertension (Dallas, Tex. : 1979), 2010, Volume: 55, Issue:1

    Topics: Angiotensin II; Animals; Aorta, Thoracic; Blood Pressure; Blotting, Western; Body Weight; Cardiomegaly; Echocardiography; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Heart; Hypertension; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Ventricular Dysfunction, Left

2010
Evidence for the importance of adiponectin in the cardioprotective effects of pioglitazone.
    Hypertension (Dallas, Tex. : 1979), 2010, Volume: 55, Issue:1

    Topics: Adiponectin; AMP-Activated Protein Kinases; Angiotensin II; Animals; Blotting, Western; Cardiomegaly; Cardiotonic Agents; Collagen Type I; Collagen Type II; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Phosphorylation; Pioglitazone; Reverse Transcriptase Polymerase Chain Reaction; Thiazolidinediones

2010
Angiotensin-(1-7) prevents cardiomyocyte pathological remodeling through a nitric oxide/guanosine 3',5'-cyclic monophosphate-dependent pathway.
    Hypertension (Dallas, Tex. : 1979), 2010, Volume: 55, Issue:1

    Topics: Angiotensin I; Angiotensin II; Animals; Animals, Newborn; Blood Pressure; Calcium; Cardiomegaly; Cell Size; Cells, Cultured; Cyclic GMP; Hypertension; Microscopy, Confocal; Myocytes, Cardiac; NFATC Transcription Factors; Nitric Oxide; Peptide Fragments; Protein Transport; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Signal Transduction

2010
The inhibitory effects of rosiglitazone on cardiac hypertrophy through modulating the renin-angiotensin system in diet-induced hypercholesterolemic rats.
    Cell biochemistry and function, 2010, Volume: 28, Issue:1

    Topics: Angiotensin II; Animals; Biphenyl Compounds; Cardiomegaly; Cholesterol, Dietary; Hypercholesterolemia; Irbesartan; Male; Myocardium; PPAR gamma; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Rosiglitazone; Tetrazoles; Thiazolidinediones

2010
Sympathetic nervous system modulation of inflammation and remodeling in the hypertensive heart.
    Hypertension (Dallas, Tex. : 1979), 2010, Volume: 55, Issue:2

    Topics: Analysis of Variance; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Hypertension; Inflammation Mediators; Male; Myocytes, Cardiac; Probability; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Substance P; Sympathectomy; Sympathetic Nervous System; Ventricular Remodeling

2010
Metabolomics in angiotensin II-induced cardiac hypertrophy.
    Hypertension (Dallas, Tex. : 1979), 2010, Volume: 55, Issue:2

    Topics: Angiotensin II; Animals; Animals, Genetically Modified; Biomarkers; Cardiomegaly; Disease Models, Animal; Fatty Acids; Female; Humans; Hypoxanthine; Linoleic Acids; Male; Metabolomics; Mitochondria, Heart; Oxidative Stress; Probability; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Values; Sirtuin 1; Survival Rate; Tetrazoles; Valine; Valsartan

2010
Modulation of angiotensin II-mediated cardiac remodeling by the MEF2A target gene Xirp2.
    Circulation research, 2010, Mar-19, Volume: 106, Issue:5

    Topics: Angiotensin II; Animals; Apoptosis; Binding Sites; Cardiomegaly; Cytoskeletal Proteins; Disease Models, Animal; DNA-Binding Proteins; Fibrosis; Gene Expression Regulation; Infusion Pumps, Implantable; Infusions, Subcutaneous; LIM Domain Proteins; MEF2 Transcription Factors; Mice; Mice, Transgenic; Myocardium; Myogenic Regulatory Factors; Myosin Heavy Chains; Nuclear Proteins; Promoter Regions, Genetic; Signal Transduction; Transcriptional Activation; Ventricular Myosins; Ventricular Remodeling

2010
Caveolin-1 ablation reduces the adverse cardiovascular effects of N-omega-nitro-L-arginine methyl ester and angiotensin II.
    Endocrinology, 2010, Volume: 151, Issue:3

    Topics: Aldosterone; Amino Acid Sequence; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Caveolin 1; Endothelial Cells; Male; Mice; Mice, Knockout; Molecular Sequence Data; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Receptor, Angiotensin, Type 1; Receptors, Mineralocorticoid; Signal Transduction

2010
Lymphocyte responses exacerbate angiotensin II-dependent hypertension.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2010, Volume: 298, Issue:4

    Topics: Angiotensin II; Animals; Body Weight; Cardiomegaly; Crosses, Genetic; Disease Progression; Heart; Hemodynamics; Hypertension; Kidney; Lymphocytes; Mice; Mice, Inbred C3H; Mice, SCID; Organ Size; RNA, Messenger

2010
Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury.
    Hypertension (Dallas, Tex. : 1979), 2010, Volume: 55, Issue:4

    Topics: Analysis of Variance; Angiotensin II; Animals; Antioxidants; Atrial Fibrillation; Blood Pressure; Blotting, Western; Cardiomegaly; Cyclic N-Oxides; Echocardiography; Fibrosis; Heart Atria; Heart Rate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mice; Mice, Knockout; Myocytes, Cardiac; Nitric Oxide Synthase Type III; Oxidative Stress; Quinolines; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Smad2 Protein; Smad3 Protein; Spin Labels; Transforming Growth Factor beta1

2010
Cardiac-specific activation of angiotensin II type 1 receptor-associated protein completely suppresses cardiac hypertrophy in chronic angiotensin II-infused mice.
    Hypertension (Dallas, Tex. : 1979), 2010, Volume: 55, Issue:5

    Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Body Weight; Cardiomegaly; Genotype; Heart Rate; Imidazoles; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mitogen-Activated Protein Kinase Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA; Tetrazoles

2010
Growth differentiation factor 15 acts anti-apoptotic and pro-hypertrophic in adult cardiomyocytes.
    Journal of cellular physiology, 2010, Volume: 224, Issue:1

    Topics: Age Factors; Angiotensin II; Animals; Apoptosis; Cardiomegaly; Cells, Cultured; Extracellular Signal-Regulated MAP Kinases; Growth Differentiation Factor 15; Male; Myocytes, Cardiac; Nitric Oxide Donors; Oligonucleotides; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Kinase Inhibitors; Rats; Rats, Wistar; Signal Transduction; Smad1 Protein; Time Factors; Transforming Growth Factor beta1; Ventricular Remodeling

2010
Inhibition of angiotensin-converting enzyme 2 exacerbates cardiac hypertrophy and fibrosis in Ren-2 hypertensive rats.
    American journal of hypertension, 2010, Volume: 23, Issue:6

    Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Fibrosis; Heart Ventricles; Imidazoles; Leucine; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Transgenic

2010
Effect of intermedin1-53 on angiotensin II-induced hypertrophy in neonatal rat ventricular myocytes.
    Journal of cardiovascular pharmacology, 2010, Volume: 56, Issue:1

    Topics: Adrenomedullin; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Heart Ventricles; Myocytes, Cardiac; Natriuretic Peptide, Brain; Neuropeptides; Rats; Rats, Wistar; RNA, Messenger

2010
Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2.
    Basic research in cardiology, 2010, Volume: 105, Issue:5

    Topics: Adrenergic beta-Agonists; Angiotensin II; Animals; Atrial Natriuretic Factor; Calcium; Cardiomegaly; Cell Line; Cyclic GMP-Dependent Protein Kinases; Humans; Isoproterenol; Kidney; Membrane Potentials; Mice; Mice, Knockout; Myocytes, Cardiac; Patch-Clamp Techniques; Receptors, Atrial Natriuretic Factor; RGS Proteins; TRPC Cation Channels; TRPC6 Cation Channel; Vasoconstrictor Agents

2010
[Inhibitory effect on activated renin-angiotensin system by astragaloside IV in rats with pressure-overload induced cardiac hypertrophy].
    Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2009, Volume: 34, Issue:24

    Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Enzyme-Linked Immunosorbent Assay; Hypertrophy, Left Ventricular; Male; Peptidyl-Dipeptidase A; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Saponins; Triterpenes

2009
Angiotensin-(1-9) regulates cardiac hypertrophy in vivo and in vitro.
    Journal of hypertension, 2010, Volume: 28, Issue:5

    Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Bradykinin; Cardiomegaly; Cell Enlargement; Cells, Cultured; Enalapril; Humans; Hypertrophy, Left Ventricular; In Vitro Techniques; Insulin-Like Growth Factor I; Male; Myocardial Infarction; Myocytes, Cardiac; Norepinephrine; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tetrazoles; Ventricular Function, Left

2010
Resveratrol induces mitochondrial biogenesis and ameliorates Ang II-induced cardiac remodeling in transgenic rats harboring human renin and angiotensinogen genes.
    Blood pressure, 2010, Volume: 19, Issue:3

    Topics: Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Cardiomegaly; Genes; Heart; Humans; Hypertension; Male; Mitochondria; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Renin; Renin-Angiotensin System; Resveratrol; Stilbenes

2010
Antihypertensive effects of Ocimum basilicum L. (OBL) on blood pressure in renovascular hypertensive rats.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2010, Volume: 33, Issue:7

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Aspartic Acid Endopeptidases; Blood Pressure; Captopril; Cardiomegaly; Disease Models, Animal; Endothelin-1; Endothelin-Converting Enzymes; Hypertension, Renovascular; Kidney; Male; Metalloendopeptidases; Ocimum basilicum; Plant Extracts; Rats; Rats, Wistar

2010
Increased dietary NaCl potentiates the effects of elevated prorenin levels on blood pressure and organ disease.
    Journal of hypertension, 2010, Volume: 28, Issue:7

    Topics: Angiotensin II; Angiotensins; Animals; Blood Pressure; Cardiomegaly; Chymosin; Enzyme Precursors; Fibrosis; Hypertension; Kidney Diseases; Male; Random Allocation; Rats; Rats, Transgenic; Renin; Retrospective Studies; Sodium Chloride, Dietary

2010
Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy.
    Journal of molecular and cellular cardiology, 2010, Volume: 49, Issue:3

    Topics: Angiotensin II; Animals; Cardiomegaly; Chemokine CCL2; Collagen; Fibroblasts; Fibrosis; Hypertension; Lung Diseases, Interstitial; Mice; Mice, Inbred C57BL; Mice, Knockout; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vasoconstrictor Agents

2010
Celecoxib, but not rofecoxib or naproxen, attenuates cardiac hypertrophy and fibrosis induced in vitro by angiotensin and aldosterone.
    Clinical and experimental pharmacology & physiology, 2010, Volume: 37, Issue:9

    Topics: Aldosterone; Angiotensin II; Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Cardiomegaly; Celecoxib; Collagen; Cyclooxygenase 2 Inhibitors; Female; Fibroblasts; Fibrosis; Heart; Hep G2 Cells; Hepatocytes; Humans; Lactones; Male; Myocardium; Myocytes, Cardiac; Naproxen; Pyrazoles; Rats; Renin-Angiotensin System; Sulfonamides; Sulfones; Vasoconstrictor Agents

2010
A distinct AMP-activated protein kinase phosphorylation site characterizes cardiac hypertrophy induced by L-thyroxine and angiotensin II.
    Clinical and experimental pharmacology & physiology, 2010, Volume: 37, Issue:9

    Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Phosphorylation; Polymerase Chain Reaction; RNA; Thyroxine; Vasoconstrictor Agents

2010
Cross-talk between MAPKs and PI-3K pathways alters the functional density of I(K) channels in hypertrophied hearts.
    Ethnicity & disease, 2010,Winter, Volume: 20, Issue:1 Suppl 1

    Topics: Angiotensin II; Animals; Cardiomegaly; Homeostasis; Insulin-Like Growth Factor I; Male; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Patch-Clamp Techniques; Phosphatidylinositol 3-Kinases; Potassium Channels; Rats; Rats, Sprague-Dawley; Receptor Cross-Talk; Signal Transduction

2010
Trimetazidine inhibits pressure overload-induced cardiac fibrosis through NADPH oxidase-ROS-CTGF pathway.
    Cardiovascular research, 2010, Oct-01, Volume: 88, Issue:1

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cell Proliferation; Cells, Cultured; Collagen; Connective Tissue Growth Factor; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Fibroblasts; Fibrosis; Hypertension; Male; Malondialdehyde; Myocardium; NADPH Oxidases; rac1 GTP-Binding Protein; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Time Factors; Trimetazidine; Vasodilator Agents

2010
Intracellular or extracellular heat shock protein 70 differentially regulates cardiac remodelling in pressure overload mice.
    Cardiovascular research, 2010, Oct-01, Volume: 88, Issue:1

    Topics: Angiotensin II; Animals; Antibodies; Benzhydryl Compounds; Blood Pressure; Cardiomegaly; Chemokine CCL2; Disease Models, Animal; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Fibrosis; HSP70 Heat-Shock Proteins; Hypertension; Male; Mice; Mice, Inbred ICR; Myocardium; p38 Mitogen-Activated Protein Kinases; Protein Transport; Pyrrolidinones; Signal Transduction; Time Factors; Toll-Like Receptor 4; Transcription, Genetic; Transforming Growth Factor beta1; Ventricular Remodeling

2010
Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR-dependent signaling.
    Journal of cellular biochemistry, 2010, Aug-01, Volume: 110, Issue:5

    Topics: Angiotensin II; Animals; Animals, Newborn; Blotting, Western; Cardiomegaly; Cell Shape; Cells, Cultured; Dose-Response Relationship, Drug; ErbB Receptors; Fibrosis; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Male; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Silybin; Silymarin

2010
Mechanical stress-evoked but angiotensin II-independent activation of angiotensin II type 1 receptor induces cardiac hypertrophy through calcineurin pathway.
    Biochemical and biophysical research communications, 2010, Jun-25, Volume: 397, Issue:2

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Calcineurin; Calcineurin Inhibitors; Cardiomegaly; Chlorocebus aethiops; COS Cells; Losartan; Mice; Mice, Mutant Strains; Receptor, Angiotensin, Type 1; Stress, Mechanical; Tacrolimus

2010
The IP3 receptor regulates cardiac hypertrophy in response to select stimuli.
    Circulation research, 2010, Sep-03, Volume: 107, Issue:5

    Topics: Age Factors; Angiotensin II; Animals; Arrhythmias, Cardiac; Calcineurin; Calcium Signaling; Cardiomegaly; Disease Models, Animal; Endothelin-1; GTP-Binding Protein alpha Subunits, Gq-G11; Inositol 1,4,5-Trisphosphate; Inositol 1,4,5-Trisphosphate Receptors; Isoproterenol; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Myocytes, Cardiac; Phenotype; Physical Exertion

2010
Apocynin attenuates pressure overload-induced cardiac hypertrophy in rats by reducing levels of reactive oxygen species.
    Canadian journal of physiology and pharmacology, 2010, Volume: 88, Issue:7

    Topics: Acetophenones; Angiotensin II; Animals; Antioxidants; Atrial Natriuretic Factor; Base Sequence; Captopril; Cardiomegaly; DNA Primers; Enzyme Inhibitors; Male; NADPH Oxidases; Phosphoproteins; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; RNA, Messenger

2010
Heparin cofactor II protects against angiotensin II-induced cardiac remodeling via attenuation of oxidative stress in mice.
    Hypertension (Dallas, Tex. : 1979), 2010, Volume: 56, Issue:3

    Topics: Analysis of Variance; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Echocardiography; Fibrosis; Heart Atria; Heparin Cofactor II; Mice; Mice, Transgenic; Myocardium; Natriuretic Peptide, Brain; Oxidative Stress; Transforming Growth Factor beta1; Ventricular Remodeling

2010
Persistent antihypertensive effect of aliskiren is accompanied by reduced proteinuria and normalization of glomerular area in Ren-2 transgenic rats.
    American journal of physiology. Renal physiology, 2010, Volume: 299, Issue:4

    Topics: Amides; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Disease Models, Animal; Fumarates; Heart Rate; Hypertension; Kidney Glomerulus; Losartan; Male; Proteinuria; Rats; Rats, Transgenic; Renin; Time Factors

2010
The nonpeptide AVE0991 attenuates myocardial hypertrophy as induced by angiotensin II through downregulation of transforming growth factor-beta1/Smad2 expression.
    Heart and vessels, 2010, Volume: 25, Issue:5

    Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cardiovascular Agents; Cell Size; Cells, Cultured; Dose-Response Relationship, Drug; Down-Regulation; Imidazoles; Myocytes, Cardiac; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; RNA, Messenger; Signal Transduction; Smad2 Protein; Transforming Growth Factor beta1

2010
Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
    Circulation, 2010, Aug-17, Volume: 122, Issue:7

    Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cardiomegaly; Cells, Cultured; CHO Cells; Collagen Type I, alpha 1 Chain; Cricetinae; Cricetulus; Down-Regulation; Fibrosis; Humans; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Peptidyl-Dipeptidase A; Recombinant Proteins

2010
Furanocoumarins-imperatorin inhibits myocardial hypertrophy both in vitro and in vivo.
    Fitoterapia, 2010, Volume: 81, Issue:8

    Topics: Angiotensin II; Animals; Cardiomegaly; Cardiovascular Agents; Cells, Cultured; Furocoumarins; Heart Failure; Molecular Structure; Myocardium; Myocytes, Cardiac; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley

2010
Preferential accumulation and export of high molecular weight FGF-2 by rat cardiac non-myocytes.
    Cardiovascular research, 2011, Jan-01, Volume: 89, Issue:1

    Topics: Angiotensin II; Animals; Biological Transport, Active; Cardiomegaly; Caspase 1; Cell Enlargement; Cells, Cultured; Culture Media, Conditioned; Fibroblast Growth Factor 2; Fibroblasts; Immunity, Innate; Molecular Weight; Myocardium; Myocytes, Cardiac; Myofibroblasts; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2

2011
Salt-induced cardiac hypertrophy and interstitial fibrosis are due to a blood pressure-independent mechanism in Wistar rats.
    The Journal of nutrition, 2010, Volume: 140, Issue:10

    Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Collagen Type I; Collagen Type III; Disease Models, Animal; Drinking; Eating; Echocardiography; Fibrosis; Gene Expression; Heart Ventricles; Hydralazine; Hypertension; Losartan; Male; Myocardium; Potassium; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Renin-Angiotensin System; Sodium; Sodium Chloride, Dietary; Transforming Growth Factor beta; Urine

2010
Gene silencing of myofibrillogenesis regulator-1 by adenovirus-delivered small interfering RNA suppresses cardiac hypertrophy induced by angiotensin II in mice.
    American journal of physiology. Heart and circulatory physiology, 2010, Volume: 299, Issue:5

    Topics: Adenoviridae; Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Extracellular Matrix; Gene Silencing; Gene Transfer Techniques; Male; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; Muscle Proteins; RNA, Small Interfering; Signal Transduction; Tissue Inhibitor of Metalloproteinase-2

2010
Cytochrome P450 1B1 contributes to angiotensin II-induced hypertension and associated pathophysiology.
    Hypertension (Dallas, Tex. : 1979), 2010, Volume: 56, Issue:4

    Topics: Angiotensin II; Animals; Aorta; Aryl Hydrocarbon Hydroxylases; Blood Pressure; Blotting, Western; Cardiomegaly; Cytochrome P-450 CYP1B1; Endothelium, Vascular; Hypertension; Infusions, Intravenous; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitogen-Activated Protein Kinases; Myocardium; NADPH Oxidases; Organ Size; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Stilbenes; Vasoconstrictor Agents

2010
Evidence that apoptotic signalling in hypertrophic cardiomyocytes is determined by mitochondrial pathways involving protein kinase Cδ.
    Clinical and experimental pharmacology & physiology, 2010, Volume: 37, Issue:12

    Topics: Acetophenones; Angiotensin II; Animals; Apoptosis; Benzopyrans; Cardiomegaly; Caspase 3; Caspase 9; Cells, Cultured; Endothelin-1; Imidazoles; Insulin-Like Growth Factor I; Mitochondria; Myocytes, Cardiac; Peptides, Cyclic; Protein Kinase C-delta; Protein Transport; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Endothelin; Signal Transduction; Triiodothyronine

2010
Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
    Clinical and experimental pharmacology & physiology, 2010, Volume: 37, Issue:12

    Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Creatinine; Diabetic Nephropathies; Diuretics; Drug Therapy, Combination; Furosemide; Hydrochlorothiazide; Hypertension; Indoles; Kidney Failure, Chronic; Labetalol; Losartan; Proteinuria; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Renin; Renin-Angiotensin System

2010
Knockdown of farnesylpyrophosphate synthase prevents angiotensin II-mediated cardiac hypertrophy.
    The international journal of biochemistry & cell biology, 2010, Volume: 42, Issue:12

    Topics: Angiotensin II; Animals; Cardiomegaly; Dimethylallyltranstransferase; Gene Knockdown Techniques; Humans; Male; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; rhoA GTP-Binding Protein; RNA, Small Interfering; Signal Transduction; Transfection

2010
Cellular FLICE-inhibitory protein protects against cardiac remodeling induced by angiotensin II in mice.
    Hypertension (Dallas, Tex. : 1979), 2010, Volume: 56, Issue:6

    Topics: Angiotensin II; Animals; Cardiomegaly; CASP8 and FADD-Like Apoptosis Regulating Protein; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Humans; Male; Mice; Mice, Transgenic; Myocardium; Vasoconstrictor Agents; Ventricular Remodeling

2010
Modulation of human embryonic stem cell-derived cardiomyocyte growth: a testbed for studying human cardiac hypertrophy?
    Journal of molecular and cellular cardiology, 2011, Volume: 50, Issue:2

    Topics: Angiotensin II; Cardiomegaly; Cell Cycle; Cell Differentiation; Cell Line; Cell Proliferation; Cell Size; Cells, Cultured; Embryonic Stem Cells; Gene Expression Regulation; Humans; MAP Kinase Kinase 3; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Phenylephrine; Protein Kinase Inhibitors; Signal Transduction; Vasoconstrictor Agents

2011
MMP-2 mediates angiotensin II-induced hypertension under the transcriptional control of MMP-7 and TACE.
    Hypertension (Dallas, Tex. : 1979), 2011, Volume: 57, Issue:1

    Topics: ADAM Proteins; ADAM17 Protein; Angiotensin II; Animals; Cardiomegaly; Fibrosis; Gene Expression Regulation, Enzymologic; Hypertension; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 7; Mice; Mice, Inbred C57BL; Myocardium; Rats; Rats, Sprague-Dawley; RNA Interference; Transcription, Genetic; Up-Regulation

2011
The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro.
    In vitro cellular & developmental biology. Animal, 2011, Volume: 47, Issue:2

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Culture Techniques; Cell Line; Disease Models, Animal; Endothelin-1; Humans; Myoblasts, Cardiac; Myocytes, Cardiac; Rats

2011
High density lipoprotein downregulates angiotensin II type 1 receptor and inhibits angiotensin II-induced cardiac hypertrophy.
    Biochemical and biophysical research communications, 2011, Jan-07, Volume: 404, Issue:1

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Down-Regulation; Lipoproteins, HDL; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Rats; Receptor, Angiotensin, Type 1

2011
Mitofusin 2 inhibits angiotensin II-induced myocardial hypertrophy.
    Journal of cardiovascular pharmacology and therapeutics, 2011, Volume: 16, Issue:2

    Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cardiomegaly; Gene Expression Regulation; GTP Phosphohydrolases; Membrane Proteins; Mitochondrial Proteins; Myocytes, Cardiac; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Up-Regulation

2011
Concerted regulation of cGMP and cAMP phosphodiesterases in early cardiac hypertrophy induced by angiotensin II.
    PloS one, 2010, Dec-03, Volume: 5, Issue:12

    Topics: Angiotensin II; Animals; Cardiomegaly; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Gene Expression Regulation, Enzymologic; Heart Ventricles; Hydrolysis; Isoenzymes; Male; Membrane Glycoproteins; Models, Biological; NADPH Oxidase 2; NADPH Oxidases; Rats; Rats, Wistar

2010
[Effect of NOS and PTEN on cardiomyocyte hypertrophy induced by angiotensin II].
    Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology, 2005, Volume: 21, Issue:1

    Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Myocytes, Cardiac; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; PTEN Phosphohydrolase; Rats; Rats, Sprague-Dawley; RNA, Messenger

2005
Impairment of cardiac function and remodeling induced by myocardial infarction in rats are attenuated by the nonpeptide angiotensin-(1-7) analog AVE 0991.
    Cardiovascular therapeutics, 2012, Volume: 30, Issue:3

    Topics: Angiotensin II; Animals; Cardiomegaly; Cardiotonic Agents; Collagen; Disease Models, Animal; Hemodynamics; Imidazoles; Male; Myocardial Contraction; Myocardial Infarction; Myocardium; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Signal Transduction; Stroke Volume; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Ventricular Function, Left; Ventricular Remodeling

2012
Thioredoxin 1 negatively regulates angiotensin II-induced cardiac hypertrophy through upregulation of miR-98/let-7.
    Circulation research, 2011, Feb-04, Volume: 108, Issue:3

    Topics: Adenoviridae; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Cyclin D2; Disease Models, Animal; Mice; Mice, Transgenic; MicroRNAs; Myocytes, Cardiac; Rats; Rats, Wistar; Signal Transduction; Thioredoxins; Up-Regulation

2011
Lack of microsomal prostaglandin E synthase-1 reduces cardiac function following angiotensin II infusion.
    American journal of physiology. Heart and circulatory physiology, 2011, Volume: 300, Issue:3

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiac Output; Cardiomegaly; Echocardiography; Hypertension; Intramolecular Oxidoreductases; Mice; Mice, Inbred C57BL; Mice, Knockout; Microsomes; Myocytes, Cardiac; Prostaglandin-E Synthases; Ventricular Function

2011
Up-regulation of p27(kip1) contributes to Nrf2-mediated protection against angiotensin II-induced cardiac hypertrophy.
    Cardiovascular research, 2011, May-01, Volume: 90, Issue:2

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p27; Feedback, Physiological; Male; Mice; Myocytes, Cardiac; NF-E2-Related Factor 2; Oxidative Stress; Phenols; Plant Extracts; Rats; RNA Processing, Post-Transcriptional; RNA, Small Interfering; Up-Regulation; Vasoconstrictor Agents

2011
Blood pressures in newborns with twin-twin transfusion syndrome.
    Journal of perinatology : official journal of the California Perinatal Association, 2011, Volume: 31, Issue:6

    Topics: Angiotensin II; Apgar Score; Birth Weight; Blood Pressure; Cardiomegaly; Critical Care; Female; Fetofetal Transfusion; Gestational Age; Heart Ventricles; Hemoglobinometry; Humans; Infant, Newborn; Male; Pregnancy; Survival Rate

2011
IRF3 regulates cardiac fibrosis but not hypertrophy in mice during angiotensin II-induced hypertension.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2011, Volume: 25, Issue:5

    Topics: Angiotensin II; Animals; Apoptosis; Blotting, Western; Bone Marrow Transplantation; Cardiomegaly; Cell Proliferation; Cells, Cultured; DNA, Complementary; Echocardiography; Fibrosis; Gene Expression Profiling; Hypertension; Immunity, Innate; Interferon Regulatory Factor-3; Leukocyte Common Antigens; Mice; Mice, Inbred ICR; Mice, Knockout; Proto-Oncogene Proteins c-bcl-2; Ventricular Remodeling

2011
Activation of peroxisome proliferator-activated receptor-γ downregulates soluble epoxide hydrolase in cardiomyocytes.
    Clinical and experimental pharmacology & physiology, 2011, Volume: 38, Issue:6

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Line; Epoxide Hydrolases; Gene Expression Regulation, Enzymologic; Humans; Ligands; Male; Mice; Mice, Knockout; Myocytes, Cardiac; PPAR gamma; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Vasodilator Agents

2011
Restriction of big hearts by a small RNA.
    Circulation research, 2011, Feb-04, Volume: 108, Issue:3

    Topics: Angiotensin II; Animals; Cardiomegaly; Cyclin D2; Disease Models, Animal; Mice; MicroRNAs; Oxidation-Reduction; Signal Transduction; Thioredoxins

2011
Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure.
    Circulation research, 2011, Apr-01, Volume: 108, Issue:7

    Topics: Angiotensin II; Animals; Cardiomegaly; Catalase; DNA Damage; DNA, Mitochondrial; Gene Expression Regulation; GTP-Binding Protein alpha Subunits, Gq-G11; Heart Failure; Mice; Mice, Transgenic; Mitochondria, Heart; Models, Animal; Myocytes, Cardiac; Oxidative Stress; Reactive Oxygen Species; Reverse Transcriptase Inhibitors; Zidovudine

2011
Cyclophilin A promotes cardiac hypertrophy in apolipoprotein E-deficient mice.
    Arteriosclerosis, thrombosis, and vascular biology, 2011, Volume: 31, Issue:5

    Topics: Angiotensin II; Animals; Animals, Newborn; Apolipoproteins E; Bone Marrow Cells; Bone Marrow Transplantation; Cardiomegaly; Cell Communication; Cell Movement; Cell Proliferation; Cells, Cultured; Cyclophilin A; Disease Models, Animal; Fibroblasts; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Myocytes, Cardiac; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Recombinant Proteins; Time Factors

2011
Histone acetylation is essential for ANG-II-induced IGF-IIR gene expression in H9c2 cardiomyoblast cells and pathologically hypertensive rat heart.
    Journal of cellular physiology, 2012, Volume: 227, Issue:1

    Topics: Acetylation; Angiotensin II; Animals; Blotting, Western; Cardiomegaly; Chromatin Immunoprecipitation; CpG Islands; DNA Methylation; Gene Expression; Histones; Hypertension; Myoblasts; Myocardium; Myocytes, Cardiac; Rats; Rats, Inbred SHR; Receptor, IGF Type 2; Reverse Transcriptase Polymerase Chain Reaction; Up-Regulation; Ventricular Remodeling

2012
Regulation of L-type inward calcium channel activity by captopril and angiotensin II via the phosphatidyl inositol 3-kinase pathway in cardiomyocytes from volume-overload hypertrophied rat hearts.
    Canadian journal of physiology and pharmacology, 2011, Volume: 89, Issue:3

    Topics: Angiotensin II; Animals; Calcium Channels, L-Type; Captopril; Cardiomegaly; Male; Myocytes, Cardiac; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Signal Transduction

2011
New take on the role of angiotensin II in cardiac hypertrophy and fibrosis.
    Hypertension (Dallas, Tex. : 1979), 2011, Volume: 57, Issue:6

    Topics: Aldosterone; Angiotensin II; Animals; Cardiomegaly; Fibrosis; Humans; Hypertension; Inflammation; Mice; Myocardium; Oxidative Stress; Receptor, Angiotensin, Type 1; Sodium; Ventricular Remodeling

2011
Mitochondrial oxidative stress mediates induction of autophagy and hypertrophy in angiotensin-II treated mouse hearts.
    Autophagy, 2011, Volume: 7, Issue:8

    Topics: Angiotensin II; Animals; Autophagy; Cardiomegaly; Catalase; Heart Failure; Mice; Mitochondria, Heart; Oxidative Stress; Peroxisomes; Reactive Oxygen Species

2011
CCR2 mediates the uptake of bone marrow-derived fibroblast precursors in angiotensin II-induced cardiac fibrosis.
    American journal of physiology. Heart and circulatory physiology, 2011, Volume: 301, Issue:2

    Topics: Analysis of Variance; Angiotensin II; Animals; Biomarkers; Blood Pressure; Bone Marrow Cells; Cardiomegaly; Cell Movement; Disease Models, Animal; Fibroblasts; Fibrosis; Heart Diseases; Heart Rate; Hypertension; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Receptors, CCR2; Stem Cells; Stroke Volume; Time Factors; Ultrasonography; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling

2011
Attenuation of microRNA-22 derepressed PTEN to effectively protect rat cardiomyocytes from hypertrophy.
    Journal of cellular physiology, 2012, Volume: 227, Issue:4

    Topics: Angiotensin II; Animals; Base Sequence; Cardiomegaly; Cell Enlargement; Cells, Cultured; DNA Primers; MicroRNAs; Models, Cardiovascular; Myocytes, Cardiac; Phenylephrine; PTEN Phosphohydrolase; Rats; Up-Regulation

2012
Targeting mitochondrial oxidative stress in heart failure throttling the afterburner.
    Journal of the American College of Cardiology, 2011, Jun-28, Volume: 58, Issue:1

    Topics: Angiotensin II; Cardiomegaly; Heart; Humans; Membrane Potentials; Mitochondria; NADPH Oxidases; Oligopeptides; Oxidative Stress; Reactive Oxygen Species

2011
Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling.
    American journal of physiology. Heart and circulatory physiology, 2011, Volume: 301, Issue:3

    Topics: Adiponectin; AMP-Activated Protein Kinases; Analysis of Variance; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Genes, Reporter; Hydrogen Peroxide; Hypertrophy, Left Ventricular; Male; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; NADPH Oxidases; Natriuretic Peptide, Brain; NF-kappa B; Oxidants; Oxidative Stress; Phosphorylation; Rats; Reactive Oxygen Species; Recombinant Proteins; RNA, Messenger; Signal Transduction; Time Factors; Transfection; Ventricular Remodeling

2011
Regulation of the instantaneous inward rectifier and the delayed outward rectifier potassium channels by Captopril and Angiotensin II via the Phosphoinositide-3 kinase pathway in volume-overload-induced hypertrophied cardiac myocytes.
    Medical science monitor : international medical journal of experimental and clinical research, 2011, Volume: 17, Issue:7

    Topics: Angiotensin II; Animals; Blotting, Western; Captopril; Cardiomegaly; Delayed Rectifier Potassium Channels; Male; Myocytes, Cardiac; Patch-Clamp Techniques; Phosphatidylinositol 3-Kinases; Potassium Channels, Inwardly Rectifying; Rats

2011
The role of E2F1 in the development of hypertrophic cardiomyopathy.
    International journal of clinical and experimental pathology, 2011, Jun-20, Volume: 4, Issue:5

    Topics: Angiotensin II; Animals; Apoptosis; Atrial Natriuretic Factor; Cardiomegaly; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cell Cycle; E2F1 Transcription Factor; Gene Expression Regulation; Humans; Isoproterenol; Male; Mice; Mice, Knockout; Mice, Transgenic; Myocytes, Cardiac; RNA, Messenger; Signal Transduction; Vasoconstrictor Agents

2011
Analysis of p53 and NF-κB signaling in modulating the cardiomyocyte fate during hypertrophy.
    Journal of cellular physiology, 2011, Volume: 226, Issue:10

    Topics: Age Factors; Angiotensin II; Animals; Animals, Newborn; Apoptosis; Cardiomegaly; Cells, Cultured; Male; Myocytes, Cardiac; NF-kappa B; Rats; Rats, Wistar; Signal Transduction; Tumor Suppressor Protein p53; Vasoconstrictor Agents

2011
Role of AT₁ receptor-mediated salt retention in angiotensin II-dependent hypertension.
    American journal of physiology. Renal physiology, 2011, Volume: 301, Issue:5

    Topics: Albuminuria; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Diet, Sodium-Restricted; Disease Progression; Hypertension, Renal; Kidney; Kidney Transplantation; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mineralocorticoid Receptor Antagonists; Receptor, Angiotensin, Type 1; Salts

2011
The antifibrotic agent pirfenidone inhibits angiotensin II-induced cardiac hypertrophy in mice.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2012, Volume: 35, Issue:1

    Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Cardiomegaly; Fibrosis; Heart; Heart Rate; Hypertension; Male; Mice; Mice, Inbred BALB C; Myocardium; Pyridones

2012
Angiotensin-converting enzyme and Angiotensin-converting enzyme 2 are involved in sinoaortic denervation-induced cardiovascular hypertrophy in rats.
    Biological & pharmaceutical bulletin, 2011, Volume: 34, Issue:9

    Topics: Angiotensin II; Animals; Baroreflex; Base Sequence; Blotting, Western; Cardiomegaly; Denervation; DNA Primers; Isoenzymes; Male; Peptidyl-Dipeptidase A; Rats; Real-Time Polymerase Chain Reaction; Sinoatrial Node

2011
Effects of ethanolic extract from Radix Scrophulariae on ventricular remodeling in rats.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2012, Feb-15, Volume: 19, Issue:3-4

    Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Chemical Analysis; Captopril; Cardiomegaly; Collagen; Coronary Vessels; Endothelin-1; Ethanol; Gene Expression Regulation; Hemodynamics; Hydroxyproline; Male; Matrix Metalloproteinase 2; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Organ Size; Plant Extracts; Plant Roots; Random Allocation; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; RNA, Messenger; Scrophularia; Tumor Necrosis Factor-alpha; Ventricular Remodeling

2012
Changes in cardiac structure and function in rats immunized by angiotensin type 1 receptor peptides.
    Acta biochimica et biophysica Sinica, 2011, Volume: 43, Issue:12

    Topics: Angiotensin II; Animals; Autoantibodies; Blood Pressure; Cardiomegaly; Cell Enlargement; Heart; Heart Rate; Male; Myocytes, Cardiac; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1

2011
Caloric restriction ameliorates angiotensin II-induced mitochondrial remodeling and cardiac hypertrophy.
    Hypertension (Dallas, Tex. : 1979), 2012, Volume: 59, Issue:1

    Topics: Angiotensin II; Angiotensinogen; Animals; Apoptosis; Autophagy; Blood Pressure; Body Temperature; Caloric Restriction; Cardiomegaly; Endoplasmic Reticulum Stress; Energy Metabolism; Heart Rate; Humans; Mitochondria; Mitochondrial Diseases; Myocytes, Cardiac; Oxidative Stress; Proteome; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Renin; Survival Rate; Vasoconstrictor Agents

2012
Angiotensin II-induced cardiomyocyte hypertrophy in vitro is TAK1-dependent and Smad2/3-independent.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2012, Volume: 35, Issue:4

    Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; MAP Kinase Kinase Kinases; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta1

2012
Pak1 as a novel therapeutic target for antihypertrophic treatment in the heart.
    Circulation, 2011, Dec-13, Volume: 124, Issue:24

    Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Female; Fingolimod Hydrochloride; Male; MAP Kinase Kinase 4; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; NFATC Transcription Factors; p21-Activated Kinases; Propylene Glycols; Rats; Signal Transduction; Sphingosine; Stress, Physiological

2011
Loss of receptor activity-modifying protein 3 exacerbates cardiac hypertrophy and transition to heart failure in a sex-dependent manner.
    Journal of molecular and cellular cardiology, 2012, Volume: 52, Issue:1

    Topics: Angiotensin II; Animals; Cardiomegaly; Cardiovascular Diseases; Disease Models, Animal; Female; Gene Expression; Gene Expression Profiling; Gene Knockout Techniques; Genetic Association Studies; Heart Failure; Hypertension; Hypertrophy, Right Ventricular; Kidney Diseases; Male; Mice; Mice, Knockout; Phenotype; Proto-Oncogene Proteins c-akt; Receptor Activity-Modifying Protein 3; Renin; Sex Factors

2012
Angiotensin-(1-7) attenuates angiotensin II-induced cardiac remodeling associated with upregulation of dual-specificity phosphatase 1.
    American journal of physiology. Heart and circulatory physiology, 2012, Feb-01, Volume: 302, Issue:3

    Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Cardiomegaly; Drug Interactions; Dual Specificity Phosphatase 1; Fibrosis; Hypertension; Male; MAP Kinase Signaling System; Myocardium; Peptide Fragments; Rats; Rats, Sprague-Dawley; Up-Regulation; Vasoconstrictor Agents; Ventricular Remodeling

2012
Hydrogen sulfide attenuates cardiac hypertrophy and fibrosis induced by abdominal aortic coarctation in rats.
    Molecular medicine reports, 2012, Volume: 5, Issue:4

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Aortic Coarctation; Cardiomegaly; Connexin 43; Enalapril; Fibrosis; Hydrogen Sulfide; Male; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley

2012
Involvement of autophagy in cardiac remodeling in transgenic mice with cardiac specific over-expression of human programmed cell death 5.
    PloS one, 2012, Volume: 7, Issue:1

    Topics: Angiotensin II; Animals; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Cardiomegaly; Cardiomyopathy, Dilated; Heart Failure; Humans; Mice; Mice, Transgenic; Myocardium; Myosin Heavy Chains; Neoplasm Proteins; Organ Specificity; Survival Analysis; Ultrasonography; Up-Regulation; Ventricular Remodeling

2012
Cardiac lineage protein-1 (CLP-1) regulates cardiac remodeling via transcriptional modulation of diverse hypertrophic and fibrotic responses and angiotensin II-transforming growth factor β (TGF-β1) signaling axis.
    The Journal of biological chemistry, 2012, Apr-13, Volume: 287, Issue:16

    Topics: Angiotensin II; Angiotensinogen; Animals; Cardiomegaly; Extracellular Matrix; Fibroblasts; Fibrosis; Heterozygote; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myosin Heavy Chains; RNA-Binding Proteins; Signal Transduction; Smad3 Protein; STAT3 Transcription Factor; Transcription Factors; Transcription, Genetic; Transforming Growth Factor beta1; Ventricular Remodeling

2012
Reduction of NADPH-oxidase activity ameliorates the cardiovascular phenotype in a mouse model of Williams-Beuren Syndrome.
    PLoS genetics, 2012, Volume: 8, Issue:2

    Topics: Acetophenones; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arteries; Blood Pressure; Cardiomegaly; Constriction, Pathologic; Disease Models, Animal; Elastin; Enzyme Activation; Enzyme Inhibitors; Humans; Hypertension; Losartan; Mice; NADPH Oxidases; Oxidative Stress; Sequence Deletion; Williams Syndrome

2012
Sirtuin 6 protects cardiomyocytes from hypertrophy in vitro via inhibition of NF-κB-dependent transcriptional activity.
    British journal of pharmacology, 2013, Volume: 168, Issue:1

    Topics: Angiotensin II; Animals; Aorta, Abdominal; Cardiomegaly; Cells, Cultured; Constriction, Pathologic; Male; Myocytes, Cardiac; NAD; NF-kappa B; Rats; Rats, Sprague-Dawley; RNA Interference; RNA, Messenger; Sirtuins; Transcription, Genetic; Ultrasonography; Up-Regulation

2013
ET-1 from endothelial cells is required for complete angiotensin II-induced cardiac fibrosis and hypertrophy.
    Life sciences, 2012, Oct-15, Volume: 91, Issue:13-14

    Topics: Angiotensin II; Animals; Blood Pressure; Blotting, Northern; Blotting, Western; Cardiomegaly; Disease Models, Animal; Endothelial Cells; Endothelin-1; Fibrosis; Gene Expression Regulation; Male; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocardium; Polymerase Chain Reaction; Protein Kinase C-delta; Protein Kinase C-epsilon

2012
Effects of proangiotensin-12 infused continuously over 14 days in conscious rats.
    European journal of pharmacology, 2012, May-15, Volume: 683, Issue:1-3

    Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Antihypertensive Agents; Cardiomegaly; Heart; Hypertension; Infusions, Subcutaneous; Male; Myocardium; Organ Size; Peptide Fragments; Random Allocation; Rats; Rats, Wistar; Time Factors; Vasoconstrictor Agents; Weight Gain

2012
Cardiac remodeling is not modulated by overexpression of muscle LIM protein (MLP).
    Basic research in cardiology, 2012, Volume: 107, Issue:3

    Topics: Angiotensin II; Animals; Animals, Newborn; Aorta; Blood Pressure; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Gene Expression Regulation; Genotype; Ligation; LIM Domain Proteins; Mice; Mice, 129 Strain; Mice, Transgenic; Muscle Proteins; Myocardial Contraction; Myocardium; Phenotype; Rats; Rats, Wistar; Ultrasonography; Ventricular Function, Left; Ventricular Remodeling

2012
Nmnat2 protects cardiomyocytes from hypertrophy via activation of SIRT6.
    FEBS letters, 2012, Mar-23, Volume: 586, Issue:6

    Topics: Amide Synthases; Angiotensin II; Animals; Cardiomegaly; Gene Knockdown Techniques; Isoenzymes; Male; Myocytes, Cardiac; NAD; Nicotinamide-Nucleotide Adenylyltransferase; Proteasome Endopeptidase Complex; Rats; Rats, Sprague-Dawley; Sirtuins; Tissue Distribution

2012
Nitroxyl (HNO) stimulates soluble guanylyl cyclase to suppress cardiomyocyte hypertrophy and superoxide generation.
    PloS one, 2012, Volume: 7, Issue:4

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Adhesion Molecules; Cyclic GMP; Endothelin-1; Guanylate Cyclase; Microfilament Proteins; Myocytes, Cardiac; NADPH Oxidases; Natriuretic Peptide, Brain; Nitrites; Nitrogen Oxides; p38 Mitogen-Activated Protein Kinases; Phosphoproteins; Phosphorylation; Rats; Reactive Oxygen Species; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Soluble Guanylyl Cyclase; Superoxides

2012
Promyelocytic leukemia zinc finger protein activates GATA4 transcription and mediates cardiac hypertrophic signaling from angiotensin II receptor 2.
    PloS one, 2012, Volume: 7, Issue:4

    Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Binding Sites; Blood Pressure; Cardiomegaly; Fibrosis; GATA4 Transcription Factor; Gene Expression Regulation; Heart; Kruppel-Like Transcription Factors; Male; Mice; Mice, Knockout; Myocytes, Cardiac; Promyelocytic Leukemia Zinc Finger Protein; Protein Binding; Receptor, Angiotensin, Type 2; Signal Transduction; Transcription, Genetic

2012
Choline inhibits angiotensin II-induced cardiac hypertrophy by intracellular calcium signal and p38 MAPK pathway.
    Naunyn-Schmiedeberg's archives of pharmacology, 2012, Volume: 385, Issue:8

    Topics: Angiotensin II; Animals; Animals, Newborn; Blotting, Western; Calcineurin; Calcium Signaling; Cardiomegaly; Cells, Cultured; Choline; Electrocardiography; Heart; Hemodynamics; In Vitro Techniques; Male; Mice; Myocytes, Cardiac; Organ Size; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Wistar; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptor, Muscarinic M3; Signal Transduction

2012
CIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy.
    Journal of molecular and cellular cardiology, 2012, Volume: 53, Issue:1

    Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Collagen; Endomyocardial Fibrosis; Gene Expression; Interleukin-18; Male; Matrix Metalloproteinase 9; Membrane Glycoproteins; Mice; Myocytes, Cardiac; NADPH Oxidase 2; NADPH Oxidases; NF-kappa B; rac1 GTP-Binding Protein; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Transcription Factor AP-1

2012
Repression of cardiac hypertrophy by KLF15: underlying mechanisms and therapeutic implications.
    PloS one, 2012, Volume: 7, Issue:5

    Topics: Angiotensin II; Animals; Binding Sites; Cardiomegaly; Cell Differentiation; COS Cells; Disease Models, Animal; DNA-Binding Proteins; Gene Expression Regulation; Genetic Therapy; Humans; Kruppel-Like Transcription Factors; Mice; Mutant Proteins; Nuclear Proteins; Oncogene Proteins, Fusion; Promoter Regions, Genetic; Trans-Activators; Transcription Factors

2012
[Hypertension-induced fibrosis: a balance story].
    Annales de cardiologie et d'angeiologie, 2012, Volume: 61, Issue:3

    Topics: Aldosterone; Angiotensin II; Animals; Bone Morphogenetic Proteins; Cardiomegaly; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Heart Failure; Hypertension; Male; Mice; Mice, Transgenic; Myocytes, Cardiac; Natriuretic Peptide, Brain; Renin; Renin-Angiotensin System

2012
Agonist-induced hypertrophy and diastolic dysfunction are associated with selective reduction in glucose oxidation: a metabolic contribution to heart failure with normal ejection fraction.
    Circulation. Heart failure, 2012, Jul-01, Volume: 5, Issue:4

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cardiomegaly; Cyclin-Dependent Kinases; E2F Transcription Factors; Energy Metabolism; Glucose; Heart Failure; Male; Mice; Mice, Inbred C57BL; Myocardium; Oxidation-Reduction; Phenylephrine; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Receptor, Angiotensin, Type 1; Receptors, Adrenergic, alpha; Retinoblastoma Protein; Signal Transduction; Stroke Volume; Time Factors; Ultrasonography; Ventricular Function

2012
Cardiomyocyte-specific transgenic expression of lysyl oxidase-like protein-1 induces cardiac hypertrophy in mice.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2012, Volume: 35, Issue:11

    Topics: Amino Acid Oxidoreductases; Aminopropionitrile; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Echocardiography; Endothelin-1; In Vitro Techniques; Leucine; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocytes, Cardiac; Rats; Rats, Wistar

2012
DIOL triterpenes block profibrotic effects of angiotensin II and protect from cardiac hypertrophy.
    PloS one, 2012, Volume: 7, Issue:7

    Topics: Angiotensin II; Animals; Apoptosis; Cardiomegaly; Cell Proliferation; Collagen; Dose-Response Relationship, Drug; Fibrosis; Male; Mice; Myofibroblasts; Oleanolic Acid; Rats; Triterpenes

2012
Interferon-γ signaling inhibition ameliorates angiotensin II-induced cardiac damage.
    Hypertension (Dallas, Tex. : 1979), 2012, Volume: 60, Issue:6

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Fibrosis; Heart; Inflammation; Interferon-gamma; Interleukin-17; Interleukin-23; Kidney; Membrane Proteins; Mice; Mice, Knockout; Microfilament Proteins; Myocardium; Podocytes; Signal Transduction

2012
Angiotensin-converting enzyme 2 over-expression in the central nervous system reduces angiotensin-II-mediated cardiac hypertrophy.
    PloS one, 2012, Volume: 7, Issue:11

    Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Brain; Cardiomegaly; Heart; Hemodynamics; Mice; Neurons; Norepinephrine; Peptidyl-Dipeptidase A; Renin-Angiotensin System

2012
The orphan receptor TR3 participates in angiotensin II-induced cardiac hypertrophy by controlling mTOR signalling.
    EMBO molecular medicine, 2013, Volume: 5, Issue:1

    Topics: Angiotensin II; Animals; Cardiomegaly; Gene Knockdown Techniques; Humans; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Inbred C57BL; Mice, Knockout; Multiprotein Complexes; Nuclear Receptor Subfamily 4, Group A, Member 1; Proteins; Rats; Signal Transduction; TOR Serine-Threonine Kinases; Tuberous Sclerosis Complex 1 Protein; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins; Ubiquitination

2013
Bone morphogenetic protein-4 mediates cardiac hypertrophy, apoptosis, and fibrosis in experimentally pathological cardiac hypertrophy.
    Hypertension (Dallas, Tex. : 1979), 2013, Volume: 61, Issue:2

    Topics: Angiotensin II; Animals; Apoptosis; Bone Morphogenetic Protein 4; Cardiomegaly; Fibrosis; Heart Failure; Humans; Mice; Myocardium; Myocytes, Cardiac; Physical Conditioning, Animal; Reactive Oxygen Species

2013
PARP-2 knockdown protects cardiomyocytes from hypertrophy via activation of SIRT1.
    Biochemical and biophysical research communications, 2013, Jan-18, Volume: 430, Issue:3

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Male; Myocytes, Cardiac; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Sirtuin 1; Transfection

2013
FHL2 prevents cardiac hypertrophy in mice with cardiac-specific deletion of ROCK2.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2013, Volume: 27, Issue:4

    Topics: Angiotensin II; Animals; Cardiomegaly; Fibrosis; Heart; LIM-Homeodomain Proteins; Male; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; Muscle Proteins; Myocytes, Cardiac; rho-Associated Kinases; Transcription Factors; Up-Regulation

2013
Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced cardiac hypertrophy and fibrosis in vivo.
    The international journal of biochemistry & cell biology, 2013, Volume: 45, Issue:3

    Topics: Alendronate; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Contraindications; Fibrosis; Gene Expression Regulation; Geranyltranstransferase; Humans; Male; Mice; Myocytes, Cardiac; Natriuretic Peptide, Brain; p38 Mitogen-Activated Protein Kinases; rho GTP-Binding Proteins; rhoA GTP-Binding Protein; Signal Transduction; Terpenes; Transforming Growth Factor beta1

2013
Atrial natriuretic peptide exerts protective action against angiotensin II-induced cardiac remodeling by attenuating inflammation via endothelin-1/endothelin receptor A cascade.
    Heart and vessels, 2013, Volume: 28, Issue:5

    Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Endothelin-1; Fibrillar Collagens; Fibroblasts; Fibrosis; Heart Diseases; Inflammation; Inflammation Mediators; Infusions, Intravenous; Macrophages; Male; Mitral Valve; Myocardial Contraction; Myocardium; Rats; Rats, Inbred WKY; Receptor, Endothelin A; Signal Transduction; Stroke Volume; Time Factors; Ventricular Function, Left; Ventricular Remodeling

2013
Apocynin attenuates oxidative stress and cardiac fibrosis in angiotensin II-induced cardiac diastolic dysfunction in mice.
    Acta pharmacologica Sinica, 2013, Volume: 34, Issue:3

    Topics: Acetophenones; Angiotensin II; Animals; Blood Pressure; Blotting, Western; Cardiomegaly; Cardiotonic Agents; Cell Culture Techniques; Cells, Cultured; Diastole; Fibroblasts; Heart Rate; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Myocardium; Oxidative Stress

2013
TNF receptor 1 signaling is critically involved in mediating angiotensin-II-induced cardiac fibrosis.
    Journal of molecular and cellular cardiology, 2013, Volume: 57

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Differentiation; Cell Size; Cells, Cultured; Coculture Techniques; Collagen; Cytokines; Fibrosis; Gene Expression; Humans; Inflammation Mediators; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Myofibroblasts; Receptors, Tumor Necrosis Factor, Type I; Signal Transduction; Transendothelial and Transepithelial Migration; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha

2013
Angiotensin II reduces cardiac AdipoR1 expression through AT1 receptor/ROS/ERK1/2/c-Myc pathway.
    PloS one, 2013, Volume: 8, Issue:1

    Topics: Acetyl-CoA Carboxylase; Adenylate Kinase; Adiponectin; Adipose Tissue; Angiotensin II; Animals; Animals, Newborn; Blood Vessels; Cardiomegaly; Enzyme Activation; Gene Expression Regulation; Male; MAP Kinase Signaling System; Membrane Glycoproteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Skeletal; Myocytes, Cardiac; NADPH Oxidase 2; NADPH Oxidases; Phosphorylation; Proto-Oncogene Proteins c-myc; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptors, Adiponectin

2013
Role of STAT3 in angiotensin II-induced hypertension and cardiac remodeling revealed by mice lacking STAT3 serine 727 phosphorylation.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2013, Volume: 36, Issue:6

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Collagen; Cytokines; Electrocardiography; Fibrosis; Heart; Hemodynamics; Hypertension; Ischemic Preconditioning, Myocardial; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardium; Myocytes, Cardiac; Phosphorylation; Serine; STAT3 Transcription Factor; Vasoconstrictor Agents

2013
ANG II causes insulin resistance and induces cardiac metabolic switch and inefficiency: a critical role of PDK4.
    American journal of physiology. Heart and circulatory physiology, 2013, Apr-15, Volume: 304, Issue:8

    Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Echocardiography; Energy Metabolism; Fatty Acids; Glucose; Glucose Tolerance Test; Heart; Heart Failure, Diastolic; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Oxidation-Reduction; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Pyruvate Dehydrogenase Complex; Renin-Angiotensin System; Sirtuin 3

2013
Increased preload directly induces the activation of heat shock transcription factor 1 in the left ventricular overloaded heart.
    Cardiovascular research, 2002, Aug-01, Volume: 55, Issue:2

    Topics: Angiotensin II; Animals; Cardiomegaly; DNA-Binding Proteins; Epinephrine; Gene Expression Regulation; Heat Shock Transcription Factors; Heat-Shock Proteins; Hemodynamics; Male; Norepinephrine; Organ Culture Techniques; Rats; Rats, Sprague-Dawley; Stress, Mechanical; Transcription Factors; Vasopressins; Ventricular Dysfunction, Left

2002
AT1 receptor blockade reduces cardiac calcineurin activity in hypertensive rats.
    Hypertension (Dallas, Tex. : 1979), 2002, Volume: 40, Issue:2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Calcineurin; Cardiomegaly; Echocardiography; Fibrosis; Gene Expression Regulation; Hypertension; Male; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; RNA, Messenger; Stress, Mechanical; Tacrolimus; Tetrazoles; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1

2002
Sodium tanshinone IIA sulfonate derived from Danshen (Salvia miltiorrhiza) attenuates hypertrophy induced by angiotensin II in cultured neonatal rat cardiac cells.
    Biochemical pharmacology, 2002, Aug-15, Volume: 64, Issue:4

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Division; Cell Survival; Cells, Cultured; Drug Interactions; Heart; Myocardium; Phenanthrenes; Rats; Rats, Wistar; Salvia miltiorrhiza

2002
Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart.
    Circulation, 2002, Sep-24, Volume: 106, Issue:13

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensinogen; Animals; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Cardiomegaly; Collagen; Fibrosis; Gene Targeting; Guanylate Cyclase; Heart Rate; Heart Ventricles; Hypertension; Imidazoles; Mice; Mice, Knockout; Myocardium; Natriuretic Peptide, Brain; Olmesartan Medoxomil; Organ Size; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Receptors, Atrial Natriuretic Factor; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Transforming Growth Factor beta1; Transforming Growth Factor beta2; Ventricular Remodeling

2002
Tissue angiotensin II during progression or ventricular hypertrophy to heart failure in hypertensive rats; differential effects on PKC epsilon and PKC beta.
    Journal of molecular and cellular cardiology, 2002, Volume: 34, Issue:10

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Disease Progression; Echocardiography; Enzyme Activation; Heart Failure; Hypertension; Male; Myocardium; Organ Size; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-epsilon; Protein Transport; Rats; Rats, Inbred Dahl; Stress, Mechanical; Tetrazoles; Valine; Valsartan; Ventricular Function, Left

2002
Gq-coupled receptor agonists mediate cardiac hypertrophy via the vasculature.
    Hypertension (Dallas, Tex. : 1979), 2002, Volume: 40, Issue:5

    Topics: Angiotensin II; Animals; Cardiomegaly; Catecholamines; Cells, Cultured; Enzyme Activation; GTP-Binding Protein alpha Subunits, Gq-G11; Heart; Hemodynamics; Heterotrimeric GTP-Binding Proteins; Infusion Pumps, Implantable; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microfilament Proteins; Mitogen-Activated Protein Kinases; Muscle Proteins; Muscle, Smooth, Vascular; Peptide Fragments; Phenylephrine; Receptors, Cell Surface; Serotonin; Signal Transduction; Time; Vasoconstrictor Agents

2002
Time-dependent expression of chymase and angiotensin converting enzyme in the hamster heart under pressure overload.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2002, Volume: 25, Issue:5

    Topics: Angiotensin II; Animals; Cardiomegaly; Chymases; Cricetinae; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Hypertension, Renal; Male; Myocardium; Myocytes, Cardiac; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Serine Endopeptidases; Time Factors; Transcription, Genetic; Ventricular Pressure

2002
[Clinico-genetic aspects of the hypotensive response and regression of left ventricular hypertrophy in arterial hypertension patients].
    Terapevticheskii arkhiv, 2002, Volume: 74, Issue:10

    Topics: Angiotensin II; Antihypertensive Agents; Cardiomegaly; Female; Humans; Hypertension; Male; Middle Aged; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Polymorphism, Genetic; Receptors, Angiotensin; Renin-Angiotensin System

2002
Melusin, a muscle-specific integrin beta1-interacting protein, is required to prevent cardiac failure in response to chronic pressure overload.
    Nature medicine, 2003, Volume: 9, Issue:1

    Topics: Angiotensin II; Animals; Aortic Coarctation; Biomechanical Phenomena; Cardiac Output, Low; Cardiomegaly; Carrier Proteins; Cytoskeletal Proteins; Echocardiography; Female; Gene Silencing; Heart Ventricles; Hemodynamics; Integrin beta1; Male; Mice; Mice, Knockout; Muscle Proteins; Muscle, Skeletal; Myocardium; Phenylephrine; Signal Transduction; Stress, Mechanical; Vasoconstrictor Agents; Ventricular Function

2003
Tonin in rat heart with experimental hypertrophy.
    American journal of physiology. Heart and circulatory physiology, 2003, Volume: 284, Issue:6

    Topics: Adrenergic beta-Agonists; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Disease Progression; Gene Expression Regulation; Isoproterenol; Male; Myocardium; Organ Size; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA Probes; Tissue Kallikreins

2003
Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP.
    Cardiovascular research, 2003, Volume: 57, Issue:2

    Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cyclic GMP; Drug Interactions; Guanylate Cyclase; Male; Muscle Cells; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Rats; Rats, Sprague-Dawley; Receptors, Atrial Natriuretic Factor

2003
[Effects of amiloride on calcium current in thyroxine-induced hypertrophied rat heart].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2000, Volume: 35, Issue:12

    Topics: Amiloride; Angiotensin II; Animals; Calcium Channels, L-Type; Cardiomegaly; Cell Separation; Female; Male; Myocytes, Cardiac; Random Allocation; Rats; Rats, Wistar; Thyroxine

2000
Cardiovascular and renal effects of cyclooxygenase inhibition in transgenic rats harboring mouse renin-2 gene (TGR[mREN2]27).
    European journal of pharmacology, 2003, Feb-14, Volume: 461, Issue:2-3

    Topics: Albuminuria; Angiotensin II; Animals; Animals, Genetically Modified; Antihypertensive Agents; Blood Pressure; Body Weight; Cardiomegaly; Cardiovascular System; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Eating; Furans; Gene Expression Regulation, Enzymologic; Isoenzymes; Kidney; Losartan; Male; Membrane Proteins; Mice; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Sulindac; Urination

2003
Sodium restriction prevents cardiac hypertrophy and oxidative stress in angiotensin II hypertension.
    American journal of physiology. Heart and circulatory physiology, 2003, Volume: 284, Issue:5

    Topics: Albuminuria; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Hypertension, Renal; Myocardium; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Renal Circulation; Sodium, Dietary; Vasoconstrictor Agents

2003
Down-regulation of bradykinin B2-receptor mRNA in the heart in pressure-overload cardiac hypertrophy in the rat.
    Biochemical pharmacology, 2003, Mar-15, Volume: 65, Issue:6

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta; Benzimidazoles; Biphenyl Compounds; Cardiomegaly; Cell Membrane; Down-Regulation; Gene Expression; Heart; Humans; Kallikreins; Kininogens; Male; Myocardium; Rats; Rats, Wistar; Receptor, Bradykinin B2; Receptors, Bradykinin; RNA, Messenger; Tetrazoles; Vasoconstriction

2003
Endothelin ETA receptor antagonism does not attenuate angiotensin II-induced cardiac hypertrophy in vivo in rats.
    Clinical and experimental pharmacology & physiology, 2003, Volume: 30, Issue:4

    Topics: Aldosterone; Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Cardiomegaly; Endothelin A Receptor Antagonists; Endothelin-1; Heart Ventricles; Infusions, Intravenous; Male; Oxazoles; Rats; Rats, Sprague-Dawley; Renin; Sulfonamides

2003
Expression of the translational repressor NAT1 in experimental models of cardiac hypertrophy.
    Molecular and cellular biochemistry, 2003, Volume: 245, Issue:1-2

    Topics: Acetyltransferases; Angiotensin II; Animals; Arylamine N-Acetyltransferase; Body Weight; Cardiomegaly; Carrier Proteins; Disease Models, Animal; Gene Expression Regulation; Heart Ventricles; Hypertension; Isoenzymes; Male; Molecular Weight; Organ Size; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar; RNA Processing, Post-Transcriptional

2003
NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy.
    Journal of molecular and cellular cardiology, 2003, Volume: 35, Issue:7

    Topics: Angiotensin II; Animals; Antioxidants; Atrial Natriuretic Factor; Cardiomegaly; Myocytes, Cardiac; NADPH Oxidases; Promoter Regions, Genetic; rac1 GTP-Binding Protein; Rats; Reactive Oxygen Species; Superoxides; Vasoconstrictor Agents

2003
Lipoic acid supplementation prevents angiotensin II-induced renal injury.
    Kidney international, 2003, Volume: 64, Issue:2

    Topics: Albuminuria; Angiotensin II; Animals; Animals, Genetically Modified; Antioxidants; Blood Pressure; Cardiomegaly; Cell Division; Glutathione; Homeostasis; Kidney; Leukocytes; Male; Myocardium; Nephritis; NF-kappa B; Oxidative Stress; Rats; Rats, Sprague-Dawley; Thioctic Acid; Transcription Factor AP-1; Vasoconstrictor Agents

2003
Activation and functional significance of the renin-angiotensin system in mice with cardiac restricted overexpression of tumor necrosis factor.
    Circulation, 2003, Aug-05, Volume: 108, Issue:5

    Topics: Age Factors; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensinogen; Animals; Body Weight; Cardiomegaly; Collagen; Hemodynamics; Losartan; Mice; Mice, Transgenic; Myocardium; Organ Size; Organ Specificity; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin; Renin-Angiotensin System; RNA, Messenger; Tumor Necrosis Factor-alpha; Ventricular Remodeling

2003
Cardiology patient page. What is an angiotensin converting enzyme inhibitor?
    Circulation, 2003, Jul-22, Volume: 108, Issue:3

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cardiomegaly; Cardiovascular Diseases; Contraindications; Drug Interactions; Humans; Hypertension; Patient Selection; Vasoconstriction

2003
Role of calcineurin in angiotensin II-induced cardiac myocyte hypertrophy of rats.
    Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih, 2001, Volume: 16, Issue:1

    Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Calcineurin; Cardiomegaly; Cells, Cultured; Cyclosporine; Myocytes, Cardiac; Rats; Rats, Wistar; RNA, Messenger

2001
Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system.
    Circulation research, 2003, Oct-17, Volume: 93, Issue:8

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angiotensin II; Animals; Aorta, Thoracic; Cardiomegaly; Cell Movement; Coronary Vessels; Endothelium, Vascular; Enzyme Inhibitors; Hypertension; Intracellular Signaling Peptides and Proteins; Macrophages; Male; NADPH Oxidases; Organ Culture Techniques; Protein Serine-Threonine Kinases; Rats; Rats, Inbred WKY; rho-Associated Kinases; Superoxides; Vasoconstrictor Agents; Vasodilation

2003
Protective effects of the angiotensin II type 1 (AT1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats.
    Clinical science (London, England : 1979), 2004, Volume: 106, Issue:3

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Cardiomegaly; Desoxycorticosterone; Endothelins; Hypertension; Isoprostanes; Kidney; Losartan; Male; Malondialdehyde; Proteinuria; Rats; Rats, Inbred SHR; Renin

2004
Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy.
    Circulation research, 2003, Oct-31, Volume: 93, Issue:9

    Topics: Angiotensin II; Animals; Aorta; Bacterial Proteins; Blood Pressure; Cardiomegaly; Constriction, Pathologic; Disease Models, Animal; Disease Progression; Hypertension; Isoenzymes; Male; Membrane Glycoproteins; Mice; Mice, Knockout; Myocardium; NADH, NADPH Oxidoreductases; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Reactive Oxygen Species

2003
Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling.
    Circulation research, 2003, Oct-31, Volume: 93, Issue:9

    Topics: Angiotensin II; Animals; Apoptosis; Blood Pressure; Body Weight; Cardiomegaly; Coronary Vessels; Disease Models, Animal; Disease Progression; Fibrosis; Gene Expression; Heart Rate; Infusion Pumps, Implantable; MAP Kinase Kinase Kinase 5; MAP Kinase Kinase Kinases; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; Myocardium; Receptor, Angiotensin, Type 1; Superoxides; Ventricular Remodeling

2003
Cardiomyocyte-specific endothelin A receptor knockout mice have normal cardiac function and an unaltered hypertrophic response to angiotensin II and isoproterenol.
    Molecular and cellular biology, 2003, Volume: 23, Issue:22

    Topics: Angiotensin II; Animals; Base Sequence; Cardiomegaly; DNA; Female; Heart; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Contraction; Myocytes, Cardiac; Receptor, Endothelin A; Receptor, Endothelin B; RNA, Messenger

2003
Elevated intracardiac angiotensin II leads to cardiac hypertrophy and mechanical dysfunction in normotensive mice.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, 2003, Volume: 4, Issue:3

    Topics: Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Cardiomegaly; Heart Rate; Mice; Mice, Transgenic; Myocardial Contraction; Myocardium; Rats; Tachycardia, Ventricular; Ventricular Remodeling

2003
Angiotensin II signaling pathways mediate expression of cardiac T-type calcium channels.
    Circulation research, 2003, Dec-12, Volume: 93, Issue:12

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Newborn; Bosentan; Butadienes; Calcium Channels, T-Type; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomegaly; Constriction, Pathologic; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Flavonoids; Gene Expression; Losartan; Male; Membrane Potentials; Mitogen-Activated Protein Kinase Kinases; Myocytes, Cardiac; Nickel; Nitriles; Oligopeptides; Peptides, Cyclic; Piperidines; Rats; Rats, Wistar; Receptors, Angiotensin; Receptors, Endothelin; RNA, Messenger; Signal Transduction; Sulfonamides

2003
Accelerated cardiac hypertrophy and renal damage induced by angiotensin II in adrenomedullin knockout mice.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2003, Volume: 26, Issue:9

    Topics: Adrenomedullin; Angiotensin II; Animals; Cardiomegaly; Male; Mice; Mice, Knockout; Peptides; Renal Insufficiency; Time Factors; Vasoconstrictor Agents; Vasodilator Agents

2003
Entacapone protects from angiotensin II-induced inflammation and renal injury.
    Journal of hypertension, 2003, Volume: 21, Issue:12

    Topics: Angiotensin II; Animals; Animals, Genetically Modified; Biomarkers; Blood Pressure; Cardiomegaly; Catechol O-Methyltransferase; Catechols; Creatinine; Dinoprost; Disease Models, Animal; Dopamine; Enzyme Inhibitors; Hypertension; Inflammation; Intercellular Adhesion Molecule-1; Kidney; Kidney Diseases; Leukocytes; Male; Models, Cardiovascular; Nitriles; Norepinephrine; Rats; Rats, Sprague-Dawley; RNA, Messenger

2003
Inhibitory effect of antisense oligodeoxynucleotide to p44/p42 MAPK on angiotensin II-induced hypertrophic response in cultured neonatal rat cardiac myocyte.
    Acta pharmacologica Sinica, 2004, Volume: 25, Issue:1

    Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Gene Expression; Genes, fos; Genes, myc; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Oligodeoxyribonucleotides, Antisense; Rats; Rats, Wistar; RNA, Messenger

2004
Inhibitory effect of epigallocatechin 3-O-gallate on vascular smooth muscle cell hypertrophy induced by angiotensin II.
    Journal of cardiovascular pharmacology, 2004, Volume: 43, Issue:2

    Topics: Angiotensin II; Animals; Cardiomegaly; Catechin; Cells, Cultured; Male; Mitogen-Activated Protein Kinase Kinases; Muscle, Smooth, Vascular; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction

2004
Role for thromboxane receptors in angiotensin-II-induced hypertension.
    Hypertension (Dallas, Tex. : 1979), 2004, Volume: 43, Issue:2

    Topics: Albuminuria; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cyclooxygenase 1; Heart; Heart Rate; Hypertension; Isoenzymes; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Prostaglandin-Endoperoxide Synthases; Receptors, Thromboxane A2, Prostaglandin H2; Survival Analysis

2004
Inhibitory effect of trilinolein on angiotensin II-induced cardiomyocyte hypertrophy.
    European journal of pharmacology, 2004, Jan-19, Volume: 484, Issue:1

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Dose-Response Relationship, Drug; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Triglycerides

2004
Angiotensin II induced upregulation of G alpha q/11, phospholipase C beta 3 and extracellular signal-regulated kinase 1/2 via angiotensin II type 1 receptor.
    Chinese medical journal, 2004, Volume: 117, Issue:1

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; GTP-Binding Protein alpha Subunits, Gq-G11; Hypertension; Isoenzymes; Male; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Phospholipase C beta; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Signal Transduction; Type C Phospholipases; Up-Regulation

2004
Tissue angiotensin II in the regulation of inflammatory and fibrogenic components of repair in the rat heart.
    The Journal of laboratory and clinical medicine, 2004, Volume: 143, Issue:1

    Topics: Aldosterone; Angiotensin II; Animals; Cardiomegaly; Collagen Type I; Disease Models, Animal; Drug Therapy, Combination; Fibrosis; Heart; In Situ Hybridization; Infusions, Parenteral; Male; Myocardium; Nephrectomy; NF-kappa B; Rats; Rats, Sprague-Dawley; Sodium Chloride, Dietary; Tetrazoles; Valine; Valsartan

2004
Direct evidence for increased hydroxyl radicals in angiotensin II-induced cardiac hypertrophy through angiotensin II type 1a receptor.
    Journal of cardiovascular pharmacology, 2003, Volume: 42 Suppl 1

    Topics: Angiotensin II; Animals; Blood Pressure Determination; Cardiomegaly; Cyclic N-Oxides; Electron Spin Resonance Spectroscopy; Hydroxyl Radical; Mice; Mice, Knockout; Myocardium; Nitrogen Oxides; Reactive Oxygen Species; Receptor, Angiotensin, Type 1

2003
Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis, and renal damage.
    Circulation, 2004, Apr-13, Volume: 109, Issue:14

    Topics: Adrenomedullin; Angiotensin II; Angiotensinogen; Animals; Aorta, Abdominal; Cardiomegaly; Collagen Type I; Constriction; Enzyme Activation; Enzyme Inhibitors; Fibroblasts; Fibrosis; Gene Expression Regulation; Genes, fos; Genes, Lethal; Glomerulosclerosis, Focal Segmental; Heterozygote; Male; MAP Kinase Signaling System; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Natriuretic Peptide, Brain; Peptides; Peptidyl-Dipeptidase A; Protein Kinase C; Proto-Oncogene Proteins c-fos; Transforming Growth Factor beta; Ventricular Remodeling

2004
Influence of cytokines and growth factors in ANG II-mediated collagen upregulation by fibroblasts in rats: role of myocytes.
    American journal of physiology. Heart and circulatory physiology, 2004, Volume: 287, Issue:1

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Coculture Techniques; Collagen; Cytokines; Fibroblasts; Interleukin-6; Myocardium; Myocytes, Cardiac; Paracrine Communication; Rats; Rats, Inbred WKY; RNA, Messenger; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Up-Regulation

2004
Activation of IP prostanoid receptors prevents cardiomyocyte hypertrophy via cAMP-dependent signaling.
    American journal of physiology. Heart and circulatory physiology, 2004, Volume: 287, Issue:3

    Topics: Angiotensin II; Animals; Biomarkers; Cardiomegaly; Cyclic AMP; Endothelin-1; Epoprostenol; Iloprost; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Receptors, Epoprostenol; Receptors, Prostaglandin; Signal Transduction

2004
High-level apoptosis is persistent in myocardiocytes of sinoaortic-denervated rats.
    Journal of hypertension, 2004, Volume: 22, Issue:3

    Topics: Angiotensin II; Animals; Apoptosis; Baroreflex; bcl-2-Associated X Protein; Body Weight; Cardiomegaly; Denervation; Fas Ligand Protein; fas Receptor; Male; Membrane Glycoproteins; Myocytes, Cardiac; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley

2004
Aldosterone antagonist facilitates the cardioprotective effects of angiotensin receptor blockers in hypertensive rats.
    Journal of hypertension, 2004, Volume: 22, Issue:5

    Topics: Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Body Weight; Cardiomegaly; Cardiotonic Agents; Collagen Type I; Collagen Type III; Drug Synergism; Fibrosis; Hypertension; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; RNA, Messenger; Spironolactone; Tetrazoles

2004
Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart.
    Journal of the American College of Cardiology, 2004, May-05, Volume: 43, Issue:9

    Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Pressure; Blotting, Northern; Cardiomegaly; Cell Adhesion; Cell Division; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Matrix; Fibroblasts; Fibrosis; Mice; Mice, Knockout; Models, Cardiovascular; Muscle Proteins; Myocardium; Nuclear Proteins; Osteopontin; Repressor Proteins; Sialoglycoproteins; Up-Regulation; Vasoconstrictor Agents

2004
Thioredoxin-interacting protein controls cardiac hypertrophy through regulation of thioredoxin activity.
    Circulation, 2004, Jun-01, Volume: 109, Issue:21

    Topics: Angiotensin II; Animals; Aortic Diseases; Cardiomegaly; Carrier Proteins; Cell Cycle Proteins; Cell Size; Cells, Cultured; Constriction, Pathologic; Disease Models, Animal; Genetic Vectors; Heart; Ligation; Male; Myocardium; Myocytes, Cardiac; Oxidation-Reduction; Phenylephrine; Random Allocation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Single-Blind Method; Stress, Mechanical; Thioredoxins; Transcriptional Activation

2004
Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy.
    Hypertension (Dallas, Tex. : 1979), 2004, Volume: 43, Issue:6

    Topics: Aldosterone; Angiotensin II; Animals; Apoptosis; Blood Pressure; Cardiomegaly; Cell Size; Eplerenone; Fibrosis; Heart Rate; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Myocytes, Cardiac; Osteopontin; Reverse Transcriptase Polymerase Chain Reaction; Sialoglycoproteins; Spironolactone; Ultrasonography; Ventricular Remodeling

2004
Vascular synthesis of aldosterone: role in hypertension.
    Molecular and cellular endocrinology, 2004, Mar-31, Volume: 217, Issue:1-2

    Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Vessels; Cardiomegaly; Cytochrome P-450 CYP11B2; Hypertension; Male; Rats; Rats, Inbred SHR; Rats, Wistar; Receptor, Angiotensin, Type 1; RNA, Messenger; Sodium Chloride; Species Specificity

2004
Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II.
    Nature cell biology, 2004, Volume: 6, Issue:6

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Cardiomegaly; COS Cells; Cytosol; GTP-Binding Proteins; Humans; Janus Kinase 2; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; Muscle Contraction; Myocytes, Cardiac; Phosphatidylinositols; Protein Transport; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Stress, Mechanical; Tetrazoles; Up-Regulation

2004
Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system.
    Circulation research, 2004, Jul-23, Volume: 95, Issue:2

    Topics: Adenoviridae; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Brain Chemistry; Cardiomegaly; Genetic Therapy; Genetic Vectors; Humans; Hypertension; Infusion Pumps, Implantable; Infusions, Parenteral; Injections, Intraventricular; Isoenzymes; Losartan; Mice; Mice, Inbred C57BL; Myocardium; Organ Size; Oxidation-Reduction; Oxidative Stress; Recombinant Fusion Proteins; Subfornical Organ; Superoxide Dismutase; Superoxides

2004
Heme oxygenase-1 inhibits angiotensin II-induced cardiac hypertrophy in vitro and in vivo.
    Circulation, 2004, Jul-20, Volume: 110, Issue:3

    Topics: Angiotensin II; Animals; Bilirubin; Cardiomegaly; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Male; Myocytes, Cardiac; Rats; Rats, Wistar; Reactive Oxygen Species

2004
A ternary complex of transcription factors, Nishéd and NFATc4, and co-activator p300 bound to an intronic sequence, intronic regulatory element, is pivotal for the up-regulation of myosin light chain-2v gene in cardiac hypertrophy.
    The Journal of biological chemistry, 2004, Sep-24, Volume: 279, Issue:39

    Topics: Amino Acid Sequence; Angiotensin II; Animals; Base Sequence; Binding, Competitive; Blotting, Northern; Blotting, Western; Cardiac Myosins; Cardiomegaly; Cell Nucleus; Cells, Cultured; Chick Embryo; DNA; DNA-Binding Proteins; DNA, Complementary; Gene Library; Genes, Reporter; Introns; Luciferases; Models, Genetic; Molecular Sequence Data; Muscle, Skeletal; Myosin Light Chains; NFATC Transcription Factors; Nuclear Proteins; Oligonucleotides; Precipitin Tests; Protein Binding; Repressor Proteins; RNA; RNA, Messenger; T-Lymphocytes; Trans-Activators; Transcription Factors; Transcription, Genetic; Transfection; Up-Regulation

2004
Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis.
    Circulation, 2004, Aug-10, Volume: 110, Issue:6

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aortic Valve Stenosis; Apoptosis; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Disease Progression; Endoplasmic Reticulum; Gene Expression Regulation; Heart Failure; Humans; Imidazoles; Ligation; Male; Mice; Mice, Inbred C57BL; Molecular Chaperones; Myocytes, Cardiac; Natriuretic Peptide, Brain; Olmesartan Medoxomil; Rats; Rats, Inbred WKY; RNA, Messenger; Signal Transduction; Stress, Physiological; Tetrazoles; Thapsigargin; Tunicamycin

2004
Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade.
    Journal of molecular and cellular cardiology, 2004, Volume: 37, Issue:5

    Topics: Aging; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Aorta; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cardiomegaly; Fibrosis; Heart Rate; Hypertrophy; Imidazoles; Myocardium; Pyridines; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 2; Telemetry; Tetrazoles; Ventricular Remodeling

2004
Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.
    Free radical biology & medicine, 2005, Jan-15, Volume: 38, Issue:2

    Topics: Angiotensin II; Animals; Antioxidants; Aorta; Blood Pressure; Blotting, Western; Cardiomegaly; Dose-Response Relationship, Drug; Echocardiography; Enzyme Activation; Free Radicals; Glutathione Peroxidase; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heart; Heart Ventricles; Hydrogen Peroxide; L-Lactate Dehydrogenase; Leucine; Lipid Peroxidation; Malondialdehyde; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Models, Chemical; Myocytes, Cardiac; NF-kappa B; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase C; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Stilbenes; Superoxide Dismutase; Time Factors; Transcription Factor AP-1

2005
Development of a substrate of atrial fibrillation during chronic atrioventricular block in the goat.
    Circulation, 2005, Jan-04, Volume: 111, Issue:1

    Topics: Aldosterone; Angiotensin II; Animals; Atrial Fibrillation; Atrial Natriuretic Factor; Cardiac Pacing, Artificial; Cardiomegaly; Cell Size; Chronic Disease; Connexin 43; Connexins; Female; Gap Junction alpha-5 Protein; Goats; Heart Block; Heart Conduction System; Hemodynamics; Hypertrophy; Myocytes, Cardiac; Neural Conduction; Norepinephrine; Refractory Period, Electrophysiological

2005
PKCepsilon-PKD1 signaling complex at Z-discs plays a pivotal role in the cardiac hypertrophy induced by G-protein coupling receptor agonists.
    Biochemical and biophysical research communications, 2005, Feb-25, Volume: 327, Issue:4

    Topics: Adrenergic alpha-Agonists; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Endothelin-1; Heart; Mutation; Myocardium; Norepinephrine; Phorbol Esters; Protein Kinase C; Protein Kinase C-epsilon; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction

2005
Magnesium supplementation prevents angiotensin II-induced myocardial damage and CTGF overexpression.
    Journal of hypertension, 2005, Volume: 23, Issue:2

    Topics: Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Blood Pressure; Cardiomegaly; Connective Tissue Growth Factor; Dietary Supplements; Fibrosis; Humans; Immediate-Early Proteins; Immunosuppressive Agents; Intercellular Signaling Peptides and Proteins; Magnesium; Male; Myocardium; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Tacrolimus

2005
Letter regarding article by Hu et al, "heme oxygenase-1 inhibits angiotensin II-induced cardiac hypertrophy in vitro and in vivo".
    Circulation, 2005, Feb-15, Volume: 111, Issue:6

    Topics: Angiotensin II; Carbon Monoxide; Cardiomegaly; Cell Proliferation; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Humans; Membrane Proteins; Organometallic Compounds; Proto-Oncogene Proteins p21(ras); Reactive Oxygen Species

2005
Angiotensin II-dependent chronic hypertension and cardiac hypertrophy are unaffected by gp91phox-containing NADPH oxidase.
    Hypertension (Dallas, Tex. : 1979), 2005, Volume: 45, Issue:4

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Chronic Disease; Collagen; Humans; Hypertension; Kidney; Membrane Glycoproteins; Mice; Mice, Transgenic; Myocardium; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Reactive Oxygen Species; Renin; Tyrosine

2005
The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling.
    The Journal of biological chemistry, 2005, May-27, Volume: 280, Issue:21

    Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cell Size; Cells, Cultured; DNA-Binding Proteins; Enzyme Activation; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Expression; Gene Expression Regulation; Growth Hormone; Heart Ventricles; Insulin; Insulin-Like Growth Factor I; Mechanoreceptors; Mice; Mice, Knockout; Microarray Analysis; Muscle Proteins; Mutagenesis; Myocytes, Cardiac; Nerve Tissue Proteins; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Receptor, Insulin; RNA, Messenger; Signal Transduction; SKP Cullin F-Box Protein Ligases; Transcription Factors; Transfection

2005
Elevated dietary sodium intake exacerbates myocardial hypertrophy associated with cardiac-specific overproduction of angiotensin II.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, 2004, Volume: 5, Issue:4

    Topics: Angiotensin II; Angiotensinogen; Animals; Cardiomegaly; Dose-Response Relationship, Drug; Mice; Mice, Transgenic; Myocardium; Organ Size; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sodium, Dietary

2004
A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury.
    Basic research in cardiology, 2005, Volume: 100, Issue:4

    Topics: Angiotensin II; Animals; Blood Glucose; Cardiac Output; Cardiomegaly; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Obesity; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha; Ventricular Remodeling

2005
Inhibition of Rho-kinase by fasudil attenuated angiotensin II-induced cardiac hypertrophy in apolipoprotein E deficient mice.
    European journal of pharmacology, 2005, Apr-11, Volume: 512, Issue:2-3

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angiotensin II; Animals; Apolipoproteins E; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Collagen Type III; Coronary Vessels; Dose-Response Relationship, Drug; Fibrosis; Gene Expression; Heart Rate; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Knockout; Myocardium; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Reverse Transcriptase Polymerase Chain Reaction; rho-Associated Kinases; RNA, Messenger; Up-Regulation

2005
Cyclooxygenase-2 inhibitors attenuate angiotensin II-induced oxidative stress, hypertension, and cardiac hypertrophy in rats.
    Hypertension (Dallas, Tex. : 1979), 2005, Volume: 45, Issue:6

    Topics: Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiomegaly; Cells, Cultured; Cyclooxygenase Inhibitors; Hypertension; Lactones; Male; Myocardium; NF-kappa B; Oxidative Stress; Rats; Rats, Sprague-Dawley; Sulfonamides; Sulfones

2005
Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo.
    Circulation, 2005, May-10, Volume: 111, Issue:18

    Topics: Angiotensin II; Animals; Apoptosis; Cardiomegaly; I-kappa B Proteins; Interleukin-6; Isoproterenol; Mice; Myocytes, Cardiac; NF-kappa B; NF-KappaB Inhibitor alpha; Receptors, Interleukin-6

2005
[Effect of danshensu and ligustrazine on related genes of myocardial hypertrophy induced by angiotensin II].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2005, Volume: 25, Issue:4

    Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Drugs, Chinese Herbal; Female; Lactates; Male; Myocytes, Cardiac; Pyrazines; Rats; Rats, Wistar; RNA, Messenger

2005
Correction of endothelial dysfunction by tetrahydrobiopterin: new hope for the treatment of arterial hypertension?
    Journal of hypertension, 2005, Volume: 23, Issue:7

    Topics: Angiotensin II; Animals; Antioxidants; Biopterins; Cardiomegaly; Endothelium, Vascular; Hypertension; Immunohistochemistry; Male; Myocardium; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; RNA, Messenger; Superoxides; Tyrosine; Up-Regulation

2005
Supplementation with tetrahydrobiopterin prevents the cardiovascular effects of angiotensin II-induced oxidative and nitrosative stress.
    Journal of hypertension, 2005, Volume: 23, Issue:7

    Topics: Acetophenones; Angiotensin II; Animals; Antioxidants; Aorta, Thoracic; Biopterins; Cardiomegaly; Disease Models, Animal; Enzyme Inhibitors; Hypertension; Immunohistochemistry; Male; NADPH Oxidases; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitrites; Oxidative Stress; Rats; Rats, Sprague-Dawley; RNA, Messenger; Superoxides; Time Factors; Tyrosine; Up-Regulation

2005
Androgen receptor gene knockout male mice exhibit impaired cardiac growth and exacerbation of angiotensin II-induced cardiac fibrosis.
    The Journal of biological chemistry, 2005, Aug-19, Volume: 280, Issue:33

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; DNA-Binding Proteins; Fibrosis; Heart Rate; Male; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase 7; Myocardium; Receptors, Androgen; RNA, Messenger; Smad2 Protein; Trans-Activators; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ventricular Remodeling

2005
Continuous inhibition of the renin-angiotensin system and protection from hypertensive end-organ damage by brief treatment with angiotensin II type 1 receptor blocker in stroke-prone spontaneously hypertensive rats.
    Life sciences, 2005, Sep-16, Volume: 77, Issue:18

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Cardiomegaly; Cerebral Cortex; Histocytochemistry; Hypertension; Intercellular Adhesion Molecule-1; Kidney; Male; Myocardium; Nephrosclerosis; Rats; Rats, Inbred SHR; Renin; Renin-Angiotensin System; Stroke

2005
Different effects on inhibition of cardiac hypertrophy in spontaneously hypertensive rats by monotherapy and combination therapy of adrenergic receptor antagonists and/or the angiotensin II type 1 receptor blocker under comparable blood pressure reduction
    Hypertension research : official journal of the Japanese Society of Hypertension, 2005, Volume: 28, Issue:1

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Atenolol; Blood Pressure; Cardiomegaly; Doxazosin; Drug Therapy, Combination; Echocardiography; Heart Rate; Hypertension; Losartan; Male; Natriuretic Peptide, Brain; Rats; Rats, Inbred SHR; RNA, Messenger

2005
Growing old, angiotensin II, cardiac hypertrophy, and death: making the connection with p66Shc.
    Hypertension (Dallas, Tex. : 1979), 2005, Volume: 46, Issue:2

    Topics: Adaptor Proteins, Signal Transducing; Aging; Angiotensin II; Animals; Cardiomegaly; Humans; Hypertension; Shc Signaling Adaptor Proteins; Src Homology 2 Domain-Containing, Transforming Protein 1

2005
Angiotensin II-mediated phenotypic cardiomyocyte remodeling leads to age-dependent cardiac dysfunction and failure.
    Hypertension (Dallas, Tex. : 1979), 2005, Volume: 46, Issue:2

    Topics: Aging; Angiotensin II; Angiotensinogen; Animals; Calcium; Calcium-Transporting ATPases; Cardiac Output, Low; Cardiomegaly; Cardiomyopathy, Dilated; Male; Mice; Mice, Transgenic; Myocardial Contraction; Myocardium; Myocytes, Cardiac; Myosin Heavy Chains; Phenotype; Promoter Regions, Genetic; Rats; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Ventricular Remodeling

2005
Role of blood pressure reduction in prevention of cardiac and vascular hypertrophy.
    American journal of hypertension, 2005, Volume: 18, Issue:7

    Topics: Adrenergic beta-Antagonists; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiomegaly; Collagen; Disease Progression; Endothelium, Vascular; Heart Rate; Hypertension; Imidazoles; Male; Mesenteric Arteries; Myocardium; Rats; Rats, Inbred SHR; Tetrazoles; Vascular Diseases; Vascular Resistance

2005
Characterizing the role of endothelin-1 in the progression of cardiac hypertrophy in aryl hydrocarbon receptor (AhR) null mice.
    Toxicology and applied pharmacology, 2006, Apr-15, Volume: 212, Issue:2

    Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Cardiomegaly; Disease Progression; Echocardiography; Endothelin A Receptor Antagonists; Endothelin-1; Fibrosis; Hypertrophy, Left Ventricular; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Organ Size; Peptides, Cyclic; Receptor, Endothelin A; Receptors, Aryl Hydrocarbon; RNA, Messenger

2006
Role of myofibrillogenesis regulator-1 in myocardial hypertrophy.
    American journal of physiology. Heart and circulatory physiology, 2006, Volume: 290, Issue:1

    Topics: Amino Acid Sequence; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Aortic Valve Stenosis; Cardiomegaly; Cell Size; Losartan; Male; Molecular Sequence Data; Muscle Proteins; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; RNA Interference

2006
Pitavastatin inhibits cardiac hypertrophy in a rat model of progressive renal injury.
    Journal of cardiovascular pharmacology, 2005, Volume: 46, Issue:4

    Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Disease Progression; Enzyme Activation; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Kidney; Male; Myocytes, Cardiac; Nephrectomy; Phosphorylation; Quinolines; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vasoconstrictor Agents

2005
Mechanical stretch-induced hypertrophy of neonatal rat ventricular myocytes is mediated by beta(1)-integrin-microtubule signaling pathways.
    European journal of heart failure, 2006, Volume: 8, Issue:1

    Topics: Angiotensin II; Animals; Animals, Newborn; Antibodies; Cardiomegaly; Cells, Cultured; Colchicine; Disease Models, Animal; In Vitro Techniques; Integrin beta1; Microscopy, Confocal; Microtubules; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Signal Transduction; Stress, Mechanical

2006
Angiotensin-converting enzyme inhibitors: a new mechanism of action.
    Circulation, 2005, Oct-18, Volume: 112, Issue:16

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cardiomegaly; Cell Division; Collagen; Heart; Kidney; Leukocyte Count; Male; Myocardium; Rats; Rats, Sprague-Dawley; Ventricular Function, Left

2005
[Relationship between apoptosis and alteration of the energetic metabolism pathways of hypertrophic cardiomyocytes induced by hypoxia-reoxygenation].
    Sheng li xue bao : [Acta physiologica Sinica], 2005, Oct-25, Volume: 57, Issue:5

    Topics: Angiotensin II; Animals; Animals, Newborn; Apoptosis; Cardiomegaly; Cell Enlargement; Cell Hypoxia; Energy Metabolism; Myocardial Reperfusion Injury; Myocytes, Cardiac; Norepinephrine; Oxygen; Rats

2005
Dominant-negative c-Jun inhibits rat cardiac hypertrophy induced by angiotensin II and hypertension.
    Gene therapy, 2006, Volume: 13, Issue:4

    Topics: Adenoviridae; Angiotensin II; Animals; Blotting, Western; Cardiomegaly; Chemokine CCL2; Collagen Type I; Collagen Type III; Collagen Type IV; Gene Deletion; Genes, Dominant; Genetic Therapy; Genetic Vectors; Hypertension; Injections; Male; Models, Animal; Natriuretic Peptide, Brain; Phosphorylation; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6 Kinases, 70-kDa; Transcription Factor AP-1

2006
Decreased perivascular fibrosis but not cardiac hypertrophy in ROCK1+/- haploinsufficient mice.
    Circulation, 2005, Nov-08, Volume: 112, Issue:19

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Fibrosis; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Protein Serine-Threonine Kinases; Quaternary Ammonium Compounds; rho-Associated Kinases; Vascular Diseases

2005
Activation of AMP-activated protein kinase enhances angiotensin ii-induced proliferation in cardiac fibroblasts.
    Hypertension (Dallas, Tex. : 1979), 2006, Volume: 47, Issue:2

    Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Angiotensin II; Animals; Cardiomegaly; Cell Proliferation; Cells, Cultured; Drug Synergism; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Multienzyme Complexes; Myocardium; Organ Size; Proline; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Ribonucleotides; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Thymidine

2006
Cardiac-specific overexpression of diacylglycerol kinase zeta prevents Gq protein-coupled receptor agonist-induced cardiac hypertrophy in transgenic mice.
    Circulation, 2006, Jan-03, Volume: 113, Issue:1

    Topics: Angiotensin II; Animals; Cardiomegaly; Diacylglycerol Kinase; Diglycerides; GTP-Binding Protein alpha Subunits, Gq-G11; Heterotrimeric GTP-Binding Proteins; Mice; Mice, Transgenic; Myocardium; Myocytes, Cardiac; Phenylephrine; Promoter Regions, Genetic; Protein Kinase C; Rats; RNA, Messenger; Signal Transduction; Ventricular Myosins

2006
Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding.
    Circulation, 2006, Jan-03, Volume: 113, Issue:1

    Topics: Angiotensin II; Animals; Aortic Valve Stenosis; Biomarkers; Cardiomegaly; Disease Models, Animal; Drug Evaluation, Preclinical; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Male; Mice; Mice, Inbred Strains; Rats; Rats, Sprague-Dawley; Treatment Outcome

2006
Role of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart.
    American journal of physiology. Heart and circulatory physiology, 2006, Volume: 290, Issue:6

    Topics: Adiponectin; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Endothelin-1; Endothelins; Image Processing, Computer-Assisted; Immunohistochemistry; Myocardial Infarction; Myocytes, Cardiac; Neurotransmitter Agents; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptors, Adiponectin; Receptors, Cell Surface; RNA, Messenger; RNA, Small Interfering; Transfection; Tumor Necrosis Factor-alpha

2006
Effects of trans-resveratrol on hypertension-induced cardiac hypertrophy using the partially nephrectomized rat model.
    Clinical and experimental pharmacology & physiology, 2005, Volume: 32, Issue:12

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cardiovascular Agents; Endothelin-1; Hypertension, Renal; Male; Myocardium; Nephrectomy; Nitric Oxide; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes

2005
Effects of cyclosporine A on angiotensin II-induced cardiomyocyte hypertrophy in neonatal rats.
    Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2005, Volume: 25, Issue:5

    Topics: Angiotensin II; Animals; Animals, Newborn; Calcium; Cardiomegaly; Cells, Cultured; Cyclosporine; Myocytes, Cardiac; Proto-Oncogene Proteins c-fos; Rats

2005
Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II.
    Hypertension (Dallas, Tex. : 1979), 2006, Volume: 47, Issue:4

    Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Aorta; Carboxypeptidases; Cardiac Output, Low; Cardiomegaly; Cells, Cultured; Constriction, Pathologic; Enzyme Activation; Gene Deletion; Gene Expression; Heart; Hypertension; Male; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; Myocardium; Myocytes, Cardiac; Osmolar Concentration; Peptidyl-Dipeptidase A; RNA, Messenger

2006
Glycogen synthase kinase 3beta together with 14-3-3 protein regulates diabetic cardiomyopathy: effect of losartan and tempol.
    FEBS letters, 2006, Apr-03, Volume: 580, Issue:8

    Topics: 14-3-3 Proteins; Angiotensin II; Animals; Apoptosis; Blood Glucose; Body Weight; Cardiomegaly; Cardiomyopathies; Cyclic N-Oxides; Diabetes Complications; Endomyocardial Fibrosis; Glycogen Synthase Kinase 3; Losartan; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinases; Myocardium; NFATC Transcription Factors; Organ Size; Oxidative Stress; Phosphorylation; Protein Transport; Signal Transduction; Spin Labels; Streptozocin

2006
[Preventive effect of trans-resveratrol on hypertension-induced cardiac hypertrophy in partially nephrectomized rats].
    Wei sheng yan jiu = Journal of hygiene research, 2005, Volume: 34, Issue:6

    Topics: Angiotensin II; Animals; Cardiomegaly; Cardiovascular Agents; Endothelin-1; Hypertension; Male; Myocardium; Nephrectomy; Nitric Oxide; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes

2005
[Atorvastatin upregulates the expression of PPAR alpha/gamma and inhibits the hypertrophy of cardiac myocytes in vitro].
    Zhonghua xin xue guan bing za zhi, 2005, Volume: 33, Issue:12

    Topics: Angiotensin II; Animals; Atorvastatin; Cardiomegaly; Cells, Cultured; Gene Expression Regulation; Heptanoic Acids; Myocytes, Cardiac; PPAR alpha; PPAR-beta; Pyrroles; Rats; Rats, Wistar; Up-Regulation

2005
Poly(ADP-ribose) polymerase-1-deficient mice are protected from angiotensin II-induced cardiac hypertrophy.
    American journal of physiology. Heart and circulatory physiology, 2006, Volume: 291, Issue:4

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Endomyocardial Fibrosis; Gene Expression Regulation, Enzymologic; Mice; Mice, Knockout; Muscle Cells; Myocardium; NAD; Oxidative Stress; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Signal Transduction; Sirtuin 1; Sirtuins

2006
Requirement of Rac1 in the development of cardiac hypertrophy.
    Proceedings of the National Academy of Sciences of the United States of America, 2006, May-09, Volume: 103, Issue:19

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Gene Deletion; MAP Kinase Kinase Kinase 5; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidases; NF-kappa B; rac1 GTP-Binding Protein; Superoxides

2006
Association of RhoGDIalpha with Rac1 GTPase mediates free radical production during myocardial hypertrophy.
    Cardiovascular research, 2006, Jul-15, Volume: 71, Issue:2

    Topics: Angiotensin II; Animals; Blotting, Western; Cardiomegaly; Cells, Cultured; Fluorobenzenes; Free Radicals; Guanine Nucleotide Dissociation Inhibitors; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoprecipitation; Leucine; Lipid Peroxidation; Mice; Mice, Inbred C57BL; Myocardium; NADPH Oxidases; Protein Binding; Pyrimidines; rac1 GTP-Binding Protein; rho Guanine Nucleotide Dissociation Inhibitor alpha; rho-Specific Guanine Nucleotide Dissociation Inhibitors; RNA Interference; Rosuvastatin Calcium; Sulfonamides; Superoxides

2006
HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
    Life sciences, 2006, Aug-29, Volume: 79, Issue:14

    Topics: Adenoviridae Infections; Amides; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Cyclin D1; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fluvastatin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoblotting; Indoles; Intracellular Signaling Peptides and Proteins; Leucine; Male; Mevalonic Acid; Myocardium; Myocytes, Cardiac; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; rho-Associated Kinases; RNA, Messenger

2006
Contribution of PI 3-kinase isoforms to angiotensin II- and alpha-adrenoceptor-mediated signalling pathways in cardiomyocytes.
    Cardiovascular research, 2006, Jul-15, Volume: 71, Issue:2

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Chromones; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Isoenzymes; Male; Microscopy, Fluorescence; Morpholines; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Phenylalanine; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Rats; Rats, Wistar; Reactive Oxygen Species; Receptors, Adrenergic, alpha; Reverse Transcriptase Polymerase Chain Reaction; Ribosomal Protein S6 Kinases; Signal Transduction; Transforming Growth Factor beta

2006
Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways.
    Free radical biology & medicine, 2006, May-15, Volume: 40, Issue:10

    Topics: Angiotensin II; Animals; Animals, Newborn; Antioxidants; Blotting, Northern; Blotting, Western; Cardiomegaly; Catechin; Electrophoretic Mobility Shift Assay; Enzyme Activation; ErbB Receptors; Hypertension; Male; MAP Kinase Kinase 4; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Transcription Factor AP-1

2006
[Protein kinase Cdelta is possibly involved in the transition from hypertrophy to apoptosis of myocardiocytes].
    Sheng li xue bao : [Acta physiologica Sinica], 2006, Jun-25, Volume: 58, Issue:3

    Topics: Angiotensin II; Animals; Animals, Newborn; Apoptosis; Cardiomegaly; Cell Enlargement; Endothelin-1; Heart Failure; Myocytes, Cardiac; Primary Cell Culture; Protein Kinase C-delta; Rats; Rats, Sprague-Dawley

2006
An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin II and endothelin-1.
    Journal of molecular and cellular cardiology, 2006, Volume: 41, Issue:2

    Topics: Adipocytes; Angiotensin II; Animals; Animals, Newborn; Autocrine Communication; Cardiomegaly; Cells, Cultured; Endothelin-1; Gene Expression Regulation; Heart Ventricles; Leptin; MAP Kinase Signaling System; Myocytes, Cardiac; Obesity; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents

2006
Estrogen and salt sensitivity in the female mRen(2). Lewis rat.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2006, Volume: 291, Issue:5

    Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Estrogens; Female; Gene Expression Regulation; Heart Rate; Hypertension; Kidney Diseases; Ovariectomy; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Lew; Renin; Renin-Angiotensin System; Sodium Chloride, Dietary

2006
[Angiotensin II induced cardiac hypertrophy is blocked by PTEN via suppressing Ca2+/Calcineurin pathway].
    Zhonghua xin xue guan bing za zhi, 2006, Volume: 34, Issue:6

    Topics: Adenoviridae; Angiotensin II; Animals; Calcineurin; Calcium; Cardiomegaly; Cells, Cultured; DNA, Complementary; Myocytes, Cardiac; PTEN Phosphohydrolase; Rats; Rats, Wistar; RNA, Messenger; Signal Transduction

2006
An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy.
    Circulation research, 2006, Sep-01, Volume: 99, Issue:5

    Topics: Angiotensin II; Animals; Apoptosis; Cardiomegaly; Diastole; Echocardiography; ErbB Receptors; Fibrosis; Genes, Dominant; Heart; Mice; Mice, Transgenic; Mutation; Myocardium; Phenylalanine; Receptor, Angiotensin, Type 1; Transcriptional Activation; Tyrosine; Ventricular Function, Left

2006
Down-regulation of cardiac apelin system in hypertrophied and failing hearts: Possible role of angiotensin II-angiotensin type 1 receptor system.
    Journal of molecular and cellular cardiology, 2006, Volume: 41, Issue:5

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apelin; Cardiomegaly; Carrier Proteins; Down-Regulation; Heart Failure; Intercellular Signaling Peptides and Proteins; Male; Rats; Rats, Inbred Dahl; Receptor, Angiotensin, Type 1; RNA, Messenger; Signal Transduction

2006
Small gene effect and exercise training-induced cardiac hypertrophy in mice: an Ace gene dosage study.
    Physiological genomics, 2006, Nov-27, Volume: 27, Issue:3

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Gene Dosage; Genetic Variation; Heart Rate; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Myocardium; Myocytes, Cardiac; Peptidyl-Dipeptidase A; Physical Conditioning, Animal; Renin; Renin-Angiotensin System; Swimming

2006
Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling.
    Circulation, 2006, Sep-12, Volume: 114, Issue:11

    Topics: Angiotensin II; Animals; Calcineurin; Calcium-Binding Proteins; Cardiomegaly; Cells, Cultured; Forkhead Box Protein O1; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Expression Regulation; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Muscle Proteins; Myocytes, Cardiac; Nerve Tissue Proteins; NFATC Transcription Factors; Phosphatidylinositol 3-Kinases; Phosphoric Monoester Hydrolases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Transcription Factors

2006
Soluble guanylate cyclase stimulation on cardiovascular remodeling in angiotensin II-induced hypertensive rats.
    Hypertension (Dallas, Tex. : 1979), 2006, Volume: 48, Issue:5

    Topics: Angiotensin II; Animals; Cardiomegaly; Cardiovascular System; Cells, Cultured; Guanylate Cyclase; Hypertension; Male; Pyrazoles; Pyridines; Rats; Rats, Wistar; Solubility

2006
Chronic angiotensin II stimulation in the heart produces an acquired long QT syndrome associated with IK1 potassium current downregulation.
    Journal of molecular and cellular cardiology, 2007, Volume: 42, Issue:1

    Topics: Action Potentials; Angiotensin II; Animals; Base Sequence; Cardiomegaly; Disease Models, Animal; DNA Primers; Down-Regulation; Electrocardiography; Humans; In Vitro Techniques; Intermediate-Conductance Calcium-Activated Potassium Channels; Long QT Syndrome; Male; Mice; Mice, Transgenic; Myocytes, Cardiac; Patch-Clamp Techniques; Potassium Channels, Inwardly Rectifying; RNA, Messenger

2007
TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy.
    The EMBO journal, 2006, Nov-15, Volume: 25, Issue:22

    Topics: Angiotensin II; Animals; Animals, Newborn; Calcium Channels, L-Type; Calcium Signaling; Cardiomegaly; Cells, Cultured; Diglycerides; Inositol 1,4,5-Trisphosphate; Ion Channel Gating; Membrane Potentials; Myocytes, Cardiac; NFATC Transcription Factors; Rats; Signal Transduction; TRPC Cation Channels; Type C Phospholipases; Vasoconstrictor Agents

2006
Integrin-linked kinase expression is elevated in human cardiac hypertrophy and induces hypertrophy in transgenic mice.
    Circulation, 2006, Nov-21, Volume: 114, Issue:21

    Topics: Alanine; Angiotensin II; Animals; Arginine; Cardiomegaly; cdc42 GTP-Binding Protein; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Fetus; Heart Ventricles; Humans; Infant; Mice; Mice, Transgenic; Mutation; Myocardium; Myocytes, Cardiac; Phosphorylation; Protein Serine-Threonine Kinases; rac1 GTP-Binding Protein; Ribosomal Protein S6 Kinases, 70-kDa; Ventricular Outflow Obstruction

2006
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney.
    Proceedings of the National Academy of Sciences of the United States of America, 2006, Nov-21, Volume: 103, Issue:47

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Gene Expression Regulation; Heart; Homeostasis; Humans; Hypertension; Kidney; Kidney Transplantation; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Receptor, Angiotensin, Type 1; Sodium

2006
Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7).
    American journal of physiology. Heart and circulatory physiology, 2007, Volume: 292, Issue:2

    Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Disease Models, Animal; Fibrosis; Heart; Hypertension; Male; Myocardium; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Time Factors; Transforming Growth Factor beta; Ventricular Remodeling

2007
Carbonic anhydrase inhibition prevents and reverts cardiomyocyte hypertrophy.
    The Journal of physiology, 2007, Feb-15, Volume: 579, Issue:Pt 1

    Topics: Age Factors; Angiotensin II; Animals; Atrial Natriuretic Factor; Calcium; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cardiomegaly; Cardiotonic Agents; Cation Transport Proteins; Cells, Cultured; Chloride-Bicarbonate Antiporters; Ethoxzolamide; Gene Expression; Humans; Kidney; Membrane Potentials; Membrane Transport Proteins; Mice; Myocytes, Cardiac; Phenylephrine; Rats; Sodium-Hydrogen Exchanger 1; Sodium-Hydrogen Exchangers; Sulfate Transporters; Transfection; Vasoconstrictor Agents

2007
Urotensin II accelerates cardiac fibrosis and hypertrophy of rats induced by isoproterenol.
    Acta pharmacologica Sinica, 2007, Volume: 28, Issue:1

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Proliferation; Collagen; Fibroblasts; Fibrosis; Hydroxyproline; Isoproterenol; Lactate Dehydrogenases; Male; Malondialdehyde; Myocardium; Random Allocation; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Urotensins

2007
Effect of pioglitazone on the expression of inflammatory cytokines in attenuating rat cardiomyocyte hypertrophy.
    Methods and findings in experimental and clinical pharmacology, 2006, Volume: 28, Issue:10

    Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Interleukin-1beta; Interleukin-6; Leucine; Myocytes, Cardiac; Natriuretic Peptide, Brain; Pioglitazone; PPAR gamma; Rats; Rats, Wistar; RNA, Messenger; Thiazolidinediones

2006
Adapter molecule DOC-2 is differentially expressed in pressure and volume overload hypertrophy and inhibits collagen synthesis in cardiac fibroblasts.
    Journal of applied physiology (Bethesda, Md. : 1985), 2007, Volume: 102, Issue:5

    Topics: Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Angiotensin II; Animals; Aorta, Abdominal; Arteriovenous Shunt, Surgical; Cardiomegaly; Cells, Cultured; Collagen; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Flavonoids; Gene Expression; Ligation; Myocytes, Cardiac; Phorbol Esters; Phosphorylation; Protein Kinase C; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Transfection; Ventricular Remodeling

2007
Effects of dietary salt load and salt depletion on the course of hypertension and angiotensin II levels in male and female heterozygous Ren-2 transgenic rats.
    Kidney & blood pressure research, 2007, Volume: 30, Issue:1

    Topics: Angiotensin II; Animals; Animals, Genetically Modified; Blood Pressure; Cardiomegaly; Female; Heterozygote; Hypertension, Renal; Kidney; Male; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; Sex Characteristics; Sodium Chloride, Dietary

2007
Primary role of angiotensin-converting enzyme-2 in cardiac production of angiotensin-(1-7) in transgenic Ren-2 hypertensive rats.
    American journal of physiology. Heart and circulatory physiology, 2007, Volume: 292, Issue:6

    Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Cardiomegaly; Disease Models, Animal; Half-Life; Hypertension; Imidazoles; Kinetics; Leucine; Male; Mice; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Renin

2007
Re-expression of proteins involved in cytokinesis during cardiac hypertrophy.
    Experimental cell research, 2007, Apr-01, Volume: 313, Issue:6

    Topics: Actomyosin; Amides; Angiotensin II; Animals; Antihypertensive Agents; Biomarkers; Calpain; Cardiomegaly; Cell Nucleus Division; Cullin Proteins; Cytokinesis; Heart; Hypertension; Intracellular Signaling Peptides and Proteins; Mice; Myocytes, Cardiac; Myofibrils; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Inbred Dahl; rho GTP-Binding Proteins; rho-Associated Kinases; Up-Regulation

2007
Contribution of different Nox homologues to cardiac remodeling in two-kidney two-clip renovascular hypertensive rats: effect of valsartan.
    Pharmacological research, 2007, Volume: 55, Issue:5

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Cardiomegaly; Disease Models, Animal; Fibrosis; Heart Ventricles; Hypertension, Renovascular; Ligation; Male; Malondialdehyde; Membrane Glycoproteins; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Rats; Rats, Sprague-Dawley; Renal Artery; Superoxides; Tetrazoles; Valine; Valsartan; Ventricular Function, Left; Ventricular Remodeling

2007
Sodium tanshinone IIA sulfonate depresses angiotensin II-induced cardiomyocyte hypertrophy through MEK/ERK pathway.
    Experimental & molecular medicine, 2007, Feb-28, Volume: 39, Issue:1

    Topics: Angiotensin II; Animals; Cardiomegaly; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; Molecular Structure; Myocytes, Cardiac; Phenanthrenes; Rats; Rats, Wistar

2007
Beta-catenin downregulation is required for adaptive cardiac remodeling.
    Circulation research, 2007, May-11, Volume: 100, Issue:9

    Topics: Angiotensin II; Animals; beta Catenin; Cardiomegaly; Gene Expression Regulation; Insulin-Like Growth Factor Binding Protein 5; Mice; Mice, Inbred C57BL; T-Box Domain Proteins; Ventricular Remodeling

2007
Angiotensin II-induced sudden arrhythmic death and electrical remodeling.
    American journal of physiology. Heart and circulatory physiology, 2007, Volume: 293, Issue:2

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Animals, Genetically Modified; Blood Pressure; Cardiac Pacing, Artificial; Cardiomegaly; Connexin 43; Death, Sudden, Cardiac; Disease Models, Animal; Electrocardiography; Heart Conduction System; Hypertension; Losartan; Male; Myocardium; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Shal Potassium Channels; Tachycardia, Ventricular; Telemetry; Time Factors; Ventricular Remodeling

2007
Overexpression of myofibrillogenesis regulator-1 aggravates cardiac hypertrophy induced by angiotensin II in mice.
    Hypertension (Dallas, Tex. : 1979), 2007, Volume: 49, Issue:6

    Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Endomyocardial Fibrosis; Female; Gene Expression Regulation; Humans; Mice; Mice, Transgenic; Muscle Proteins; Myocardium; Natriuretic Peptide, Brain; NF-kappa B; RNA, Messenger; Signal Transduction; Vasoconstrictor Agents; Ventricular Remodeling

2007
CD59 or C3 are not requred for angiotensin II-dependent hypertension or hypertrophy in mice.
    Immunology, 2007, Volume: 121, Issue:4

    Topics: Angiotensin II; Animals; Aorta, Thoracic; Body Weight; Cardiomegaly; CD59 Antigens; Complement Activation; Complement C3; Cyclic GMP; Dose-Response Relationship, Drug; Hypertension; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Platelet Endothelial Cell Adhesion Molecule-1; Receptor, Angiotensin, Type 1; Tissue Culture Techniques

2007
MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy?
    The American journal of pathology, 2007, Volume: 170, Issue:6

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Gene Expression Profiling; Heart; Mice; Mice, Inbred C57BL; MicroRNAs; Myocytes, Cardiac; Oligonucleotide Array Sequence Analysis; Oligonucleotides, Antisense; Rats; Rats, Sprague-Dawley

2007
Genetic disruption of guanylyl cyclase/natriuretic peptide receptor-A upregulates ACE and AT1 receptor gene expression and signaling: role in cardiac hypertrophy.
    Physiological genomics, 2007, Oct-22, Volume: 31, Issue:2

    Topics: Angiotensin II; Animals; Captopril; Cardiomegaly; Cyclic GMP; Fibrosis; Gene Expression Regulation; Guanylate Cyclase; Heart Ventricles; Hydralazine; Hypertension; Interleukin-6; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptors, Atrial Natriuretic Factor; Renin-Angiotensin System; Signal Transduction; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha

2007
Classic interleukin-6 receptor signaling and interleukin-6 trans-signaling differentially control angiotensin II-dependent hypertension, cardiac signal transducer and activator of transcription-3 activation, and vascular hypertrophy in vivo.
    The American journal of pathology, 2007, Volume: 171, Issue:1

    Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Cardiomegaly; Hypertension; Hypertrophy; Interleukin-6; Mice; Myocardium; Receptors, Interleukin-6; Recombinant Fusion Proteins; Signal Transduction; STAT3 Transcription Factor; Transcriptional Activation

2007
Simvastatin reverses target organ damage and oxidative stress in Angiotensin II hypertension: comparison with apocynin, tempol, and hydralazine.
    Journal of cardiovascular pharmacology, 2007, Volume: 50, Issue:3

    Topics: Acetophenones; Albuminuria; Angiotensin II; Animals; Antihypertensive Agents; Antioxidants; Cardiomegaly; Carotid Arteries; Cyclic N-Oxides; Hydralazine; Hypertension; Hypolipidemic Agents; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Simvastatin; Spin Labels; Superoxides; Tunica Media

2007
Angiotensin II receptors subtypes mediate diverse gene expression profile in adult hypertrophic cardiomyocytes.
    Clinical and experimental pharmacology & physiology, 2007, Volume: 34, Issue:11

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Aorta, Abdominal; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Gene Expression Profiling; Gene Expression Regulation; Imidazoles; Interleukin-1beta; Interleukin-6; Ligation; Losartan; Male; Myocytes, Cardiac; Oligonucleotide Array Sequence Analysis; Pyridines; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Time Factors; Tumor Necrosis Factor-alpha

2007
Imbalance between CaM kinase II and calcineurin activities impairs caffeine-induced calcium release in hypertrophic cardiomyocytes.
    Biochemical pharmacology, 2007, Dec-15, Volume: 74, Issue:12

    Topics: Angiotensin II; Animals; Calcineurin; Calcium; Calcium-Binding Proteins; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; Cells, Cultured; Endothelin-1; Immunohistochemistry; Indazoles; Phenylephrine; Phosphorylation; Rats; Rats, Wistar

2007
Anabolic steroids induce cardiac renin-angiotensin system and impair the beneficial effects of aerobic training in rats.
    American journal of physiology. Heart and circulatory physiology, 2007, Volume: 293, Issue:6

    Topics: Anabolic Agents; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Cardiomegaly; Collagen; Gene Expression Regulation; Heart Rate; Hydroxyproline; Losartan; Male; Myocardial Contraction; Myocardium; Nandrolone; Nandrolone Decanoate; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Swimming; Testosterone; Time Factors; Ventricular Function, Left; Ventricular Remodeling

2007
Absence of peroxisome proliferator-activated receptor-alpha abolishes hypertension and attenuates atherosclerosis in the Tsukuba hypertensive mouse.
    Hypertension (Dallas, Tex. : 1979), 2007, Volume: 50, Issue:5

    Topics: Aldosterone; Angiotensin II; Animals; Atherosclerosis; Blood Pressure; Cardiomegaly; Diet, Atherogenic; Disease Models, Animal; Fenofibrate; Genotype; Humans; Hypertension; Hypolipidemic Agents; Mice; Mice, Knockout; Mice, Transgenic; PPAR alpha; Renin; Renin-Angiotensin System

2007
Synergetic antioxidant and vasodilatory action of carbon monoxide in angiotensin II - induced cardiac hypertrophy.
    Hypertension (Dallas, Tex. : 1979), 2007, Volume: 50, Issue:6

    Topics: Angiotensin II; Animals; Antioxidants; Aorta; Blood Pressure; Carbon Monoxide; Carboxyhemoglobin; Cardiomegaly; Hydralazine; Hypercholesterolemia; Lipid Peroxides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidases; Phosphorylation; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Receptors, LDL; Vasodilator Agents

2007
Calsarcin-1 protects against angiotensin-II induced cardiac hypertrophy.
    Circulation, 2007, Nov-27, Volume: 116, Issue:22

    Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Calcineurin; Calcium-Binding Proteins; Cardiomegaly; Carrier Proteins; Genetic Therapy; Intracellular Signaling Peptides and Proteins; Mice; Mice, Transgenic; Muscle Proteins; RNA, Messenger; Signal Transduction

2007
Mice expressing ACE only in the heart show that increased cardiac angiotensin II is not associated with cardiac hypertrophy.
    American journal of physiology. Heart and circulatory physiology, 2008, Volume: 294, Issue:2

    Topics: Alleles; Angiotensin I; Angiotensin II; Angiotensinogen; Animals; Aorta, Abdominal; Blood Pressure; Blotting, Western; Cardiac Catheterization; Cardiomegaly; Connexin 43; DNA; Electrocardiography; Heart; Kidney; Mice; Mice, Knockout; Mice, Transgenic; Myocardium; Osmolar Concentration; Peptidyl-Dipeptidase A; Reverse Transcriptase Polymerase Chain Reaction; Tissue Distribution; Ventricular Function, Left

2008
Novel anti-inflammatory mechanisms of N-Acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damage.
    American journal of physiology. Heart and circulatory physiology, 2008, Volume: 294, Issue:3

    Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Azo Compounds; Blotting, Western; Cardiomegaly; Cell Separation; Collagen; Fibrosis; Galectin 3; Heart Rate; Hypertension; In Vitro Techniques; Inflammation; Kidney; Male; Mice; Mice, Inbred C57BL; Myocardium; Neutrophil Infiltration; Oligopeptides; Stem Cells; Tumor Necrosis Factor-alpha

2008
Propofol depresses angiotensin II-induced cardiomyocyte hypertrophy in vitro.
    Experimental biology and medicine (Maywood, N.J.), 2008, Volume: 233, Issue:2

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Survival; Cells, Cultured; Cytoprotection; Extracellular Signal-Regulated MAP Kinases; Mitogen-Activated Protein Kinase Kinases; Myocytes, Cardiac; NF-kappa B; Phosphorylation; Propofol; Rats; Rats, Wistar; Reactive Oxygen Species

2008
Peroxisome proliferator-activated receptor beta/delta activation improves angiotensin II-induced cardiac hypertrophy in vitro.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2008, Volume: 30, Issue:2

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Membrane; Cells, Cultured; Cytokines; Down-Regulation; Fluorescent Antibody Technique; In Vitro Techniques; Leucine; Myocytes, Cardiac; PPAR delta; PPAR-beta; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Staining and Labeling; Thiazoles

2008
Involvement of calcium-sensing receptor in cardiac hypertrophy-induced by angiotensinII through calcineurin pathway in cultured neonatal rat cardiomyocytes.
    Biochemical and biophysical research communications, 2008, May-02, Volume: 369, Issue:2

    Topics: Angiotensin II; Animals; Animals, Newborn; Calcineurin; Calcium; Cardiomegaly; Cells, Cultured; Myocytes, Cardiac; Rats; Rats, Wistar; Receptors, Calcium-Sensing; Signal Transduction

2008
Protein kinase CK2 links extracellular growth factor signaling with the control of p27(Kip1) stability in the heart.
    Nature medicine, 2008, Volume: 14, Issue:3

    Topics: Aging; Angiotensin II; Animals; Cardiomegaly; Casein Kinase II; Cell Proliferation; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p27; Humans; Intercellular Signaling Peptides and Proteins; Mice; Mice, Knockout; Myocardium; Myocytes, Cardiac; Protein Binding; Rats; Signal Transduction

2008
Angiotensin II regulates cardiac hypertrophy via oxidative stress but not antioxidant enzyme activities in experimental renovascular hypertension.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2008, Volume: 31, Issue:2

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Catalase; Glutathione; Hypertension, Renovascular; Losartan; Male; NADPH Oxidases; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase

2008
Angiotensin II activates myostatin expression in cultured rat neonatal cardiomyocytes via p38 MAP kinase and myocyte enhance factor 2 pathway.
    The Journal of endocrinology, 2008, Volume: 197, Issue:1

    Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; MADS Domain Proteins; MAP Kinase Signaling System; MEF2 Transcription Factors; Myocytes, Cardiac; Myogenic Regulatory Factors; Myostatin; p38 Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Protein Biosynthesis; Rats; Rats, Wistar; Signal Transduction

2008
Estrogen inhibits cardiac hypertrophy: role of estrogen receptor-beta to inhibit calcineurin.
    Endocrinology, 2008, Volume: 149, Issue:7

    Topics: Angiotensin II; Animals; Calcineurin; Calcium-Binding Proteins; Cardiomegaly; Collagen; Estradiol; Estrogen Receptor beta; Estrogens; Female; Fibrosis; Intracellular Signaling Peptides and Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Biological; Muscle Proteins; Myocardium; Myosin Heavy Chains; Ovariectomy

2008
Involvement of tumor necrosis factor-alpha in angiotensin II-mediated effects on salt appetite, hypertension, and cardiac hypertrophy.
    Hypertension (Dallas, Tex. : 1979), 2008, Volume: 51, Issue:5

    Topics: Angiotensin II; Animals; Appetite; Blood Pressure; Cardiomegaly; Heart; Hypertension; Male; Mice; Mice, Knockout; NF-kappa B; Receptor, Angiotensin, Type 1; Sodium Chloride; Thirst; Tumor Necrosis Factor-alpha

2008
Prevention of salt-induced hypertension and fibrosis by AT1-receptor blockers in Dahl S rats.
    Journal of cardiovascular pharmacology, 2008, Volume: 51, Issue:5

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Benzimidazoles; Benzoates; Blood Pressure; Cardiomegaly; Dose-Response Relationship, Drug; Fibrosis; Heart Rate; Hypertension; Hypertrophy; Kidney; Losartan; Male; Myocardium; Organ Specificity; Rats; Rats, Inbred Dahl; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sodium, Dietary; Telmisartan

2008
Chromogranin B regulates calcium signaling, nuclear factor kappaB activity, and brain natriuretic peptide production in cardiomyocytes.
    Circulation research, 2008, May-23, Volume: 102, Issue:10

    Topics: Age Factors; Angiotensin II; Animals; Calcium; Calcium Signaling; Cardiomegaly; Cells, Cultured; Chromogranin B; Inositol 1,4,5-Trisphosphate Receptors; Myocytes, Cardiac; Natriuretic Peptide, Brain; NF-kappa B; NFATC Transcription Factors; Promoter Regions, Genetic; Rats; Transcription, Genetic; Vasoconstrictor Agents

2008
Alpha2-antiplasmin is a critical regulator of angiotensin II-mediated vascular remodeling.
    Arteriosclerosis, thrombosis, and vascular biology, 2008, Volume: 28, Issue:7

    Topics: Angiotensin II; Animals; Apoptosis; Cardiomegaly; Cell Proliferation; Collagen Type I; Cyclin-Dependent Kinase Inhibitor p21; Disease Models, Animal; Eye Proteins; Fibrosis; Gelatinases; Hypertension; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Nerve Growth Factors; NG-Nitroarginine Methyl Ester; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Serpins; Thoracic Arteries; Tumor Suppressor Protein p53

2008
Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension.
    American journal of physiology. Renal physiology, 2008, Volume: 295, Issue:2

    Topics: Albuminuria; Angiotensin II; Animals; Cardiomegaly; Cell Proliferation; Cytoskeleton; Disease Models, Animal; Hypertension; Immunosuppressive Agents; Interferon-gamma; Kidney Diseases; Male; Mice; Mice, Knockout; Mycophenolic Acid; Sodium Chloride, Dietary; T-Lymphocytes; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vasoconstrictor Agents

2008
Renal hypertension in the Brattleboro diabetes insipidus rat.
    Annals of the New York Academy of Sciences, 1982, Volume: 394

    Topics: Angiotensin II; Animals; Body Weight; Cardiomegaly; Constriction; Deamino Arginine Vasopressin; Diabetes Insipidus; Diuresis; Drinking; Hematocrit; Hypertension, Renal; Rats; Rats, Brattleboro; Rats, Mutant Strains; Renal Artery; Renin

1982
Left ventricular mass in middle-aged men. Relationship to blood pressure, sympathetic nervous activity, hormonal and metabolic factors.
    Clinical and experimental hypertension. Part A, Theory and practice, 1983, Volume: 5, Issue:9

    Topics: Angiotensin II; Blood Glucose; Blood Pressure; Cardiomegaly; Echocardiography; Humans; Hypertension; Insulin; Isometric Contraction; Male; Middle Aged; Norepinephrine; Renin-Angiotensin System; Sympathetic Nervous System

1983
Pulmonary vascular changes in young and aging rats exposed to 5,486 m altitude.
    Respiration; international review of thoracic diseases, 1984, Volume: 46, Issue:3

    Topics: Aging; Altitude; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Dose-Response Relationship, Drug; Hematocrit; Hypoxia; Male; Muscle, Smooth, Vascular; Polycythemia; Pulmonary Circulation; Rats; Rats, Inbred Strains; Vasoconstriction

1984
The role of pulmonary vascular responses to chronic hypoxia in the development of chronic mountain sickness in rats.
    Respiration physiology, 1984, Volume: 58, Issue:2

    Topics: Altitude Sickness; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Hypertension, Pulmonary; Hypoxia; Lung; Polycythemia; Rats; Rats, Inbred Strains; Vascular Resistance; Vasoconstriction

1984
[Prevention of the development of genetic hypertension by MK 421 in the SHR].
    Archives des maladies du coeur et des vaisseaux, 1982, Volume: 75 Spec No

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Cardiomegaly; Dipeptides; Enalapril; Hypertension; Male; Norepinephrine; Rats; Rats, Inbred Strains

1982
Effects of losartan, an angiotensin II antagonist, on the development of cardiac hypertrophy due to volume overload.
    Biological & pharmaceutical bulletin, 1995, Volume: 18, Issue:5

    Topics: Angiotensin II; Animals; Biphenyl Compounds; Blood Pressure; Cardiac Volume; Cardiomegaly; Imidazoles; Losartan; Male; Organ Size; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Renin; Tetrazoles

1995
Angiotensin AT1 receptor-mediated attenuation of cardiac hypertrophy due to volume overload: involvement of endothelin.
    European journal of pharmacology, 1995, Jun-23, Volume: 280, Issue:1

    Topics: Amino Acid Sequence; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Azepines; Biphenyl Compounds; Cardiac Volume; Cardiomegaly; Endothelin Receptor Antagonists; Endothelins; Heart; Heart Ventricles; Hypertrophy, Left Ventricular; Imidazoles; Indoles; Losartan; Male; Molecular Sequence Data; Myocardium; Organ Size; Rats; Rats, Wistar; Receptors, Angiotensin; Tetrazoles; Time Factors

1995
Basal and angiotensin II-induced cytosolic free calcium in adult rat cardiomyocytes and fibroblasts after volume overload.
    Hypertension (Dallas, Tex. : 1979), 1995, Volume: 26, Issue:6 Pt 2

    Topics: Analysis of Variance; Angiotensin II; Animals; Atrial Natriuretic Factor; Calcium; Cardiac Volume; Cardiomegaly; Cells, Cultured; Culture Media; Cytosol; Fibroblasts; Male; Myocardium; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Stimulation, Chemical; Vasoconstrictor Agents

1995
Comparable effects of angiotensin II and converting enzyme blockade on hemodynamics and cardiac hypertrophy in spontaneously hypertensive rats.
    Japanese circulation journal, 1995, Volume: 59, Issue:9

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Cardiac Output; Cardiomegaly; Heart; Hemodynamics; Hypertension; Kidney; Lisinopril; Male; Organ Size; Rats; Rats, Inbred SHR; Rats, Wistar; Renal Circulation; Tetrazoles

1995
Induction of immediate-early genes by angiotensin II and endothelin-1 in adult rat cardiomyocytes.
    Journal of hypertension, 1993, Volume: 11, Issue:9

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; DNA-Binding Proteins; Early Growth Response Protein 1; Endothelins; Gene Expression Regulation; Genes, fos; Genes, Immediate-Early; Immediate-Early Proteins; Male; Myocardium; Rats; Rats, Inbred WKY; RNA; Transcription Factors

1993
Effect of indapamide on cyclic adenosine 3',5'-monophosphate signal transduction system in isolated adult rat cardiomyocytes from normal myocardium and cardiac hypertrophy.
    Journal of cardiovascular pharmacology, 1993, Volume: 22 Suppl 6

    Topics: 1-Methyl-3-isobutylxanthine; Angiotensin II; Animals; Binding, Competitive; Carbachol; Cardiomegaly; Colforsin; Cyclic AMP; Heart; In Vitro Techniques; Indapamide; Isoproterenol; Male; Myocardium; Rats; Rats, Wistar; Signal Transduction

1993
Angiotensin II maintains, but does not mediate, isoproterenol-induced cardiac hypertrophy in rats.
    The American journal of physiology, 1994, Volume: 267, Issue:4 Pt 2

    Topics: Actins; Angiotensin II; Animals; Base Sequence; Biphenyl Compounds; Blood Pressure; Captopril; Cardiomegaly; DNA; DNA Primers; Dose-Response Relationship, Drug; Gene Expression; Genes, fos; Heart; Hydralazine; Hydroxyproline; Imidazoles; Isoproterenol; Labetalol; Losartan; Male; Methyldopa; Molecular Sequence Data; Myocardium; Myosins; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; RNA; RNA, Messenger; Tetrazoles; Transcription, Genetic

1994
Angiotensin II induced alteration of cyclic adenosine 3',5'-monophosphate generation in the hypertrophic myocardium of Dahl salt-sensitive rat on a high-salt diet.
    Canadian journal of physiology and pharmacology, 1994, Volume: 72, Issue:6

    Topics: 1-Methyl-3-isobutylxanthine; Adenylate Cyclase Toxin; Angiotensin II; Animals; Cardiomegaly; Cell Size; Colforsin; Cyclic AMP; Diet; Flow Cytometry; In Vitro Techniques; Isoproterenol; Male; Muscle Proteins; Pertussis Toxin; Rats; Rats, Inbred Strains; Sodium Chloride; Virulence Factors, Bordetella

1994
Trophic effects of angiotensin II on neonatal rat cardiac myocytes are mediated by cardiac fibroblasts.
    The American journal of physiology, 1995, Volume: 269, Issue:3 Pt 1

    Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Fibroblasts; Heart; Myocardium; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Tissue Distribution; Transforming Growth Factor beta

1995
Ca(2+)-growth coupling in angiotensin II-induced hypertrophy in cultured rat cardiac cells.
    Cardiovascular research, 1995, Volume: 30, Issue:3

    Topics: Angiotensin II; Animals; Calcium; Cardiomegaly; Cell Size; Cells, Cultured; Gene Expression Regulation; Image Processing, Computer-Assisted; Microscopy, Fluorescence; Myocardium; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Tetradecanoylphorbol Acetate; Vasoconstrictor Agents

1995
Rapamycin selectively inhibits angiotensin II-induced increase in protein synthesis in cardiac myocytes in vitro. Potential role of 70-kD S6 kinase in angiotensin II-induced cardiac hypertrophy.
    Circulation research, 1995, Volume: 77, Issue:6

    Topics: Analysis of Variance; Angiotensin II; Animals; Anti-Bacterial Agents; Cardiomegaly; Cells, Cultured; Enzyme Activation; Genes, fos; Immunoblotting; Muscle Proteins; Myocardium; Phenotype; Phosphorylation; Polyenes; Precipitin Tests; Protein Biosynthesis; Protein Serine-Threonine Kinases; Radioimmunoassay; Rats; Sirolimus; Staining and Labeling

1995
Cardiac renin-angiotensin system in the hypertrophied heart.
    Circulation, 1995, Nov-01, Volume: 92, Issue:9

    Topics: Angiotensin II; Animals; Base Sequence; Cardiomegaly; Male; Molecular Sequence Data; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; RNA, Messenger

1995
Angiotensin II partly mediates mechanical stress-induced cardiac hypertrophy.
    Circulation research, 1995, Volume: 77, Issue:2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Cardiomegaly; Cells, Cultured; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Mitogen-Activated Protein Kinase Kinases; Myocardium; Phenylalanine; Protein Kinases; Rats; Rats, Wistar; Receptors, Angiotensin; Saralasin; Signal Transduction; Stress, Mechanical; Tetrazoles

1995
Mechanical stress activates protein kinase cascade of phosphorylation in neonatal rat cardiac myocytes.
    The Journal of clinical investigation, 1995, Volume: 96, Issue:1

    Topics: Amino Acid Sequence; Angiotensin II; Animals; Animals, Newborn; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomegaly; Cells, Cultured; Enzyme Activation; MAP Kinase Kinase Kinases; Molecular Sequence Data; Myocardium; Phosphorylation; Protein Kinase C; Protein Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-raf; Rats; Rats, Wistar; Ribosomal Protein S6 Kinases; Signal Transduction; Stress, Mechanical

1995
[Effect of angiotensin and taurine on arrhythmia in cultured neonatal rat hypertrophic heart myocytes].
    Yao xue xue bao = Acta pharmaceutica Sinica, 1995, Volume: 30, Issue:5

    Topics: Action Potentials; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Myocardial Contraction; Myocardium; Rats; Rats, Sprague-Dawley; Taurine

1995
Cardiac renin-angiotensin system: role in development of pressure-overload hypertrophy.
    The Canadian journal of cardiology, 1995, Volume: 11 Suppl F

    Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve Stenosis; Blood Pressure; Cardiomegaly; Disease Models, Animal; Heart Failure; Humans; Myocardial Contraction; Rats; Renin-Angiotensin System; Ventricular Function, Left

1995
Increased vulnerability of hypertrophied myocardium to ischemia and reperfusion injury. Relation to cardiac renin-angiotensin system.
    Chinese medical journal, 1995, Volume: 108, Issue:1

    Topics: Angiotensin II; Animals; Cardiomegaly; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Wistar; Renin; Renin-Angiotensin System

1995
Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats.
    The Journal of pharmacology and experimental therapeutics, 1995, Volume: 273, Issue:1

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta; Benzimidazoles; Biphenyl Compounds; Cardiomegaly; Enalapril; Extracellular Matrix Proteins; Gene Expression Regulation; Hypertension; Male; Mesenteric Arteries; Myocardium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta

1995
Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist.
    Hypertension (Dallas, Tex. : 1979), 1995, Volume: 25, Issue:4 Pt 1

    Topics: Administration, Oral; Angiotensin II; Animals; Blood Pressure; Body Weight; Bosentan; Cardiomegaly; Endothelin Receptor Antagonists; Endothelins; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sulfonamides

1995
Effect of angiotensin II on calcium release phenomena in normal and hypertrophied single cardiac myocytes.
    Journal of molecular and cellular cardiology, 1994, Volume: 26, Issue:12

    Topics: Angiotensin II; Animals; Blood Pressure; Calcium; Cardiomegaly; Electric Stimulation; Heart Ventricles; Hypertension; In Vitro Techniques; Male; Rats; Rats, Sprague-Dawley; Reference Values

1994
Intracellular signaling and genetic reprogramming during agonist-induced hypertrophy of cardiomyocytes.
    Annals of the New York Academy of Sciences, 1995, Mar-27, Volume: 752

    Topics: Adrenergic alpha-Agonists; Angiotensin II; Animals; Cardiomegaly; Cell Division; Cells, Cultured; Endothelins; Heart; Phosphatidylinositols; Receptors, Adrenergic, alpha-1; Signal Transduction; Thrombin

1995
[Cardiac function in isolated working rat heart with pressure overload hypertrophy: correlation with myocardial angiotensin II].
    Zhonghua yi xue za zhi, 1995, Volume: 75, Issue:2

    Topics: Angiotensin II; Animals; Blood Flow Velocity; Cardiomegaly; Coronary Circulation; Heart Rate; In Vitro Techniques; Male; Rats; Rats, Wistar; Renin-Angiotensin System; Ventricular Function, Left

1995
Angiotensin II induces cardiac phenotypic modulation and remodeling in vivo in rats.
    Hypertension (Dallas, Tex. : 1979), 1995, Volume: 25, Issue:6

    Topics: Actins; Angiotensin II; Animals; Atrial Natriuretic Factor; Base Sequence; Body Weight; Cardiomegaly; Collagen; Gene Expression; Heart; Male; Molecular Sequence Data; Phenotype; Rats; Rats, Wistar; RNA, Messenger; Transforming Growth Factor beta

1995
Cardiovascular hypertrophy in one-kidney, one clip renal hypertensive rats: a role for angiotensin II?
    Journal of hypertension, 1994, Volume: 12, Issue:10

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Biphenyl Compounds; Blood Pressure; Body Weight; Cardiomegaly; Hypertension, Renovascular; Hypertrophy; Imidazoles; Indoles; Losartan; Male; Muscle, Smooth, Vascular; Perindopril; Rats; Rats, Inbred WKY; Tetrazoles

1994
[Role of cardiac renin-angiotensin system in swimming induced physiological myocardial hypertrophy].
    Sheng li xue bao : [Acta physiologica Sinica], 1994, Volume: 46, Issue:5

    Topics: Angiotensin II; Animals; Cardiomegaly; Female; Peptidyl-Dipeptidase A; Physical Exertion; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System

1994
Effect of chronic treatment with prazosin and L-arginine on the elevation of blood pressure during cold exposure.
    Pharmacology, 1994, Volume: 49, Issue:6

    Topics: Adrenal Glands; Angiotensin II; Animals; Arginine; Blood Pressure; Cardiomegaly; Cold Temperature; Epinephrine; Hypertension; Levodopa; Male; Prazosin; Rats; Rats, Sprague-Dawley; RNA, Messenger; Stress, Physiological; Thyroid Hormones; Tyrosine 3-Monooxygenase

1994
Effect of an AT1 receptor antagonist (CV-11974) on angiotensin II-induced cardiomyocyte hypertrophy in vitro.
    Blood pressure. Supplement, 1994, Volume: 5

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blotting, Northern; Cardiomegaly; Cells, Cultured; DNA, Complementary; Endothelin-1; Endothelins; Heart; Imidazoles; Muscle, Smooth, Vascular; Myocardium; Protein Precursors; Pyridines; Rats; Rats, Wistar; Receptors, Angiotensin; Receptors, Endothelin; RNA, Messenger; Tetrazoles

1994
Angiotensin II receptor antagonist, TCV-116, prevents myocardial hypertrophy in spontaneously hypertensive rats.
    Blood pressure. Supplement, 1994, Volume: 5

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cardiomegaly; Endomyocardial Fibrosis; Hypertension; Iodine Radioisotopes; Kinetics; Myocardium; Prodrugs; Rats; Rats, Inbred SHR; Receptors, Angiotensin; Tetrazoles

1994
Role of polyamines in hypertension induced by angiotensin II.
    Cardiovascular research, 1995, Volume: 29, Issue:1

    Topics: Angiotensin II; Animals; Aorta; Cardiomegaly; Disease Models, Animal; Heart Ventricles; Hypertension; Liver; Male; Mesenteric Arteries; Myocardium; Polyamines; Putrescine; Rats; Rats, Inbred WKY; Spermidine; Spermine

1995
Hypertrophic growth of cultured neonatal rat heart cells mediated by type 1 angiotensin II receptor.
    The American journal of physiology, 1994, Volume: 266, Issue:6 Pt 2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Newborn; Biphenyl Compounds; Calcium; Cardiomegaly; Cells, Cultured; Imidazoles; Intracellular Membranes; Losartan; Myocardium; Osmolar Concentration; Protein Biosynthesis; Protein Kinase C; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; RNA, Messenger; Tetrazoles

1994
Distribution and function of cardiac angiotensin AT1- and AT2-receptor subtypes in hypertrophied rat hearts.
    The American journal of physiology, 1994, Volume: 267, Issue:2 Pt 2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Binding Sites; Biphenyl Compounds; Cardiomegaly; Hemodynamics; Imidazoles; Losartan; Male; Myocardium; Pyridines; Rats; Rats, Wistar; Receptors, Angiotensin; Reference Values; Tetrazoles; Tissue Distribution

1994
[Effect of angiotensin II on collagen metabolism in cultured rat cardiac fibroblasts: its relation to cardiac hypertrophy].
    [Hokkaido igaku zasshi] The Hokkaido journal of medical science, 1994, Volume: 69, Issue:1

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Collagen; Fibroblasts; Heart; Myocardium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar

1994
Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat.
    Circulation research, 1994, Volume: 74, Issue:4

    Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Fibronectins; Gene Expression; Male; Rats; Rats, Wistar; RNA, Messenger; Transforming Growth Factor beta

1994
Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-beta 1 expression.
    Hypertension (Dallas, Tex. : 1979), 1994, Volume: 23, Issue:5

    Topics: Angiotensin II; Animals; Aortic Coarctation; Atrial Natriuretic Factor; Biphenyl Compounds; Cardiomegaly; Gene Expression Regulation; Imidazoles; Losartan; Male; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Tetrazoles; Transforming Growth Factor beta

1994
Renin-angiotensin system and minoxidil-induced cardiac hypertrophy in rats.
    The American journal of physiology, 1993, Volume: 265, Issue:5 Pt 2

    Topics: Angiotensin II; Animals; Biphenyl Compounds; Blood Pressure; Cardiomegaly; Enalapril; Heart; Hemodynamics; Imidazoles; Losartan; Male; Minoxidil; Rats; Rats, Wistar; Renin; Renin-Angiotensin System; Tetrazoles; Ventricular Function, Left

1993
Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro.
    Cell, 1993, Dec-03, Volume: 75, Issue:5

    Topics: Actins; Angiotensin I; Angiotensin II; Angiotensinogen; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Cytoplasmic Granules; Endothelins; Gene Expression Regulation; Genes, fos; Hypertrophy; In Vitro Techniques; Mechanoreceptors; Myocardium; Peptidyl-Dipeptidase A; Rats; Renin; RNA, Messenger; Stress, Mechanical

1993
Identification of functional angiotensin II receptors on rat cardiac fibroblasts.
    Circulation, 1993, Volume: 88, Issue:6

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Collagen; Endomyocardial Fibrosis; Extracellular Matrix; Fibroblasts; Fibronectins; Gene Expression Regulation; Kinetics; Myocardium; Rats; Receptors, Angiotensin; RNA, Messenger

1993
Contractile function of right ventricular papillary muscle after left ventricular infarction in rats: effects of early and late inhibition of angiotensin converting enzyme.
    European heart journal, 1993, Volume: 14, Issue:11

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Male; Myocardial Contraction; Myocardial Infarction; Papillary Muscles; Rats; Rats, Wistar; Ventricular Function, Right

1993
Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes.
    The Journal of clinical investigation, 1993, Volume: 92, Issue:1

    Topics: Angiotensin II; Animals; Base Sequence; Biphenyl Compounds; Cardiomegaly; Cells, Cultured; Endothelin Receptor Antagonists; Endothelins; Gene Expression; Imidazoles; In Vitro Techniques; Losartan; Molecular Sequence Data; Muscle Proteins; Myocardium; Oligodeoxyribonucleotides; Oligonucleotides, Antisense; Peptides, Cyclic; Rats; Rats, Wistar; RNA, Messenger; Tetrazoles

1993
Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype.
    Circulation research, 1993, Volume: 73, Issue:3

    Topics: Angiotensin II; Angiotensinogen; Animals; Cardiomegaly; Cells, Cultured; Fibroblasts; Gene Expression Regulation; Genes, fos; Hyperplasia; Myocardium; Rats; Receptors, Angiotensin; Transforming Growth Factor beta

1993
Rat angiotensin II (type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy.
    Circulation research, 1993, Volume: 73, Issue:3

    Topics: Angiotensin II; Animals; Base Sequence; Cardiomegaly; Heart; Hypertension; Male; Molecular Sequence Data; Myocardium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; RNA, Messenger

1993
[Tissue factors contributing to cardiac hypertrophy in cardiomyopathic hamsters (BIO14.6): involvement of transforming growth factor-beta 1 and tissue renin-angiotensin system in the progression of cardiac hypertrophy].
    [Hokkaido igaku zasshi] The Hokkaido journal of medical science, 1993, Volume: 68, Issue:1

    Topics: Angiotensin II; Animals; Cardiomegaly; Cardiomyopathy, Hypertrophic; Cells, Cultured; Cricetinae; Guinea Pigs; Male; Mesocricetus; Myocardium; Peptidyl-Dipeptidase A; Phosphatidylinositols; Renin-Angiotensin System; RNA, Messenger; Transforming Growth Factor beta

1993
Angiotensin II, sodium, and cardiovascular hypertrophy in spontaneously hypertensive rats.
    Hypertension (Dallas, Tex. : 1979), 1993, Volume: 21, Issue:1

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Hypertension; Indoles; Male; Perindopril; Rats; Rats, Inbred SHR; Sodium

1993
The renin-angiotensin system and volume overload-induced cardiac hypertrophy in rats. Effects of angiotensin converting enzyme inhibitor versus angiotensin II receptor blocker.
    Circulation, 1993, Volume: 87, Issue:3

    Topics: Angiotensin II; Animals; Aorta; Arteriovenous Shunt, Surgical; Biphenyl Compounds; Body Weight; Cardiac Volume; Cardiomegaly; Enalapril; Hemodynamics; Imidazoles; Losartan; Male; Myocardium; Organ Size; Rats; Rats, Wistar; Renin; Renin-Angiotensin System; Tetrazoles; Venae Cavae

1993
Endothelin-1 and angiotensin II receptors in cells from rat hypertrophied heart. Receptor regulation and intracellular Ca2+ modulation.
    Circulation research, 1996, Volume: 78, Issue:2

    Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Calcium; Cardiomegaly; Cells, Cultured; Endothelins; Male; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptors, Angiotensin; Receptors, Endothelin

1996
Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts.
    Journal of molecular and cellular cardiology, 1995, Volume: 27, Issue:10

    Topics: Angiotensin II; Animals; Cardiomegaly; Culture Media, Conditioned; Endomyocardial Fibrosis; Fibroblasts; Gene Expression Regulation; Male; Myocardium; Rats; Rats, Sprague-Dawley; RNA, Messenger; Stimulation, Chemical; Transforming Growth Factor beta

1995
Activation of p70 S6 protein kinase is necessary for angiotensin II-induced hypertrophy in neonatal rat cardiac myocytes.
    FEBS letters, 1996, Feb-05, Volume: 379, Issue:3

    Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cardiomegaly; Cells, Cultured; Enzyme Activation; Gene Expression; Genes, fos; Immunosuppressive Agents; Myocardium; Phosphorylation; Polyenes; Protein Serine-Threonine Kinases; Rats; Rats, Wistar; Receptors, Angiotensin; Ribosomal Protein S6 Kinases; Sirolimus

1996
Vascular smooth muscle polyploidy and cardiac hypertrophy in genetic hypertension.
    Hypertension (Dallas, Tex. : 1979), 1996, Volume: 27, Issue:3 Pt 2

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Cardiomegaly; Female; Hypertension; Imidazoles; Indoles; Losartan; Male; Muscle, Smooth, Vascular; Perindopril; Polyploidy; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles

1996
Heparin and heparan sulfate block angiotensin II-induced hypertrophy in cultured neonatal rat cardiomyocytes. A possible role of intrinsic heparin-like molecules in regulation of cardiomyocyte hypertrophy.
    Circulation, 1996, Feb-15, Volume: 93, Issue:4

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Heart; Heparin; Heparin Lyase; Heparitin Sulfate; Humans; Hypertrophy; Leucine; Myocardium; Polysaccharide-Lyases; Rats; Recombinant Proteins

1996
Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats.
    The Journal of clinical investigation, 1996, Jun-01, Volume: 97, Issue:11

    Topics: 5-Lipoxygenase-Activating Proteins; Altitude; Angiotensin II; Animals; Arachidonate 5-Lipoxygenase; Cardiomegaly; Carrier Proteins; Endothelium, Vascular; Gene Expression; Hypertension, Pulmonary; Hypoxia; Immunohistochemistry; In Situ Hybridization; Indoles; Inflammation; Lipoxygenase Inhibitors; Male; Membrane Proteins; Mice; Mice, Knockout; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Vasoconstriction

1996
Cardiac hypertrophy in the Dahl rat is associated with increased tyrosine phosphorylation of several cytosolic proteins, including a 120 kDa protein.
    American journal of hypertension, 1996, Volume: 9, Issue:3

    Topics: Angiotensin II; Animals; Blotting, Western; Cardiomegaly; Cytosol; Heart Ventricles; Hypertension; Molecular Weight; Muscle Proteins; Muscle, Skeletal; Myocardium; Phosphorylation; Phosphotyrosine; Precipitin Tests; Rats; Rats, Mutant Strains; Sodium Chloride, Dietary; Tyrosine

1996
[Heart hypertrophy. Determinant factors and molecular mechanisms].
    Arquivos brasileiros de cardiologia, 1995, Volume: 65, Issue:6

    Topics: Adult; Age Factors; Aged; Angiotensin II; Cardiomegaly; Female; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Obesity; Racial Groups; Risk Factors; Sex Factors; Thyroid Hormones

1995
[Effect of cilazapril, a converting enzyme inhibitor, on cardiovascular hypertrophy in the hypertensive patient].
    Medicina, 1996, Volume: 56, Issue:1

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Cilazapril; Endothelium, Vascular; Humans; Hypertension; Rats; Renin-Angiotensin System; Vasodilation

1996
Autocrine secretion of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro.
    Contributions to nephrology, 1996, Volume: 118

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Genes, fos; Rabbits; Rats

1996
The effect of afterload and angiotensin II on proto-oncogene mRNA levels in the isolated working rat heart.
    Cardiovascular research, 1996, Volume: 31, Issue:6

    Topics: Angiotensin II; Animals; Blotting, Northern; Cardiomegaly; Female; Gene Expression; Hypertension; Perfusion; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-myc; ras Proteins; Rats; Rats, Wistar; RNA, Messenger

1996
Effect of acute and chronic losartan treatment on glucose tolerance and insulin sensitivity in fructose-fed rats.
    American journal of hypertension, 1996, Volume: 9, Issue:7

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Body Weight; Cardiomegaly; Diet; Fructose; Glucose Tolerance Test; Hyperinsulinism; Imidazoles; Insulin; Insulin Resistance; Losartan; Male; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tetrazoles

1996
Renin-angiotensin system in stretch-induced hypertrophy of cultured neonatal rat heart cells.
    European journal of pharmacology, 1996, Jun-20, Volume: 307, Issue:1

    Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Antihypertensive Agents; Biphenyl Compounds; Captopril; Cardiomegaly; Cells, Cultured; Heart; Imidazoles; Losartan; Muscle Proteins; Muscle Spindles; Myocardium; Rats; Rats, Sprague-Dawley; Renin; Tetrazoles

1996
Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy.
    Hypertension (Dallas, Tex. : 1979), 1996, Volume: 28, Issue:4

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Imidazoles; Proteins; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin

1996
Local stress, not systemic factors, regulate gene expression of the cardiac renin-angiotensin system in vivo: a comprehensive study of all its components in the dog.
    Proceedings of the National Academy of Sciences of the United States of America, 1996, Oct-01, Volume: 93, Issue:20

    Topics: Angiotensin II; Animals; Cardiomegaly; Chymases; Dogs; Gene Expression; Heart Failure; Myocardium; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin; RNA, Messenger; Serine Endopeptidases

1996
Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen.
    Science (New York, N.Y.), 1996, Nov-08, Volume: 274, Issue:5289

    Topics: Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Cardiomegaly; Crosses, Genetic; Disease Models, Animal; Female; Humans; Hypertension; Kidney Glomerulus; Male; Mice; Mice, Transgenic; Placenta; Pregnancy; Pregnancy Complications, Cardiovascular; Renin

1996
Desmin gene expression in cardiac myocytes is responsive to contractile activity and stretch.
    The American journal of physiology, 1996, Volume: 270, Issue:4 Pt 1

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Newborn; Base Sequence; Cardiomegaly; Dactinomycin; Desmin; Gene Expression; Molecular Sequence Data; Myocardial Contraction; Myocardium; Oligonucleotide Probes; Physical Stimulation; Rats; Receptors, Angiotensin; RNA Polymerase II; RNA, Messenger; Stress, Mechanical

1996
Altered signal transduction system in hypertrophied myocardium: angiotensin II stimulates collagen synthesis in hypertrophied hearts.
    Journal of cardiac failure, 1996, Volume: 2, Issue:4 Suppl

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Cardiomegaly; Cells, Cultured; Collagen; Fibroblasts; Imidazoles; Losartan; Male; Myocardium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; RNA, Messenger; Saralasin; Signal Transduction; Tetrazoles

1996
Angiotensin II mediates mechanical stress-induced cardiac hypertrophy.
    Diabetes research and clinical practice, 1996, Volume: 30 Suppl

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomegaly; Cells, Cultured; Culture Media, Conditioned; Enzyme Activation; Heart; Hypertrophy, Left Ventricular; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Myocardial Contraction; Myocardium; Protein Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-raf; Rats; Rats, Wistar; Stress, Mechanical

1996
Cardiac angiotensin converting enzyme and endothelin receptor in rats with chronic myocardial infarction.
    Japanese circulation journal, 1996, Volume: 60, Issue:12

    Topics: Angiotensin II; Animals; Autoradiography; Cardiomegaly; Chronic Disease; Endothelin-1; Female; Heart Failure; Image Processing, Computer-Assisted; Iodine Radioisotopes; Ligation; Myocardial Infarction; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptors, Endothelin; Renin; Ventricular Function, Left

1996
Endothelin and angiotensin II stimulation of Na+-H+ exchange is impaired in cardiac hypertrophy.
    The Journal of clinical investigation, 1997, Jan-01, Volume: 99, Issue:1

    Topics: Amiloride; Ammonium Chloride; Angiotensin II; Animals; Body Weight; Calcium; Cardiomegaly; Cell Size; Cells, Cultured; Endothelin-1; Hydrogen-Ion Concentration; Male; Myocardium; Phorbol Esters; Protein Kinase C; Rats; Rats, Wistar; Sodium-Hydrogen Exchangers

1997
Differences in cultured cardiac fibroblast populations isolated from SHR and WKY rats.
    Clinical and experimental pharmacology & physiology. Supplement, 1995, Volume: 22, Issue:1

    Topics: Actins; Angiotensin II; Angiotensinogen; Animals; Cardiomegaly; Cells, Cultured; Fibroblasts; Heart Ventricles; Immunohistochemistry; Myocardium; Plasmids; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; RNA, Messenger

1995
Down-regulation of aortic and cardiac AT1 receptor gene expression in transgenic (mRen-2) 27 rats.
    British journal of pharmacology, 1997, Volume: 121, Issue:1

    Topics: Analysis of Variance; Angiotensin II; Animals; Animals, Genetically Modified; Aorta; Base Sequence; Blood Pressure; Cardiomegaly; Down-Regulation; Heart; Hypertension; Mice; Molecular Sequence Data; Muscle Contraction; Muscle, Smooth, Vascular; Myocardium; Polymerase Chain Reaction; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Renin-Angiotensin System; RNA, Messenger; Vasoconstrictor Agents

1997
Cardiac hypertrophy in diabetic spontaneously hypertensive rats: role of angiotensin II?
    Clinical and experimental pharmacology & physiology, 1997, Volume: 24, Issue:6

    Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Cardiac Volume; Cardiomegaly; Diabetes Mellitus, Experimental; Heart Septum; Hypertension; Hypertrophy, Left Ventricular; Male; Organ Size; Rats; Rats, Inbred SHR

1997
Pressure-independent effects of AT1-receptor antagonism on cardiovascular remodeling in aortic-banded rats.
    The American journal of physiology, 1997, Volume: 272, Issue:5 Pt 2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta; Biphenyl Compounds; Blood Pressure; Cardiomegaly; Constriction; Coronary Circulation; Coronary Vessels; Heart; Imidazoles; Losartan; Male; Organ Size; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Vascular Resistance

1997
Humoral factor(s) produced by pressure overload enhance cardiac hypertrophy and natriuretic peptide expression.
    The American journal of physiology, 1997, Volume: 273, Issue:1 Pt 2

    Topics: Angiotensin II; Animals; Aortic Coarctation; Atrial Natriuretic Factor; Atrophy; Blood Pressure; Body Weight; Cardiomegaly; Endothelin-1; Heart Rate; Heart Transplantation; Hypertension; Male; Myosins; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Rats; Rats, Inbred Lew; RNA, Messenger; Transcription, Genetic; Transplantation, Heterotopic; Transplantation, Isogeneic

1997
Volume-overload cardiac hypertrophy is unaffected by ACE inhibitor treatment in dogs.
    The American journal of physiology, 1997, Volume: 273, Issue:2 Pt 2

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Cell Separation; Chymases; Collagen; Dogs; Heart Ventricles; Hemodynamics; Hyperemia; Myocardium; Peptidyl-Dipeptidase A; Receptors, Angiotensin; RNA, Messenger; Serine Endopeptidases

1997
Cross-talk between receptor-mediated phospholipase C-beta and D via protein kinase C as intracellular signal possibly leading to hypertrophy in serum-free cultured cardiomyocytes.
    Journal of molecular and cellular cardiology, 1997, Volume: 29, Issue:9

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Culture Media, Serum-Free; Down-Regulation; Endothelin-1; Histones; Immunoblotting; Isoenzymes; Myocardium; Phenylephrine; Phospholipase C beta; Phospholipase D; Protein Biosynthesis; Protein Kinase C; Proteins; Rats; Rats, Wistar; Signal Transduction; Tetradecanoylphorbol Acetate; Type C Phospholipases

1997
Contractile systolic and diastolic dysfunction in renin-induced hypertensive cardiomyopathy.
    Hypertension (Dallas, Tex. : 1979), 1997, Volume: 30, Issue:3 Pt 1

    Topics: Angiotensin II; Animals; Animals, Genetically Modified; Calcium-Binding Proteins; Calcium-Transporting ATPases; Cardiomegaly; Collagen; Diastole; Heart; Hydroxyproline; Hypertension; Mice; Myocardial Contraction; Myocardium; Myosin Heavy Chains; Rats; Renin; RNA, Messenger; Sarcoplasmic Reticulum; Systole

1997
Role of angiotensin II in early cardiovascular growth and vascular amplifier development in spontaneously hypertensive rats.
    Journal of hypertension, 1997, Volume: 15, Issue:9

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Antihypertensive Agents; Body Weight; Cardiomegaly; Cardiovascular System; Hypertension; Hypertrophy; Indoles; Kidney; Losartan; Male; Mesenteric Arteries; Organ Size; Papaverine; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Time Factors; Vascular Resistance

1997
Trophic effect of human pericardial fluid on adult cardiac myocytes. Differential role of fibroblast growth factor-2 and factors related to ventricular hypertrophy.
    Circulation research, 1997, Volume: 81, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Animals; Atrial Natriuretic Factor; Body Fluids; Cardiomegaly; Female; Fibroblast Growth Factor 2; Heart; Heart Ventricles; Humans; Male; Middle Aged; Myocardium; Pericardium; Rats; Rats, Wistar; Transforming Growth Factor beta

1997
Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes.
    Circulation, 1997, Nov-18, Volume: 96, Issue:10

    Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cattle; Coculture Techniques; Culture Media, Conditioned; Endothelin Receptor Antagonists; Endothelin-1; Hypertrophy; Lipoproteins, LDL; Myocardium; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Paracrine Communication; Rats; Rats, Wistar; Receptors, Angiotensin; Receptors, Endothelin; RNA, Messenger; Transforming Growth Factor beta; Ventricular Function

1997
The effects of angiotensin II and specific angiotensin receptor blockers on embryonic cardiac development and looping patterns.
    Developmental biology, 1997, Dec-15, Volume: 192, Issue:2

    Topics: Actins; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cardiomegaly; Fetal Heart; Fibroblasts; Heart Ventricles; Hypertrophy; Imidazoles; Losartan; Morphogenesis; Myocardium; Myosin Heavy Chains; Organ Culture Techniques; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin

1997
Reduction of angiotensin II-induced activation of mitogen-activated protein kinase in cardiac hypertrophy.
    Cellular and molecular life sciences : CMLS, 1997, Volume: 53, Issue:11-12

    Topics: Angiotensin II; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomegaly; Cell Compartmentation; Enzyme Activation; Muscle, Skeletal; Protein Kinase C; Rats; Rats, Mutant Strains; Signal Transduction; Sodium Chloride, Dietary

1997
Biphasic activation of the JAK/STAT pathway by angiotensin II in rat cardiomyocytes.
    Circulation research, 1998, Feb-09, Volume: 82, Issue:2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Cardiomegaly; Cells, Cultured; Interferon-gamma; Interferons; Janus Kinase 2; Myocardium; Phosphorylation; Phosphotransferases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Rats, Wistar; Signal Transduction; Stereoisomerism; Tetrazoles; Trans-Activators; Tyrosine

1998
Effect of ecadotril, a neutral endopeptidase inhibitor, on myocardial hypertrophy in the rat aortic insufficiency model.
    The Canadian journal of cardiology, 1998, Volume: 14, Issue:1

    Topics: Angiotensin II; Animals; Aortic Diseases; Blood Pressure; Cardiomegaly; Disease Models, Animal; Guanosine Monophosphate; Male; Protease Inhibitors; Rats; Rats, Wistar; Thiorphan

1998
Role of ion channels and exchangers in mechanical stretch-induced cardiomyocyte hypertrophy.
    Circulation research, 1998, Mar-09, Volume: 82, Issue:4

    Topics: Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomegaly; Cytoplasm; Endothelin-1; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Guanidines; Hydrogen-Ion Concentration; Ion Channels; MAP Kinase Kinase 1; Mechanoreceptors; Mitogen-Activated Protein Kinase Kinases; Muscle Proteins; Peptides, Cyclic; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-raf; Rats; Rats, Wistar; Signal Transduction; Sodium-Hydrogen Exchangers; Sulfones; Tetrazoles

1998
Pressure-overload hypertrophy is unabated in mice devoid of AT1A receptors.
    The American journal of physiology, 1998, Volume: 274, Issue:3

    Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Cardiomegaly; Heterozygote; Mice; Mice, Knockout; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renin

1998
Increased mRNA expression of cardiac renin-angiotensin system and collagen synthesis in spontaneously hypertensive rats.
    Molecular and cellular biochemistry, 1998, Volume: 178, Issue:1-2

    Topics: Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Cardiomegaly; Collagen; Hypertension; Myocardium; Organ Size; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; RNA, Messenger

1998
Acute pressure overload could induce hypertrophic responses in the heart of angiotensin II type 1a knockout mice.
    Circulation research, 1998, Apr-20, Volume: 82, Issue:7

    Topics: Angiotensin II; Animals; Aorta; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomegaly; Gene Expression; Genes, fos; Genes, jun; Hemodynamics; Infusions, Intravenous; Mice; Mice, Knockout; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Polymerase Chain Reaction; Transcription, Genetic; Ventricular Pressure

1998
A calcineurin-dependent transcriptional pathway for cardiac hypertrophy.
    Cell, 1998, Apr-17, Volume: 93, Issue:2

    Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Calcineurin; Cardiomegaly; Cell Nucleus; DNA-Binding Proteins; GATA4 Transcription Factor; Immunosuppressive Agents; Mice; Mice, Transgenic; Myocardium; Natriuretic Peptide, Brain; NFATC Transcription Factors; Nuclear Proteins; Phenylephrine; Promoter Regions, Genetic; Rats; Recombinant Fusion Proteins; Signal Transduction; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Zinc Fingers

1998
Signal transduction and activator of transcription (STAT) protein-dependent activation of angiotensinogen promoter: a cellular signal for hypertrophy in cardiac muscle.
    Proceedings of the National Academy of Sciences of the United States of America, 1998, May-12, Volume: 95, Issue:10

    Topics: Angiotensin II; Angiotensinogen; Animals; Cardiomegaly; Cells, Cultured; DNA-Binding Proteins; Gene Expression Regulation; Heart; Male; Milk Proteins; Promoter Regions, Genetic; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar; Signal Transduction; STAT3 Transcription Factor; STAT5 Transcription Factor; STAT6 Transcription Factor; Trans-Activators; Transcriptional Activation

1998
Endothelin-1 expression in hearts of transgenic hypertensive mice overexpressing angiotensin II.
    Journal of cardiovascular pharmacology, 1998, Volume: 31 Suppl 1

    Topics: Angiotensin II; Animals; Cardiomegaly; Disease Progression; Endothelin Receptor Antagonists; Endothelin-1; Hemodynamics; Humans; Hypertension; Indans; Male; Mice; Mice, Transgenic; Myocardium; Polymerase Chain Reaction; Receptor, Endothelin A; Receptor, Endothelin B; RNA, Messenger

1998
Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice.
    Circulation, 1998, May-19, Volume: 97, Issue:19

    Topics: Angiotensin II; Animals; Aorta, Abdominal; Blood Pressure; Cardiomegaly; Echocardiography; Hypertension; Mice; Mice, Knockout; Polymerase Chain Reaction; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; RNA, Messenger; Signal Transduction; Transcription, Genetic

1998
Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system.
    Hypertension (Dallas, Tex. : 1979), 1998, Volume: 31, Issue:6

    Topics: Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Blotting, Northern; Blotting, Southern; Blotting, Western; Cardiomegaly; DNA; Heart Rate; Immunohistochemistry; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Myocardium; Polymerase Chain Reaction; Rabbits; Rats; Renin; Renin-Angiotensin System; RNA; Transgenes

1998
Angiotensin II stimulation in vitro induces hypertrophy of normal and postinfarcted ventricular myocytes.
    Circulation research, 1998, Jun-15, Volume: 82, Issue:11

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Size; Cells, Cultured; Male; Microscopy, Confocal; Muscle Fibers, Skeletal; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Up-Regulation; Vasoconstrictor Agents; Ventricular Function, Left; Ventricular Function, Right

1998
Taurine improves angiotensin II-induced hypertrophy of cultured neonatal rat heart cells.
    Advances in experimental medicine and biology, 1998, Volume: 442

    Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Heart; Myocardium; Rats; Rats, Wistar; Taurine

1998
Effects of taurine on signal transduction steps induced during hypertrophy of rat heart myocytes.
    Advances in experimental medicine and biology, 1998, Volume: 442

    Topics: Angiotensin II; Animals; Calcium; Cardiomegaly; Cells, Cultured; Heart; Myocardium; Nifedipine; Ouabain; Rats; Ryanodine; Signal Transduction; Taurine

1998
Angiotensin II receptor subtype AT1 and AT2 expression after heart transplantation.
    Cardiovascular research, 1998, Volume: 38, Issue:2

    Topics: Adult; Analysis of Variance; Angiotensin II; Cardiomegaly; Female; Gene Expression Regulation; Heart Transplantation; Humans; Male; Middle Aged; Polymerase Chain Reaction; Postoperative Period; Receptors, Angiotensin; RNA, Messenger; Time Factors

1998
Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II.
    Circulation, 1998, Aug-25, Volume: 98, Issue:8

    Topics: Angiotensin II; Animals; Animals, Newborn; Antioxidants; Butylated Hydroxyanisole; Cardiomegaly; Catalase; Cells, Cultured; Leucine; Rats; Rats, Wistar; Reactive Oxygen Species; Recombinant Proteins; Tritium; Tumor Necrosis Factor-alpha; Vitamin E

1998
Effects of angiotensin II on expression of the gap junction channel protein connexin43 in neonatal rat ventricular myocytes.
    Journal of the American College of Cardiology, 1998, Volume: 32, Issue:3

    Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Connexin 43; Culture Techniques; Gap Junctions; Heart Ventricles; Microscopy, Confocal; Microscopy, Electron; Microscopy, Fluorescence; Rats; Signal Transduction; Up-Regulation

1998
Angiotensin II-induced hypertrophy of adult rat cardiomyocytes is blocked by nitric oxide.
    The American journal of physiology, 1998, Volume: 275, Issue:4

    Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Angiotensin II; Animals; Bradykinin; Cardiomegaly; Cells, Cultured; Coculture Techniques; Cyclic GMP; Endothelium, Vascular; Heart; Iloprost; Indomethacin; Male; Molsidomine; Myocardium; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; omega-N-Methylarginine; Phenylalanine; Protein Biosynthesis; Rats; Rats, Sprague-Dawley

1998
Differential activation of cardiac c-jun amino-terminal kinase and extracellular signal-regulated kinase in angiotensin II-mediated hypertension.
    Circulation research, 1998, Oct-05, Volume: 83, Issue:7

    Topics: Analysis of Variance; Angiotensin II; Animals; Aorta; Blood Pressure; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomegaly; Dose-Response Relationship, Drug; Enzyme Activation; Heart Ventricles; Hypertension; Infusions, Intra-Arterial; Infusions, Intravenous; JNK Mitogen-Activated Protein Kinases; Male; Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley

1998
Angiotensin and endothelin: messengers that couple ventricular stretch to the Na+/H+ exchanger and cardiac hypertrophy.
    Circulation research, 1998, Oct-19, Volume: 83, Issue:8

    Topics: Angiotensin II; Cardiomegaly; Endothelin-1; Humans; Myocardium; Signal Transduction; Sodium-Hydrogen Exchangers

1998
Perindopril effects on angiotensin I elimination in lung after experimental myocardial injury induced by intracoronary microembolization in rats.
    Journal of cardiovascular pharmacology, 1998, Volume: 32, Issue:4

    Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Cardiomegaly; Chromatography, High Pressure Liquid; Hemodynamics; Indoles; Infusions, Intravenous; Lung; Male; Microspheres; Perindopril; Rats; Rats, Wistar

1998
Local renin-angiotensin system contributes to hyperthyroidism-induced cardiac hypertrophy.
    The Journal of endocrinology, 1999, Volume: 160, Issue:1

    Topics: Analysis of Variance; Angiotensin II; Animals; Cardiomegaly; Hyperthyroidism; Male; Myocardium; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thyroxine

1999
Tissue-localized angiotensin II enhances cardiac and renal disorders in Tsukuba hypertensive mice.
    Journal of hypertension, 1998, Volume: 16, Issue:12 Pt 2

    Topics: Angiotensin II; Angiotensinogen; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Catecholamines; Humans; Hydralazine; Hypertension; Kidney Diseases; Lisinopril; Mice; Mice, Inbred C57BL; Mice, Transgenic; Renin

1998
Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts.
    Cardiovascular research, 1998, Volume: 40, Issue:2

    Topics: Angiotensin II; Animals; Animals, Newborn; Blotting, Northern; Blotting, Western; Cardiomegaly; Cells, Cultured; Coculture Techniques; Culture Media, Conditioned; Endothelin-1; Fibroblasts; Microscopy, Fluorescence; Myocardium; Paracrine Communication; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; RNA, Messenger; Transforming Growth Factor beta; Vasoconstrictor Agents

1998
Role of NO and angiotensin II in the early development of endothelial functions impairment and cardiac hypertrophy in deoxycorticosterone acetate-salt hypertension.
    Canadian journal of physiology and pharmacology, 1998, Volume: 76, Issue:6

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Cardiomegaly; Desoxycorticosterone; Endothelium, Vascular; Hypertension; In Vitro Techniques; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Organ Size; Rats; Rats, Sprague-Dawley; Sodium Chloride; Splanchnic Circulation

1998
Effects of angiotensin II on inotropy and intracellular Ca2+ handling in normal and hypertrophied rat myocardium.
    Journal of molecular and cellular cardiology, 1998, Volume: 30, Issue:11

    Topics: Angiotensin II; Animals; Calcium; Cardiomegaly; Heart; Male; Myocardial Contraction; Myocardium; Rats; Rats, Inbred Lew

1998
Rho family small G proteins play critical roles in mechanical stress-induced hypertrophic responses in cardiac myocytes.
    Circulation research, 1999, Mar-05, Volume: 84, Issue:4

    Topics: Angiotensin II; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomegaly; Cells, Cultured; Enzyme Activation; GTP-Binding Proteins; Guanine Nucleotide Dissociation Inhibitors; Mutation; Myocardium; Phenylalanine; ras Proteins; Rats; Rats, Wistar; rho-Specific Guanine Nucleotide Dissociation Inhibitors; rhoA GTP-Binding Protein; src-Family Kinases; Stress, Mechanical

1999
Comparison of irbesartan with captopril effects on cardiac hypertrophy and gene expression in heart failure-prone male SHHF/Mcc-fa(cp) rats.
    Journal of cardiovascular pharmacology, 1999, Volume: 33, Issue:3

    Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Biphenyl Compounds; Blood Pressure; Body Weight; Captopril; Cardiomegaly; Dose-Response Relationship, Drug; Echocardiography; Gene Expression; Heart Failure; Irbesartan; Isoenzymes; Male; Myosin Heavy Chains; Organ Size; Rats; Rats, Inbred Strains; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; RNA, Messenger; Systole; Tetrazoles

1999
Renin-angiotensin system stimulates cardiac and renal disorders in Tsukuba hypertensive mice.
    Clinical and experimental pharmacology & physiology, 1999, Volume: 26, Issue:3

    Topics: Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Cardiomegaly; Humans; Hydralazine; Hypertension; Kidney Diseases; Lisinopril; Mice; Mice, Inbred C57BL; Renin; Renin-Angiotensin System; Survival Rate

1999
Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 289, Issue:1

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Bradykinin; Cardiomegaly; Cyclic GMP; Drug Synergism; Indoles; Male; Myocardial Infarction; Neprilysin; Peptidyl-Dipeptidase A; Perindopril; Potassium; Protease Inhibitors; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Renin; Sodium; Thiorphan

1999
[Modelling of myocardial hypertrophy in vitro for solving problems of medicinal correction].
    Tsitologiia, 1998, Volume: 40, Issue:12

    Topics: Adrenergic alpha-Agonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Blood Physiological Phenomena; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Fibroblasts; Models, Biological; Norepinephrine; Protein Biosynthesis; Rats; Stimulation, Chemical; Surface Properties

1998
Evidence for angiotensin-converting enzyme- and chymase-mediated angiotensin II formation in the interstitial fluid space of the dog heart in vivo.
    Circulation, 1999, May-18, Volume: 99, Issue:19

    Topics: Angiotensin II; Animals; Cardiomegaly; Chymases; Dogs; Extracellular Space; Myocardium; Peptidyl-Dipeptidase A; Serine Endopeptidases

1999
Activation of cardiac aldosterone production in rat myocardial infarction: effect of angiotensin II receptor blockade and role in cardiac fibrosis.
    Circulation, 1999, May-25, Volume: 99, Issue:20

    Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Atrial Natriuretic Factor; Cardiomegaly; Fibrosis; Gene Expression; Heart; Heart Ventricles; Male; Myocardial Infarction; Myocardium; Norepinephrine; Rats; Rats, Wistar; Steroids

1999
Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes.
    Circulation research, 1999, May-28, Volume: 84, Issue:10

    Topics: Angiotensin II; Animals; Antigens, CD; Autocrine Communication; Calcium; Carcinogens; Cardiomegaly; Cells, Cultured; Cytokine Receptor gp130; DNA-Binding Proteins; Endothelin-1; Gene Expression Regulation, Enzymologic; Interleukin-6; Janus Kinase 1; Janus Kinase 2; Membrane Glycoproteins; Mice; Mice, Inbred ICR; Muscle Fibers, Skeletal; Myocardial Contraction; Myocardium; Paracrine Communication; Phosphorylation; Protein Kinase C; Protein-Tyrosine Kinases; Proteins; Proto-Oncogene Proteins; Rats; Rats, Wistar; Signal Transduction; Sodium-Potassium-Exchanging ATPase; STAT1 Transcription Factor; STAT3 Transcription Factor; Stress, Mechanical; Tetradecanoylphorbol Acetate; Trans-Activators; TYK2 Kinase

1999
[Myocardial hypertrophy in rabbits with vasorenal arterial hypertension during pharmacological blockade of formation of angiotensin II and its interaction with specific receptors].
    Biulleten' eksperimental'noi biologii i meditsiny, 1999, Volume: 127, Issue:5

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Male; Myocardium; Rabbits; Receptors, Angiotensin; Tetrazoles; Valine; Valsartan

1999
Interaction between endothelin and angiotensin II.
    Clinical and experimental pharmacology & physiology, 1999, Volume: 26, Issue:7

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Endothelin Receptor Antagonists; Endothelins; Heart Atria; Heart Ventricles; Male; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptors, Endothelin

1999
Hyperglycaemia abolishes the antihypertrophic efficacy of bradykinin in rat ventricular myocytes.
    Clinical and experimental pharmacology & physiology, 1999, Volume: 26, Issue:7

    Topics: Angiotensin II; Animals; Aorta; Bradykinin; Cardiomegaly; Cattle; Coculture Techniques; Endothelium, Vascular; Glucose; Heart Ventricles; Hyperglycemia; Male; Myocardium; Phenylalanine; Rats; Rats, Sprague-Dawley

1999
Lovastatin prevents angiotensin II-induced cardiac hypertrophy in cultured neonatal rat heart cells.
    European journal of pharmacology, 1999, Jul-02, Volume: 376, Issue:1-2

    Topics: Angiotensin II; Animals; Animals, Newborn; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomegaly; Cell Division; Cell Membrane; Cells, Cultured; DNA; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Myocardium; Naphthalenes; Pravastatin; Proto-Oncogene Proteins p21(ras); Rats; Rats, Sprague-Dawley; RNA; Simvastatin

1999
Downregulation of cardiac AT1-receptor expression and angiotensin II concentrations after long-term blockade of the renin-angiotensin system in cardiomyopathic hamsters.
    Journal of cardiovascular pharmacology, 1999, Volume: 34, Issue:3

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Binding, Competitive; Cardiomegaly; Cricetinae; Down-Regulation; Heart Ventricles; Losartan; Male; Mesocricetus; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System

1999
Angiotensin II enhances integrin and alpha-actinin expression in adult rat cardiac fibroblasts.
    Hypertension (Dallas, Tex. : 1979), 2000, Volume: 35, Issue:1 Pt 2

    Topics: Actinin; Age Factors; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antigens, CD; Antihypertensive Agents; Biphenyl Compounds; Cardiomegaly; Cell Adhesion; Cell Adhesion Molecules; Cells, Cultured; Collagen; Fibroblasts; Fibronectins; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Gene Expression; Heart Ventricles; Hydralazine; Imidazoles; Integrin alphaV; Integrin beta Chains; Integrin beta1; Integrin beta3; Integrins; Irbesartan; Laminin; Losartan; Myocardium; Phosphorylation; Platelet Membrane Glycoproteins; Protein-Tyrosine Kinases; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Tetrazoles; Up-Regulation; Vitronectin

2000
The brain renin-angiotensin system modulates angiotensin II-induced hypertension and cardiac hypertrophy.
    Hypertension (Dallas, Tex. : 1979), 2000, Volume: 35, Issue:1 Pt 2

    Topics: Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Atrial Natriuretic Factor; Blood Pressure; Brain Chemistry; Cardiomegaly; Collagen; Gene Expression; Heart Ventricles; Hypertension, Renal; Male; Myocardium; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; RNA, Messenger

2000
Myosin light chain kinase mediates sarcomere organization during cardiac hypertrophy in vitro.
    Nature medicine, 2000, Volume: 6, Issue:2

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Myosin-Light-Chain Kinase; Phenotype; Phenylephrine; Phosphorylation; Rats; Rats, Wistar; Sarcomeres

2000
Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy.
    Proceedings of the National Academy of Sciences of the United States of America, 2000, Feb-01, Volume: 97, Issue:3

    Topics: Adenoviridae; Angiotensin II; Animals; Apoptosis Regulatory Proteins; Atrial Natriuretic Factor; Calcineurin; Calcineurin Inhibitors; Cardiomegaly; Carrier Proteins; Cattle; Cells, Cultured; DNA-Binding Proteins; Fetal Blood; Gene Expression Regulation; Genes; Genetic Therapy; Genetic Vectors; Hypertrophy; Myocardium; NFATC Transcription Factors; Nuclear Proteins; Phenylephrine; Rats; Reverse Transcriptase Polymerase Chain Reaction; Transcription Factors; Transfection

2000
Blood pressure-independent effects in rats with human renin and angiotensinogen genes.
    Hypertension (Dallas, Tex. : 1979), 2000, Volume: 35, Issue:2

    Topics: Albuminuria; Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Diuresis; Glomerular Filtration Rate; Humans; Hydralazine; Hydrochlorothiazide; Ki-67 Antigen; Kidney; Male; Myocardium; Natriuresis; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Renal Circulation; Renin; Reserpine; Sodium; Transgenes

2000
Chronic antisense therapy for angiotensinogen on cardiac hypertrophy in spontaneously hypertensive rats.
    Cardiovascular research, 1999, Volume: 44, Issue:3

    Topics: Analysis of Variance; Angiotensin II; Angiotensinogen; Animals; Cardiomegaly; Gene Expression; Genetic Therapy; Injections, Intravenous; Liver; Male; Myocardium; Oligodeoxyribonucleotides, Antisense; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Ventricular Remodeling

1999
Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro.
    The Biochemical journal, 2000, Apr-01, Volume: 347 Pt 1

    Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Enzyme Inhibitors; Heart; Heart Ventricles; Imidazoles; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Models, Cardiovascular; Myocardium; p38 Mitogen-Activated Protein Kinases; Phenylephrine; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Wistar; Recombinant Proteins; Signal Transduction; Transfection

2000
Sodium-induced cardiac aldosterone synthesis causes cardiac hypertrophy.
    Endocrinology, 2000, Volume: 141, Issue:5

    Topics: Aldosterone; Angiotensin II; Animals; Cardiomegaly; Cytochrome P-450 CYP11B2; Heart; Male; Myocardium; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Sodium

2000
Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy.
    Proceedings of the National Academy of Sciences of the United States of America, 2000, Jun-06, Volume: 97, Issue:12

    Topics: Angiotensin II; Animals; Cardiomegaly; Gene Expression Profiling; Gene Expression Regulation; Isoproterenol; Male; Mice; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction

2000
Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes.
    The Journal of biological chemistry, 2000, Sep-22, Volume: 275, Issue:38

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Cytokines; Fibroblasts; Growth Inhibitors; Interleukin-6; Leukemia Inhibitory Factor; Lymphokines; Mice; Mice, Inbred ICR; Myocardium; Rats; Rats, Wistar; Vasoconstrictor Agents

2000
Inability to induce hypertension in normotensive rat expressing AT(1) receptor antisense.
    Circulation research, 2000, Jun-09, Volume: 86, Issue:11

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Dose-Response Relationship, Drug; Drinking; Female; Gene Transfer Techniques; Hypertension; Oligonucleotides, Antisense; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Reference Values; Renal Circulation; Time Factors; Vasoconstriction

2000
Angiotensin II stimulates hypertrophic growth of cultured neonatal rat ventricular myocytes: roles of PKC and PGF2alpha.
    Prostaglandins, leukotrienes, and essential fatty acids, 2000, Volume: 62, Issue:4

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Fractionation; Cells, Cultured; Dinoprost; Enzyme Activation; Enzyme Inhibitors; Heart Ventricles; Myocardium; Phorbol 12,13-Dibutyrate; Protein Kinase C; Rats

2000
Reverse remodeling of cardiac myocyte hypertrophy in hypertension and failure by targeting of the renin-angiotensin system.
    Circulation, 2000, Jul-11, Volume: 102, Issue:2

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cardiomegaly; Echocardiography; Enalapril; Female; Heart Failure; Hypertension, Renal; Imidazoles; Muscle Fibers, Skeletal; Myocardium; Organ Size; Rats; Rats, Inbred Strains; Renin-Angiotensin System; Tetrazoles; Ventricular Remodeling

2000
Involvement of calcineurin in angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibroblast hyperplasia of rats.
    Heart and vessels, 1999, Volume: 14, Issue:6

    Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Calcineurin; Calcineurin Inhibitors; Calcium; Cardiomegaly; Cell Division; Cells, Cultured; Cyclosporine; DNA; Fibroblasts; Fura-2; Hyperplasia; Losartan; Myocardium; Protein Kinase C; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Signal Transduction

1999
Effect of bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damage.
    Hypertension (Dallas, Tex. : 1979), 2000, Volume: 36, Issue:2

    Topics: Albuminuria; Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Antihypertensive Agents; Blood Pressure; Bosentan; Cardiomegaly; Fibronectins; Heart; Humans; Hydralazine; Immunohistochemistry; Inflammation; Intercellular Adhesion Molecule-1; Kidney; Macrophages; Male; NF-kappa B; Rats; Rats, Sprague-Dawley; Renin; Sulfonamides; Thromboplastin; Transcription Factor AP-1; Vascular Cell Adhesion Molecule-1

2000
G1 cyclins are involved in the mechanism of cardiac myocyte hypertrophy induced by angiotensin II.
    Japanese circulation journal, 2000, Volume: 64, Issue:8

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Cycle Proteins; Cells, Cultured; Cyclin G; Cyclin G1; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; Myocardium; p21-Activated Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Rats; Rats, Wistar; Retinoblastoma Protein; Signal Transduction

2000
Taurine attenuates hypertrophy induced by angiotensin II in cultured neonatal rat cardiac myocytes.
    European journal of pharmacology, 2000, Sep-08, Volume: 403, Issue:3

    Topics: Angiotensin II; Animals; Blotting, Northern; Cardiomegaly; Cell Size; Cells, Cultured; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Myocardium; Protein Kinase C; Rats; Rats, Wistar; RNA, Messenger; Taurine; Vasoconstrictor Agents

2000
Unchanged cardiac angiotensin II levels accompany losartan-sensitive cardiac injury due to nitric oxide synthase inhibition.
    European journal of pharmacology, 2000, Jul-21, Volume: 400, Issue:2-3

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Cardiomegaly; Dose-Response Relationship, Drug; Enzyme Inhibitors; Heart; Losartan; Male; Myocardial Infarction; Myocardium; Nitric Oxide Synthase; Nitroarginine; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Vasculitis

2000
[Cardiac and vascular hypertrophy in hypertension due to angiotensin II. Effect of losartan and bosentan].
    Archives des maladies du coeur et des vaisseaux, 2000, Volume: 93, Issue:8

    Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Bosentan; Cardiomegaly; Carotid Arteries; Endothelin Receptor Antagonists; Endothelins; Follow-Up Studies; Hypertension; Hypertrophy; Losartan; Male; Organ Size; Rats; Rats, Sprague-Dawley; Sulfonamides

2000
Early sequence of cardiac adaptations and growth factor formation in pressure- and volume-overload hypertrophy.
    American journal of physiology. Heart and circulatory physiology, 2000, Volume: 279, Issue:3

    Topics: Adaptation, Physiological; Angiotensin II; Animals; Blood Pressure; Cardiac Volume; Cardiomegaly; Disease Models, Animal; Echocardiography; Endothelin-1; Female; Hemodynamics; In Situ Hybridization; Insulin-Like Growth Factor I; Male; Myocardium; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Swine

2000
Angiotensin II-induced cardiac hypertrophy is associated with different mitogen-activated protein kinase activation in normotensive and hypertensive mice.
    Journal of hypertension, 2000, Volume: 18, Issue:9

    Topics: Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Cardiomegaly; Cells, Cultured; Enzyme Activation; Female; Hypertension; In Vitro Techniques; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Kinase 4; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Myocardium; Myosin Heavy Chains; p38 Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Renin; Stress, Mechanical; Transgenes; Vasoconstrictor Agents

2000
Cardiac hypertrophy and cardiac renin-angiotensin system in Dahl rats on high salt intake.
    Journal of hypertension, 2000, Volume: 18, Issue:9

    Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Brain Chemistry; Cardiomegaly; Gene Expression; Heart Ventricles; Immunoglobulin Fab Fragments; Male; Myocardium; Organ Size; Ouabain; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Dahl; Renin; Renin-Angiotensin System; RNA, Messenger; Sodium, Dietary; Sympathetic Nervous System

2000
Calcineurin blockade prevents cardiac mitogen-activated protein kinase activation and hypertrophy in renovascular hypertension.
    The Journal of biological chemistry, 2000, Dec-29, Volume: 275, Issue:52

    Topics: Angiotensin II; Animals; Calcineurin; Calcineurin Inhibitors; Cardiomegaly; Cyclosporine; Enzyme Activation; Hypertension, Renovascular; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Myocardium; Protein Kinase C

2000
Cardiac aldosterone production in genetically hypertensive rats.
    Hypertension (Dallas, Tex. : 1979), 2000, Volume: 36, Issue:4

    Topics: Adrenalectomy; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Corticosterone; Cytochrome P-450 CYP11B2; Heart Ventricles; Hypertension; In Vitro Techniques; Mineralocorticoid Receptor Antagonists; Myocardium; Organ Size; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin; RNA, Messenger; Spironolactone

2000
Important role of angiotensin II-mediated c-Jun NH(2)-terminal kinase activation in cardiac hypertrophy in hypertensive rats.
    Hypertension (Dallas, Tex. : 1979), 2000, Volume: 36, Issue:4

    Topics: Acute Disease; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Binding, Competitive; Blood Pressure; Cardiomegaly; Chronic Disease; DNA; Heart Rate; Hypertension; Isoenzymes; JNK Mitogen-Activated Protein Kinases; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Organ Size; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Transcription Factor AP-1

2000
Congestive heart failure: fifty years of progress.
    Circulation, 2000, Nov-14, Volume: 102, Issue:20 Suppl 4

    Topics: Angiotensin II; Apoptosis; Calcium; Cardiomegaly; Cardiomyopathies; Cytokines; Heart Failure; History, 20th Century; Humans; Models, Cardiovascular; Myocardial Contraction; Myocardial Ischemia; Signal Transduction

2000
Interaction between angiotensin II and Smad proteins in fibroblasts in failing heart and in vitro.
    American journal of physiology. Heart and circulatory physiology, 2000, Volume: 279, Issue:6

    Topics: Active Transport, Cell Nucleus; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Cardiomegaly; Cell Nucleus; Cells, Cultured; Collagen; Cytosol; DNA-Binding Proteins; Fibroblasts; Heart Failure; In Vitro Techniques; Losartan; Male; Myocardial Infarction; Myocardium; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptor Cross-Talk; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Smad2 Protein; Smad4 Protein; Trans-Activators; Transforming Growth Factor beta; Vimentin

2000
Rho plays an important role in angiotensin II-induced hypertrophic responses in cardiac myocytes.
    Molecular and cellular biochemistry, 2000, Volume: 212, Issue:1-2

    Topics: Actins; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Enzyme Activation; Gene Expression Regulation; Genes, fos; Heart; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinases; Myocardium; Promoter Regions, Genetic; Rats; Rats, Wistar; Recombinant Proteins; rho GTP-Binding Proteins; Transfection

2000
Myocardial cell death in human diabetes.
    Circulation research, 2000, Dec-08, Volume: 87, Issue:12

    Topics: Angiotensin II; Apoptosis; Cardiomegaly; Diabetes Mellitus, Type 2; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Oxidative Stress; Reactive Oxygen Species; Renin-Angiotensin System; Tyrosine

2000
Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length.
    Circulation, 2000, Dec-19, Volume: 102, Issue:25

    Topics: Angiotensin II; Blotting, Northern; Cardiomegaly; Diastole; Heart Atria; Heart Ventricles; Humans; In Vitro Techniques; Isometric Contraction; Muscle Fibers, Skeletal; Myocardial Contraction; Myocardium; Natriuretic Peptide, Brain; RNA, Messenger; Stress, Mechanical

2000
The effects of sarpogrelate on cardiomyocyte hypertrophy.
    Life sciences, 2000, Nov-03, Volume: 67, Issue:24

    Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Endothelin-1; Fibroblasts; Heart Ventricles; Leucine; Myocardium; Rats; Rats, Wistar; Serotonin; Serotonin Antagonists; Succinates; Tritium

2000
Genetic variation in angiotensin-converting enzyme does not prevent development of cardiac hypertrophy or upregulation of angiotensin II in response to aortocaval fistula.
    Circulation, 2001, Feb-20, Volume: 103, Issue:7

    Topics: Angiotensin II; Animals; Aorta; Arteriovenous Fistula; Cardiomegaly; Chymases; Disease Models, Animal; Genetic Variation; Male; Mice; Mice, Knockout; Myocardium; Organ Size; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Serine Endopeptidases; Up-Regulation; Vena Cava, Inferior; Ventricular Dysfunction, Left

2001
Temporary treatment of prepubescent rats with angiotensin inhibitors suppresses the development of hypertensive nephrosclerosis.
    Journal of the American Society of Nephrology : JASN, 2001, Volume: 12, Issue:4

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cardiomegaly; Gene Expression; Genetic Predisposition to Disease; Hydralazine; Hypertension; Indans; Kidney; Male; Nephrosclerosis; Proteinuria; Rats; Rats, Inbred SHR; Renin; Stroke; Tetrazoles; Time Factors; Vasodilator Agents

2001
The role of angiotensin II, endothelin-1 and transforming growth factor-beta as autocrine/paracrine mediators of stretch-induced cardiomyocyte hypertrophy.
    Molecular and cellular biochemistry, 2001, Volume: 218, Issue:1-2

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Culture Media, Conditioned; Endothelin-1; Endothelium, Vascular; Fibroblasts; Gene Expression; Genes, fos; Muscle, Smooth, Vascular; Myocardium; Rats; Rats, Wistar; RNA, Messenger; Stress, Mechanical; Transforming Growth Factor beta; Vasoconstrictor Agents

2001
[Changes of mitogen-activated protein kinase activity in cardiac tissues, Ang II and cardiac hypertrophy in spontaneously hypertensive rats].
    Sheng li xue bao : [Acta physiologica Sinica], 1998, Volume: 50, Issue:5

    Topics: Angiotensin II; Animals; Cardiomegaly; Hypertension; In Vitro Techniques; Male; Mitogen-Activated Protein Kinases; Myocardium; Rats; Rats, Inbred SHR; Rats, Inbred WKY

1998
Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes.
    Proceedings of the National Academy of Sciences of the United States of America, 2001, Jun-05, Volume: 98, Issue:12

    Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; DNA-Binding Proteins; I-kappa B Proteins; NF-kappa B; NF-KappaB Inhibitor alpha; Phenylephrine; Rats; Rats, Sprague-Dawley

2001
AT(2), judgment day: which angiotensin receptor is the culprit in cardiac hypertrophy?
    Circulation, 2001, Jul-17, Volume: 104, Issue:3

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; GTP-Binding Proteins; Humans; Mice; Mice, Knockout; Myocardium; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Signal Transduction; Up-Regulation

2001
[The role of nitric oxide in the angiotensin II-induced hypertrophy of cardiac myocytes].
    Sheng li xue bao : [Acta physiologica Sinica], 1999, Volume: 51, Issue:6

    Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley

1999
[Involvement of calcineurin-dependent signal pathway in the angiotensin II-induced cardiac myocyte hypertrophy].
    Sheng li xue bao : [Acta physiologica Sinica], 1999, Volume: 51, Issue:5

    Topics: Angiotensin II; Animals; Calcineurin; Cardiomegaly; Cells, Cultured; Cyclosporine; Myocardium; Rats; Signal Transduction

1999
Redox-sensitive intermediates mediate angiotensin II-induced p38 MAP kinase activation, AP-1 binding activity, and TGF-beta expression in adult ventricular cardiomyocytes.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2001, Volume: 15, Issue:12

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Enzyme Activation; Heart Ventricles; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Models, Biological; Myocardium; Oxidation-Reduction; p38 Mitogen-Activated Protein Kinases; RNA, Messenger; Transcription Factor AP-1; Transcriptional Activation; Transforming Growth Factor beta

2001
Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
    Journal of hypertension, 2001, Volume: 19, Issue:8

    Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Blood Vessels; Cardiomegaly; Cardiovascular System; Drug Administration Schedule; Heart Rate; Hydralazine; Hypertension; Kidney; Male; Motor Activity; Perindopril; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles; Vasodilator Agents

2001
Effect of chronic angiotensin II inhibition on the nitric oxide synthase in the normal rat during aging.
    Journal of hypertension, 2001, Volume: 19, Issue:8

    Topics: Aging; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Cardiomegaly; Enalapril; Losartan; Male; NADPH Dehydrogenase; Nitrates; Nitric Oxide Synthase; Nitrites; Rats; Rats, Wistar; Reference Values; Time Factors

2001
Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes.
    Circulation, 2001, Oct-02, Volume: 104, Issue:14

    Topics: Angiotensin II; Animals; Animals, Newborn; Biological Transport; Cardiomegaly; Cells, Cultured; Chromans; Heart; Leucine; Myocardium; Natriuretic Peptide, Brain; NF-kappa B; Phenylephrine; Prostaglandin D2; Rats; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Stress, Mechanical; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone

2001
Interaction between sodium intake, angiotensin II, and blood pressure as a cause of cardiac hypertrophy.
    American journal of hypertension, 2001, Volume: 14, Issue:9 Pt 1

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Cardiomegaly; Circadian Rhythm; Cross-Over Studies; Disease Models, Animal; France; Heart; Hypertension, Renovascular; Kidney; Losartan; Models, Cardiovascular; Organ Size; Rats; Rats, Wistar; Renin; Sodium, Dietary; Telemetry

2001
Overexpression of the human angiotensin II type 1 receptor in the rat heart augments load induced cardiac hypertrophy.
    Journal of molecular medicine (Berlin, Germany), 2001, Volume: 79, Issue:10

    Topics: Angiotensin II; Animals; Animals, Genetically Modified; Animals, Newborn; Binding, Competitive; Blood Pressure; Calcium; Cardiomegaly; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Heart Ventricles; Hemodynamics; Humans; Membranes; Myocardium; Organ Size; Perfusion; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; RNA, Messenger; Time Factors; Transgenes

2001
Angiotensin II in cardiac pressure-overload hypertrophy in fetal sheep.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2001, Volume: 281, Issue:6

    Topics: Adrenal Glands; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Brain; Cardiomegaly; Female; Gestational Age; Heart; Imidazoles; Kidney; Lung; Organ Size; Phenylephrine; Pregnancy; Pulmonary Artery; Pyridines; Receptor, Angiotensin, Type 2; Sheep

2001
Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system.
    American journal of physiology. Heart and circulatory physiology, 2001, Volume: 281, Issue:6

    Topics: Adrenergic beta-Agonists; Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Collagen; Coronary Circulation; Heart Rate; Isoproterenol; Isoquinolines; Losartan; Male; Myocardium; Organ Size; Peptidyl-Dipeptidase A; Quinapril; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renin; Renin-Angiotensin System; Tetrahydroisoquinolines

2001
Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy.
    The Journal of clinical investigation, 2001, Volume: 108, Issue:10

    Topics: Angiotensin II; Animals; Antioxidants; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Heart; Mice; Myocardium; Oxidation-Reduction; Promoter Regions, Genetic; rac1 GTP-Binding Protein; Rats; Rats, Sprague-Dawley; Simvastatin; Superoxides

2001
Dilated cardiomyopathy and impaired cardiac hypertrophic response to angiotensin II in mice lacking FGF-2.
    The Journal of clinical investigation, 2001, Volume: 108, Issue:12

    Topics: Angiotensin II; Animals; Cardiomegaly; Cardiomyopathy, Dilated; Cells, Cultured; Enzyme Activation; Fibroblast Growth Factor 2; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Myocardium

2001
Inhibitory effect of quercetin on cultured neonatal rat cardiomyocytes hypertrophy induced by angiotensin.
    Acta pharmacologica Sinica, 2001, Volume: 22, Issue:12

    Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Hypertrophy; Myocardium; Myocytes, Cardiac; Protein Kinase C; Protein-Tyrosine Kinases; Quercetin; Rats; Rats, Wistar

2001
Effects of adrenomedullin on hypertrophic responses induced by angiotensin II, endothelin-1 and phenylephrine.
    Peptides, 2001, Volume: 22, Issue:11

    Topics: Adrenomedullin; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cyclic AMP; Cyclic GMP; Drug Interactions; Endothelin-1; Gene Expression; Heart; Heart Ventricles; In Vitro Techniques; Myocardium; Natriuretic Peptide, Brain; Peptides; Phenylephrine; Rats; Sarcomeres

2001
Angiotensin II induced cardiac hypertrophy in vivo is inhibited by cyclosporin A in adult rats.
    Molecular and cellular biochemistry, 2001, Volume: 226, Issue:1-2

    Topics: Angiotensin II; Animals; Blotting, Northern; Body Weight; Calcineurin; Calcium; Cardiomegaly; Cyclosporine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Hypertrophy; Myocardium; Organ Size; Rats; Rats, Wistar; RNA; Signal Transduction; Up-Regulation

2001
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy.
    Nature medicine, 2002, Volume: 8, Issue:1

    Topics: ADAM Proteins; ADAM12 Protein; Angiotensin II; Animals; Aorta, Thoracic; Cardiomegaly; Disease Models, Animal; Disintegrins; Epidermal Growth Factor; ErbB Receptors; Glycine; GTP-Binding Proteins; Heart Ventricles; Heparin-binding EGF-like Growth Factor; Hydroxamic Acids; Hypertension; Intercellular Signaling Peptides and Proteins; Male; Membrane Proteins; Metalloendopeptidases; Phenylephrine; Protease Inhibitors; Protein Processing, Post-Translational; Rats; Signal Transduction; Systole; Transcriptional Activation

2002
Downregulation of ANG II receptor is associated with compensated pressure-overload hypertrophy in the young dog.
    American journal of physiology. Heart and circulatory physiology, 2002, Volume: 282, Issue:2

    Topics: Adaptation, Physiological; Age Factors; Angiotensin II; Animals; Aorta; Arrhythmias, Cardiac; Blood Pressure; Cardiac Volume; Cardiomegaly; Disease Models, Animal; Dogs; Down-Regulation; Electrophysiology; Gene Expression; Muscle Fibers, Skeletal; Myocardium; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renin-Angiotensin System; RNA, Messenger; Ventricular Function, Left

2002
[Simvastatin attenuates cardiovascular effects and oxidative stress induced by angiotensin II].
    Archives des maladies du coeur et des vaisseaux, 2001, Volume: 94, Issue:11

    Topics: Angiotensin II; Animals; Anticholesteremic Agents; Blood Pressure; Cardiomegaly; Hypertension; Lipid Peroxidation; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Simvastatin

2001
Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice.
    Circulation, 2002, Jan-22, Volume: 105, Issue:3

    Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Collagen; Membrane Glycoproteins; Mice; Mice, Knockout; Myocardium; Myosin Heavy Chains; NADPH Oxidase 2; NADPH Oxidases; Organ Size; RNA, Messenger; Superoxides

2002
Specific role for the extracellular signal-regulated kinase pathway in angiotensin II- but not phenylephrine-induced cardiac hypertrophy in vitro.
    Pflugers Archiv : European journal of physiology, 2002, Volume: 443, Issue:3

    Topics: Angiotensin II; Animals; Carbon Radioisotopes; Cardiomegaly; Cells, Cultured; Heart Ventricles; In Vitro Techniques; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Muscle Fibers, Skeletal; Myocardium; Phenylalanine; Phenylephrine; Protein Kinase C; Rats; Rats, Wistar; Ribosomal Protein S6 Kinases; Vasoconstrictor Agents

2002
Treatment of heart failure: state of the art and prospectives.
    Journal of cardiovascular pharmacology, 2001, Volume: 38 Suppl 2

    Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cardiomegaly; Drug Therapy; Endothelins; Heart Failure; Humans; Norepinephrine; Review Literature as Topic; Spironolactone; Tumor Necrosis Factor-alpha; Ventricular Dysfunction, Left

2001
Apoptosis signal-regulating kinase/nuclear factor-kappaB: a novel signaling pathway regulates cardiomyocyte hypertrophy.
    Circulation, 2002, Jan-29, Volume: 105, Issue:4

    Topics: Angiotensin II; Animals; Cardiomegaly; Cytokines; Endothelin-1; GTP-Binding Protein alpha Subunits, Gq-G11; Heterotrimeric GTP-Binding Proteins; MAP Kinase Kinase Kinase 5; MAP Kinase Kinase Kinases; NF-kappa B; Phenylephrine; Reactive Oxygen Species; Signal Transduction

2002
Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy.
    Circulation, 2002, Jan-29, Volume: 105, Issue:4

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Size; Cells, Cultured; Dose-Response Relationship, Drug; Endothelin-1; Heterotrimeric GTP-Binding Proteins; I-kappa B Proteins; Kinetics; MAP Kinase Kinase Kinase 5; MAP Kinase Kinase Kinases; Mutation; Myocardium; NF-kappa B; Phenylephrine; Rats; Rats, Wistar; Reactive Oxygen Species; Receptors, Cell Surface; Sarcomeres

2002
Protective effect of Salvia miltiorrhiza on angiotensin II-induced hypertrophic responses in neonatal rat cardiac cells.
    Japanese journal of pharmacology, 2001, Volume: 87, Issue:4

    Topics: Angiotensin II; Animals; Animals, Newborn; Blotting, Northern; Cardiomegaly; Cell Count; Cell Size; Cell Survival; Cells, Cultured; Chromatography, High Pressure Liquid; DNA; Myocardium; Plant Extracts; Plant Roots; Rats; Rats, Wistar; RNA, Messenger; Salvia

2001
Angiotensin II induced inflammation in the kidney and in the heart of double transgenic rats.
    BMC cardiovascular disorders, 2002, Volume: 2

    Topics: Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Cardiomegaly; Electrophoretic Mobility Shift Assay; Enzyme Inhibitors; Heart; Humans; Intercellular Adhesion Molecule-1; Kidney; Models, Animal; Myocarditis; Necrosis; Nephritis; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxidative Stress; Proline; Rats; Rats, Sprague-Dawley; Renin; Thiocarbamates; Vascular Cell Adhesion Molecule-1

2002
Decoy oligonucleotide characterization of GATA-4 transcription factor in hypertrophic agonist induced responses of cardiac myocytes.
    Journal of molecular medicine (Berlin, Germany), 2002, Volume: 80, Issue:1

    Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Binding Sites; Cardiomegaly; DNA-Binding Proteins; Endothelin-1; GATA4 Transcription Factor; Gene Expression Regulation; Myocardium; Natriuretic Peptide, Brain; Oligodeoxyribonucleotides; Phenylephrine; Promoter Regions, Genetic; Protein Binding; Rats; Transcription Factors

2002
Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo.
    Circulation, 2002, Mar-12, Volume: 105, Issue:10

    Topics: Actins; Angiotensin II; Animals; Atrial Natriuretic Factor; Body Weight; Cardiomegaly; Cell Size; Cells, Cultured; Chromans; Disease Models, Animal; Gene Expression; Heart; Heterozygote; Hypoglycemic Agents; Ligands; Mice; Mice, Knockout; Myocardium; Organ Size; Pioglitazone; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone

2002
Serial killer: angiotensin drives cardiac hypertrophy via TGF-beta1.
    The Journal of clinical investigation, 2002, Volume: 109, Issue:6

    Topics: Angiotensin II; Animals; Cardiomegaly; Gene Expression Regulation; Humans; Myocardium; Signal Transduction; Transforming Growth Factor beta; Transforming Growth Factor beta1

2002
TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II.
    The Journal of clinical investigation, 2002, Volume: 109, Issue:6

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Size; Echocardiography; Heart; Hemodynamics; Mice; Mice, Inbred Strains; Mice, Knockout; Myocardium; Myosin Heavy Chains; Transforming Growth Factor beta; Transforming Growth Factor beta1

2002
Interactions between sodium and angiotensin.
    Clinical and experimental pharmacology & physiology, 2001, Volume: 28, Issue:12

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Drug Interactions; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; Sodium Chloride; Water-Electrolyte Imbalance

2001
Tissue Angiotensin-converting enzyme activity plays an important role in pressure overload-induced cardiac fibrosis in rats.
    Journal of cardiovascular pharmacology, 2002, Volume: 39, Issue:4

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Collagen Type I; Constriction, Pathologic; Dose-Response Relationship, Drug; Endomyocardial Fibrosis; Imidazoles; Imidazolidines; Male; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Tissue Distribution; Transforming Growth Factor beta; Transforming Growth Factor beta1

2002
Impact of HMG CoA reductase inhibition on small GTPases in the heart.
    Cardiovascular research, 2002, Volume: 53, Issue:4

    Topics: Angiotensin II; Animals; Atorvastatin; Atrial Natriuretic Factor; Cardiac Myosins; Cardiomegaly; Cell Membrane; Cells, Cultured; Gene Expression Regulation; GTP Phosphohydrolases; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase Kinases; Myocardium; Myosin Light Chains; Pyrroles; rac1 GTP-Binding Protein; Rats; Rats, Sprague-Dawley; rhoA GTP-Binding Protein; RNA, Messenger; Simvastatin

2002
Cardiovascular influences of alpha1b-adrenergic receptor defect in mice.
    Circulation, 2002, Apr-09, Volume: 105, Issue:14

    Topics: Angiotensin II; Animals; Aorta; Arterioles; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Cardiovascular System; Echocardiography; Heart Rate; Heart Ventricles; Hypertension; Male; Mesentery; Mice; Mice, Transgenic; Norepinephrine; Organ Size; Phenylephrine; Receptors, Adrenergic, alpha-1; RNA, Messenger; Vasoconstrictor Agents; Ventricular Remodeling

2002
[MKP-1 regulates the cardiomyocyte hypertrophic responses induced by angiotensin II].
    Sheng li xue bao : [Acta physiologica Sinica], 2000, Volume: 52, Issue:5

    Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cell Cycle Proteins; Cells, Cultured; Dual Specificity Phosphatase 1; Immediate-Early Proteins; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Phosphoprotein Phosphatases; Protein Phosphatase 1; Protein Tyrosine Phosphatases; Rats; Rats, Sprague-Dawley

2000
Effects of all-trans retinoic acid on angiotensin II-induced myocyte hypertrophy.
    Journal of applied physiology (Bethesda, Md. : 1985), 2002, Volume: 92, Issue:5

    Topics: Angiotensin II; Animals; Animals, Newborn; Calcium; Cardiomegaly; Cell Count; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Fibroblasts; Golgi Apparatus; Hyperplasia; Intracellular Fluid; Myocardium; Proteins; Rats; Rats, Wistar; Sarcomeres; Tretinoin

2002
Angiotensin II binding and extracellular matrix remodelling in a rat model of myocardial infarction.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, 2000, Volume: 1, Issue:4

    Topics: Angiotensin II; Animals; Biomarkers; Cardiomegaly; Cicatrix; Coronary Circulation; Extracellular Matrix; Female; Kinetics; Myocardial Infarction; Myocardium; Perfusion; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Time Factors; Tissue Distribution

2000
Effects of long-term enalapril and losartan therapy of heart failure on cardiovascular aldosterone.
    Journal of endocrinological investigation, 2002, Volume: 25, Issue:5

    Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiac Output, Low; Cardiomegaly; Cardiovascular System; Chronic Disease; Enalapril; Losartan; Male; Mesenteric Arteries; Myocardial Infarction; Rats; Rats, Wistar

2002
[Molecular mechanism of nitric oxide in preventing cardiomyocytes from hypertrophic response induced by angiotensin II].
    Sheng li xue bao : [Acta physiologica Sinica], 2002, Jun-25, Volume: 54, Issue:3

    Topics: Angiotensin II; Animals; Animals, Newborn; Arginine; Cardiomegaly; Fungal Proteins; In Vitro Techniques; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Nitric Oxide; Rats; Rats, Sprague-Dawley; Signal Transduction

2002
Humoral regulation of vascular resistance after 30 days of pulmonary artery constriction.
    The American journal of physiology, 1979, Volume: 236, Issue:6

    Topics: Angiotensin II; Animals; Cardiomegaly; Catecholamines; Dopamine; Epinephrine; Guinea Pigs; Heart Failure; Norepinephrine; Papaverine; Phentolamine; Phenylephrine; Saralasin; Sympathetic Nervous System; Tyrosine 3-Monooxygenase; Vascular Resistance

1979
Diastolic compliance of the left ventricle in man.
    The American journal of cardiology, 1975, Volume: 36, Issue:2

    Topics: Adolescent; Adult; Aged; Angina Pectoris; Angiotensin II; Aortic Valve Stenosis; Blood Pressure; Cardiac Catheterization; Cardiac Output; Cardiac Volume; Cardiomegaly; Cineangiography; Coronary Disease; Female; Heart; Heart Diseases; Heart Function Tests; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Male; Mathematics; Middle Aged; Myocardial Contraction; Prognosis

1975
Differences in the regulation of vascular resistance in guinea pigs with right and left heart failure.
    Circulation research, 1977, Volume: 41, Issue:1

    Topics: Angiotensin II; Animals; Aorta; Arterial Occlusive Diseases; Blood Gas Analysis; Cardiomegaly; Electric Stimulation; Guinea Pigs; Heart Failure; Heart Ventricles; Hemodynamics; Hindlimb; Male; Norepinephrine; Papaverine; Pulmonary Artery; Sympathectomy; Vascular Resistance; Vasomotor System

1977
U vectorcardiograms in left ventricular overloading.
    Advances in cardiology, 1978, Volume: 21

    Topics: Adult; Angiotensin II; Aortic Valve Insufficiency; Cardiomegaly; Electrocardiography; Female; Humans; Hypertension; Male; Middle Aged; Vectorcardiography

1978
Pulmonary vascular reactivity in the spontaneously hypertensive rat.
    Blood vessels, 1979, Volume: 16, Issue:2

    Topics: Altitude; Angiotensin II; Animals; Blood Pressure; Body Weight; Cardiomegaly; Heart; Hematocrit; Hypertension, Pulmonary; Hypoxia; Lung; Male; Organ Size; Prostaglandins F; Rats; Vascular Resistance

1979
Cardiac effects of angiotensin antagonists in normotensive rats.
    Clinical science (London, England : 1979), 1979, Volume: 56, Issue:5

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Catecholamines; Rats; Saralasin

1979
[Endothelin-1 as an autocrine factor in hypertrophy of cardiomyocytes].
    Japanese circulation journal, 1992, Volume: 56 Suppl 5

    Topics: Angiotensin II; Animals; Cardiomegaly; Cell Division; Cell Size; Endothelins; Gene Expression; In Vitro Techniques; Myocardium; Peptides, Cyclic; Protein Kinase C; Rats

1992
Cardiac angiotensin converting enzyme and diastolic function of the heart.
    Agents and actions. Supplements, 1992, Volume: 38 ( Pt 3)

    Topics: Angiotensin I; Angiotensin II; Animals; Cardiomegaly; Diastole; Enalaprilat; Heart; In Vitro Techniques; Male; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Reference Values; RNA, Messenger; Ventricular Function, Left

1992
Effects of losartan, a nonpeptide angiotensin II receptor antagonist, on cardiac hypertrophy and the tissue angiotensin II content in spontaneously hypertensive rats.
    Life sciences, 1992, Volume: 51, Issue:5

    Topics: Analysis of Variance; Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Body Weight; Cardiomegaly; Heart Rate; Heart Ventricles; Hypertension; Imidazoles; Losartan; Male; Organ Size; Radioimmunoassay; Rats; Rats, Inbred SHR; Renin; Tetrazoles

1992
Long-term angiotensin II antagonism in spontaneously hypertensive rats: effects on blood pressure and cardiovascular amplifiers.
    Clinical and experimental pharmacology & physiology, 1992, Volume: 19, Issue:5

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Cardiomegaly; Cardiovascular Agents; Cardiovascular Physiological Phenomena; Cardiovascular System; Hindlimb; Hypertension; Imidazoles; Losartan; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles; Time Factors

1992
Reactive and reparative myocardial fibrosis in arterial hypertension in the rat.
    Cardiovascular research, 1992, Volume: 26, Issue:7

    Topics: Aldosterone; Angiotensin II; Animals; Cardiomegaly; Collagen; Disease Models, Animal; Fibrosis; Hypertension, Renovascular; Male; Myocardium; Rats; Rats, Sprague-Dawley; Sodium, Dietary; Spironolactone

1992
Angiotensin II-induced protein phosphorylation in the hypertrophic heart of the Dahl rat.
    Hypertension (Dallas, Tex. : 1979), 1992, Volume: 20, Issue:5

    Topics: Angiotensin II; Animals; Calcimycin; Cardiomegaly; Cell Separation; Drug Resistance; Electrophoresis; Ionomycin; Methionine; Muscle Proteins; Myocardium; Phosphoproteins; Phosphorylation; Rats; Rats, Inbred Strains; Sodium Chloride; Tetradecanoylphorbol Acetate

1992
Angiotensin II stimulation of left ventricular hypertrophy in adult rat heart. Mediation by the AT1 receptor.
    American journal of hypertension, 1992, Volume: 5, Issue:5 Pt 1

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Cardiomegaly; Imidazoles; Infusion Pumps; Losartan; Male; Organ Size; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Tetrazoles

1992
[Vasoactive substances and growth].
    Zeitschrift fur Kardiologie, 1992, Volume: 81, Issue:3

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Cell Division; Heart Failure; Humans

1992
Role of cardiac angiotensin II in isoproterenol-induced left ventricular hypertrophy.
    Hypertension (Dallas, Tex. : 1979), 1992, Volume: 19, Issue:6 Pt 2

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Cardiomegaly; Heart Rate; Hydralazine; Indoles; Isoproterenol; Male; Myocardium; Nephrectomy; Rats; Rats, Inbred Strains; Renin

1992
Converting enzyme inhibitors regressed cardiac hypertrophy and reduced tissue angiotensin II in spontaneously hypertensive rats.
    Journal of hypertension, 1991, Volume: 9, Issue:7

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Enalapril; Heart Atria; Heart Ventricles; Indoles; Male; Myocardium; Organ Size; Rats; Rats, Inbred SHR; Renin-Angiotensin System

1991
Reversal of angiotensin II effect on the cyclic adenosine 3',5' monophosphate response to isoprenaline in cardiac hypertrophy.
    Cardiovascular research, 1991, Volume: 25, Issue:11

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Cyclic AMP; Heart; Isoproterenol; Male; Myocardium; Rats; Rats, Inbred Strains; Stimulation, Chemical

1991
Cardiac and renal hypertrophy is independent of tissue angiotensin converting enzyme and circulating angiotensin II in hypertensive rats.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1991, Volume: 9, Issue:6

    Topics: Angiotensin II; Animals; Cardiomegaly; Desoxycorticosterone; Hypertension; Hypertension, Renovascular; Hypertrophy; Kidney; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Strains; Sodium Chloride

1991
Remodeling of the rat right and left ventricles in experimental hypertension.
    Circulation research, 1990, Volume: 67, Issue:6

    Topics: Aldosterone; Angiotensin II; Animals; Cardiomegaly; Collagen; Fibrosis; Heart Ventricles; Hemodynamics; Hypertension; Hypertension, Renovascular; Male; Rats; Rats, Inbred Strains; Staining and Labeling

1990
Cardiac remodelling and myocardial contractility in patients with congestive heart failure treated with furosemide and enalapril.
    Basic research in cardiology, 1991, Volume: 86 Suppl 1

    Topics: Aged; Angiotensin II; Cardiomegaly; Drug Therapy, Combination; Enalapril; Furosemide; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction

1991
Cardiac myocyte necrosis induced by angiotensin II.
    Circulation research, 1991, Volume: 69, Issue:5

    Topics: Angiotensin II; Animals; Aorta, Abdominal; Blood Pressure; Captopril; Cardiomegaly; DNA; Fibrosis; Heart; Ligation; Male; Myocardium; Necrosis; Rats; Rats, Inbred Strains; Sympatholytics; Vasoconstriction

1991
Effects of tryptophan on the development of deoxycorticosterone acetate (DOCA)-induced hypertension in rats.
    Advances in experimental medicine and biology, 1991, Volume: 294

    Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Cardiomegaly; Desoxycorticosterone; Diencephalon; Drinking; Eating; Female; Hypertension; Nephrectomy; Protein Binding; Rats; Rats, Inbred Strains; Serotonin; Sodium Chloride; Tryptophan

1991
Regression of left ventricular hypertrophy by angiotensin converting enzyme inhibitor in reduced renal mass hypertensive rats.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1991, Volume: 9, Issue:6

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Heart Ventricles; Hypertension, Renal; Indoles; Male; Nephrectomy; Organ Size; Perindopril; Rats; Rats, Inbred Strains; Renin

1991
Role of angiotensin II receptor antagonism and converting enzyme inhibition in the progression and regression of cardiac hypertrophy in rats.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1991, Volume: 9, Issue:6

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Abdominal; Biphenyl Compounds; Bridged Bicyclo Compounds; Cardiomegaly; Constriction; Hypertension; Imidazoles; Losartan; Male; Ramipril; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Tetrazoles

1991
Isolated myocardial cells: a new tool for the investigation of hypertensive heart disease.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1990, Volume: 8, Issue:4

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Heart Rate; Hypertension; Isoproterenol; Myocardial Contraction; Myocardium; Rats; Rats, Inbred Strains

1990
Excitation-contraction coupling in hypertrophied myocardium.
    Journal of cardiovascular pharmacology, 1985, Volume: 7 Suppl 6

    Topics: Age Factors; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Epinephrine; Heart; Hypertension; Hypertension, Renal; Male; Myocardial Contraction; Myocardium; Prazosin; Protein Kinases; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta

1985
Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats.
    Clinical and experimental hypertension. Part A, Theory and practice, 1989, Volume: 11, Issue:7

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Bridged Bicyclo Compounds; Cardiomegaly; Dihydralazine; Hypertension; Male; Nifedipine; Ramipril; Rats; Rats, Inbred Strains

1989
Study of cardiac hypertrophy--humoral factors that stimulate protein metabolism of cultured rat heart cells.
    Japanese circulation journal, 1989, Volume: 53, Issue:7

    Topics: Angiotensin II; Animals; Biological Factors; Cardiomegaly; Cells, Cultured; Chromatography, High Pressure Liquid; Dogs; Isoproterenol; Male; Myocardium; Norepinephrine; Proteins; Rats; Rats, Inbred WKY; Tissue Extracts

1989
Study of the pathogenesis of cardiac hypertrophy--biochemical differences of cultured heart cells from normotensive and spontaneously hypertensive rats.
    Japanese circulation journal, 1989, Volume: 53, Issue:10

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Hypertension; Isoproterenol; Leucine; Myocardium; Protein Biosynthesis; Proteins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Stimulation, Chemical; Uridine

1989
Impaired relaxation of the hypertrophied myocardium is potentiated by angiotensin II.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1989, Volume: 7, Issue:6

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Myocardial Contraction; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Stimulation, Chemical

1989
Isoform-specific modulation of Na+, K+-ATPase alpha-subunit gene expression in hypertension.
    Science (New York, N.Y.), 1988, Jul-08, Volume: 241, Issue:4862

    Topics: Angiotensin II; Animals; Cardiomegaly; Desoxycorticosterone; Heart Ventricles; Hypertension; Isoenzymes; Rats; RNA, Messenger; Sodium-Potassium-Exchanging ATPase

1988
Monocrotaline pyrrole-induced cardiopulmonary toxicity is not altered by metergoline or ketanserin.
    The Journal of pharmacology and experimental therapeutics, 1986, Volume: 237, Issue:1

    Topics: Angiotensin II; Animals; Blood Platelets; Blood Pressure; Cardiomegaly; Ergolines; Ketanserin; Lung; Male; Metergoline; Monocrotaline; Organ Size; Piperidines; Pyrrolizidine Alkaloids; Rats; Receptors, Serotonin; Serotonin

1986
Vascular hyperresponsiveness in perfused lungs from monocrotaline-treated rats.
    The American journal of physiology, 1986, Volume: 251, Issue:1 Pt 2

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Hydrogen-Ion Concentration; Hypertension, Pulmonary; Hypoxia; Male; Monocrotaline; Perfusion; Pulmonary Artery; Pulmonary Circulation; Pulmonary Edema; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Vasoconstriction

1986
Chronic treatment with L-5-hydroxytryptophan prevents the development of DOCA-salt-induced hypertension in rats.
    Journal of hypertension, 1987, Volume: 5, Issue:5

    Topics: 5-Hydroxytryptophan; Administration, Cutaneous; Angiotensin II; Animals; Cardiomegaly; Catecholamines; Desoxycorticosterone; Female; Hypertension; Infusion Pumps; Kidney Concentrating Ability; Nephrectomy; Rats; Rats, Inbred Strains; Sodium, Dietary

1987
Beta-adrenergic receptors in rat myocardium during the development and reversal of hypertrophy and following chronic infusions of angiotensin II and epinephrine.
    Archives internationales de pharmacodynamie et de therapie, 1985, Volume: 274, Issue:1

    Topics: Aging; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Dihydroalprenolol; Epinephrine; In Vitro Techniques; Male; Membranes; Myocardium; Nephrectomy; Nucleotidases; Organ Size; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Rats, Inbred WKY; Receptors, Adrenergic, beta; Time Factors

1985
[Clinical study of cardiac asthma].
    Japanese circulation journal, 1967, Volume: 31, Issue:8

    Topics: Aged; Angiotensin II; Blood Pressure; Bradycardia; Cardiac Output; Cardiomegaly; Circadian Rhythm; Dyspnea, Paroxysmal; Epinephrine; Exercise Test; Female; Heart Failure; Heart Valve Diseases; Hemodynamics; Humans; Hypertension; Infusions, Parenteral; Male; Middle Aged; Norepinephrine; Posture; Pulmonary Circulation; Serum Albumin, Radio-Iodinated

1967
Left ventricular function in children studied by increasing peripheral resistance with angiotensin.
    Circulation, 1968, Volume: 37, Issue:5

    Topics: Adolescent; Angiotensin II; Blood Pressure; Cardiac Catheterization; Cardiomegaly; Child; Child, Preschool; Chlorpromazine; Endocardial Fibroelastosis; Female; Glycogen Storage Disease; Heart Valves; Heart Ventricles; Humans; Infant; Male; Meperidine; Mitral Valve Insufficiency; Mucopolysaccharidosis II; Promethazine; Ventricular Function

1968
Effects of cortisone on renal sodium excretion in rabbits.
    Endocrinology, 1968, Volume: 82, Issue:6

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cortisone; Desoxycorticosterone; Edema; Female; Glomerular Filtration Rate; Hematocrit; Kidney; Male; Pleural Effusion; Potassium; Pulmonary Edema; Rabbits; Sodium; Vena Cava, Inferior; Water-Electrolyte Balance

1968
Myocardial function in patients with coronary artery disease.
    The American journal of cardiology, 1969, Volume: 23, Issue:3

    Topics: Adolescent; Adult; Aged; Angiocardiography; Angiotensin II; Arteriosclerosis; Cardiomegaly; Cineangiography; Coronary Disease; Female; Heart; Heart Function Tests; Heart Ventricles; Humans; Male; Middle Aged; Stress, Physiological

1969
The production of sustained hypertension in dogs by a single transient anoxic episode.
    Angiology, 1969, Volume: 20, Issue:5

    Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Dogs; Hypertension; Kidney; Models, Biological; Photomicrography; Renal Artery; Renal Artery Obstruction; Renin; Time Factors

1969
[Clinical considerations and hemodynamic studies in some cases of dynamic hypertrophic stenosis of the left ventricle].
    Bollettino della Societa italiana di cardiologia, 1970, Volume: 15, Issue:6

    Topics: Adolescent; Adult; Angiotensin II; Blood Pressure; Butylamines; Cardiac Catheterization; Cardiomegaly; Electrocardiography; Epinephrine; Female; Heart; Heart Diseases; Heart Ventricles; Hemodynamics; Humans; Kinetocardiography; Male; Middle Aged; Nitrites; Norepinephrine; Phonocardiography; Radiography, Thoracic; Strophanthins; Sympatholytics

1970
Left ventricular function in chronic obstructive lung disease.
    The New England journal of medicine, 1971, Aug-12, Volume: 285, Issue:7

    Topics: Angiotensin II; Blood Pressure; Bronchitis; Carbon Dioxide; Cardiac Catheterization; Cardiac Output; Cardiomegaly; Cineangiography; Coronary Angiography; Heart Failure; Heart Function Tests; Heart Ventricles; Hemodynamics; Humans; Hypercapnia; Lung Diseases; Lung Diseases, Obstructive; Oxygen; Pulmonary Emphysema; Spirometry

1971
[The epidermolysis syndrome (Lyell) from the viewpoint of internal medicine].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1970, Apr-15, Volume: 25, Issue:8

    Topics: Acute Disease; Aged; Angiotensin II; Cardiomegaly; Cholangitis; Chronic Disease; Diabetes Complications; Glomerulonephritis; Humans; Liver Cirrhosis; Male; Methicillin; Middle Aged; Pancreatic Diseases; Potassium; Prednisolone; Prognosis; Stevens-Johnson Syndrome

1970
Cardiac hypertrophy in spontaneously hypertensive rats.
    Circulation research, 1974, Volume: 35, Issue:5

    Topics: Age Factors; Angiotensin II; Animals; Cardiomegaly; DNA; Heart Ventricles; Hydralazine; Hypertension; Methyldopa; Organ Size; Rats; Rats, Inbred Strains; Renin

1974
Characteristics of hypertension in the black population.
    Circulation, 1974, Volume: 50, Issue:5

    Topics: Adult; Angiotensin II; Animals; Black or African American; Cardiomegaly; Cerebrovascular Disorders; Chlorthalidone; Coronary Disease; Drug Therapy, Combination; Female; Guanethidine; Heart Ventricles; Humans; Hydralazine; Hypertension; Male; Methyldopa; Middle Aged; New York City; Rabbits; Radioimmunoassay; Renin; Sodium; Spironolactone

1974
The relation of plasma renin activity to left ventricular hypertrophy and retinopathy in patients with arterial hypertension.
    Acta medica Scandinavica, 1974, Volume: 196, Issue:4

    Topics: Adolescent; Adult; Aged; Angiotensin II; Cardiomegaly; Heart Ventricles; Humans; Hyperaldosteronism; Hypertension; Kidney Diseases; Middle Aged; Radioimmunoassay; Renin; Retinal Diseases; Sodium Chloride

1974
chemdatabank.com